Exploring the role of the CEO in innovation in life science R&D firms by Rosier, Jan
 
 
 
 
 
 
CRANFIELD UNIVERSITY 
 
 
 
 
 
 
Jan Rosier 
 
 
 
 
 
 
 
EXPLORING THE ROLE OF THE CEO IN INNOVATION  
IN LIFE SCIENCE R&D FIRMS 
 
 
 
 
 
 
 
SCHOOL OF MANAGEMENT 
 
 
 
 
 
 
 
PhD Thesis 
Academic Year 2013-2014 
 
 
 
 
 
 
 
 
 
 
CRANFIELD UNIVERSITY 
 
 
SCHOOL OF MANAGEMENT 
 
 
 
 
 
PhD Thesis 
Academic Year 2013-2014 
 
 
 
JAN ROSIER 
 
 
 
 
EXPLORING THE ROLE OF THE CEO IN INNOVATION  
IN LIFE SCIENCE R&D FIRMS 
 
 
 
 
 
 
 
 
 
 
Supervisor Keith Goffin 
 
 
October 2013 
 
 
 
© Cranfield University 2005. All rights reserved. No part of this publication may 
be reproduced without the written permission of the copyright owner 
ii 
 
 
  
iii 
 
 
 
 
 
 
 
 
ABSTRACT 
 
 
In order for firms to remain competitive CEOs acknowledge the importance of 
innovation. In life science R&D firms scientists are crucial for innovation because they 
hold knowledge to create competitive new products. They are also known to fall outside 
of full control of management. Therefore, understanding the role of the CEO in 
innovation in life science R&D is key to understanding innovation in these firms. 
In order to gain insight into the role of the CEO a comprehensive review of the literature 
was conducted. It showed that the role of the CEO was mainly explored by means of 
survey-based investigations. The knowledge thus obtained has not offered insight into 
what CEOs actually do to lead innovation in life science R&D firms, nor does it take into 
account how it is perceived by R&D. 
It was therefore decided to conduct structured interviews of 15 CEOs of life science R&D 
firms to obtain a better understanding of what they actually do to lead innovation. Their 
views were contrasted against the perceptions of 33 R&D managers who report to the 
CEOs. It was found that CEOs need to make considerable use of their absorptive capacity 
to lead innovation and that they use this capacity to focus R&D. The R&D function refers 
to the need for the CEO’s absorptive capacity but emphasizes a relationship with the 
CEO based on trust. 
The unique contribution of this research is that not only takes into account the view of 
the CEO but also of the R&D function. For academics, it opens new avenues for research 
in innovation using CEO absorptive capacity. For practitioners, it advises CEOs to make 
efforts to improve their absorptive capacity in order to be able to lead innovation in life 
science R&D firms. 
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1 Introduction  
1.1 The nature of the phenomenon and the reason for this 
research 
1.1.1 The role of the CEO: supervising projects you don’t understand 
The problem of the role of the CEO in innovation in life science R&D firms can best be 
illustrated by the following case (Loch et al., 2011): 
‘At one point during the development of a new drug, both the vice president for drug 
discovery and the vice president for drug development of a life science R&D firm were 
confronted with new trial data that hinted toward heart-damaging effects of the drug 
candidate. Both went to the CEO who had the supervisory role of the project seen its 
importance for the firm’s future. However, the complexity of the problem was such that 
the CEO asked his vice presidents to take the decision. Both decided to introduce the drug 
into the market but with damaging effects for the company. While the CEO decided to 
trust his scientific top management and hoped that they would be able to control the 
situation, he abdicated his responsibility’ 
As Loch et al. argue, what this CEO actually meant was not that he trusted his 
management but that he implied: ‘I do not understand any of this, so you make a 
decision’ (Loch et al., 2011)1. The question whether CEOs play a role in innovation in the 
research and development of drugs, vaccines or diagnostics therefore is a valid one. 
Although it is generally believed they play a role, it is not yet clear how this is achieved 
and – if such a role exists – how it is discharged.  
It could be argued that CEOs do not have to play a role as long as the R&D function 
operates along its objectives. They do not even have to understand the science behind 
R&D as well as they do not have to understand the specialized knowledge of supply chain 
management, IP, manufacturing or finance.  However, firms are under constant pressure 
to innovate products driven as they are by intensified competition (Goffin and Mitchell, 
2005). CEOs are therefore under constant pressure to find new ways to remain 
competitive. Abdicating their responsibility to the R&D function because of a lack of 
understanding is particularly risky as illustrated by the case above. Especially in new 
product development requiring high-tech approaches, this pressure translates into 
considerable budgets and high risks making the strategic choices of CEOs pivotal for a 
company’s long-term survival.  
When asked about their role in innovation CEOs generally offer a ‘recipe’ for innovation: 
articulate a vision, attract and keep the innovators, make funding available, set the 
boundaries and reward successful innovators (Berger et al., 2009).  Surveys have shown 
that CEOs consider innovation as key in their efforts to remain competitive and invest 
more in customer insights than in any other functional area thereby stressing the need 
to innovate to address customer needs (IBM, 2013). CEOs also recognize the increasing 
                                                          
1 This is reported in an INSEAD Faculty & Research Working Paper in which Loch et al. use an interview based investigation to 
describe how senior management handles projects that are difficult to understand. 
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complexity of life science R&D and feel that they are ‘ill-equipped’ to face the upcoming 
challenges. For example, life sciences CEOs anticipate much more complexity than they 
feel confident about handling and recognize that they lag behind their peers when it 
comes to simplifying products and processes to manage the complexity of life science 
R&D more effectively (IBM, 2010).  
These findings are corroborated by data reported in a survey conducted by McKinsey 
(Barsh et al., 2008). It shows that most senior executives do not actively foster 
innovative behavior and few of them explicitly lead and manage the innovation process 
in their companies. About one-third say they manage innovation on an ad-hoc basis 
while another third manage innovation as part of their leadership’s team agenda. Most 
executives however are disappointed in their ability to stimulate innovation and to 
create a culture of innovation.   
In other words, CEOs do not seem to be in a position to innovate, especially when they 
have difficulty in handling the complexities of life science R&D and understanding what 
their R&D function is reporting. If this is the case, how do the CEOs lead innovation in 
life science R&D? 
1.1.2 The role of the CEO in innovation as discussed in the scholarly literature 
There has been considerable debate in the scholarly management literature on the 
impact of CEOs on innovation. Some argue that the impact of CEOs on innovation is that 
they are simply not very relevant in driving innovation and that the locus of innovation 
lies in the middle of the firm, with middle—and senior R&D scientists and engineers 
(Burgelman et al., 2004; Christensen and Diehl, 1997). More importantly, this group of 
knowledge workers seems to be a particular difficult group to manage seen its 
autonomous character and particular social practice (Styhre, 2005; Gabriel, 1999). 
Today, the common view of the role of the CEO in innovation is that they have an effect 
on innovation at the project level through their support of individuals and team working 
(Yadav et al., 2007; Hegarty and Hoffman, 1990; Montoya-Weiss and Calantone, 1994).  
From the different innovation activities that can take place in an organization, this thesis 
focuses on innovations that are based upon the research of scientists and engineers and 
the development that lead to new products, i.e. on science-based product innovation 
(‘SBPI’2).  We do not distinguish between breakthrough and incremental innovation or 
between developed science-based innovation and developing science-based 
innovation. We argue that in the context of science-based product innovations, 
incremental vs breakthrough or developed vs developing science-based innovations 
does not matter. An example from the drug industry make this clear: whether new drugs 
are developed with a new therapeutic focus in mind or established drugs are 
reformulated using high tech drug delivery systems may not make much difference from 
a complexity point of view. In both cases, the breakthrough of a new therapeutic area 
or the ‘incremental’ innovation introduced in an established drug may be equally 
complex and full of risk and require similar leadership skills from the CEO.  We decided 
to explore the leadership role of the CEO in science-based product innovation as we 
                                                          
2 The abbreviation is proposed by Styhre (2009) 
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argue with Styhre (2005) that science-based innovation is a ‘particular social practice 
entangled with mutually dependent resources: for example, ideologies, machinery, 
conceptual schemes, laboratory practices, political skills, narrative capabilities 
integrated in a semi-unified process that enables knowledge to be continued’ which 
makes science-based organizations struggle with the integration of this ‘particular’ 
nature of innovation into business objectives.  
The role of CEOs in innovation in a science-based R&D environment may be 
fundamentally different from the role of CEOs in other functions in the firm.  In contrast 
with, for example, a supply chain unit, the R&D function can take initiatives that affect 
the direction of the entire company (Grove, 1996), making the CEO’s role in innovation 
doubtful.  In addition, scientists, especially those working in life science R&D 
environments, are educated to the highest academic level to act creatively and 
innovatively. Valuable knowledge and creative ideas are owned by middle level R&D 
scientists who are known as a particular difficult group to manage seen its autonomous 
and individualistic character and particular linguistic and social practices (Burgelman et 
al., 2004; Styhre, 2009).  R&D scientists are also seen as a self-monitoring and 
enterprising group of agents, who fall outside full management control (Florida, 2004) 
and who have fiercely criticized the use of management practices (Uitdehaag, 2008).  In 
other words, while the objective of finance, supply chain management and other 
functions in the firm is to align them with the strategy of the firm, the R&D function is 
capable to redirect the strategy because of its knowledge and creative capabilities. If on 
the one hand the R&D function represents powerful knowledge and ideas and does not 
require top management leadership, while on the other hand a CEO represents power 
and strategy wishing to impact on firm performance, how then does the most influential 
leader in the organization play a role in innovation?  
This thesis is an attempt to better understand the role of the CEO in innovation in the 
context of life science R&D firms.  
1.2 Literature 
The literature only offers scarce information about the role of the CEO in environments 
of intensive R&D and in life science R&D firms in particular. The majority of the research 
focuses on the role of the CEO in innovation from the viewpoint of either CEO 
characteristics or from his/her leadership behavior. In both cases, the role of the CEO in 
innovation is explored by trying to link either CEO age, tenure or leadership behavior to 
innovational output, in an attempt to establish a model that could predict the level of 
innovation.  This research was useful as it offered some insight into the effect of these 
parameters when compared with roles discharged by CEOs and when weighed against 
environmental variables such as non-for-profit or commercial organizations. This 
research concluded that - for example - CEO attitude towards innovation is a factor that 
impacts innovation. Besides attitude, other role behaviors such as involvement and 
commitment were studied but they were used in different industrial settings ranging 
from governmental organizations to banking to IT and it proved to be difficult – if not 
impossible – to identify CEO roles that impact innovation. More specifically, there is no 
data available how CEOs actually discharge their role in innovation in life science R&D 
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firms. This is hardly surprising as the methodology used until now to understand the role 
of the CEO in innovation may miss the point: trying to understand this role by looking 
for relationships between CEO age or leadership styles and innovation, as will be 
reported in chapter 2, does not shed light on what CEOs actually do.  So the question 
what CEOs do in innovation, when its complexity is such that they have difficulties 
understanding it, is a valid one. Answering this question will be difficult to do using the 
research approaches reported in the literature as will be discussed in chapter 2 and so 
an alternative more descriptive research – what is the CEO actually doing to solve this 
challenge? – is required. This thesis attempts to fill that gap in the literature.  
1.3 Research  
The research is divided in 4 phases: literature review, research design, research & 
findings and contribution to theory and practice.  
1.3.1 Literature review 
In order to obtain a good overview of and insight in the current knowledge on the role 
of the CEO in innovation, a literature review was initiated that consisted of a traditional 
review and a systematic review of the literature. During the traditional review of the 
literature, the leadership literature was explored to inquire what data is available on 
innovation while the innovation leadership literature was explored to inquire what data 
is available on leadership. This traditional ‘bifocal’ review of the literature was then 
supplemented with a systematic review of the literature. It was assumed that by 
combining a traditional review with a systematic review, a clear picture of the available 
knowledge on the role of the CEO in innovation would be obtained. Based on this review, 
gaps were identified in the literature that are addressed by new research that deepens 
our insight into the CEO’s role. 
1.3.2 Research design 
A research design is developed and a decision is taken how the research gap can be 
addressed. The question is asked whether the research is of a quantitative or qualitative 
and of a confirmatory or an exploratory nature and which methods are most suitable to 
investigate the phenomenon. A conceptual framework is identified that allows the 
findings to be structured along existing theoretical insights into the role of the CEOs. 
1.3.3 Research and findings 
The third phase consists of two steps. During a first step, CEOs of life science R&D firms 
are approached to inquire about their role of innovation. Doing so, the objective is to 
obtain insight into the actual role that CEOs play in innovation. During the second step, 
the R&D executives who report to the CEOs are invited to join the research project in an 
attempt to understand how R&D executives perceive their CEOs as drivers of innovation. 
This is particularly important seen the rather autonomous character of the R&D function 
in highly intensive R&D environments. The findings are collected, analyzed and 
discussed. 
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1.3.4 Contribution to theory and practice 
A conceptual framework is developed that links the findings together, allows a theory 
to be build and further research to be conducted. The findings are also viewed from the 
angle of the practitioner and a number of recommendations are proposed for CEOs of 
life science R&D firms. 
1.4 Objective  
The objective of the research is threefold. The first objective is to obtain a better insight 
in the actual roles discharged by CEOs in innovation in life science R&D firms by 
approaching CEOs directly and having them describe their roles. The second objective is 
to develop a conceptual framework that helps our thinking about the role of CEOs and 
opens new avenues for research. The third objective is to generate knowledge that can 
be used for management practice and to assist CEOs in their management of innovation. 
1.5 Expected contribution 
The expected contribution of this research is threefold. First and foremost, it is my 
objective to clearly describe what CEOs do to lead innovation in life science R&D firms.  
Second, an attempt will be made to develop a conceptual framework on the role of the 
CEO in life science R&D firms (contribution to theory). In addition, I will put forward 
recommendations that allow CEOs to improve their impact on innovation in life science 
R&D firms (contribution to practice).  
1.6 Structure of the thesis 
This thesis is structured along six major parts and Figure 1-1 presents a schematic 
overview. The research starts with a systematic and traditional review of the literature 
on the role of the CEO in innovation (Chapter 2).  
The research design is presented in Chapter 3. The review of the literature leads to 2 
research projects, the first one exploring the role in innovation of 15 CEOs of life science 
R&D firms (Chapter 4). It is followed by a research project in which 33 senior R&D 
executives, who report to the CEOs, are inquired about the role of their CEOs (Chapter 
5). The findings of both research projects are compared in Chapter 6. The thesis ends 
with a discussion and conclusion and presents the contribution to both theory and 
practice and a proposal for continued research in Chapter 7. 
1.7 Structure of the document 
This document is divided in three major parts that are linked to each other as described 
in the diagram below (Figure 1-2): the main text, the literature references and an 
Appendix. The Appendix contains data that are excluded from the main text to increase 
its readability. It contains 16 separate appendices covering for example: 
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Figure 1-1 The structure of the thesis 
i. a description of the procedures used for the literature review  (A) 
ii. a review of the outcome of the literature studies (B,C,D) 
iii. a description of the research approach for the qualitative studies (E, F, J, L) 
iv. interview observations of pilot CEO (n=2) and pilot R&D interviews (n=6) (E, L) 
v. interview observations of the final CEO (n=15) and R&D interviews (n=33) (H, I, 
K, P) 
vi. an overview of the interviewed CEOs and R&D executives (E, M) 
vii. operational data of the interviews (interview time etc.) (G, N) 
viii. the step-by-step categorization of R&D interview data (O) 
The literature references refer to papers mentioned in the main text and to papers 
mentioned in the appendices. 
 
 
 
Figure 1-2 The structure of the document 
1.8 Ontological and epistemological assumptions 
This research starts from the ontological assumption that the external world consists of 
representations created by individual minds. According to Blakie (Blakie, 2007) 
‘whatever is regarded as being real is only because we think it is real; it is simply an idea 
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that has taken on the impression of being real’. As social actors ‘socially construct their 
social reality’, the epistemological grounding from which knowledge can be gathered is 
social constructivism or the inter-subjectively shared knowledge in that meaning giving 
is social rather than individual. For social constructionists, the source of knowledge of 
ideas is the product of the inter-subjective meaning giving activity of human beings in 
their everyday lives (Blakie, 2007). 
1.9 Summary 
The objective of the research is to deepen the insight of the actual role of the CEO in 
innovation in life science R&D firms, to contribute to the theory on the role of the CEO 
in innovation and to develop recommendations for CEOs to perform better in highly 
intensive R&D settings.  
The core question that this research attempts to answer can therefore be summarized 
in the following general inquiry: 
‘How does a CEO discharge his/her role in innovation  
in the context of a life science R&D firm?’ 
 
The nature of the question implies that the first and main objective of this research will 
be to obtain insight in what the actual role is of the CEO and how this role can best be 
described.  The overall structure of the thesis that attempts to provide an answer to this 
inquiry is as follows. The thesis is divided in three main sections: the main text, the 
literature references and the appendices. The main text is divided in 7 chapters: an 
introduction in Chapter 1, the literature review in Chapter 2, the research design in 
Chapter 3, the findings in Chapter 4 and 5, a comparison of the findings in Chapter 6 and 
the discussion and conclusion in Chapter 7. The appendices contain data that presents 
supportive and detailed descriptions of the procedures, operational data, interview 
observations and other supplementary information.   
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2 Literature review  
2.1 Introduction  
In order to generate a comprehensive and accurate view of the role of the CEO in 
innovation3, it was found necessary to combine a number of approaches in conducting 
what was termed a bifocal review of the literature. During a traditional review of the 
literature, the leadership literature was explored to inquire what data is available on 
innovation while the innovation leadership literature was explored to inquire what data 
is available on leadership. The traditional review was then supplemented with a 
systematic review of the literature. It was assumed that by combining a traditional 
review with a systematic review, a clear picture of the available knowledge on the role 
of the CEO in innovation would be obtained. This approach is presented in Figure 2-1 
and the details of the procedure are explained in Appendix A. In addition to the 
traditional and systematic review of the literature, two additional literature reviews 
were conducted: one focusing on the context and leadership of R&D and another 
inquiring whether leadership theories, other than those currently used, can be of 
interest to explore the role of the CEO. The outcome of these reviews is structured as 
follows. First, the context of R&D is discussed in Section 2.2. and it is inquired whether 
research conducted in the context of R&D can help guide the research on the role of the 
CEO. Then, the results of the review of the literature on the role of the CEO are 
presented in Section 2.3. and it will be questioned whether there is an appropriate and 
promising theoretical perspective available to study the role of the CEO, a research gap 
worthwhile to explore and methodologies capable to do so. The conclusion and the 
research gap are presented in Section 2.4. The content of this chapter is summarized in 
Section 2.5. 
2.2 The R&D function 
Two scholarly works were helpful in laying the foundation of a better understanding of 
the context of R&D: Alvesson’s work on knowledge intensive firms (Alvesson, 2004) and 
Styhre’s on science-based innovation (Styhre, 2009).  The discussion that follows 
borrows heavily from the ideas and concepts presented by these authors. In addition, it 
was felt that an understanding of leadership roles and styles used by middle and senior 
managers in R&D would be valuable for a better understanding of the role of the CEO 
because an understanding how leadership is effectuated at a lower level in R&D could 
enrich the understanding of the role of the CEO and eventually directs the research.  
Therefore the literature on leadership in R&D at the level of R&D teams and team 
leaders was also explored. In this case, the approach consisted of a search for recent 
review papers from which current research data can be retrieved.  A review article by 
Elkins and Keller (2003) that addresses leadership in R&D was used.  
                                                          
3 When reference is made to the ‘role’ of the CEO in innovation it should be recognized that the concept of role behaviour is used 
as a way to describe the influence that CEOs may have in the innovational process. According to Sheard and Kakabadse (2007), 
who studied the role based perspective of leadership  in an industrial setting, top management members can be described by 
means of the ‘roles’ that they take on as part of the leadership that they discharge. This is further discussed in Chapter 3. 
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2.2.1 Science-based innovation 
Whilst scientific research for the sake of intellectual curiosity was once predominantly 
an academic activity and Nobel Prize winners were selected among university scholars, 
an important and clear change took place during the last decades of the 20th century. 
Industry - and more specifically biotech firms - took part in the advancement of 
 
 
 
Figure 2-1 A bifocal review of the literature 
 
 
science, an activity that was previously reserved for academic and not-for-profit 
institutions. This differs from the introduction of science into industry during the 19th 
century whereby scientific expertise and knowledge was used for the exploration of new 
commercial opportunities4. In contrast, during the 20th century, scientists at Chiron who 
invented the polymerase chain reaction5 and Sir James Black6 of Glaxo-Wellcome were 
awarded the Nobel Prize in medicine for extending our basic knowledge of biochemical 
phenomena (Pisano, 2006). These events were a sign of the time:  science, as an activity 
that leads to knowledge (‘truth’) and to a better understanding of biological 
phenomena, was no longer the exclusive province of not-for-profit institutions; it was 
                                                          
4 An example on how science led to commercial opportunities is presented in Jenny Uglow’s book ”The Lunar Men, 
The friends who made the future”, Faber and Faber, 2003, London 
5 Polymerase Chain Reaction or PCR is one of the most important techniques used today in genetic research 
6 Sir James Black spent his career both as an industrial researcher and an academic. Black established the physiology 
department at the University of Glasgow and then went to work for ICI Pharmaceuticals in 1958 . He won the Nobel 
Prize for his scientific discoveries at ICI Pharmaceuticals in 1988. 
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now manifesting itself in the industry. Drug companies not only used new technologies 
to discover new drugs but also engaged in fundamental research to discover new targets 
and to develop techniques that broadened scientific knowledge. Whereas previously 
companies were recipients of new technologies, little by little they became developers 
of science and know-how.  The sharp line that once differentiated academic and non-
for-profit R&D institutions from commercial R&D corporations gradually disappeared 
(Pisano, 2006). 
Firms that rely on their intellectual capital and capabilities as their central resource are 
known as knowledge intensive firms (or ‘KIFs’). Alvesson defines KIFs as ‘firms where 
work is said to be of an intellectual nature and where well-educated, qualified 
employees form the major part of the workforce’ and ‘typical examples of such 
companies are law and accounting firms, management, engineering and computer 
consultancy companies, advertising companies, R&D units and high tech companies’ 
(Alvesson, 2004).  Corporations who use a scientific-technological knowledge base are 
specific cases of KIFs and although some principles used to study KIFs may well apply to 
them, the nature of scientific practice precludes extending the statements made about 
KIFs into the world of science-based innovating firms (SBIF’s). Oliver and Montgomery 
refer to these SBIF’s as hybrid forms of corporations where ‘advanced knowledge is 
generated by scientific professionals’ and ‘used in the creation of new products, such as 
in the biotechnology or computer industries’ (Oliver and Montgomery, 2000).  There is 
a difference between a set of specific skills and expertise on the one hand and a highly 
professional domain regulated and monitored by a series of institutions and 
stakeholders on the other hand (Styhre, 2009).  An important characteristic of these 
firms is that ‘they treat knowledge as a tool or instrumental resource aimed at providing 
some utility or serving some function’ and that they are ‘increasingly dependent upon 
their ability to develop, exploit and share particular knowledge bases’. However, there 
is a difference between knowledge as a general term and scientific competence since 
science operates along its own idiosyncratic and paradigmatic routes, guided by 
institutions and practices, so that one must not think that a KIF and a science-based 
corporation are synonyms (Styhre, 2009). 
More specifically ‘science-based product innovation is a social practice that is anchored 
in routines and institutions that are located outside of the particular firm while know-
how in general may be local and situational, science-based innovation work is always 
already established qua legitimate social practice prior to its organizational inclusions’ 
and ‘science-based product innovation is a social practice with its own idiosyncratic and 
paradigmatic routines and operating within a field of expertise that is highly regulated, 
uses its own cultural and social interactions and procedures’ (Styhre, 2009).  In this 
regard, science-based innovation must be regarded as a field of scientific practice 
characterized ‘by alliances, negotiations, political struggles, controversy, passions and 
desires, short-term gains and long-term strategies, quarrels over credibility and 
resources’ and therefore, ‘the influence of leadership in high performing scientific 
teams’ should not be downgraded (Styhre, 2009). (In the present thesis, the term “R&D 
innovation” is considered synonymous with “science-based product innovation”. The 
term “R&D function” is used to describe a group of scientists and engineers in middle- 
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and senior- R&D management engaged in and responsible for day-to-day scientific work 
in laboratories and workshops, as team members or as team leaders whose focus is to 
invent and develop products). 
The sociology of science offers interesting insights into the professional conduct of 
scientists. Sociological studies of the activity of science are made by Merton (1973), 
Lenoir (1997) and Jasanoff (2005) (cited by Styhre, 2009). Latour and Woolgar (1979) 
posited that scientists work for peer recognition which eventually lead to career 
perspectives.  This cycle of peer recognition that leads to increased research funding, 
which in turn translates into career perspectives, is called the credibility cycle of the 
scientific community. Some earlier sociologists of science, such as Bourdieu (1983) 
called this competition among scientists ‘symbolic capital’ or ‘gift-exchanging’.  
Scientists make information available for free in return for ‘gifts’ such as recognition, 
prices or funding.  Besides the symbolic capital built up by scientists as part of (peer) 
recognition and the potential for increased research funding associated with it, the 
extensive networking within the field of their expertise has been called social capital 
(Bourdieu, 1983)7. These scientific networks have been called ‘invisible collages’ (Crane, 
1970) or ‘communities of practice’ (Wegner, 1998) and are used to exchange tacit 
knowledge, to nurture new knowledge, to further develop social capital and to stimulate 
innovation. There are different incentives for engaging in these networks: access to 
expertise, fertilisation across disciplines, better access to funds, obtaining prestige or 
visibility, acquisition of tacit knowledge about a technique, pooling knowledge for 
tackling large and complex problems, enhancement of productivity, student education, 
increased scientific specialisation and finally, fun and pleasure. May, Korzcynski and 
Frenkel (2002) observed that knowledge workers were committed to their corporations 
but even more so to their scientific communities beyond the boundaries of their firms; 
R&D scientists are therefore more likely to identify themselves with their peers in their 
respective scientific disciplines then with their own companies and their management. 
2.2.2 Locus of innovation 
Emphasizing the R&D function has been empirically linked with a competitive strategy 
of innovation (Martell et al., 1996). According to Styhre ‘the crux with science-based 
innovation is that even though it may be organized and managed like any other 
organizational procedure or process, it still demands that some of the co-workers be 
willing to fully commit themselves to the project. Scientific breakthroughs are not a 
matter of administrative competence but of skilful scientific expertise, hard work, 
systematic routines and to some extent luck’. In addition, ‘owing to the complexity of 
the work, senior managers frequently do not understand what actually goes on in the 
workplace and cannot rely on simple indirect, quantitative performance indicators to 
manage the process’ (Styhre, 2009). ‘Leadership in these firms differs from that in other 
organizations as the co-workers are professionals capable of executing their tasks on 
their own, making effective leadership potentially doubtful’ (Alvesson, 2004). Especially 
for highly complex technologies encountered in drug research and development, R&D 
                                                          
7 To the scientist, excellence is measured in terms of primacy. Researchers that are first to make a significant scientific discovery 
receive important rewards such as research grants, endowed chairs or fame (Mudambi and Swift, 2011) 
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personnel ‘did not feel their managers were capable of seeing the full implications of 
the new tools and techniques’ (Styhre, 2009). Often ‘the majority of employees are 
capable of acting autonomously, and single individuals can sometimes take initiatives 
that affect the direction of the entire company’ (Grove, 1996). A knowledge worker in 
science-based innovation therefore ‘is a self-monitoring and enterprising agent, 
basically outside of the full control of management’ (Florida, 2004). In line with this 
observation, Burgelman et al. observed that the locus of innovation lies in the middle of 
the firm, the levels that are comprised of middle- and senior-R&D scientists and 
engineers (Burgelman et al., 2004; Christensen and Diehl, 1997). In other words, if the 
locus of innovation is in middle-management, the question about the role of the CEO in 
innovation is a valid one, seen the hierarchical distance between the two actors8. 
 
One of the premises of this thesis is that the world of science – the micro-world of the 
science-based product innovators, scientists and engineers – is different from the world 
of business, the micro-world of the manager and the CEO and his/her top management 
team (TMT). This observation is addressed by Styhre (2009) in the context of high-tech 
spin-off companies as follows: ‘The alliance of venture capitalists and researchers is a 
curious one in which venture capitalists initially did not really know how to evaluate 
scientific contributions such as journal publishing and conference presentations’. It 
illustrates a strange relationship between two actors who play in different theatres. 
Pisano comments on these very different worlds as follows: ‘science-based businesses 
are challenged by rules, organizational technologies, and management practices’ and 
‘science-based business entails unique challenges, that require different kinds of 
organizational and institutional arrangements and different approaches to 
management. Posed simply, what works well in other settings may not work as well in a 
science-based setting’ (Pisano, 2006). In other words, if the world of science and 
technology is governed by its specific practice, conceptual frameworks, knowledge base, 
narratives, storytelling and writing (Alvesson, 2004), there is reason to believe that the 
top manager, as a generalist, has a limited role to play in the endeavors of this world.  
Consequently, the need of the R&D group for leadership by the CEO and its top 
management is posited to be minimal (Styhre, 2009). 
2.2.3 Management and upward influence 
The cultures of management and research do not mix very well and scientists have 
written vigorously against the use of management practices such as management 
control, implementation of control measures, rigorous execution and regular, consistent 
output (Uitdehaag, 2008, Bernal, 2007). R&D managers and CEOs belong to different 
‘professional guilds’, subscribing to different belief systems and valuing different types 
of incentives (Mudambi and Swift, 2009). To management, excellence is measured in 
terms of market performance (Dasgupta and David, 1994; Gittelman and Kogut, 2003) 
while for the scientist, the knowledge creation process has intrinsic value (Duncan and 
James, 1974).  Mudambi and Swift argue that the divergent interests of R&D scientists 
and firm management helps to understand why scientists can thwart management’s 
                                                          
8 In the life science industry, progress in R&D is difficult to observe, and managers are often unable to compel R&D project 
managers to truly disclose the prospects for long-run projects. Management rarely has currently available data that can be used to 
evaluate or refute project managers claims (Mudambi and Swift, 2011) 
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efforts to evaluate accurately R&D projects with scientific merit but little commercial 
value (Mudambi and Swift, 2011). In addition, seen the complexity of life science R&D, 
CEOs face an increasing difficulty to understand the science that governs the R&D in 
their firms and risk abdicating their responsibility (Loch et al., 2011). In contrast with 
accepted management practice, the R&D function consists of unforeseen outcome, luck, 
diverse ways of achieving targets and reward systems that do not fall into line with the 
reward systems of the rest of the firm’s community. That does not mean that R&D 
scientists do not look for leadership in the classical sense but for a leadership that is 
capable of leading ‘clever people’9 by offering them the environment and resources 
necessary for experimentation without submitting them to rigorous procedural 
execution schemes and protocols and by allowing them to lead themselves (Uitdehaag, 
2008; Goffee and Jones, 2007).  Uitdehaag presents an analogy between ‘warriors’10 on 
the one hand, who, benefiting from sufficient training and using appropriate operational 
equipment, are capable of entering the battlefield where they make their own decisions 
and take up their own leadership, and scientists on the other hand, who consider that 
they lead themselves, encouraged by the fact that their knowledge cannot be grasped 
by top management, which is therefore unable to exercise control.  The question 
however remains in how far R&D, seen the potential gap in knowledge between CEO 
and R&D, is capable to exercise upward influence because ‘innovation is largely a 
process of influence’ (Howell and Higgins, 1990) and to introduce the view of R&D into 
the strategy formulation of a firm. Lee and Bohlen (1997) define influence as ‘the 
process by which people persuade others to follow their advice, accept their suggestions 
and comply with their orders’. Upward influence is defined as ‘attempts to influence 
someone higher in the formal hierarchy of authority in the organization’ (Porter et al, 
1981). Championing is one form of upward influence that is intended to secure project 
support and project promotion (Floyd and Wooldridge, 1997) and successful project 
championing can lead to input into corporate strategy.  Shim and Lee observed that R&D 
project leaders use different upward influence tactics but no data is available on the 
process and impact of upward influence from R&D to the CEO (Shim and Lee, 2001).   
2.2.4 Roles and leadership 
It is not desired to confine this study of the role of the CEO to ‘the CEO’s office’ but 
rather to put him/her into the broader context of the firm and its R&D. It is argued that 
an understanding of leadership behavior and roles played by middle and senior R&D 
leaders is helpful in reaching an understanding of the role of the CEO because this role 
may be subject to an upward influence by R&D personnel (Shim and Lee, 2001). Also, an 
understanding of how leadership is discharged at a lower level in R&D, and how it is 
researched could enrich our understanding of the leadership of the CEO.  
The management of scientists and engineers has long been a topic of interest in the 
management literature, Drucker having introduced the subject in 1985 (Drucker, 1985 
cited by Styhre, 2009).  There is also considerable literature on how to manage experts 
(Reed, 2007; Blackler, 1995; Mueller and Dyerson, 1999) but it offers little information 
                                                          
9 The term “clever people” to denote R&D scientists is used by Uitdehaag, 2008 
10 The term “warrior” to denote R&D scientists is used by Uitdehaag, 2008 
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on what these experts do and how managers can gain insights into their activities 
(Styhre, 2009). The latter problem was addressed by the innovation literature in which 
management researchers specifically investigated leadership in the context of R&D in 
an effort to identify components of leadership that impact positively upon innovation.  
West et al. (2003) observed that leadership, i.e. the presence of an identifiable leader,  
is necessary for innovation to proceed. In the following sections, the roles played and 
leadership styles used by R&D team leaders are discussed.  
2.2.4.1 Roles played by R&D team leaders 
The innovation literature has approached the problem of leadership in a R&D context 
by addressing the roles that R&D team leaders discharge. The results can be summarized 
as follows: 
 
i. When team leaders act as (product) champions and deliberately cross the 
boundaries of their teams, thereby interacting with the larger community in 
which their teams operate, they are more successful in keeping their projects on 
top management’s list of priorities (Markham et al., 1991).  
 
ii. When team leaders adopt a transformational leadership style and combine this 
with a championing activity, their projects are more successful, especially if they 
were able to obtain support from top management (Waldman and Atwater, 
1992).  
 
iii. When project leaders are technically less skilled, higher performance was 
associated with granting team members the freedom to explore new avenues 
for research in innovation (Andrews and Farris, 1967). When team leaders are 
technically highly skilled individuals, high innovation performance was 
associated with critical assessment of the work of subordinates. In highly 
innovative teams, supervisors were not regarded as the source of new innovative 
ideas during the stage of exploration and idea generation. However, during the 
later phases, when projects reached a more advanced stage of development, 
supervisors were considered important because of their critical evaluation and 
technical/administrative support (Farris, 1972).   
 
iv. When a team leader creates a climate for innovation, a number of antecedents 
favoring innovation can be identified:  vision, participative safety, a climate 
promoting excellence, operational autonomy/freedom, good project 
management, encouragement, organizational resources, recognition time, 
challenge and pressure (Elkins and Keller, 2003). The managerial practices 
considered necessary for an organizational culture to drive innovation include 
the creation of a sense of community by giving subordinates operational 
autonomy, personalized recognition, a continuity of slack resources and by 
ensuring group cohesiveness.  
 
v. In a study in the pharmaceutical industry, Cardinal found a close relationship 
between the diversity of specialists in the R&D programs, contacts with outside 
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experts on the one hand, and both radical and incremental drug development 
innovations on the other (Cardinal, 2001). 
In summary, the roles played by R&D team leaders refer to technical skills and product 
championing behavior as well as the capability to efficiently manage projects and set a 
climate for innovation such as participative safety, operational freedom and 
organizational resources.  
2.2.4.2 Leadership styles used by R&D team leaders 
Leadership researchers have explored transformational, path-goal and leader-member 
exchange (LMX) theory in a R&D context.  
Transformational theory  
Transformational theory was first articulated by Burns (1978) and later developed by 
Bass and Avolio (1994) into a leadership theory for organizations. Transformational 
leadership theory states that transformational leaders create personal and professional 
commitment from subordinates and increase their self-esteem and self-actualization 
(Bass and Avolio, 1994). It is now part of what Avolio et al. have defined as ‘new genre 
leadership theory’ (Avolio et al., 2009).  This leadership style can be seen as an expansion 
or extension of transactional behavior which is characterised by the ‘skill and ability 
required to handle the more mundane, operational, day-to-day transactions of daily life’ 
(Kakabadse and Kakabadse, 1999). A transformational leader is capable of influencing 
followers by creating a connection between their self-concept and the mission of the 
organization or group and by modifying their values and self-esteem in such a way that 
these are aligned with the mission of the organization (Kark et al., 2003; Felfe and Goihl, 
2002).  Bass (Bass et al., 2003; Bass and Avolio, 1997) developed a model that allows 
conceptualization of the transformational leadership style by means of four dimensions: 
idealized influence, intellectual stimulation, individualised consideration, and 
inspirational motivation. 
i. Idealised influence is based on the ability of a leader to evoke admiration, 
respect and trust in the followers, 
ii. Intellectual stimulation refers to the ability of a leader to arouse within followers 
an awareness of problems and a recognition of their own beliefs and values (Bass 
and Avolio, 1994), 
iii. Individualised consideration means that a leader gives personal attention to 
individuals, taking into account their differences (Felfe and Goihl, 2002; Bass, 
1990; Felfe et al., 2004), 
iv. Finally, inspirational motivation refer to the ability of a leader to create an 
inspiring vision of the future (Bass and Avolio, 1994).  
Although transformational theory offers an interesting theoretical perspective for the 
study of leadership in innovation, and research has shown that transformational 
behavior improves leadership effectiveness (Bass and Avolio, 1997), not many studies 
have shown a consistent effect of this leadership style on innovation (Reuvers et al., 
2008) although some showed an impact on employee creativity and innovation (Oldham 
and Cummings, 1996; Amabile et al., 1996; Zhou, 1998). The effectiveness of 
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transformational leadership in innovation was moderated by the level in the 
organization at which leadership was deployed and on the type of project (Keller, 1992). 
For example, transformational leadership style was positively related to project quality 
and budget/schedule performance. This relation seemed to be stronger for research 
projects than for development projects.  Transactional leadership style on the other 
hand, was more important for development projects than for research projects. 
Intellectual stimulation, individualised consideration and charisma of senior R&D 
managers (but not team leaders) also play an important role in project success 
(Waldman and Atwater, 1992). According to Waldman and Bass (Waldman and Bass, 
1991), transformational leadership is important in the early research stages when team 
leaders play a major role. During later phases of innovation, project success is supported 
by a charismatic leadership style displayed by higher-level members in the R&D 
organization. Project effectiveness therefore is linked to transformational leadership on 
the part of project leaders in the research phase and higher-level leaders in the 
development phase. However, only two studies have evidenced a link between 
transformational leadership and innovation (Janssen, 2002; Wilson-Evered et al., 2001) 
whilst other studies failed to support that hypothesis (Kahai et al., 2003; Jaskyte, 2004). 
Moreover, some findings point in the direction of a link between innovativeness and 
systematic management control, a behavior that is associated with transactional 
leadership behavior (Turner and Makhija, 2006; Gilson et al., 2005). In other words, 
empirical support for a strong, overall and general relationship between trans-
formational leadership style and innovation is not available.  
Path-goal theory 
A second theoretical framework used to understand leadership in R&D context is path-
goal theory. According to path-goal theory, an effective leader uses behaviors that 
facilitate goal attainment and maximise the value of this achievement, ‘thereby affecting 
subordinates’ expectancies, performance and satisfaction’ (House, 1971; House, 1996). 
The theory suggests that leaders engage in different leadership styles warranted by the 
nature and demands of a given situation. These leadership styles may shift from 
directive to achievement-oriented to participative to supportive. Path-goal theory posits 
that a leader may use different styles according to the situation. The leadership styles 
have the following characteristics: 
i. A directive path-goal leader is a leader who clarifies the goal that needs to be 
attained and the path that is best suited to achieve the goal.  
ii. The achievement-orientation style refers to behaviors through which leaders set 
challenging goals, expect their subordinates to perform at the limit of their 
potential and show confidence in their capabilities.  
iii. A participative leader involves his/her subordinates in the decision-making 
process and consults with them for suggestions in making these decisions.  
iv. A supportive leader assures satisfaction of subordinates’ needs and preferences 
and is concerned with their psychological well-being.  
The leader-behavior relationship is moderated by environmental (task structure, 
authority system, work group) and follower characteristics (experience, locus of control, 
 
 
Chapter 2 Literature review 
17 
 
ability). Effective leaders clarify the path to assist subordinates to achieve their goals, 
remove obstacles that hinder the achievement of goals and adapt their leadership style 
to environmental and subordinates’ characteristics. However, path-goal theory has not 
enabled the study of the relationship between leadership and innovation to take a step 
forward. Path-goal theory assumes a close relationship between leader and follower and 
therefore its usefulness in exploring the role of the CEO who is separated several 
hierarchical levels from R&D middle-management is dubious. The theory therefore is 
posited to offer a poor starting point to study the role of the CEO in innovation.  
LMX theory 
A third approach is Leader-Member Exchange theory or ‘LMX’ and was introduced by 
Graen and Ulh-Bien (1991). It focuses on the social exchange in the relationship between 
supervisor and subordinate. The theory divides the social exchange process into three 
stages: 
i. initial testing and evaluations of motives, attitudes and role expectations, 
ii. development of trust, loyalty and respect, and 
iii. development of mutual commitment to organizational units/goals (Graen and 
Uhl-Bien, 1991; House and Aditya, 1997).  
According to LMX, it is the quality of the social exchange process between leader and 
follower that influences organizational outcomes (Graen and Uhl-Bien, 1995). The 
impact of the social exchange process on innovative behaviors and on subordinates’ 
motivation and commitment was investigated by Yukl (2002). Several studies have made 
an attempt to elucidate the impact of factors in the social exchange processes on 
creativity and innovation (Amabile and Conti, 1999; Mumford and Gustafson, 1988), 
such as providing subordinates with challenging tasks (Liden and Graen, 1980), leader 
support in high-risk undertakings (Graen and Uhl-Bien, 1995), leaders who secure task-
related resources (Graen and Scandura, 1987), recognition (Graen and Cashman, 1975) 
and supervisory advocacy (Duchon et al., 1986).  Consistent with the above-noted 
prediction, it was found that a high-quality social exchange impacts positively on 
innovation and creativity. Scott and Bruce for example, observed that in a large R&D 
facility, a high quality exchange was related to innovative behavior and the perception 
of an organizational climate that supports innovation (Scott and Bruce, 1994). LMX 
theory offers a poor departure to study the role of the CEO because it assumes a close 
relationship between leader and follower which is assumed to be minimal between CEO 
and R&D seen the distant hierarchical levels. 
2.2.5 Summary and conclusion 
An overview of the theoretical perspectives used in the research of leadership R&D and 
their usefulness for CEO research in innovation is presented in Table 2-1. The main 
objection to using these leadership theories to study the role of the CEO in innovation is 
that they do not take into account the autonomous character of the R&D function, the 
individualistic character of scientists and its resistance to management leadership 
practices such as control and oversight. On the contrary, they are based upon a 
relationship between the leader and the follower in which the follower is willing to 
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accept – or undergo - managerial leadership behavior. In other words, the role of the 
CEO should be viewed against the perspective of the R&D function about that role.  
2.3 The CEO 
This section presents the results of both the traditional and systematic review of the 
literature and discusses the role of the CEO through the lens of upper echelon and 
leadership theory in Section 2.3.1. and 2.3.2. respectively. Section 2.3.3. compares the 
impact of CEO leadership with the impact of context on innovation. Section 2.3.4. 
explores CEO role behaviors and Section 2.3.5. concludes the findings.  
 
2.3.1 Upper echelon theory 
Some argue that organizational performance is not driven by leadership effects (Hall, 
1977) and posit that organizational and environmental factors have more impact on firm 
outcomes (Kimberley, 1986): CEOs are subject to environmental constraints (Aldrich, 
1979) and corporate performance owes little to CEO contributions (Galbraith, 1984). 
Studies that examine the impact of CEOs on innovation tend to focus on small-sized 
firms (Julian, 2005; Lefebvre and Lefebvre, 1992) as in small firms the influence of CEOs 
on the strategy and performance is higher and potentially more observable (Miller and 
Toulouse, 1986b). Recent research suggests that the impact of CEOs on innovation 
adoption and innovation may be significant in large organizations also (Damanpour and 
Schneider, 2006; Jung et al., 2008). Top managers are largely responsible for the cultural 
values that support innovation in their firms (Elenkov et al., 2005; Bantel and Jackson, 
1989) and their personal characteristics, functional expertise, general management 
experience, and attitude towards change may influence the innovational climate (Ekvall 
and Ryhammar, 1999; Hoffman and Hegarty, 1993; West and Anderson, 1996). 
Hambrick and Mason (Hambrick and Mason, 1984)  in response to the arguments that 
CEOs ‘do not matter’ and in an attempt to explore their role, put forward the upper-
echelons perspective in which personal experiences, values and beliefs of managers 
influence their interpretations of situations and affect their decisions and choices.  
 
Research conducted under the upper-echelons perspective uses demographic variables 
(e.g. age) and CEO characteristics (e.g. experience) instead of actual leadership 
behaviors (Cannella and Monroe, 1997) to assess the impact of CEO characteristics 
(demographic or personality) on strategy (Miller and Toulouse, 1986b), organizational 
culture (Deal & Kennedy, 1982), corporate norms (Tichy and Ulrich, 1975) and more 
generally providing effective leadership (Schein, 1985). It disclosed the effect of 
demographics on the adoption of innovation in firms (West et al., 2003; Scott and Bruce, 
1994; Howell and Higgins, 1990; Bantel and Jackson, 1989) and led to a wide variety of 
studies linking CEO demographics and characteristics with measures of innovation. 
Appendix B offers a detailed - granular - overview of upper echelon research and 
innovation. 
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Author Sample Dependent variables Findings &  
comments 
Usefulness 
for CEO 
research 
Transformational theory 
Keller (1992) Sample 1: 462 professional 
employees from 66 project 
groups from 3 industrial 
R&D organizations; Sample 
2: 440 professional 
employees from 61 project 
groups from three 
industrial R&D 
organizations 
Project group 
performance 
(ratings of project 
quality and 
budget/schedule 
performance by 
project members 
and managers) 
Transformational leadership of 
project leader is positively related 
to project quality and 
budget/schedule performance. The 
relationship between 
transformational leadership and 
project quality is stronger for 
research projects than for 
development projects.   
Yes 
Waldman and 
Atwater (1992) 
Interviews: 40 project 
members, leaders and 
higher-level managers in 
R&D units of two 
organizations; Surveys: 147 
project members, leaders 
and higher-level managers 
in R&D units 
R&D project 
effectiveness 
(ratings by higher-
level managers) 
Transformational leadership an 
championing behavior is positively 
related to project effectiveness 
Path-goal theory 
Keller (1989) 477 professional employees 
from four R&D 
organizations 
Job satisfaction and 
employee 
performance 
Need for clarity moderated the 
relationship between initiating 
structure and job satisfaction and 
between initiating structure and 
performance  
No 
LMX theory 
Scott and Bruce 
(1994) 
172 engineers, scientists, 
and technicians and 26 
managers at an R&D facility 
of a US industrial 
corporation 
Innovative behavior 
(ratings by 
managers) and 
climate for 
innovation (ratings 
of subordinates) 
Positive relationship between high 
quality LMX and innovative 
behavior and also climate for 
innovation. Positive relationship 
between supervisor’s expectations 
and innovative behavior of 
technicians 
 
No 
Scott and Bruce 
(1998) 
Sample 1: 110 R&D 
engineers and R&D 
scientists and 22 managers 
of a US industrial 
corporation; Sample 2: 149 
R&D engineers and 26 
managers at an electronic 
equipment manufacturing 
company 
Innovative behavior 
(ratings by 
managers) 
Positive relationship between high-
quality LMX and innovative 
behavior 
Tierney et al. 
(1999) 
191 research managers, 
research scientists, section 
leaders, project leaders, 
work group professionals, 
and work group technicians 
in the R&D sector of a 
chemical corporation 
Creativity as 
measured by ratings 
by managers, 
invention disclosure 
forms and number 
of research reports 
Positive relationship between high-
quality LMX and creativity for 
adaptors 
 
Table 2-1 Empirical investigations of leadership in R&D 
 
2.3.2 Leadership theories 
2.3.2.1 Transformational leadership theory 
In the previous section, the impact on innovation of CEO characteristics (demographics, 
tenure etc.) was discussed as part of the upper echelon perspective. These individual 
characteristics may impact the relationship between a CEO and his/her subordinates, 
but CEOs with similar demographics can manifest their leadership styles and behaviors 
in different ways. This section addresses the impact of CEO leadership styles on 
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innovation. In the section on R&D (2.2) it was shown that R&D team leaders who exhibit 
transformational behavior may impact innovation. Until now transformational 
leadership styles have been studied mostly at the level of employees or organizational 
subunits.  However, Jung et al. (2008) showed that there is a positive relationship 
between the transformational leadership style of the CEO and organizational 
innovation. However, the existence of such a relationship does not necessarily imply 
causality. The empirical data that show or point to an impact of a given leadership style 
of the CEO on firm innovation are limited. Although data suggest an impact of a 
transformational CEO on innovation, there is no understanding how this impacts 
innovation in middle management R&D, considered the locus of innovation (Burgelman 
et al, 2004). This  assumes the CEO’s impact on the top management team and from 
there to percolate through the organization, making the transformational leadership 
style by the CEO ‘felt’ in the more distant (lower) layers of the organization. However, 
no research data support this proposition. There is also no research data that show 
impact of the R&D function on the leadership style of a CEO.  
The step from project level - where the transformational leadership style was found to 
have potential impact impact on innovation - to firm level is substantial and it is 
questionable whether the tentative conclusions reached at the team level apply at firm 
level. Ling et al. (Ling et al. 2008) argue that the mechanisms underlying the trans-
formational impact of the CEO on innovational output remain largely unexplored, and 
given that the individuals most closely influenced by a firm’s CEO are its top 
management team (TMT) members, they focused on the CEO-TMT interface. Although 
Jung et al. (2008) alluded to the possible impact of transformational leadership of the 
CEO on innovation, the mechanism of this impact is still not understood and it is needed 
to delve more deeply into the organization. In line with this reasoning, Ling et al. posited 
that transformational CEOs influence TMTs’ behavioral integration, risk propensity and 
decentralization of  responsibilities.  In addition, a TMT’s shared preference for risky 
growth opportunities is likely to be encouraged by transformational CEOs and such 
leaders possess both a vision and a measured degree of optimism about change, and 
they tend to communicate inspirational messages that both challenge TMT members to 
think ‘outside of the box’ and instill in them the confidence that obstacles can be 
overcome (Bass, 1985). Ling et al. argue that when a transformational CEO stimulates 
TMT members’ efforts to be innovative and creative by questioning the team’s 
assumptions, reframing problems and facilitating consideration of new ways to 
approach existing situations, the leader helps to alleviate some of the concerns they 
have about such undertakings (Amabile, 1998), thereby increasing the TMT’s propensity 
to take risks. In their analysis of 152 firms in which CEOs had held their positions for 14 
years on average, CEO transformational leadership was positively associated with risk 
propensity.  
2.3.2.2 Alternative leadership theories 
Besides transformational theory, other theoretical approaches may be useful to study 
the CEO in innovation. It was already argued in Section 2.2. that path-goal and LMX 
theory would not be ideal candidates as theoretical frameworks, but other theories may 
be. An analysis of alternative leadership theories is included in Appendix C. The 
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conclusion drawn from this analysis is that the majority of the leadership theories were 
not developed to study a key individual such as the CEO in the context of innovation and 
it would be difficult if not impossible to use these frameworks to explore his/her role. 
However, some theories do offer interesting avenues to explore the role of the CEO 
because they study leadership from a viewpoint of roles such as Sheard and Kakabadse’s 
role-based leadership theory or because they put the CEO in the middle of their focus 
such as Arendt et al.’s CEO-adviser model (Sheard and Kakabadse, 2007; Arendt et al., 
2005). The latter model states that the CEO is not the ultimate and isolated strategy 
formulator nor an ‘over-socialized’ decision maker but rather a strategy formulator who 
acts in the center of a network of advisers at different levels in- and outside of the firm. 
Because of this interesting perspective for our research, Arendt et al.’s model will be 
described in more detail in Chapter 3. 
 
2.3.3 The impact of context 
In the exploration of the impact of demographics on innovation, it was observed that 
context plays an important role. For example, it was only when firm context was taken 
into account, that CEO age and tenure became factors of influence and potential 
predictors of innovation (DeTienne and Koberg, 2002). For scholars of the 
environmental determinism school, the role of top managers is limited to ‘an effort to 
combine techno-economic factors which, if it is successful, enables the organization, 
considered as an open system, to equilibrate or match its internal resources with the 
requirements of the external environment, thereby assuring the survival of the 
organization’ (Papadakis and Bourantas, 1998). On the other hand, strategic-choice 
theorists emphasize the role of the strategic-decision makers and argue that the 
decision-making process is influenced by demography and personality traits. The 
strategic-choice perspective however does not make the impact of organizational 
and/or environmental characteristics obsolete. The question, therefore, is not 
necessarily whether top managers matter, but ‘how much they matter in a specific 
context’ (Gupta and Govindarajan, 1984). In other words, there is reason to believe that 
both CEO characteristics (personality and demographics) and contextual variables 
(organizational and environmental) play a role in innovation. Consequently, the main 
issue, as far as the impact of CEO characteristics on innovation is concerned, is how this 
impact compares with the impact of organizational and environmental factors.  Hage 
and Dewar (1973) suggest that among organizational, environmental and leader factors, 
the leadership factor was an important predictor of innovation in an organization. 
Lefebvre and Lefebvre (1992) observed that the entrepreneurial mindset of CEOs, their 
attitude towards risk, their locus of control and their engineering/production experience 
and the nature of their decision-making process explain the largest component of the 
variance in firm innovativeness, whilst firm characteristics only marginally impact the 
firm’s innovation level. Lefebvre and Lefebvre built further on a number of studies 
investigating the role of the CEO and their positive influence on firms (Maidique and 
Hayes, 1984) and negative influence on technological developments (Meyer and Goes, 
1988; Bakos and Treacy, 1986). Top management characteristics proved to impact 
strategic influence on innovation more than corporate practices do. No data could be 
retrieved from the literature that showed the impact of the specific context of life 
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science R&D on the emergence of specific leadership styles discharged by CEOs. This is 
not surprising as studies that attempt to explore leadership in these settings start from 
the premise of a leadership theory which is then tested in a specific context. In order to 
assess whether a specific context leads to specific role behaviors, another approach is 
required as was shown by Sheard and Kakabadse (2007) who described different types 
of roles taken up by senior managers in a specific context. Sheard and Kakabadse were 
able to observe and identify these roles using qualitative based research (interviews) 
which then led to the description of very specific roles (identified as ‘macro, legitimate, 
social, task’). Their research was entirely descriptive in nature and showed how senior 
managers behave in the context of intensive managerial networks. 
The following sections address the organizational and environmental context in which 
the CEO plays his/her role. First, the macro- context of the firm and environment is 
discussed followed by the micro-context of the top management team and the board.  
2.3.3.1 Macro-context 
Two studies are presented that address the comparative impact of leadership and 
context on innovation. 
 
Comparison of the impact of the CEO attitude and of context on innovation  
Damanpour and Schneider (2006) compared the influence of environmental and 
organizational characteristics  with top managers’ characteristics  on the  initiation,  
adoption decision and implementation of innovation. They observed that the external 
environment, organizational characteristics and top manager demographics contribute 
to the initiation, adoption, decision and implementation of innovation. However, CEO 
personality data, such as attitude towards innovation, contribute substantially to 
innovation and it became clear that CEO attitude towards innovation is a predictor of 
innovation, more than environmental and organizational factors or CEO demographics. 
This shows that CEO demographics have only a limited effect on innovation as compared 
with CEO personality characteristics and environmental/firm characteristics. The data 
also show that CEO’s age does not impact negatively on innovation, i.e. older CEOs do 
not necessarily reduce innovational output.  In addition, there was no gender impact 
innovation and the level of CEO education did not influence innovation positively, whilst 
CEO tenure did not impact negatively on innovation.  
Whereas Damanpour and Schneider compared the impact of environmental and firm 
characteristics with CEO characteristics (demographics or personality), another study 
conducted by Papadakis and Bourantas (1998) attempted to weigh the relative impact 
of CEO characteristics and of organizational and environmental variables on new 
product innovation (NPI), significant product innovation (SPI), incremental product 
innovation (IPI) and on innovations in production processes (IPP). It was found that CEO 
characteristics significantly influenced NPI, but that the organizational and 
environmental context was more influential.  However, none of the CEO demographics 
such as tenure and the level of education, had a significant effect on innovative behavior 
(NPI, SPI, IPI, IPP), whereas CEO personality characteristics such as need for 
achievement, goal of reputation and goal of power appeared to be strongly linked with 
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innovative behavior. Papadakis and Bourantas also introduced the principle of CEO 
discretion into the study of the role of the CEO in innovation. The authors linked the 
principle of discretion to firm size, realising that in smaller firms, the power of the CEO 
and his/her latitude in making decisions that impact the strategic direction, are greater. 
CEO personality characteristics are more important than CEO demographics in fostering 
new product innovation, and are found to be more important than contextual factors.  
 
The observations made by Damanpour and Schneider and by Papadakis and Bourantas 
are schematically presented in Figure 2-2 (the width of the arrows indicate the impact 
of the parameter on the innovation in general or on new product innovation). In 
summary, CEO demographics seem to be a poor predictor of innovation, whilst CEO 
attitude towards innovation and the appropriate organizational environment are 
important drivers of innovation. New product introduction is driven to a greater extent 
by CEO personality than by organizational and environmental characteristics.  A detailed 
comparative study of the data obtained by the Damanpour and Schneider and by 
Papadakis and Bourantas is presented in Appendix B.  
 
The combined effect of CEO and context 
The question can be asked whether CEO characteristics and context, when taken 
together, play a role in innovation. For example, is the impact on innovation of a younger 
CEO in a young company higher than the impact of an older CEO in a mature firm? 
Detienne and Koberg (2002) conducted a study in three industries (aerospace, 
telecommunications and electronics) to assess the impact of environmental and 
organizational variables and managerial characteristics, such as age and tenure, on 
discontinuous innovation. Detienne and Koberg inquired whether CEO demographics, 
such as the age of the CEO, impact upon the level of discontinuous innovation because, 
they argued, following Bantel and Jackson, that younger managers ‘typically have less 
commitment to the status quo and adopt favourable attitudes toward a greater risk 
orientation that favours innovation’ (Bantel and Jackson, 1989). In addition, it was 
argued that tenure of the CEO impacts on innovation because ‘by virtue of their personal 
characteristics, managers will vary in the degree to which they develop and promote 
different types of innovation’ (DeTienne and Koberg, 2002). Long CEO tenure seems to 
be associated with conformance to maintaining current performance (Finkelstein and 
Hambrick, 1990), whereas short CEO tenure overcomes inertia and allows strategic 
change to take place (Wiersema and Bird, 1996).  Detienne and Koberg observed that 
organizational characteristics such as firm age and size and intrafirm structural linkages 
explain the variance in discontinuous innovation to a greater extent than environmental 
dynamism. Firm process capabilities such as improvisation, experimentation and 
transitioning between development phases can explain variances in discontinuous 
innovations among firms but to a degree comparable to firm size and age and 
intrastructural linkages. Managerial demographics, however, such as CEO age and 
tenure, were not a significant factor in explaining discontinuous innovation variance.   
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Figure 2-2 The impact of CEO variables and organization/environment on innovation 
 
After further analysis, Detienne and Koberg showed that discontinuous innovation: 
i. decreases with the age of the firm but more rapidly with older CEOs, 
ii. decreases with the size of the firm and more rapidly with long-tenured CEOs, 
iii. increases with the number of intra-firm linkages and more rapidly with younger 
CEOs. 
The effect of CEO tenure was explored in more detail by Wu et al. (2005) who 
hypothesised an inverted U-shaped relationship between CEO tenure and innovative 
output as predicted by Hambrick and Fukutomi (1991). It was found that the inverted U-
shape relationship is moderated by the dynamics of the environment. For example, in a 
technologically dynamic environment short-tenured CEOs fostered innovation more 
than long-tenured CEOs, while in technologically stable environments, long-tenured 
CEOs generated more innovative output than short-tenured CEOs. With increasing CEO 
tenure, the firm’s innovativeness increases during a first phase but starts to decrease 
with prolonged CEO tenure. In high-dynamic environments, the longer the CEO tenure, 
the more dramatic the decrease in the firm’s inventiveness, whereas in low-dynamic 
environments, the increase in CEO tenure increases the firm’s inventiveness but levels 
off with long CEO tenure. 
 
Not only upper-echelon based research showed that context plays a role in the impact 
of CEO demographics on innovation, studies using transformational theory also point 
into the direction of an effect of context upon the impact of transformational leadership 
of the CEO on innovation. Jung et al. (2008) showed that the environment (uncertainty 
and competition) and firm characteristics (such as innovational climate, formalisation, 
centralisation and empowerment) have moderating effects on the relationship. 
 
During a longitudinal research of companies exposed to the new and emerging 
technology of fibre optics, Eggers and Kaplan (Eggers and Kaplan, 2009) observed that 
both the CEO’s attention to new emerging technologies and organizational orientation 
are important factors in understanding a firm’s response to new technical opportunities, 
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and that considering them simultaneously provides a more nuanced understanding of 
their relative and interrelated effects.  
2.3.3.2 Micro-context 
As the CEO is a member of a top management team (TMT), the impact of other high-
level leaders in his/her team and their interactions with him/her may help to understand 
the role of the CEO in innovation. The systematic review of the literature was therefore 
extended to include a study of the role of the TMT in innovation in an attempt to find 
research data that yield insight into the effect of the immediate environment of the CEO. 
Several papers report on the role of the TMT in innovation and these mirror the studies 
conducted to assess the role of the CEO in innovation. For example, the impact of 
heterogeneity, prior experience, educational level  and even team conflict on innovation 
has been studied and reported (Bantel and Jackson, 1989; Daellenbach et al., 1999; Lyon 
and Ferrier, 2002; Flood et al., 1997; Schoenecker et al., 1995; Camelo-Ordaz et al., 2005; 
Auh and Menguc, 2005; Wu et al., 2002; Srivastava and Lee, 2005; Elenkov and Manev, 
2005; Kor, 2006; Patzelt et al., 2008; Talke et al., 2010). Only a small number of papers 
report research that introduced the CEO’s direct environment as a factor influencing 
his/her impact on innovation.  Kickul and Gundry (Kickul and Gundry, 2001) explored the 
degree of openness, the sharing of information, and idea generation promoted by the 
CEO within the TMT and the effect of these factors on innovation. Their study discloses 
how CEOs who use differences in background and perspectives within their TMT, are 
able to channel these differences into creative discussion and debate. The authors 
maintain that it is likely that the CEO’s intention to foster creativity within the TMT 
encourages the adoption of several managerial practices, such as open, honest and 
supportive communication. Such management practices have been linked with 
innovation and other organizational outcomes in previous research (Oldham and 
Cummings, 1996; Amabile, 1998; Cummings and Oldham, 1997). Simsek  (Simsek, 2007) 
showed that CEO tenure indirectly influenced performance through its direct influence 
on TMT risk-taking propensity and the firm’s pursuit of entrepreneurial initiatives. Wu 
(Wu et al., 2002), surveying 198 industrial firms in Taiwan, found that board involvement 
in decisions made by CEOs resulted in an inverted U-shaped relationship with new 
product introduction performance and that board involvement was linked to a poorer 
performance of new product introductions in conditions of greater market instability. 
Finally, an inverted U-relationship was observed between social ties between the board 
and CEOs on the one hand and new product introduction performance on the other 
hand. 
2.3.4 CEO roles 
In the previous chapters the impact of CEO demographics and characteristics, of CEO 
leadership styles and the moderating role of context was discussed. Besides CEO 
characteristics and leadership, the systematic review of the literature also identified 
other factors which were used to explore the role of the CEO in innovation. For example, 
researchers tried to understand the impact of so-called ‘singular’ concepts such as 
attitude of the CEO towards innovation.  Others explored the impact of attention of the 
CEO to his/her environment in driving innovational performance.  Other role concepts 
such as commitment, involvement and innovativeness were also introduced in research. 
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The sections below offer an overview of the role descriptions used in the literature to 
study the role of the CEO (an exhaustive comparative study and an overview of the 
research papers in which these CEO role behaviors are used is included in Appendix D). 
2.3.4.1 CEO attitude 
According to Damanpour and Schneider (2006), a top executives’ favorable attitude 
toward innovation facilitates the initiation of innovation by building feelings of 
confidence and providing support to organizational members for proposing new ideas’ 
and ‘facilitates adoption decision because strategic decision-makers with a more 
favorable attitude toward innovation would more likely decide to adopt innovative 
ideas’. Attitude has been linked to innovativeness (Bang Nam Jeon et al., 2006), risk 
propensity (Papadakis and Bourantas, 1998), perception (Rogers, 2003), functional 
specialization (Datta and Guthrie, 1994), tenure (Young et al., 2001), international work 
experience and flexibility (Kitchell, 1997) and age (Detienne and Koberg, 2002). The 
authors refer to ‘attitude’ in the context of innovation as a positional stance of the CEO 
towards change such that it impacts on the organizational climate and facilitates 
innovation  (Ekvall, 1996; Hoffman and Hegarty, 1993; West and Anderson, 1996, Ekvall 
and Arvonen, 1991; Yukl, 2002; Damanpour, 1991; Dewar and Dutton, 1986; Hage and 
Dewar, 1973). Because the term attitude is defined as ‘the state, condition or conjecture 
of a person, as likely to have a certain result’ (Thatcher and McQueen, 1980), it is a 
‘positional’ conception.  
2.3.4.2 CEO attention 
CEOs face competing claims on their attention. A scarce resource for many firms is no 
longer information but processing capacity to attend to information (Hambrick and 
Abrahamson, 1995; Hambrick and Mason, 1984; Smith and Tushman, 2005; Yadav et al., 
2007). Attention is the chief bottleneck in organizational activity, and the bottleneck 
becomes narrower as we move to the top of organizations (Yadav et al., 2007). 
‘Attention’ is defined as ‘the act of keeping one’s mind closely on something or the 
ability to do this; the mental concentration or mental readiness for such concentration’ 
(Thatcher and McQueen, 1980). The focus of the CEO on the future and on the internal 
or external environment impacts the speed of detection and development of new 
technologies and explains why some top managers have a greater impact on innovation 
than others (Yadav et al., 2007). Kaplan and Kaplan et al. showed that CEO attention to 
an emerging technology is associated with the subsequent (italic by the authors) 
investment in its development (Kaplan et al. 2003; referenced in Yadav et al., 2007). 
Attention is a ‘forward-looking’ conception in that it collects data and information that 
may lead to investment decisions and focuses innovation.  
2.3.4.3 CEO commitment  
Commitment is ‘the act of committing, or putting in charge, to entrust, to bind to a 
certain line of conduct’ (Thatcher and McQueen, 1980). Managerial attention to building 
supportive systems and infrastructure is a critical step in enhancing innovation speed 
(Carbonell and Rodriguez, 2009). The long-range nature of technological innovation 
makes commitment important to the R&D organization (Starling, 1991). CEO 
commitment is made visible in a variety of ways: ‘by acting as an executive sponsor, 
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helping a team to surmount obstacles, providing encouragement, maintaining open 
channels of communication, streamlining decision-making processes, and providing 
adequate capital and human resource’ (Gupta and Wilemon, 1990; Smith and 
Reinertsen, 1992; cited by Carbonell and Rodriguez, 2009; Daellenbach et al., 1999). 
Commitment makes available appropriate funds and resources (Llorens et al., 2004; 
Cooper and Edgett, 2004; Swink, 2000; cited by Sanzo et al., 2012) and – thus - by 
accepting the risky nature of innovation projects (Menon et al., 1997; cited by Sanzo et 
al., 2012). Commitment is a ‘facilitating’ conception, in that it creates the financial and 
human circumstances for R&D to flourish.  
2.3.4.4 CEO involvement 
The act of involvement is ‘to connect by way of natural result or consequence, to blend’ 
(Thatcher and McQueen, 1980). This ‘blending’ is at the core of the concept of CEO 
involvement and presents the CEO as a participant in innovation. It requires the CEO to 
take a step beyond attitude, attention and commitment, as these roles may be played 
‘outside’ of innovation, while the CEO who becomes involved in innovation requires 
his/her blending with the innovational discussions and his/her understanding of the 
underlying technology.  On the one hand, there is rare involvement of top management 
in specific projects (Markham et al., 1991; cited by Green, 1995), but on the other hand, 
in small, high-growth design firms, CEOs were deeply involved in design decisions 
(Dickson et al., 1995). In the case of intranet adoption, CEO involvement appeared to be 
the only factor to impact innovation (Al-Qirim, 2007b). Laforet and Tann observed that 
in more innovative companies the CEO was found to be more involved in developing 
new products than in less innovative companies. Involvement is a ‘knowledge based’ 
conception as it requires prior knowledge in the field of R&D (Laforet and Tan, 2006).  
2.3.4.5 CEO innovativeness 
The term innovativeness is frequently used to describe the innovative character of an 
organization (‘firm innovativeness’ or ‘corporate innovatineness’) but it is rarely used to 
described the innovative behavior of a CEO. Thong and Yap and Al-Qirim have 
introduced the term ‘CEO innovativeness’ as the characteristic of a CEO as ‘an 
entrepreneurial figure who is crucial in determining the innovative attitude of a small 
business’11 (Thong  and Yap, 1995; Al Qirim, 2007a).  The entrepreneur is considered ‘the 
central figure in successful technological innovation’ and ‘one who actively promotes 
the adoption of innovations’ (Schon, 1963; Maidique, 1980, p. 72; Roberts, 1969, p. 259; 
cited by Lefebvre and Lefebvre, 1992). Thong and Yap describe ‘CEO innovativeness’ as 
a CEO who has original ideas, would sooner create something new than improve 
something existing and often risks doing things differently’. Among organizational, 
technological and environmental factors, CEO innovativeness is the only significant 
factor in the adoption of technological innovations (Al-Qirim, 2007b; Al-Qirim, 2007a). 
CEO innovativeness is an ‘entrepreneurial’ conception. 
                                                          
11 Although these research papers use the term ‘CEO innovativeness’, they do not refer to the capability to think innovatively or 
the ability to come up with innovative ideas in the area of innovation but define it as a combination of involvement and attitude. 
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2.3.4.6 Discussion 
The role descriptors presented above i.e. attitude, attention, commitment, involvement 
and innovativeness have been used in the literature to try to address the role of the CEO 
in innovation. The main disadvantage of these ‘role descriptors’ is that they have not 
been identified as a result of descriptive research but were proposed by management 
researchers as ‘a priori’ parameters. They are also poorly defined and contrasted and 
their further use in research is hampered by a lack of clarity. Nevertheless, they are 
potentially useful to conduct research because they allow the structure of findings 
obtained from conversations or interviews. It was therefore decided to define and 
contrast these terms. Table 2-2 summarizes these terms and offers a definition, a clear 
contrasting and an explanation of what they are not. They allow the description of an 
increasing impact of the CEO in the innovational environment: from a general attitude 
that allows innovation to take place, the CEO becomes attentive to future opportunities 
and defines a future for the company by directing and focusing the firm on these 
opportunities, is then willing to make formal resource commitments and then becomes 
involved in the intellectual discussions. At the end of the CEO innovation spectrum 
he/she is an innovator in his/her own right. The advantage of these role concepts is that 
– when clearly defined and contrasted – they can be used as ‘research instruments’ 
because they encompass a spectrum of roles that a CEO may be able to discharge in an 
environment of innovation. 
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 CEOs IN RESEARCH AND DEVELOPMENT – CONCEPTUAL ROLES FROM THE LITERATURE 
 Attitude Attention Commitment Involvement Innovator 
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The state, condition or conjecture 
of a person , as likely to have a 
certain result 
The noticing, encoding, interpreting 
and focusing of time and effort by 
organizational decisions makers 
(Ocasio, 1997). The act of keeping 
one’s mind closely on something or 
the ability to do this; the mental 
concentration or mental readiness 
for such concentration 
 
The act of committing, or putting in 
charge, to entrust, to bind to a 
certain line of conduct 
To connect by way of natural result 
or consequence, to blend 
To head and lead innovation in 
person disrupting the market with 
new products 
 CEO attitude CEO attention CEO commitment CEO involvement CEO innovator 
Li
te
ra
tu
re
 d
e
fi
n
it
io
n
 
Studies in leadership posit a 
leadership behavior that is referred 
to as ‘change –oriented’ behavior 
(Ekvall and Arvonen, 1991;  Yukl, 
1999)  This leadership behavior 
refers to executives who:  
- present long-term perspectives 
- offers an appealing vision of the 
future 
- is receptive of new ideas 
- makes agreements with people 
inside and outside of the firm 
- in order to initiate and 
implement change from the 
current state of affairs 
This behavior is described as an 
‘attitude favoring innovation’ which 
‘facilitates the initiation of 
innovation by building feelings of 
confidence and providing support 
to organizational members for 
proposing new ideas’ (Mumford, 
2000). (cited by Damanpour and 
Schneider, 2006). 
‘Detection, development and 
deployment (of innovation) require 
the awareness of external 
opportunities and the anticipation 
of future events’. According to 
Yadav et al.(2007), CEO attention 
has a temporal and spatial 
component that increases this 
awareness.  According to Yadav et 
al. the discretion CEOs exercise on 
events that have yet to occur or on 
events that have a locus outside the 
company , are predictive of a firm’s 
innovative outcomes. ‘When CEOs 
focus their attention on the future 
and on external entities, their 
communications and actions reflect 
this focus and serve to drive 
employees’ attention to events and 
opportunities in the future and 
outside the firm’ and ‘CEO 
attention is a critical driver of 
innovation ‘(Yadav etal., 2007). 
CEO commitment refers to the 
support that the CEO is willing to 
give to the new product 
development. It can be made visible 
in a variety of ways (Gupta and 
Wilemon, 1990; Smith and 
Reinertsen, 1992): by acting as n 
executive sponsor, helping a team 
to surmount obstacles, providing 
encouragement of the team, 
maintaining open channels of 
communication with people 
involved in new product 
development, streamlining 
decision-making processes and 
providing adequate capital and 
human resources.  It plays a 
positive role in accelerating 
innovation speed (Mabert etal., 
1992; Emmanuelides, 1993; Kessler 
and Chakrabarthi, 1996) (cited by 
Carbonell and Rodrigueze-
Escudero, 2009) 
The CEO is involved in new product 
development (processes) –  ‘CEO 
involvement’ is the degree by 
which the CEO takes final 
responsibility for making product 
design decisions, either alone or 
jointly (Dickson et al., 1995) and is 
personally involved in new product 
development (Laforet and Tann, 
2006). 
The CEO acts as the new product 
champion (Laforet and Tann, 2006), 
i.e. the new product is the ‘CEO’s 
product’. CEO innovativeness is 
characterized by an 
entrepreneurial perseverant CEO 
whose qualities as a 
transformational leader are the 
determinants of the overall 
management style of the business - 
it is the role of the CEO that 
determines the innovateveness of 
the business (Thong and Yap, 1995; 
Kitchel, 1997). The innovator CEO 
prefers solutions that change the 
structure in which a problems is 
embedded, in other words, 
solutions that have not been tried 
out and are therefore risky (Kirton, 
1984, cited by Thong and Yap, 
1995) 
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Non-for profit public  organizations, 
manufacturing firms, small IT firms 
 
 
Communications technology, retail 
banking industry, electronics, 
financial services, home appliances, 
food and beverages, industrial 
equipment, lumber, construction, 
retailing, mining, manufacturing 
firms, machinery and metalworking 
firms 
 
Manufacturing firms, food, 
chemicals, plastic, mechanical 
equipment, electrical equipment, 
transportation, large industrial R&D 
projects, office and residential 
furniture industry 
 
 
Packaging design, small IT firms, 
manufacturing industry, high 
growth firms (no detail), IT e-
business, small manufacturing 
firms 
 
Information technology, 
manufacturing firms, small 
manufacturing firms, machinery 
and metalworking firms, small IT 
firms 
W
h
at
 it
 is
 
The CEO takes a positive stance 
towards innovation, creates an 
environment in which innovation 
can foster,  presents a long-term 
vision for the firm,  is receptive of 
new ideas in order to initiate and 
implement change for the better. 
 
The CEO takes the time and effort 
to be informed about the potential 
of innovations in and outside the 
firm, scans the environment for 
opportunities, takes the time to 
learn  about new product 
opportunities and customer needs 
and transforms these into a 
strategic vision. This attention is 
transformed in an innovative  
direction put forward by the CEO  
 
The CEO commitment is the 
behavior by which R&D is taken 
forward by making available 
financial and human resources and 
by supporting underlying processes 
(communication, encouragement, 
decision-making etc.) to achieve 
these goals.  A CEO may be 
formally, personally (and even 
passionately) committed to NPD 
but is not able to contribute 
technically or scientifically 
The CEO is capable to take part in 
the innovational activities and the 
development of new products, i.e. 
the CEO is present during the 
technical discussions and 
contributes – a role he can 
discharge because oh his 
knowledge. He/she can do so at all 
levels, at all levels within the R&D 
function  
Being an innovator in his/her own 
right, an individual who develops 
the ideas for new products, pushes 
these through the organization and 
acts as the new product champion.  
 
Examples: 
the iPad® is ‘Steve Job’s product’; 
the Airblade® is ‘James Dyson’s’ 
hand dryer etc.. 
K
e
y 
CEO -> develops a culture  
(that drives innovation) 
CEO -> collects information  
(to direct R&D) 
CEO -> offers resources  
(to support R&D) 
CEO -> has relevant knowledge  
(to discuss R&D) 
CEO-> is an innovator 
(and develops ‘own’ NPs) 
N
at
u
re
 
Positional Forward looking Facilitating Knowledge based entrepreneurial 
W
h
at
 it
 is
 n
o
t 
It is not a CEO who attempts to 
portray a positive and innovative 
image of his firm while concur- 
rently preventing a culture of trust, 
discussion, openness, organizes his 
firm bureaucratically through strict 
procedures  etc. 
It does not mean that an attentive  
CEO should be either technically 
proficient or should become 
involved in R&D discussions. He can 
delegate all technical 
responsibilities to a CSO or CTO and 
focus on the market. He may be 
interested in new markets but may 
find the commitment (and 
associated risk) to invest in R&D 
too high. 
It does not mean that a committed 
CEO has technical knowledge – this 
CEO can be fully committed to this 
firm and the R&D that can take 
place but needs an intermediary to 
bridge the gap between the 
business and the R&D function 
It does not mean that the involved 
CEO is capable of conducting highly 
specialized lab experiments or 
perform development activities or 
is capable to act as an R&D team 
leader of a NPD project, but he/she 
is capable to engage in discussions 
at that level either in the lab or 
during meetings with specialists 
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 Damanpour and Schneider, 2006  
 Thong and Yap, 1995  
 Papadakis and Bourantas (1998)  
 
 Yadav et al, 2007 
 Eggers and Kaplan, 2009 
 Makri and Scandura, 2010 
 Miller & Toulouse, 1986a and 
1986b 
 Kitchel, 1997 
 Note : the term “attention” 
differs from the term 
“importance assigned to” used 
by Calantone et al., 1995 in 
which “attention” is given by the 
CEO to specific parts of the NPD 
process 
 
 
 Carbonell & Rodriguez-Garcia, 
2006 
 Green, 1995  
 Swink, 2000  
 Calantone et al., 1995 
 
 Dickson et al., 1995 
 Laforet & Tann, 2006 
 Bang et al. 2006 
 Thong and Yap, 1995 
 
 Kitchel, 1997 
 Lefebvre & Lefebvre, 1992 
 Harrison et al, 1997 
 Laforet and Tann, 2006 
 Thong and Yap, 1995 
 
Table 2-2 CEO conceptual roles from the literature
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2.3.5 Conclusion 
The upper echelon theory offers an interesting perspective from which to study the role 
of the CEO in innovation because it starts from the premise that CEO decisions are at 
least partly driven by education, experience, demographics, values and beliefs which 
influence their interpretation of situations and impact their strategy formulation. This 
has led to a considerable literature the results of which may be characterized as 
‘granular’ seen the variety of linkages studied between CEO characteristics and 
innovation. While upper echelon theory led to a wide variety of linkages between CEO 
characteristics and innovational output measures, the mere granularity of the research 
output prevents a generalized conclusion on the role of the CEO in innovation. Although 
the upper-echelons theory opened new perspectives in our understanding of the role of 
the top manager in innovation, it has not yet led to a better insight into the actual role 
of the CEO in innovation. That is why the proponents of the upper-echelons perspective 
were criticized for not directly studying strategic leadership behavior (Damanpour and 
Schneider, 2006; Cannella and Monroe, 1997; Boal and Hooijberg, 2000; Priem, 1990; 
DeTienne and Koberg, 2002; Markoczy, 1997; Young et al., 2001). Although there are 
research data on transformational leadership that point into the direction of an impact 
on innovation, there still remains uncertainty whether the impact of this leadership 
style, when used by a CEO, is capable to percolate through the organization into middle 
management levels to impact innovation. Although this cascading mechanism into the 
lower regions of the organization provides an interesting perspective, it is doubtful that 
the transformational effect is felt by knowledge workers in R&D, who are particularly 
unreceptive to management practices. The literature shows that the combined effect of 
CEO characteristics, transformational leadership style and context play an important 
role in the output of innovation. Accordingly, if demographics and leadership style are 
moderated by context, it can be argued that the role of the CEO in innovation is 
moderated by the presence of a R&D function and that a study of the role of the CEO in 
an environment of R&D needs to take into account the R&D function seen its strategic 
knowledge and autonomy and its rejection of managerial practices. Although the 
research that addresses the role of the CEO in innovation has offered some insight in 
the impact of CEO characteristics and leadership behavior on innovation, there is still a 
clear lack of knowledge on the actual roles that CEOs play in leading innovation. This is 
– in my opinion – due to the mainly quantitative research that was conducted to 
understand the role of the CEO. Doing so, researchers were capable to link parameters 
(eg. transformational leadership – innovation output) but were not able to determine 
what CEOs do to support or drive innovation. 
2.4 Research gap 
The literature review addresses 2 major topics. The first topic was the context and 
leadership of R&D (Section 2.2) explored to better understand a possible role of the CEO 
in innovation through a better understanding of the context of R&D. The role of the CEO 
seen from the angle of upper echelon and leadership theory, their relationship with 
context and roles played by the CEO constituted the second major topic (Section 2.3). 
What can be learned from the literature?  
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The first topic focused on the context of R&D and it was found that R&D team leaders 
play a role in innovation, by discharging roles such as product champion or boundary 
spanner. These roles can only be fulfilled by team leaders with intricate knowledge on 
the science of the firm’s R&D. In other words, a similar role - such as product champion 
- is not available for the CEO, if he/she lacks the necessary knowledge to lead a team of 
scientists. Second, the effect of transformational leadership in the context of R&D is 
more pronounced in the early phases of research while it’s effect is not pronounced 
during the later development phases. Third, the R&D function sees management 
practices and management interference as incompatible with effective R&D and 
therefore their receptivity for direction by the CEO may be minimal. Fourth, there is no 
data showing that there is upward influence of R&D to the CEO and for the CEO to 
effectively absorb R&D intelligence in his/her strategy formulation. In other words, the 
literature review of the context of R&D casts doubt on the role of the CEO and a study 
of his/her role should be conducted by exploring the role of the CEO through the 
perspective of R&D.  
The second topic focused on theory, the research supporting the theory and the impact 
of context. Among these, upper echelon theory was given considerable attention and it 
was used to study the impact of CEO characteristics. These factors were weighed against 
contextual factors such as environment and firm characteristics but the impact of 
individual CEO characteristics (age etc.) as drivers or contributors to innovation is not 
clear. The literature also offers the transformational leadership theory as an approach 
to understanding the role and impact of the CEO. However, the arguments in favor of 
this theory in an innovational context are not based upon extensive empirical research 
into the effect of transformational CEOs on innovation. The lesson from the review of 
the literature is that the impact of transformational top management leadership on 
innovation is dubious. One can therefore not assume that such an impact on innovation 
exists through a transformational CEO who is separated from the R&D function by 
several hierarchical layers.  
The literature also addressed singular concepts such as attitude, attention, 
commitment, involvement and innovativeness. It became clear that the CEO’s attitude 
towards innovation is a more important innovation driver than age, firm tenure, 
educational background or work experience. These concepts may prove useful 
instruments to study the role of the CEO as compared with demographic or personality 
characteristics. Also, firms with the same underlying organizational orientations might 
move in different directions if the CEOs’ attention to the future technologies differs. In 
other words, CEO attitude and attention are crucial factors that may impact innovation 
in a life science R&D firm. The literature review revealed the use of still other concepts 
besides CEO-attitude and -attention and they have been identified as CEO- commitment, 
-involvement and -innovativeness. The literature concepts can be categorized in 
hierarchical order, in which each level of the hierarchy constitutes an increased level of 
the impact of the role of the CEO in innovation. The hierarchical organization of the role 
is as follows: attitude -> attention -> commitment -> involvement -> innovativeness.  The 
concepts describe an increasing role of the CEO in R&D, starting with a positive attitude, 
increasing to CEO attention to the future to identify opportunities, to commitment by 
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investing in financial and human resources, to actual involvement in the R&D discussion 
and finally by taking the helm as the innovator in the development of new products. 
These concepts offer an interesting alternative approach to the study of the role of the 
CEO because they focus on the role of the CEO rather than on his/her demographics. 
Until now these concepts have been used separately in different industrial settings (from 
manufacturing to IT and banking) and it is argued here that - seen their complementarity 
- they could be used together to study the role of the CEO in a qualitative research 
setting. Also, because the literature makes use of these concepts and has shown their 
importance and usefulness in describing the role of CEOs in innovation, but lack clear 
and differentiating definitions, this thesis proposes definitions for each of them to allow 
clear differentiation and use in qualitative research.  
 
Table 2-3 below presents an overview of the research domains in the literature, ranging 
from upper echelon (1) and transformational theory (2) and the weighing of CEO 
leadership and context (1,2), to the impact of the top management team and the board 
(3) and the study of CEO role behaviors (4). It also shows that the research agenda 
whereby the role of the CEO in innovation was studied in the context of life science R&D 
and by combining the CEO role behaviors was not subject of research (5). It therefore 
constitutes a research gap. Also, the role of the CEO in innovation in R&D cannot be 
disconnected from the view of the R&D function on that role, seen R&D’s strategic 
knowledge and potential impact on strategy formulation.  
 
 
Research topic - role of the CEO in innovation, explored through the lens 
of: 
Research 
reported in 
the literature 
Life science 
R&D 
context 
1 
Upper echelon theory + the impact of organizational and environmental 
impact 
√ - 
2 
Transformational theory + the impact of organizational and environmental 
impact 
√ √ 
3 The impact of the top management team and board √ - 
4 
Singular concepts (attitude, attention, commitment, involvement, 
innovativeness) studied separately in different organizational contexts,  √ - 
5 
Singular concepts (attitude, attention, commitment, involvement, 
innovativeness) studied together in a single organizational context of life 
science R&D  
- - 
 
Table 2-3 The research gap 
However, there are still other observations that can be drawn from the literature and 
they address the methods that were used to conduct the research reported. 
 
It was observed that three major research strategies were used and they are 
represented in box A, B and C in Figure 2-3. First, survey based research was used by 
upper echelon and transformational theory researchers in an attempt to develop 
prediction models (box A). These models attempted to answer the question whether a 
transformational leadership style of a CEO or the age of a CEO impacts innovation. Box 
B refers to the CEO research conducted by means of attitude, attention and other role 
conceptualizations used separately in different organizational contexts. Box C refers to 
the research strategy whereby either transformational theory or upper echelon theory 
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or role conceptualizations were used to understand the role of the CEO but excluding 
the R&D function, which is the locus of innovation ‘par excellence’.  The combination of 
boxes A, B and C therefore represents current research strategy. The same figure offers 
an alternative approach and they are represented in boxes A’, B’ and C’: 
 
- box A’: in this research strategy, the quantitative survey based model - because 
it has not offered substantially better insight in the actual role of the CEO - is 
replaced by a qualitative approach in which the CEO is approached directly  
- box B’: in this research strategy, the role conceptualizations attitude, attention, 
commitment, involvement and innovativeness which were previously used 
separately in different contexts, are used together in a single context (for 
example in a life science R&D firm)  
- box C’: in this research strategy,  the role of the CEO is investigated by involving 
the actors that form the locus of innovation - the R&D function - seen its peculiar 
character: high autonomy and limited receptivity for managerial leadership 
 
The combination of approaches A’, B’ and C’ constitute a new research strategy and is 
an alternative to the previous research strategy reported in the literature. By combining 
the observations of the review of the literature in Table 2-3 and in Figure 2-3 not only 
becomes the research gap visible from a content point of view but also from a 
methodology point of view.  
 
 
 
Figure 2-3 The proposed research strategy contrasted with established research strategies 
 
It is therefore proposed that the study of the role of the CEO should proceed by going 
beyond the study of CEO characteristics (demographics or personality), their leadership 
and the search for predictive models, but should: 
 
Quantitative based 
approaches (i.e. 
surveys) 
to develop 
prediction models
Qualitative 
approaches to 
develop insight
A
A’
CEO role 
conceptualizations 
such as attitude, 
attention etc used 
together in a single 
context
B’
CEO role 
conceptualizations 
such as attitude, 
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different contexts
B
CEO research by 
looking to the CEO 
and involving the 
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CEO alone
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i. study the CEO directly by means of a qualitative approach (box A’) and 
ii. use a combination of role concepts of CEO attitude, -attention,-commitment, -
involvement and –innovativeness in a single context of life science R&D firms 
(box B’) and 
iii. involve the R&D function to inquire how it perceives the role of the CEO (box C’) 
 
This approach is entirely descriptive in nature as it attempts to answer the question what 
the CEO is actually doing to overcome the challenges of complex life science  innovation. 
It assumes a direct interaction with the CEO and his/her R&D function. By taking this 
approach, it is aimed to obtain a better insight into the actual role of the CEO in 
innovation in the context of life science R&D firms. 
2.5 Summary 
A systematic review of the literature on the role of the CEO in innovation and a bifocal 
review of the literature reveals that research on the role of CEOs in innovation primarily 
used survey-based approaches employing upper echelon or transformational leadership 
theory. Using the upper echelon perspective, CEO demographics such as age, tenure 
and/or background were used as explanatory and predictive factors of the role of the 
CEO. Alternatively, a leadership-based perspective was used to explore the relationship 
between CEO transformational leadership and firm innovation but both perspectives 
have not further elucidated the actual role discharged by CEOs in innovation. The review 
also revealed research in which CEO behaviors such as attitude, attention, commitment, 
involvement and innovativeness were used to explore the role of the CEO. They describe 
an increasing role of the CEO in R&D, starting with a positive attitude towards 
innovation, to attention to the future, to commitment by making available financial and 
human resources, to involvement in R&D and finally to innovativeness in which the CEO 
takes the helm in the development of innovative new products. They are potentially 
better suited to explore the role of the CEO in innovation, because they reflect CEO 
behaviors instead of CEO demographics. A problem however with the use of these 
concepts is that they are not well defined, were used separately in survey-based studies 
and explored in different industrial settings. The literature was therefore explored 
further and a clear definition is proposed that contrast these concepts accurately such 
that they can be used in further research. A research gap was identified that addresses 
as well the content as the research strategy. 
2.6 Conclusion 
The question what CEOs do to lead innovation in life science R&D firms remain 
unanswered in the literature.  Answering this question will be difficult when researchers 
remain focused on quantitative survey-based research because the actual role will 
remain ‘undiscovered’ or may only be inferred or assumed from the relationships 
detected between predetermined variables (e.g. transformational leadership behavior 
of the CEO and firm innovation) or from the identification of (leadership or 
demographic) factors that may or may not impact innovation. What individuals actually 
do can only become known if these individuals are asked what they do.  In other words, 
successful research of what CEOs do to lead innovation and how they are capable to do 
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so, should result in a clear role description. How this can be achieved is discussed in the 
next chapter.  
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3 Research design 
 
3.1 Introduction 
The literature review pointed to a research gap that consists of both a research topic and a 
research methodology.  It became clear that little is known about the actual role of the CEO 
in innovation in life science R&D firms and that a qualitative study of the role of the CEO in 
innovation has not yet been conducted.  Therefore there is no research data in the literature 
that looks for confirmation and the research topic lends itself to exploration. This chapter 
proceeds as follows. First, it offers arguments to support the proposition that the proposed 
research project is exploratory in nature rather than confirmatory (Section 3.2). This 
distinction is crucial because it impacts the chosen methodology and methods (Section 3.3.). 
The theoretical perspective from which this research is conducted is presented in Section 3.4. 
The research questions and procedures are presented in Section 3.5. and Section 3.6 
summarizes the chapter. 
3.2 Exploratory research 
3.2.1 Defining exploration 
Much of the understanding of the concept of exploration stems from Stebbins’ treatise on 
exploratory research in the social sciences (Stebbins, 2001). The term ‘exploration’ seems to 
have entered qualitative social research through Glaser and Strauss’s seminal volume The 
Discovery of Grounded Theory (Glaser and Strauss, 1967). According to Stebbins, exploration 
can be defined in different ways, based as it is, on the verb ‘to explore’ (Stebbins, 2001, p2).  
Exploration means: 
- ‘to study, examine, analyze or investigate something, i.e. investigative exploration 
- to become familiar with something by testing it or experimenting with it, i.e. 
innovative exploration 
- to travel through a particular space for the purpose of discovery and adventure, i.e. 
exploration for discovery 
- to examine a thing or idea for diagnostic purposes, whilst the explorer realizing what 
he/she is looking for, i.e. limited exploration’ 
Stebbins, building upon a previous proposal by Vogt (1999), defines exploratory research in 
the social sciences as follows: 
‘Social science exploration is a broad-ranging, purposive, systematic, 
prearranged undertaking designed to maximize the discovery of 
generalizations leading to description and understanding of an era of social 
or psychological life. Such exploration is, depending on the standpoint 
taken, a distinctive way of conducting science – a scientific process – a 
special methodological approach (as contrasted with confirmation), and a 
pervasive personal orientation of the explorer. The emergent 
generalizations are many and varied; they include the descriptive facts, 
folk concepts, cultural artifacts, structural arrangements, social processes, 
and beliefs and belief systems normally found there’ 
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3.2.2 Arguments for exploration 
There are complementary reasons why this research is to be defined as exploratory in nature. 
The reasons are given by Stebbins (2001) who describes researchers as explorers when: 
‘they have little or no scientific knowledge about the group, process, 
activity or situation they want to examine but nevertheless have 
reason to believe it contains elements worth discovering’  
and by Karlsson (2009) who argues that: 
‘With little to base the theoretical development on, the study will by 
necessity take on an explorative character. Hence early phase research 
will often be explorative’ 
There is little or no scientific knowledge available about the role of the CEO in innovation, 
except for some linkages between CEO demographics (age, gender etc) and innovational 
output. However, the actual role of the CEO in the process of innovation remains largely 
unexplored.  Also, the investigation of the role of the CEO in innovation – although not a new 
research topic, as we have seen in the literature review – has addressed this role only by 
looking into the effect of so-called ‘CEO-proxies’ such as pay, education or experience.  No 
empirical study was identified in the literature that approached the CEOs individually in an 
attempt to gain insight into what they consider to be their role and how they fulfill it. The 
reason for this absence of empirical studies may lie in the fact that CEOs are particularly 
difficult to approach seen their extraordinary time pressure which prevents them to become 
actively involved in academic research projects (Yadav et al., 2007). Also, there is no scientific 
knowledge retrieved from the CEO’s interaction with the R&D function and its potential 
impact on innovation. In other words, based upon the outcome of the literature review, there 
is still 'reason to believe it contains elements worth discovering’. 
According to Stebbins (2001), there are three conditions under which exploration is the 
preferred approach: 
- when the unit of analysis (the group, the process, the activity or situation) has received  
little or no systematic empirical scrutiny  
- when the unit of analysis has been largely examined using prediction and control 
rather than flexibility and open-mindedness 
- when the unit of analysis has grown to maturity along a continuum that reaches from 
early exploration to full qualitative and quantitative confirmatory studies but has 
changed so much along the path of investigation,  it ‘begs to be explored anew’.   
In view of the proposed research project these conditions are met.  
First, until now the CEO’s point of view and what he/she considers to be his/her role, have 
not received attention from management researchers. As stated above, the CEO him/herself 
has received little or no systematic empirical attention. 
Second, until now the role of the CEO in innovation was investigated by means of variables 
that would predict changes in innovation as a result of variation of age, tenure, education. 
The literature review has shown that the research was conducted in order to generate 
predictive parameters. For example, if the CEO is old, will this drive or hamper innovation? 
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Or, if the CEO has an engineering background will this reflect in the way a new manufacturing 
plant is organized? 
Third, the results of the studies that have been conducted are not corroborative, even 
contradictory and still have not been able to fully assess the role of the CEO. This stage of 
‘mature’ research has not been reached in the field of CEOs and innovation and therefore 
does not apply. In other words, the topic still ‘begs itself for exploration’”. 
 
Also, according to Yin, the fact that a research question focuses mainly on the ‘what’ instead 
of the ‘why’ of a phenomenon, offers a justifiable rationale for conducting an exploratory 
study, the goal being to develop pertinent hypotheses and propositions for further study (Yin, 
2009; p9). 
Therefore the conclusion can be drawn that the research into the role of the CEO in innovation 
can be categorized as exploratory in nature. 
3.2.3 Goals of exploration 
Exploration aims to generate new ideas and ‘weave them together to form grounded theory, 
or theory that emerges from data’ (Stebbin, 2001) while the outcome of exploration is 
‘inductively derived generalizations about the group, process, activity or situation under 
study’ (Glauser and Strauss, 1967; Stebbins, 2001). In simpler terms: the explorer searches for 
generalizations leading to detailed and profound understanding of the group, the process, or 
activity under study.  
3.2.4 Studying elites 
Exploratory studies can be done in different settings and under different contexts, but the 
investigative efforts needed to explore elites such as top-politicians, movie stars, high level 
army commanders ask for specific sensitivities. Hertz and Imber have addressed the research 
peculiarities when studying  elites by informing the potential elite-researchers as follows 
(Hertz and Imber, 1995; Zuckerman, 1972) : 
- if at all possible, study the elites directly and do not engage in exploring public records 
as these are vastly insufficient to study these individuals, because they may offer a 
“glossy” description of the role of the elite 
- each research approach requires a specific strategy and there is no general elite-study-
methodology 
- it may be worthwhile to combine several approaches such as surveys and interviews 
if possible 
- acquire information from within the firm and not from outside sources 
- use the executive’s own network for approaching him/her 
- investigate in depth as the information required to address the research question may 
be hidden  
- listen carefully when the elites describe their worlds 
In other words, an ‘elite-explorer’ should  
- be careful using data which are external to the firm  
- approach the role of the CEO from within the firm  
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- use several research methods if possible 
- inquire deeply into the information offered 
- connect to other CEOs by means of the CEO’s network. 
In addition, Kvale and Brinkmann argue that ‘… elites are being used to being asked about 
their opinions and thoughts, and an interviewer with some expertise concerning the interview 
topic may provide for an interesting conversation partner. The interviewer should be 
knowledgeable about the topic of concern and master the technical language’ (Kvale and 
Brinkman, 2009). One point of caution that is offered by Kvale and Brinkman is that experts 
could have their ‘talk tracks’ ready for any interview and the interviewer should ‘require 
considerable skill to get beyond’. One way of reducing this trap is to involve an interviewer 
who is skilled enough to go through the obvious glossiness that may appear and the ‘pep-talk’ 
that the elite may offer. A thorough understanding of the pipeline of their products and 
technologies therefore is necessary to convince the interviewed CEO that the researching 
interviewer is sufficiently skilled to understand the arguments and go behind the ‘obvious 
talk’. 
3.2.5 Rigor in exploratory research  
A key contribution to the topic of rigor in exploratory social research is given by Stebbins who 
offers a full and detailed overview of its implications (Stebbins, 2001).  
 
Stebbins argues that in the case of exploratory research projects, a clear research framework 
may still be in an embryonic phase: logical argumentation therefore is required but does not 
follow a pre-established framework, whereby pattern matching is difficult to achieve as 
previously established or predicted patterns are hardly available. In addition, theory 
triangulation, whereby findings and conclusions can be supported by different theoretical 
frameworks is difficult if not impossible to achieve in case of exploration. Internal validity 
therefore will need to be achieved by strong internal logical argumentation.  Construct 
validity, referring to the ‘extent to which a study investigates what it claims to investigate’ 
can be achieved by a clear chain of evidence reconstructing the path from initial research 
question to final conclusion and by means of triangulation strategies, if at all possible. In 
addition to strong internal logical argumentation, rigor in exploratory research can be 
strengthened by using research instruments that are clearly defined.  
 
Therefore the concepts that were identified in the literature, i.e. attitude, attention, 
commitment, involvement and innovativeness have been assigned clear definitions such that 
they can be used in research projects to validate the findings of previous studies.  
 
3.2.5.1. Addressing the validity of the research 
Validity refers in ordinary language to the truth, the correctness and the strength of the 
statement (Kvale and Brinkman, 2009). Generalizations are the exploratory study’s ‘raison 
d’être’ and the ‘principle of supremacy of generalization should also guide the structure of 
the report’ adding that ‘generalizations are rarely simple and straightforward: they must 
usually be qualified, put into context and related to other generalizations’ (Stebbins, 2001). 
However, generalization may impede true understanding: ‘properties shared by all 
organizations are superficial, obvious or unimportant’ (Harrison, 2002; p161). Therefore, the 
issue of generalization should be ‘contextualized’ in that the observations made during a 
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research project can be generalizable to the specific context under which the exploration took 
place and the need for concatenation as argued by Stebbins (Stebbins, 2001). 
 
Validity in exploratory studies refers to the way a researcher is capable of gaining an accurate 
or true impression of the group, process, or activity under study and how this can be 
accomplished. Validity refers to the question whether the data that are proposed as a result 
of an exploratory study can be considered credible and valid.  Stebbins argues that validity in 
exploratory research  
 
‘concerns with the explorer’s capacity to acquire directly an accurate 
impression of a group, process, activity or situation ... and is more easily 
resolved , for example, by asking key informants to comment on the 
familiarity and reasonableness of observations and finding recurrent 
evidence for each generalization’ (Stebbins, 2001; p26) 
Validity in exploratory research is difficult for three reasons: 
- reactive effects of the observer’s presence or activities in the phenomenon being 
observed 
- distorting effects of selective perception and interpretation on the observer’s part 
- limitations on the observer’s ability to witness all relevant aspects of the phenomena in 
question  
Especially the second element is worrisome for the exploratory researcher ‘because of the 
heavy subjective element involved when a lone researcher (the usual way exploration is 
conducted) observes and interviews’ (Stebbins, 2001; p48). Exploratory researchers, 
therefore, should increase the validity of their research in three ways: 
- by discussing the generalizations with the people they are investigating to determine if 
these ideas ‘have a familiar ring’, in other words that they are considered plausible in 
the eyes of the respondents: i.e. the plausibility of the observations 
- by looking ‘assiduously’ for evidence that might contradict the observations as the 
observer is aware of potential bias in his research and that they are not held with ‘great 
unbending conviction’; i.e. the removal of bias 
- by asking themselves whether there is a sufficient number of occurrences of an event 
or process to ‘constitute grounds for a valid generalization’, i.e. the grounds for 
generalizations 
These three concerns were addressed in this research as follows: 
- plausibility of the observations: this is achieved by presenting the outcome of the 
research interviews with the individual CEOs to the focus CEO group and by checking 
the CEO interview observations with the R&D managers 
- the removal of bias: the awareness of bias is specifically addresses by checking the CEO 
arguments against those of the R&D managers, i.e. do R&D managers support the 
arguments made by the CEos therebut preventing a potentially biased observations on 
the part of the interviewer 
- the grounds for a valid generalization, was achieved by taking Krippendrof’s approach 
in that themes are collected and their frequency counted in order to obtain insight in 
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the weight by which themes and subthemes emerge (Krippendrof, 2013). Therefore, 
the theme emergence was also weighed, taking into account that the evaluation of 
qualitative data using quantitative data should be done with utmost caution 
(Krippendorff, 2013). 
Exploratory researchers should do their best to ensure it (validity), recognizing however that 
their efforts in this regard for any single study will be only partially successful and that they 
will have to wait for future explorations before the tale of validity is fully told’ (Stebbins, 2001; 
p49). Finally, ‘validity in exploration is linked to representativeness of the sample of groups, 
processes, or activities being examined’ and ‘it will be strongest when hypothetical 
generalizations emerge from direct empirical study of a set of representative instances’ 
(Stebbins, 2001; p26).  
3.2.5.2. Addressing reliability 
Reliability demonstrates that  
 
‘the operation of a study – such as the data collection procedures – 
can be repeated with the same results.  It is usually impossible to 
repeat data collection exactly, because the conditions have 
changed. But demonstrating that you have detailed evidence 
available (for example, taped interviews, transcript and coding) and 
that you have analyzed the data in a systematic way that others 
could repeat is a key reliability test’ (Partington, 2002).  
 
In other words, reliability pertains to ‘the consistency and trustworthiness of research data; 
it is often treated in relation to whether a finding is reproducible at other times and by other 
researchers (Kvale and Brinkman, 2009). In case of exploratory research, ‘reliability’ refers to 
the replication of the findings of a researcher and asks the question whether the same data 
will be obtained if the exploratory study would have been conducted by another researcher 
(Stebbins, 2001).   
 
Reliability is linked to the representativeness of a sample because the data obtained from a 
representative sample include instances of all relevant factors such as a sample of firms within 
a given range of size either by turnover, R&D expenses, number of employees, R&D activities 
or organizational structure and culture.  
 
The reliability of the approach is also addressed by adhering to a strict procedural process 
that is described in detail in Appendix E, J and L of the thesis. Reliability in interview based 
research, according to Kvale (Kvale, 2009) pertains to ‘the consistency and trustworthiness of 
research findings and ... to the issue of whether a finding is reproducible at other times and 
by other researchers’. During the conduct of this research great care was given to the 
development of and adherence to procedures that could be repeated by other researchers in 
order to increase the reliability of the data.  Reliability of the research data was achieved 
through the following steps described in detail in the table below (Table 3-1). 
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Action to increase reliability: Impact on research 
Detailed description of the development of the 
research questions for both CEO and R&D 
executives and a detailed description of the 
translation of research questions into interview 
questions using the pentathlon innovation 
framework (Goffin and Mitchell, 2011; Appendix E) 
 
To allow the repeatability of the approach used by 
other researchers when attempting to interview 
CEOs and R&D executives by offering a set of 
interview questions based on previous research on 
innovation 
Establishment of a procedure for the selection of 
firms and of the approach of each CEO or R&D 
executive (see Appendix E) 
 
To allow identical approaches in identifying firms 
and approaching each individual CEO and R&D 
executive 
Detailed procedure for the re-analysis of the 
interview transcripts after the last interview 
transcript was analyzed and themes were identified 
(see Appendix E, J and L) 
 
To ascertain that  a/ each transcript was a 
trustworthy replication of the interview and to 
ascertain that the information collected through 
the interviews is identifiable by other researchers  
and that b/ each transcript is analyzed in exactly 
identical conditions  
 
Development of detailed theme definitions  based 
upon an extensive literature review and analysis 
(see Chapter 2 and Appendix D) 
To allow other researchers to use identical themes 
for the analysis of transcripts of CEO and R&D 
interviews 
Table 3-1 Reliability enhancing actions 
3.3 Methodological fit  
This research project meets the requirements of an exploratory research project for the 
following reasons. The unit of analysis (the CEO) has received little or no systematic empirical 
scrutiny, it has been largely examined using prediction and control rather than open-
mindedness and it ‘begs to be explored anew’. The fact that this research project is of an 
exploratory nature has consequences with respect to the issue of validity and reliability as 
was discussed above, but also upon the research methodology as will be discussed below. 
As this research is exploratory in nature, it is necessary to define the type of methodology 
that is most appropriate for an exploratory research project. Stebbins observes  that:  
‘Exploration is no place for data collection formulas distilled from 
conventional theory and methodological practice. On the contrary, 
exploration is where the art of science is most widely exercised, the art of 
science where imagination reigns freely. Creativity in this domain comes 
through inductive reasoning, as researchers discover order in what initially 
appeared to them as chaos’ 
The question however is whether the exploratory nature of our research project permits the 
use of any methodological approach that suits the purpose.  It was Edmondson and McManus 
who argued that ‘compared to experimental studies, analyses of published data sets, or 
computer simulations, achieving fit between the type of data collected in and the theoretical 
contribution of a given field research project is a dynamic and challenging process’ and have 
therefore introduced ‘a framework for assessing and promoting methodological fit as an 
overarching criterion for ensuring quality field research’ (Edmondson and McManus, 2007).  
As Stebbins has focused particularly on exploratory research we will investigate 
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methodological fit in exploratory research from the viewpoint of exploratory researchers such 
as Stebbins. However, it is appropriate to look for methodological fit from the other angle, 
whereby the starting point is not the exploratory nature of the project but a more general 
framework from which methodological fit can be derived, such as the  approach presented 
by Edmondson and McManus. First, Stebbin’s view on exploratory methodology will be 
discussed followed by Edmundson and McManus’ approach. 
3.3.1 Exploratory research 
As it was argued that the proposed research is of an exploratory nature, the next question is 
which research methodology is appropriate. As stated above, exploration aims to generate 
‘inductively derived generalizations about the group, process, activity or situation under 
study’ (Glauser and Strauss, 1967; Stebbins, 2001). According to Stebbins (Stebbins, 2001; p1), 
the concept of exploratory research in the social sciences is ‘usually mentioned, if at all, only 
in passing, in Glaser and Strauss’s The Discovery of Grounded Theory (1967): Exploration aims 
to generate new ideas and weave them together to form grounded theory, or theory that 
emerges directly from data’ (Glaser and Strauss, 1967, referenced in Stebbins, 2001; p9). 
Harrison presents a matrix of research strategies that allow a fit between the researcher’s 
style and the phenomenon under study (Harrison, 2002; p170). The researcher’s style can be 
categorized between two extremes, ranging from structured to unstructured while the 
context of the phenomenon can range between fixed in time and dynamic in nature. 
Researching a fixed phenomenon can be either structured by means of a fixed route map or 
via an unstructured, rather exploratory route.  The researcher with a preference for 
unstructured methods such as grounded theory would for example address a fixed 
phenomenon – such as the role of the CEO in innovation – in a heuristic way or, as Harrison 
puts it: ‘the phenomenon exists but the researcher adapts the method to the context’.  In 
addition, ‘these ideas (generated through exploratory research) are the raison d’être of the 
enterprise, and everything else – study design, measurement techniques – is subordinate to 
them’ and  ‘a (social science) explorer is first and foremost a theorist’ while ‘theory is the 
primary goal of exploratory research and that grounded data are only a means to this end…’ 
(Stebbins, 2001; p9 and p51).  
As was stated earlier, Stebbins (2001) offered three conditions under which an exploratory 
approach is justified, especially when the unit of analysis has received  little or no systematic 
empirical scrutiny, has been largely examined using prediction and control and begs to be 
explored anew. It was argued above, that the research into the role of the CEO in innovation 
complies with these requirements. From this point of view, a grounded theory approach is 
justified as it would start to generate knowledge ground up, to generate new ideas and 
generalizations. Therefore, at first sight and seen the exploratory nature of the research, a 
grounded theory approach seems to be an appropriate strategy as it allows the explorer to 
be free and unrestricted in view of the data to be collected. However, the discussion on the 
methodology needs to be taken a step further. 
The grounded theory method relies on continuous comparison of data and theory beginning 
with data collection and emphasizes the emergence of theoretical categories solely from 
evidence and an incremental approach to case selection and data gathering (Eisenhardt, 
1989). A grounded theory approach was already used in the area of innovation and CEO-
research. For example, some researchers used grounded theory approaches in exploring 
innovation networks and the role of CEOs in change (Hargadon and Sutton, 2000; Gioia and 
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Chittipeddi, 1991). In grounded theory, ‘all the codes are discovered in the data (or developed 
from the data) in the sense that the coding is grounded in the data’. A grounded theory 
approach is therefore justified in view of an exploratory nature of a research project that is 
new and examined for the first time, which is the essence of exploration (Glauser and Strauss, 
1967; Stebbins, 2001). 
The above argument however is justified when prior knowledge on the topic would be 
minimal or non-existing and when it would explore the world of the CEO in innovation ‘ground 
up’ as if no prior empirical or conceptual knowledge was available. However this is not the 
case. In the section on the literature review, five concepts were identified which were based 
on empirical studies on the impact of CEOs in innovation:  CEO attitude, CEO attention, CEO 
commitment, CEO involvement and CEO innovativeness. In other words the research does 
not – cannot – start ‘ground up’, unless a deliberate neglect of all previous research data and 
conclusions would be assumed. This is not only a difficult psychological stance from the 
explorer’s point of view but can also be considered inappropriate as it can hardly be justified 
to neglect previous research. Therefore, a grounded theory approach – although compatible 
with an exploratory mindset and attractive in its own right – is difficult to justify.  
Therefore, a methodology needs to be identified that is  
- compatible with the exploratory state of mind,  
- takes into account previous research and the concepts developed,  
- allows an interview based approach as we will address the CEOs directly,   
- is capable to develop ideas from which to build hypothesis or generalizations and is 
- specifically developed to study the phenomenon within its context  
These parameters for selection are discussed. 
Compatibility with the exploratory state of mind. The methodology should allow for a focused 
topic of conversation which is determined in advance and for the collection of reactions and 
interpretations in a relatively open form. This requires a methodology that allows a 
conversation to take place that allows the parties to have an ‘inter-view’ and the free 
exchange of ideas (Kvale and Brinkmann, 2009). 
Account of previous research and the developed concepts. The methodology should be open 
for the introduction of concepts or categories which have been developed previously either 
through a literature review of via empirical or conceptual studies. In other words, it should be 
open for the introduction of a priori categories and theoretical frameworks in which to discuss 
and interpret the data. 
An interview based approach. In view of the nature of the unit of analysis (the CEO), it is 
imperative that we take into account the limitations posed upon our research by the poor 
availability of top managers for these type of studies (Yadav et al., 2007). One may consider 
methodologies such as ethnographic studies but should realize that this puts a heavy burden 
on the agenda of CEOs and it is not clear whether these individuals are open to the presence 
of an individual that may potentially be  ‘contaminated’ with highly confidential company 
information.  From a viewpoint of the exploratory nature of the study it is argued that the 
selected methodology should be compatible with  a focused interview of limited duration. 
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Capability to develop ideas from which to build hypotheses or generalizations. The 
methodology should allow for the building of theory from which to develop hypotheses or 
propositions that can be tested in a follow-up research project. 
Methods that are specifically developed in view of the context. As the goal of the research 
project is to better understand a real-life phenomenon, realizing that such an understanding 
encompasses important contextual conditions which are highly pertinent to the phenomenon 
of study, the methodology should – by definition – allow the phenomenon-context 
relationship.  
3.3.2 Methodological fit in management field research 
Edmondson and McManus developed an approach that addresses the methodological fit in 
management field research (Edmondson and McManus, 2007). They define methodological 
fit as ‘an internal consistency among elements of a research project’. They offer four key 
elements  of field research: research question, prior work, research design and contribution 
to literature. According to Edmondson and McManus, ‘producing methodological fit depends 
on the state of relevant theory at the time the research is designed and executed’ because ‘it 
(the relevant theory) serves as a given, reasonably fixed context in which new research is 
developed: it is the one element over which the researcher has no control (i.e. the state of 
extant theoretical development cannot be modified to fit the current research project)’.  
Edmondson and McManus propose a ‘continuum of theory’ that may drive methodological 
fit considerations. This continuum ranges from nascent theory over intermediate theory to 
mature theory and is presented in Figure 3-1 below. 
 
Figure 3-1 Theory continuum 
As was already argued above, in the case of this research, there is no solid argument to state 
that this research is taking place in an environment of mature or even intermediate theory. 
The literature review has shown that tentative theoretical concepts have been developed to 
describe the role of a CEO in high tech ventures (Makri and Scandura, 2010). As Jung et al. 
argue, transformational theory has not yet shown its value to better understand the role of a 
CEO in innovation (Jung et al., 2008). Also, the upper echelon theory was criticized for the use 
Mature 
theory
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theory
Intermediate
theory
Tentative answers to novel 
questions of how and why, 
often merely suggesting 
new connections among 
phenomena
Provisional explanations
of phenomena, often 
introducing a new construct 
and proposing relationships 
between it and established or 
tentative constructs
Well developed constructs 
and models that have been 
studied over time with 
increasing precision by a 
variety of scholars
A body of work consisting of 
points of broad agreement 
that represent cumulative 
knowledge gained
Theory continuum (acc. to Edmundson and McManus, 2007)
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of proxies such as CEO-age and CEO-tenure, as an explanatory and predictive factor for the 
role of the CEO in innovation (Boal and Hooijberg, 2000; Priem, 1990). Finally, Arendt’s model 
in strategic decision making is a useful but tentative starting point for addressing the role of 
CEOs in innovation, but again cannot reach the status of a mature theory as no empirical 
studies have underpinned the proposed model (Arendt et al., 2005). 
Therefore, it can be argued that the theoretical environment is not mature but nascent.  
According to Edmondson and McManus, in studies where theory is nascent or immature, 
researchers do not know what issues may emerge from the data and so avoid hypothesizing 
specific relationships between variables and because the theory is nascent and not much is 
known about the field or area of research, there is a need for ‘rich, detailed and evocative 
data’ to ‘shed light on the phenomenon’ (Edmondson and McManus, 2007). Edmondson and 
McManus therefore propose the use of interviews, observations, open-ended questions and 
longitudinal investigations as they are considered methods of learning with an open mind. 
This can happen through the use of ethnographic approaches or through ‘more simply 
exploratory interviews with organizational informants’. Edmondson and McManus therefore 
propose the grounded theory approach as was already discussed above and which is – 
although compatible with an exploratory mindset and attractive in its own right – difficult to 
justify. In order to allow a justified selection of a methodology,  Edmondson and McManus 
reviewed research projects that were conducted under the ‘nascent theory’ approach and 
observed that these explorative studies collected qualitative longitudinal data that were 
obtained through the use of open-ended interviews, observations of meetings, review of 
archival qualitative data, observation of all group meetings and conversations. Data analysis 
took the form of iterative, exploratory content analysis.  
The approach proposed by Edmondson and McManus asks for the collection of data retrieved 
from interviews, observations of meetings, archival qualitative data and observation of group 
meetings etc. It assumes an approach that encompasses a large variety of variables. As the 
approach in investigating the role of the CEO in innovation consists of directly approaching 
CEOs and inquiring about their role in innovation, each CEO becomes a suitable case for 
investigation. It is therefore logical that the approach consists in taking a number of ‘cases’ 
and investigate them in great detail. The obvious question therefore is whether the case study 
approach is an appropriate methodological research strategy.  
3.3.3 Case study research and its limitations for our research 
As argued by Yin in his treatise on the selection on the method of investigation, in an 
exploratory study any of the existing and acceptable methodologies could be used, ranging 
from an experiment, through survey, archival and /or historical analysis and case study (Yin, 
2009; p9). The fundamental argument used by Yin for the selection of a case study is when 
the context of the research topic is of importance: 
‘when one wants to understand a real-life phenomenon in depth, but 
such understanding encompasses important contextual conditions and 
because they are highly pertinent to your phenomenon of study’  
In addition, the case method lends itself to early, exploratory investigations where the 
variables are still unknown and the phenomenon not at all understood (Karlsson, 2009; 
Eisenhardt, 1989). In this research project the goal is to investigate the role of the CEO in the 
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specific context of science-based innovation (R&D), a context that is substantially different 
from those in which innovation is not separated  from the other activities and functions in a 
firm but – on the contrary -  constitutes a highly-specialized and bounded knowledge base of 
people, equipment, procedures, language, routines and output .   
According to Harrison, case study research is of particular value where the theory is 
comparatively weak and the environment under study is messy (Harrison, 2002). These 
comments are of relevance in our research for the following reason.  
Firstly, the proponents of the upper echelon theory were criticized for not directly studying 
the strategic leadership behavior because, in spite of the new perspectives that it opened in 
the understanding of the role of top managers in innovation, it was primarily used to study 
the influence of demographic variables to predict the behavior of top managers. However, 
top managers and their roles in innovation, remained out of focus.  
Secondly, others have used other perspectives to try to explain the CEO’s behavior in 
innovation by focusing on the leadership style (Jung et al., 2008) or by introducing new 
perspectives such as the creative and operational leadership concepts (Makri and Scandura, 
2010).  Still others have explored compensation (agency theory) to explain the CEOs behavior 
in innovation.  
Thirdly, the studies to understand the role of the CEO were conducted in very different 
industrial settings, varying from small and medium-sized companies to major corporations, 
from governmental to private organizations, and within very different fields of innovational 
settings ranging from electronics to manufacturing to banking. Some studies explored the role 
of the CEO in innovational R&D assuming that the R&D environment in one context (e.g. the 
IT industry) is managed according to the same principles and risk ratios as in another context 
(such as in the life science R&D industry).  This resulted in generalized propositions about the 
role of the CEO in innovation which hardly took into account the specific context (Harrison, 
2002, p161).   
One of the advantages of a case study, and of particular importance in our case, is that it is 
essential to draw a boundary around a study, whereby the circumstances under which the 
conclusions apply will be apparent (Harrison, 2002, p158).  
In addition, field based research can narrow the gap between practice and research because 
it takes the researcher to the field for dialogue and observation (Harrison, 2002; p.163). 
According to Harrison, case study research is actually an envelope for several possible 
research methods and structured interviews, field studies and surveys are all possible 
methods which can be deployed under the case study banner (Harrison, 2002, p. 164). A case 
study, according to Yin, is an ‘empirical inquiry that investigates a contemporary phenomenon 
in depth and within its real life context, especially when the boundaries between 
phenomenon and context are not clearly evident’ (Yin, 2009). Finally, case studies are 
considered appropriate tools in the critical, early phases of a new management theory, when 
key variables and their relationships are being explored (Yin, 2009; Eisenhardt, 1989).  
However, caution is required in view of a possible use of the case study approach, as it implies 
the collection of a variety of research data such as archival data, meeting minutes, research 
reports and even reporting of R&D meetings.  There is no guarantee that CEOs who – for 
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example – would be willing to be interviewed, would also accept to make available archival 
data (agendas, R&D meeting minutes etc) for research purposes.  Therefore, there is need for 
caution in selecting a case study approach and it was decided that in a first stage, the research 
project would consist of interviews, realizing that when trust and respect developed between 
the interviewer and the interviewee (the CEO) there would be a point in time when these 
archival data would be made available and a full case study approach can be undertaken.   
It became clear as from the first interviews, that CEOs were not prepared to make their 
agendas, meeting minutes and reports available for research purposes and therefore the case 
study approach was not selected. Therefore, it was decided to conduct this research entirely 
based on research interviews. 
3.3.4 Exploratory descriptive research 
Although it is argued that the research presented is of an exploratory nature, seen the limited 
prior knowledge of the actual role of the CEO in innovation, the use of research interviews 
leads the qualitative interviewer to 
‘encourage the subject to describe as precisely as possible what 
they experience and feel, and how they act. The focus of the 
interview therefore is on descriptions that depict the differences 
and varieties of the phenomenon’ (Kvale, 2009). 
Descriptive research is used to describe characteristics of a phenomenon. Descriptive 
research generally precedes explanatory and confirmatory research. Exploratory descriptive 
research does not answer questions about how/when/why the characteristics occurred but 
rather addresses the "what" question’ (Shields and Rangarajan, 2013). Shields and Rangarajan 
offer the example of the periodic table of elements. The table is now taken for granted by 
every chemist, but it took descriptive research by Mendeljev to construct it. For example, over 
time the periodic table’s description of the elements allowed scientists to explain chemical 
reactions and make sound predictions of what would happen if the elements described in the 
table were combined. Hence, the exploratory research in this thesis is not used to look for 
causative factors within the observed phenomenon (although it does not prevent the 
development of hypotheses for future research). Therefore exploratory research often has 
the aim of description and researchers may follow-up with examinations of why the 
observations exist and what the implications of the findings are. Another example comes from 
Sheard and Kakabadse’s study on the extent to which a role based perspective can provide 
insight into a networked form of leadership. They selected a number of individuals drawn 
from senior management teams and by means of descriptive research they were able to 
identify the actions, attitudes and beliefs of the senior managers, in view of their relationships 
within the firm’s managerial network (Shear and Kakabadse, 2007). In addition, Loch et al. 
(2007) use an interview based investigation to describe how top managers manage projects 
that they have difficulties understanding. 
In analogy, our research will need to result in a clear role description of the CEO. Instead of 
trying to find linkages between parameters (leadership behaviors, firm innovation output), 
this research specifically wants to show what CEOs do when they take responsibility and 
accountability for innovation in life science R&D firms. 
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3.3.5 Conclusion 
Quantitative (survey based) research is not an attractive approach to study the role of the 
CEO in innovation, because it has shown not to offer a better insight into the actual role of 
the CEO in innovation, let alone in the context of life science R&D. Therefore the decision was 
taken to address the research topic using an exploratory qualitative approach. Although 
compatible with an exploratory mindset and attractive in its own right, a grounded theory 
approach is not an appropriate starting point for our research either, because there is prior 
knowledge which is considered sufficiently large to develop a priori concepts. Alternatively, 
and supported by Edmondson and McManus’ view on methodological fit, the case research 
methodology allows for a focused topic of conversation which is determined in advance and 
for the collection of reactions and interpretations in a relatively open form.  The case method 
also is open for the introduction of concepts or categories which have been developed 
previously either through a literature review or via an empirical or conceptual study and is 
compatible with a focused interview of limited duration. This methodology also allows for the 
building of theory from which to develop hypotheses that can be tested in a follow-up 
research project and allows for the exploration of the phenomenon in a phenomenon-context 
relationship. Finally, the case study research approach is compatible with an exploratory 
research project. However, because CEOs were not inclined to make available confidential   
Method Use Decision Arguments Reference in 
this thesis 
Survey based 
research 
Used in surveys in an 
attempt to link CEO 
demographics to 
innovation output 
Not 
selected 
Quantitative based approaches have not 
led to a better insight into the role of the 
CEO in innovation and does not elucidate 
the actual role of the CEO 
Section 2.4 
Grounded 
theory  
Not used in CEO-
innovation research 
Not 
selected 
The research does not – cannot – start 
‘ground up’, unless a deliberate neglect of 
all previous research data and conclusions 
would be assumed. It can hardly be justified 
to neglect previous research data. 
Section 3.3.1. 
Case research Not (yet) used in 
CEO-innovation 
research 
Not 
selected 
At first sight an acceptable approach but 
seen the reluctance of the CEOs to open up 
their confidential data (agendas and 
meeting minutes) this approach was not 
selected. 
Section 3.3.3. 
Exploratory 
descriptive 
research using 
research 
interviews 
Not (yet) used in 
CEO-innovation 
research 
Selected Seen the availability of the CEOs and their 
willingness to enter into a interview 
conversation, an interview based approach 
was selected as part of exploratory 
descriptive research (Kvale, 2009) 
Section 3.3.3. 
and Section 
3.3.4. 
 
Table 3-2 Ranges of possible approaches for the research and reasons for the choices 
documents such as agendas and/or meeting minutes for reasons of confidentiality, the case 
study approach – in which each case would be explored and studied using all available 
information, processes, routines and personal data, was not feasible either. It was therefore 
decided to conduct this research using research interviews only as a means to explore and 
describe the roles of CEOs. In other words, the proposed research is of an exploratory 
descriptive nature and will make use of research interviews exclusively. The arguments for 
the selected methods are summarized in the table below. 
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3.4 Theoretical perspectives and a priori concepts 
Exploration (in the social sciences) is ‘positivistic, in part, because it is nomothetic, its principle 
goal being production of valid generalizations about a type of group, process, activity or 
situation’ (Stebbins, 2001; p11). It was already argued by Stebbins (2001) that ‘exploratory 
researchers are frequently enjoined to enter their area of study purged of all 
conceptualizations acquired in their past that might slant the present collection and 
interpretation of data’. According to Partington (2003): 
‘Apart from the obvious impossibility of … a theory-neutral state, 
management researchers attempting to operate from a ‘clean slate’ would 
be facing the impossible task of operationalizing an infinitely large number 
of potential variables. If you are building a theory it is important to start out 
with an explicit framework on which that theory can be developed. The 
framework should suit both your purpose and your research questions’  
Partington (2003) argues that ‘Theoretical frameworks in management research come in 
many different forms. They can range from elaborate multivariate conceptual-lizations and 
models to simple relationships between a few basic concepts’ and ‘...frameworks which make 
explicit the researcher’s ontological and epistemological assumptions provide the best 
foundation on which to construct and defend a theoretical argument’.  Stebbins (2001) adds 
that ‘basic concepts do abound that can help guide and expand exploration, while posing no 
significant threat of contamination to the collection and interpretation of data’.   
In view of this research, Partington’s statement that ‘.much management research is 
conducted in the positivist tradition, which holds that through observing regularities 
researchers can make generalizations, within defined limits, of relationships between 
variables’ also applies to this research (Partington, 2003). However, as argued by the same 
author, these generalizations cannot be considered as predictive certainties as ‘in the social 
world, observed regularities can do no  more than express tendencies caused by underlying 
generative mechanisms which may or may not be brought into play in a given situation’. This 
critical realist theory of reality allows speculation about possible and plausible underlying 
generative mechanisms (Bashkar, 1975). The concept of the ‘underlying generative 
mechanism’ is what generated the first data on the role of the CEO in innovation, in an 
attempt to show that the causal factors for innovation were to be found in age, tenure, 
education, experience of the CEO etc.. Seen from this angle, the upper-echelons perspective 
(Hambrick and Mason, 1984) as discussed in the literature review, touches upon the critical 
realist framework proposed by Bashkar.  Although the upper-echelons perspective was 
constructed to think about and research the role of the CEO, the proponents were criticized 
for not directly studying strategic leadership (Boal and Hooijberg, 2000; Priem, 1990; 
Damanpour and Schneider, 2006; DeTienne and Koberg, 2002). Nevertheless, this research 
has led to interesting conceptual thinking and allowed the weighing of CEO versus 
organizational and environmental factors on innovation. Other theoretical perspectives from 
leadership research have been explored and Appendix C offers an overview and discussion of 
theoretical frameworks that have not yet been used in CEO research.   
Although it was not developed to understand the role of the CEO in innovation, Arendt’s CEO 
model offers interesting perspectives to understand the role of the CEO in innovation (Arendt 
et al., 2005). According to Arendt et al., two models have been used to try to understand top-
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level organizational decision making. The first model addresses the CEO as the unit of analysis 
and is presented in the literature as the ‘CEO model’.  It has resulted in research papers that 
study the impact of CEO-age, CEO -cognition, CEO-environmental scanning and CEO-pay 
among others, on strategic decision making.  To the extent that the CEO model  focuses on 
CEOs as lone decision makers ‘the CEO model is an atomized, undersocialized conception of 
human action’ that neglects ‘the CEO’s social context’ (Granovetter, 1985) and ‘CEOs would 
wield their power and make unilateral decisions... despite needing to address multiple, 
conflicting goals and evaluate a myriad options’ (Cyert and March, 1963). Garten concludes 
that ‘this would likely limit the extent to which CEOs would choose to be ‘lone rangers’ and 
make strategic decisions single-handedly’ (Garten, 2001). The second model (TMT-model) 
used the top management team as the unit of analysis and depicts a decision making process 
that is shared by its members. The concept resulted in a broad range of scientific 
investigations addressing TMT-conflict, TMT-consensus, TMT-demographics and -
composition, among others.  According to Granovetter (Granovetter, 1985; p485), however, 
this model is an ‘oversocialized conception’ that ‘does not recognize that TMTs tend to be 
hierarchical decision-making bodies in which involvement is not equal but, rather, is driven 
by the influence of advisory systems within and outside the firm’. In other words, equal 
participation by a firm’s top managers is hindered by the presence of intrafirm coalitions, 
information asymmetries (Edmondson et al., 2003) or can ‘presage adverse decisions when a 
firm’s top managers do participate equally’ (Arendt et al., 2005).  
In view of the two models presented above and their criticism, Arendt et al. argue that 
‘accepting that the strategic decision making process for some decisions in some firms may 
conform to either the CEO model or the TMT model, many strategic decisions in many firms 
are neither made by a unilateral CEO nor by a TMT’. The authors therefore propose the ‘CEO-
Adviser model’ which ‘blends individual and group decision making... by recognizing that 
individuals involved in strategic decision making may come from anywhere in the firm’s 
hierarchy and may not be consulted on all decisions’ and which, they argue, is ‘more 
authentic’. The CEO-Adviser model involves four characteristics: the CEO as the principal 
decision maker, the advisers to the CEO who can be internal or external to the firm, the 
selection of advisers by the CEO, and the dyadic communication between the CEO and 
advisers.   
Applying the concept to this research. In view of the proposed CEO-Adviser model, the 
appropriateness of this model to the context of R&D and this research is discussed.   
First, the model proposes – in line with established theory – that the CEO is the ultimate 
decision maker in the firm. This argument is independent of the firm’s internal or external 
environment and therefore is applicable in the context of life science based R&D.   
Second, the CEO-Adviser model’s assertion is that strategic decision making is cha-racterized 
by ambiguity and complexity.  
Third, because the ‘type of information processed from a firm’s environment is likely to be 
too great for any one person’ this generates potential information overload.  
Fourth, the model allows the study of the CEO in view of his/her interaction with social 
networks such as the R&D function (Florida, 2004; Alvesson, 2004)  
 
 
Chapter 3 Research design 
54 
 
These arguments are relevant in the context of a life science R&D firm where the complexities 
of science make it highly unlikely for a CEO to take decisions unilaterally and where the 
decision making process is complicated by the potential knowledge asymmetry between CEO 
and R&D (Styhre, 2009). Based upon the assumption that the role of the CEO in life science 
R&D may be driven by the interaction with the R&D function, Arendt et al.’s CEO-Adviser 
model offers a conceptual framework that is suitable and appropriate to conduct research in 
life-science R&D firms.  
3.5 Research approach  
3.5.1 Introduction 
The literature review led to the decision to conduct research along 3 lines of conduct (see 
Chapter 2): 
i. to study the CEO directly by means of a qualitative approach  
ii. to use a combination of literature based themes of CEO attitude, -attention,-
commitment, -involvement and –innovativeness in the single context of life science 
R&D firms  
iii. to involve the R&D function to inquire how it perceives the role of the CEO seen its 
resistance to managerial practice and autonomy  
 
In addition, it was decided to take a case study approach using interview based explorations 
(see Section 3.3). This means that the research requires the identification of CEOs and R&D 
executives who report to these CEOs both of whom are prepared to accept interview based 
inquisitive conversations. The 15 CEOs (plus 2 pilot CEOs) and the 33 R&D executives (plus 6 
pilot R&D executives) who agreed to join the research project are listed in Appendix E and M 
respectively.  
 
This section proceeds as follows. First, the context of the research is presented (3.5.2.) 
followed by a description of the research approach of the 2 research projects: CEO interviews 
(3.5.3.) and R&D interviews (3.5.4.). The section on CEO interviews is further divided in two 
sub-sections: Individual CEO interviews (3.5.3.1.) and CEO focus group research (3.5.3.2). 
3.5.2 The context of research 
The research takes place in small and medium-sized firms (according to EU, EMA (European 
Medicines Agency)-definition) known for their intensive life science R&D. The reason for the 
selection of these firms is as follows: 
i. in SME life science R&D firms, the locus of innovation resides in senior and middle 
management and - if the CEO plays a role in innovation - that role should become 
clearly observable either through the arguments raised by the CEO and/or the 
arguments raised by R&D 
ii. in SMEs, CEOs have a greater - more observable - impact on firm performance and 
innovation than in larger firms (Miller and Toulouse, 1986a) 
 
In other words, small and medium-sized life science R&D firms were selected to increase the 
level of detection of observable roles of the CEO. In addition, to the group of SMEs, two big-
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pharma cases were introduced (more than 1000 employees in R&D) to contrast the 
observations made with their CEOs and R&D executives with those of the CEOs and R&D 
executives of smaller firms. The following sections discuss the case study approach for the 
CEO and the R&D executives’ interviews.  
3.5.3 The research process 
The process of the research presented in this thesis consists of 5 steps which are summarized 
in the table below. The table presents the 5 research steps, the description of each step, the 
objective, the decision point at the end of the research step, the outcome of the decision and 
the next step (Table 3-2 below; columns 1-6). Each step of the research process includes a 
decision point that is introduced in the table (4th column). Each decision point leads to a 
decision (5th column, outcome of the decision) that drives the next step (6th column). The first 
step of the research is the literature review. The second step addresses the individual 
interviews of the CEOs. The outcome of this research is then evaluated by means of a CEO 
focus group research (step 3) in which the observations of the CEO interviews are submitted 
to the group of CEOs to ‘assess their familiarity with the individual observations’ (Stebbins, 
2001).  The use of a focus group to ascertain a researcher’s results against the group of 
interviewed individuals is considered an acceptable approach (Merton et al., 1990). In 
addition, the questions used during the interviews with the CEOs are then used to interrogate 
senior R&D managers who report to the CEOs (step 4). Doing so, the outcome of the research 
interviews of the CEOs are checked against the focus group observations and against the R&D 
interview observations. A schematic overview of the relationship between data collection, 
the instruments for data collection, data analysis and conclusion is presented in Figure 3-2 
below. 
3.5.4 CEO interviews 
The CEO interviews were initiated with two pilot interviews (CEO1P and CEO2P) of which the 
procedure and the results are included in Appendix E. These pilot interviews were conducted 
to structure the final CEO interviews. 
3.5.4.1 Individual CEO interviews 
 
Research question 
An essential element in a research project is ‘that there should be one or more research 
questions to guide the inquiry and to provide focus’ (Partington, 2003). The five concepts 
attitude, attention, commitment, involvement, innovativeness were previously used to 
conduct research on the role of the CEO in innovation in different industrial settings. The 
question whether they appear in different industrial contexts and therefore are 
‘generalizable’ is a valid one. In other words, it is not clear whether concepts retrieved in – 
for example – governmental non-for-profit organizations can be found in life science R&D 
firms.  Leseure (Leseure, 2000; cited by Laforet and Tann, 2006) observes that ‘what works in 
one organization does not necessarily apply to another and managerial practices vary from 
one socio-economic culture to another’. For example, ‘attitude’ as a conceptual role of  
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Research 
step 
Description of the 
research step 
Objective of the 
research step 
Decision point Outcome of the decision Next step 
1 
Literature review 
(Chapter 2) 
To obtain a 
comprehensive 
overview of scholarly 
research on the role of 
the CEO in innovation 
Decision point 1 : Does the literature offer 
insight into the role of the CEO in innovation? 
The research does not offer 
insight into the actual role of 
the CEO in innovation in life 
science R&D firms and is 
limited to quantitative surveys 
The decision is taken to 
engage in qualitative 
descriptive research to 
explore the role of the CEO 
 -> step 2 
2 
Individual  CEO 
interviews  
(Chapter 4) 
To obtain insight into 
the role of the CEO in 
innovation in life 
science R&D firms 
Decision point 2  : The interview data 
represent a unidirectional view on the role of 
individual CEOs and it is therefore  required to 
inquire whether these observations – when 
put forward to a group of CEOs can be – 
substantiated. In other words: do the data 
require additional scrutiny in order to increase 
our understanding of the role of the CEO and 
to validate the findings? 
It is argued that the data of 
the individual CEO interviews 
require further substantiation  
by means of additional 
research within this group of 
CEOs   
The research proceeds to the 
next step by submitting the 
research interview data to a 
group of CEOs as part of a 
focus group research  
-> step 3 
3 
CEO focus group 
research  
(Chapter 4) 
To obtain confirmation 
of the findings of the 
actual role of the CEO 
in innovation from  
individual interviews by 
a group of CEOs 
Decision point 3 : Do the combined focus 
group research data and the individual CEO 
interview data warrant further confirmation 
by inquiring with senior R&D managers about 
the role of the CEO? 
It is argued that the research 
interview and the focus group 
data – although valuable in 
their own right – would profit 
from an additional research 
project in which these 
observations are checked 
against the observations made 
by senior R&D executives on 
the role of their CEOs  
The research should proceed 
to the next step by conduc-
ting research interview of 
senior R&D managers 
reporting to the CEOs  
-> step 4 
4 
Individual research 
interviews of senior 
R&D managers 
(Chapter 5) 
To obtain confirmation 
of the findings of the 
role of the CEO in 
innovation from  the 
individual CEO 
interviews and the 
focus group  
Decision point  4 : Are the results of the 
individual interviews with the senior R&D 
managers such that a conclusion can be made 
about research steps 1, 2 and 3? 
The combined data offer a 
comprehensive view of the 
role of the CEO as argued by 
CEOs and by R&D executives. 
The data have reached a level 
whereby a full analysis and 
comparison can be conducted 
Analysis of all data and final 
conclusion  
-> step 5 
5 
Analysis and conclusion 
(Chapter 6 and 7) 
    
 
Table 3-2 The research process and its decision points 
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Figure 3-2 The research process
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the CEO, was mentioned in Damanpour and Schneider’s study in non-for profit 
organizations (Damanpour and Schneider, 2006) but was not mentioned in large 
industrial R&D or small IT firms. It can therefore not be assumed that the concept 
‘attitude’, or any of the other concepts, can be used to describe the role of the CEO in a 
life science R&D firm or that no other concepts are required to describe that role.  
Therefore, the research question is twofold 
 
RQ 1  Do the literature concepts describing the role of a CEO in innovation reappear 
in the context of a life science R&D firm? 
RQ2  Do new concepts describing the role of a CEO in innovation, other than those 
described in the literature, emerge in the context of a life science R&D firm? 
 
From research questions to interview questions 
As learned from the pilot interviews during which open ended interview questions were 
used but found unacceptable (see Appendix E), the interview approach for the final CEO 
interviews will need to consist of fixed, focused questions that ‘pull’ the CEO into a 
structured conversation. An important aspect of this research therefore involves the 
development of interview questions. Interview questions were developed that address 
the innovational environment in which the CEO operates, the goal of which is to 
generate reflections by the CEO that will offer the CEO’s personal view on his role in 
innovation. A detailed description on how the interview questions were developed using 
the pentathlone framework of Goffin and Mitchell is presented in Appendix F. The final 
CEO interview questions are presented in Figure 3-3. The CEO reflections, collected 
through an interview and transcribed, will then be categorized according to a procedure 
presented in Appendix E.  
 
The nature of the interview questions 
It was argued in the beginning of this chapter that this research is of an exploratory 
nature and the use of structured interview questions may ‘feel’ contradictory: if 
research is exploratory then the nature of the questions should be less structured, on 
the contrary, they should be ‘open’ to allow exploration. It was found however that the 
use of open questions as tried during the first pilot interview was a risky approach 
because of the nature of the interviewees. The problem of interviewing elite is that it 
may have its ‘talk tracks’ ready for any interview and the interviewer requires 
considerable skill to get beyond. In order to obtain a better control on the interview 
process it was argued that a more structured approach was required in order to prevent 
the strong CEO personalities to direct the interview into ‘war stories’ that offer ‘gloss’ 
but not necessarily insight into their roles. In addition, structured interview questions 
do not necessarily limit the range of topics to be explored. The argument that only open 
interview questions would lead to a better insight is contradicted by the use of 
structured interviews that are broadly distributed over a wide range of innovation 
concepts using the innovation pentathlon of Goffin and Mitchell (2011) (see appendix 
F). 
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Figure 3-3 CEO interview questionnaire 
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Data collection and analysis 
As it was decided to conduct the research by means of structured interviews, there is a 
need to structure the approach and subsequent analysis of the interview transcripts. 
The analysis of interviews takes place by means of content analysis that consists in the 
detection of themes that emerge from the interviews (Krippendorff, 2013). A theme is 
then defined as an idea, conviction, view or proposition made by the interviewee (the 
CEO) that bears relevance to the topic of research, i.e. his/her role in innovation. The 
literature concepts of attitude, attention, commitment, involvement and innovativeness 
are used as ‘major themes’ that consist of ‘subthemes’ that contribute to the major 
theme. For example, a statement such as ‘the CEO fosters a culture of innovation’ is 
assigned as a subtheme to the major theme of ‘attitude’. Each major theme and 
subtheme is codified to allow a structured analysis of the text. For example, if a CEO 
‘argues that he/she fosters a culture of innovation’, this is identified as a subtheme that 
is assigned to the major theme of ‘attitude’ and is given a code ‘ATI1’.  Themes that 
cannot be assigned to any of the major themes or their subthemes are identified as 
‘other themes’  and codified as ‘CEO-OTHx’ (or abbreviated as ‘OTHx’) indicating that 
the theme emerged from an interview with a CEO (‘CEO-‘), is different from the major 
and subthemes (’OTH’) and is given a number ‘x’. A detailed description of the procedure 
used for the transcription and content analysis, the identification of themes, subthemes 
and other themes, is presented in Appendix E. It is appropriate at this time to define 
terms that are used in this and the following research projects. They are summarized in 
Table 3-3. 
 
Term Definition/description 
Role concept Syn. role conceptualization: a role concept /conceptualization 
describes a characteristic that reflects an underlying role behavior. 
For example, attitude describes a positional stance that can be 
observed when discussing innovation with CEOs 
A priori role 
concept 
A role concept that is defined in the literature, for example: CEO 
attention or CEO attitude 
A priori theme (or 
major theme) 
A  theme that emerges from the systematic content analysis of the 
interview transcript and can be identified as an a priori role concept 
Sub theme A  theme that emerges from the systematic content analysis of the 
interview transcript and is supportive of an a priori theme 
Other theme (or 
new theme) 
A  theme that emerges from the systematic content analysis of the 
interview transcript and cannot be assigned to an a priori theme   
 
Table 3-3 Overview of terms used in the research 
The general approach for the systematic analysis is as follows: 
Step 1. A theme structure identified as a primary/secondary node structure (PSN 
structure) for use in NVivo analysis is developed based on the 2 CEO pilot interviews (see 
Appendix E). The ‘primary’ nodes in this PSN structure represent the major themes: 
attitude ATI, attention ATT, commitment COM, involvement INV, innovativeness INN 
while the secondary nodes represent subthemes such as ATI1, ATI2 etc. derived from 
 
 
Chapter 3 Research design 
61 
 
the literature. The pilot interviews also led to other themes and they are presented as 
‘CEO-OTH’ or abbreviated as ‘OTH’ (primary node) and respective secondary nodes 
(OTH1, 2 etc.). This is presented in Table 3-4. 
ATI Attitude  
ATI1 CEO fosters a culture of innovation 
ATI2 CEO fosters experimentation and accepts failures 
ATI3 CEO fosters internal communication 
ATI4 CEO fosters the exchange of diverse ideas 
ATI5 CEO fosters external collaboration to increase internal innovation 
ATI6 CEO fosters flexibility and adaptability 
ATI7 CEO fosters learning in the organization 
ATT Attention 
ATT1 CEO sets the direction/goal and vision in which innovation to take place 
ATT2 CEO sets the focus and boundaries in which innovation to take place  
COM Commitment 
COM1 CEO hires selects and develops innovative leadership 
COM2 CEO creates incentives and rewards for the R&D function 
COM3 CEO prioritizes resources 
COM4 CEO makes available human and financial resources 
COM5 CEO empowers R&D to execute on new ideas 
COM6 CEO creates hierarchical flat organizational structures for innovation 
COM7 CEO reduces development risk by hiring expert people and developing options 
INV Involvement 
INV1 CEO challenges R&D for efficiency 
INV2 CEO challenges R&D technically 
INV3 CEO acts as sounding board 
INV4 CEO interacts with R&D to solve technical problems 
INV5 CEO is involved in NPD 
INV6 CEO holds frequent formalized meetings with R&D 
INN Innovator 
INN1 CEO drives new product development in person 
INN2 CEO takes control of every detail of NDP 
INN3 CEO wants to transform/disrupt the market 
OTH Other roles or themes (from the pilot studies) 
OTH1 CEO admits limited knowledge in specific R&D area 
OTH2 CEO admits not driving innovation but rather the direction of innovation 
OTH3 CEO interacts with R&D only in those matters he/she has personal knowledge in 
OTH4 CEO should not focus on technology 
OTH5 CEO stresses the importance of strong knowledge in the field of innovation 
OTH6 CEO requires R&D data to be simplified for strategic decision and communicaton 
OTH7 CEO wants R&D to step out of academic thinking 
OTH8 CEO role model is knowledge based 
OTH9 CEO aims to obtain respect from R&D 
OTH10 CEO attempts to understand R&D expertise 
OTH 11 CEO carries R&D through difficult times 
OTH12 CEO considers it an advantage to be untrained in science 
OTH13 CEO considers himself at a disadvantage as a non-scientist 
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OTH14 CEO informs R&D about the company's position 
OTH15 CEO role model is business driven 
OTH16 CEO wants to protect R&D from the mundane aspects of running a firm 
 
Table 3-4 Primary/secondary node structure ‘PSN2’ 
This primary/secondary node structure is identified as primary/secondary node 
structure ‘PSN2’ because it was developed after the second pilot interview (see 
Appendix E).  
 
Step 2. the PSN2 instrument is then used to systematically analyze the CEO interview 
transcripts. As a result of this analysis, new themes were introduced in the 
primary/secondary node structure PSN2 and hence PSN2 developed in a more extended 
primary/secondary node structure as more and more interviews were analyzed. This led 
eventually to ‘PSNn’, or the nth primary/secondary node structure obtained after the 
last CEO interview. This PSNn instrument was then used again to re-analyze all the 
interviews of the CEOs. This approach is represented in extensive detail in Appendix E.  
 
Step3. The themes are then collected and their frequency counted in order to obtain 
insight in the weight by which themes and subthemes emerged from the interviews 
(Krippendorff, 2013). 
3.5.4.2 CEO focus group research 
Introduction 
The objective of this research is to inquire how CEOs, when brought together, respond 
to the findings of the interviews of their colleague-CEOs. Doing so, this focus group 
research acts as validation instrument to evaluate whether the observations made by 
the interviewer sound familiar with the CEOs and whether any of the comments raised, 
generate new ideas or themes that would give additional clarification of their roles in 
innovation. It was therefore decided to establish a focus group whereby the interviewed 
CEOs were invited to attend and to participate in a discussion of the findings of the CEO 
interviews.  
 
According to Morgan (1997), ‘focus groups are basically group interviews, although not 
in the sense of an alternation between a researcher’s questions and the research 
participants’ responses. Instead, the reliance is on interaction within the group, based 
on topics that are supplied by the researcher who typically takes the role of a 
moderator’.  Although focus group research can be used as a ‘self-contained social 
inquiry method in which they serve as the principal source of data, in this case, the 
method is used as a supplementary source of data in studies that rely on some other 
primary method such as individual interviews’ (Morgan, 1997). In other words, the focus 
group research method is used to add to the data gathered through the individual CEO 
interviews and the same CEOs who were interviewed were invited to take part. Four 
broad criteria should be met for the conduct of effective focus group interview:  
 
- the range of topics: the range of the topics covered in the focus group research 
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- the specificity of the data: the provision of data for a focus group research  
- the depth of the interaction: the fostering of interaction that explores the 
participant’s feelings in some depth 
- the personal context:  the taking into account of the context that participants 
use in generating their responses to the topic 
These four requirements are discussed below in view of our research project.  
The range of topics refers to topics which may have been identified via other qualitative 
techniques and which reappear during the focus group discussions. Alternatively, new 
topics or themes emerge that the researchers had not anticipated (Merton et al., 1990). 
However,  according to Merton, ‘researchers sometimes inad-vertently narrow the 
discussion by implicitly assuming which themes are important’ (Merton et al., 1990). It 
should be avoided to moderate the discussion such that the observations are either up- 
or downgraded. In this research, the range of topics that was introduced in the focus 
group discussion was limited by and derived from the CEO interviews.  
Merton et al. emphasize ‘specificity to direct the focus group discussions toward 
concrete and detailed accounts of the participants’ experiences’ because ‘it can be all 
too easy for participants to drift into generalities, but an emphasis on hearing about the 
participants experiences can help to counteract this tendency’. This is particularly 
important, as it was observed during the pilot interviews that they tended to drift into 
the story telling of ‘war stories’ (see Appendix E), an observation that forced the decision 
to develop a structured interview rather than an open interview approach (which was 
used for the pilot interviews, see Appendix E). In the case of the focus group meeting, 
their interest into the topic became clear during the interviews and the interaction 
afterwards, and guaranteed focus without the tendency of falling back into ‘war story’ 
telling. 
A third topic of interest is the topic of ‘depth of interaction’ which is linked to the 
participant’s involvement with the material he/she discusses. According to Merton et al. 
the ‘goal is to avoid a discussion of vague generalities’. This is less important, according 
to Merton et al. (1990), with ‘participants who are highly involved with a topic because 
they already have a motivation to share opinions and experiences’. This is the case with 
our focus group research as the CEOs who volunteered to join the focus group showed 
a keen interest in discussing the role of the CEO in innovation. 
The final criterion offered by Merton et al. is the attention to the personal context from 
which the individual comments arise and ‘the point of doing a focus group research is to 
bring a number of different perspectives into contact‘ (Merton et al. 1990). In our case, 
not only are the 4 CEOs different personalities with different educational backgrounds 
and experiences, they also run companies that are different in view of the number of 
R&D scientists that they employ and the nature of life science R&D that they conduct. 
Research question 
The main objective of a focus group research– in contrast with an individual interview 
approach – is to observe the interaction among the focus group participants (Morgan, 
1997). To observe the interaction is to specifically look for assertion, comments, and 
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quotes that are the direct result of that interaction in order to either ascertain previous 
themes or to identify new themes. The objective of this focus group research with the 
CEOs is to answer the following research question (which is the interview question): 
RQ Are the conclusions of the CEO and the R&D interviews, either strengthened, 
weakened or even extended with new themes when put forward to this group of 
CEOs to which the research conclusions are presented? 
3.5.4.3 Research procedure 
The selection of the CEOs for the focus group and the approach used, is presented in 
Appendix J. 
3.5.5 R&D interviews 
The objective of the interviews of the R&D executives is to gain insight in the role of the 
CEO as perceived by the R&D function. The interviews started with 6 R&D pilot 
interviews, of which the procedures and results are included in Appendix L. The R&D 
executives who joined the interviews are listed in Appendix M.  
3.5.5.1 Research question 
This research addresses the question whether the CEO role behaviors, as stated by the 
CEOs, are also perceived as such by R&D executives and whether they use the same – 
or other - CEO role descriptions.  Therefore, the research questions are:  
 
RQ 1  Are the role concepts used by CEOs in innovation in life science R&D also 
perceived by the R&D function? 
RQ2  Does the R&D function use concepts to describe the role of a CEO in 
innovation, other than those used by the CEOs? 
 
These research questions are transformed into interview questions. The approach used 
for this transformation is presented in Appendix J. The resulting R&D questionnaire is 
presented in Figure 3-4 below. 
3.5.5.2 Research procedure 
The analysis of the R&D interviews takes place by means of a systematic content analysis 
of the interview transcripts and consists in the detection of themes that emerge from 
the interviews. A theme is defined as an idea, conviction, view or proposition made by 
the interviewee (the R&D executive) that bears relevance to the topic of research, i.e. 
his/her perception of the CEO’s role in innovation. The literature based a priori themes 
of attitude, attention, commitment, involvement and innovativeness are used as ‘major 
themes’ that consist of ‘subthemes’ that contribute  
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Figure 3-4 R&D interview questionnaire 
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to the major theme. For example, a statement such as ‘our CEO fosters a culture of 
innovation’ is assigned as a subtheme to the major theme of ‘CEO attitude’. Each major 
theme and subthemes are codified to allow a structured analysis of the R&D executives’ 
interview transcript. For example, if a R&D executive argues that ‘my CEO fosters a 
culture of innovation’, this is defined as a subtheme that is assigned to the major theme 
of ‘attitude’ and is given a code (ATI1). Themes that emerge from the R&D executive 
interviews and that cannot be assigned to any of the literature based a priori themes are 
either assigned to a theme that was developed earlier by the CEOs during their 
interviews and codified using codes ‘CEO-OTHx’ (see above) or to a new theme, 
exclusively used by R&D executives and codified as ‘RD-OTHx’, indicating that the theme 
emerged from an interview with a R&D executive (‘RD’), is different from the other 
themes (either literature based or developed by a CEO) (‘OTH’) and is given a number 
‘x’. A detailed description of the procedure used for the interviews of the R&D executives 
is presented in Appendix L. 
3.6 Analysis of the data 
3.6.1 Quantitative analysis of qualitative data 
As will be observed in the following chapters, the interview data will not only undergo a 
qualitative analysis using the a priori based concepts, but they will also be subjected to 
a quantitative analysis in order to obtain an understanding of the intensity by which 
some concepts re-emerge during the interviews. According to Krippendorf, themes can 
be collected and their frequency counted in order to obtain insight in the weight by 
which themes and subthemes emerge (Krippendorff, 2013). When analyzing transcripts 
from interviews, one is tempted – especially when one has a natural science background 
- to quantify the data that emerges from qualitative sources. The analysis of the content 
of the interview transcripts therefore draws from Krippendorff’s treatise on content 
analysis (Krippendorff, 2013) in which the author argues that the evaluation of 
qualitative data using quantitative analysis is feasible and acceptable but only with 
utmost caution because 
 
‘it is most important to keep their Janus-faced character in mind’ 
 
Therefore, our analysis draws only tangentially from a quantitative analysis. Ward (2007) 
comments upon on the quantification of qualitative data as follows: 
‘Qualitative researchers may criticize quantification of qualitative 
data, suggesting that such an inversion sublimates the very qualities 
that make qualitative data distinctive: narrative layering and textual 
meaning. … (However) with the quantifying of qualitative data, 
framing it in a scientific construct, one is capable … of allowing 
numbers to “speak” in order to enhance our understanding of data’ 
Therefore, the data that will emerge from the interviews will also undergo a simple 
quantitative analysis (by means of measuring the frequency of appearance of themes).  
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3.6.2 Data 
The analysis of the interviews for the CEO interviews, the CEO focus group and the R&D 
interviews is presented in extensive detail (procedures, questionnaire, interview 
observations, operational data, content analysis etc.) in the appendices summarized 
below.  
 
Research data: 
 
CEO interviews Individual R&D 
interviews Individual CEO 
interviews 
CEO focus 
group 
Introduction and pilot 
studies 
App. E App. J App. L 
From research questions 
to interview questions 
App. F App. J App. L 
Interview transcript 
analysis& results 
App. H App. K App. O 
List of CEOs and R&D 
executives 
App. E App. J App. M 
Interview observations App. I App. K App. P 
Operational data App. G App. J App. N 
 
Table 3-5 Overview of the appendices in which detailed research data can be found 
Figure 3-5 offers a schematic overview of how the data find their way into the final 
conclusion in the last chapter.  
 
3.7 Alignment of purpose, method and outcome 
The alignment of purpose, method and outcome is presented in the table below (Table 
3.6). It presents the purpose of the proposed research, the methods used to achieve the 
objective and the outcome of each. The main purpose of the research is to obtain  insight 
into the actual role of the CEO. In order to do achieve this purpose, it was decided to 
explore this role by directly approaching CEOs and R&D executives by means of research 
interviews, an approach that hitherto was not used in research that addresses the role 
of the CEO in innovation. It stands in contrast with previous investigations where the 
role of the CEO was explored using surveys and by linking CEO demographics to 
innovation output. Therefore, it is argued here that the purpose of the study 
(understanding the CEO’s role), the methods (structured research interviews) and the 
outcomes (a better understanding) are aligned. 
 
As a result, the outcome of each of these methods (CEO interviews, CEO focus group 
and R&D interviews) is aligned with the purpose of the research, i.e. the description of 
the role of the CEO in in innovation in a life science firm. We will come back to this table 
in Chapter 7 Discussion and conclusion. 
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Figure 3-5 Overview of data analysis and flow 
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Research interviews 
of 15 CEOs  
 
To obtain a description 
of the role of the CEO in 
innovation as seen by 
CEOs 
 
A description of the role that CEOs play in 
innovation in a R&D life science setting as 
viewed by the CEOs 
 
CEO focus group of 4 
CEOs to which the 
observations of the 
individual CEO 
interviews are 
presented  
To inquire whether CEOs 
agree among themselves 
about the described role 
by each of the CEOs 
To find support by the focus group CEOs for the 
statements made individually by the their 
colleague CEOs thereby supporting the validity of 
the research observations during the individual 
CEO interviews 
 
Research interviews 
of 33 R&D managers 
reporting to the 15 
CEOs  
To inquire whether the 
role description offered 
by the CEO is perceived 
as such by R&D 
To ascertain the validity of the research 
observations during the individual CEO 
interviews by using the R&D manager’s point of 
view on the role of the CEO thereby avoiding 
potential bias from the part of the interviewer  
 
             
Table 3-6 Alignment of purpose, method and outcome 
3.8 Summary 
The research design consists of exploratory descriptive research into the role of CEOs in 
innovation in life science R&D firms using structured interviews. It is divided in two parts.  
Literature 
review
A priori 
themes
Content 
analysis
CEO 
interview 
recordings
Overview of 
themes from 
interviews: 
A priori  themes +
CEO  themes
R&D
interview 
recordings
Discussion
Discussion
Comparing data
Final conclusion and 
conceptual framework
Contribution to theory
Contribution to practice
Overview of 
themes from 
interviews: 
A priori  themes 
+
CEO  themes +
R&D themes
CEO
Interview
transcript
CEO
Interview
transcript
CEO
Interview
transcript
CEO
Focus
Grou
transcripts
CEO
Interview
transcript
CEO
Interview
transcript
CEO
Interview
transcript
CEO
transcripts
CEO
Interview
transcript
CEO
Interview
transcript
CEO
Interview
transcript
R&D
transcripts
CEO 
Focus group
recordings
Content 
analysis
Chapter 2
Chapter 7
Chapter 6
Chapter 4
Chapter 5
App O
App E
Findings –
the role of 
the CEO as 
seen by 
CEOs
Findings –
the role of 
the CEO as 
seen by R&D
App I
App H
App J
App K
App P
App L
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The first part (Chapter 4) consists of structured interviews of 15 CEOs, the majority of 
which run small and medium sized life science R&D firms that have an R&D function 
headed by a director/VP R&D or a CSO and innovate by internal R&D. Two CEOs run a 
big-pharma company. The interviews are continued during a CEO focus group research 
of 4 CEOs. The concepts retrieved from the literature, and used as a priori themes for 
content analysis, are: CEO-attitude, -attention, -commitment, -involvement and -
innovativeness. New themes that emerge during the interviews will be assigned to an a 
priori theme codified as ATI (attitude), ATT (attention), COM (commitment), INV 
(involvement) and INN (innovativeness) or to a new theme that cannot be assigned to 
the literature based a priori concepts. The objective of the first part of our research is to 
allow the 15 CEOs to describe their role in innovation such that it becomes clear of what 
they actually do when they lead innovation in their firms. 
The second part (Chapter 5) consists of structured interviews of 33 R&D executives who 
report to the interviewed CEOs in an attempt to explore whether the description that 
CEOs use to refer to their role in innovation and the themes raised, are perceived as 
such by R&D executives or whether new themes emerge. 
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4 Findings - the role of the CEO as seen by CEOs 
4.1 Introduction 
This chapter is the first part of the research and constitutes the view of CEOs as they 
reflect on their role in innovation. It presents the findings of the structured interview of 
15 CEOs. It is divided in five parts. First the findings of the individual CEO interviews are 
presented in Section 4.2. It is divided in an example interview (4.2.1.) and the findings 
of the final CEO interviews (4.2.2.). It is then followed by the findings of the CEO focus 
group research (4.3). The data are discussed in Section 4.4. and summarized in Section 
4.5. The objective of the research reported in this chapter was to explore the self-
perception of the CEOs as to their role in innovation in life science R&D firms and to 
inquire whether they use literature based a priori themes such as attitude, attention, 
commitment, involvement or innovativeness to describe their roles and/or use other 
themes. 
4.2 Individual CEO interviews 
4.2.1 Example interview 
This section presents an example of a CEO interview in an attempt to offer the reader a 
flavor of the richness of the interviews. It is not a complete transcript but a four page 
extract of some crucial moments during the interview with CEO2, a serial CEO of some 
well known and reputed life science R&D firms. The sample starts when the discussion 
is on innovation in life science R&D firm and the unusual characters scientists are. 
INTERVIEWER  
Dr. (name of CEO), thank you for this interview, let us start with the first 
question : what do you think are the attributes of the role of a CEO in 
innovation? 
 
CEO2  
I think what you try to do is create an environment where it can happen, 
I think you have to do that - when you’ve got an organization like ours, 
you know … we’ve gone from an academic start up to a platform 
company, through to products in the clinic and going through all those 
phases you become more and more formalized as you go through, you 
raise more money, you become public, you have more deadlines that 
are important and meet more demanding stakeholders and within that 
framework you have a lot of delivery tasks to achieve whether it be 
financial goals, R&D goals whatever they may be and at the same time 
what you’re trying to do is to keep the structure out here where 
innovation is more free to occur because I think that’s important. By 
that…I just mean…allowing people, allowing some space for pure 
research ideas to take place outside the very tough constraints of the 
day to day deliver this by tomorrow… 
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.... if we’re talking about the research innovators, they are more unusual 
characters very often, they’re not normally straight forward in the way 
they behave or they interact and its really keeping a cage where you 
protect them from the outside organization and also protect the 
organization from them to some degree .... they’re moving in a different 
way than the rest of the organization, you don’t expect them to turn up 
for the corporate meetings, you don’t expect them to know what our 
cash balance is, you don’t expect them to know what the next milestone 
is, that’s the way they think about the world at all and it is that dynamic 
between that and the rest of the organization... they are very powerful 
individuals generally, with a lot more freedom to explore ideas, to think 
about anything basically that they want to think about ... I’m not exactly 
sure to say what they’re doing... 
 
INTERVIEWER 
What  are in your opinion the major leadership characteristics of a CEO 
in a life science R&D firm …? 
 
CEO2 
Grey hair is always helpful! I think that particularly in life science 
companies though I think most of our employees are scientists now … 
I’m a PhD in science but I stopped science very soon after I did a PhD so 
I would never call myself a scientist, I think one of my most important 
functions I think is to make sure that the scientists in the company 
believe I understand at any level what they’re doing … one of the things 
a CEO has to be able to do is that everybody should be very, very afraid 
of trying to tell him anything that’s not true about the science, not that 
I can compete with these people in the science but I can tell when I’m 
being told rubbish, I can tell when there isn’t support to the idea and I 
think that allows me to challenge not just the finance guy, not just the 
commercial guy but also any science that is presented to me, or all 
clinical data that’s presented to me, not above that level but I think I’m 
stronger from the high level side of its principles that if the sound data 
isn’t there … and most importantly I think the ability to be confident to 
say I don’t understand what you just told me, tell me again until I do 
and we’re not leaving the room until you do, if you feel weak about 
yourself in the science, it’s very hard for you to do I think, I don’t feel 
weak and I just sometimes take three times to understand it, but if I 
don’t get it by the third time it’s their fault, there’s something wrong 
about their logic, about the thing ...  
 
I think the other key thing is to be able to reduce this complexity to 
simple ideas, one of my current themes in the organization is that the 
technical people will come and present me with a new idea … it will be 
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35 power point slides and by number 3 I’m already twitching and I know 
it’s very simple…but the idea that you can’t reduce half a pager to one 
or two slides, an important idea or concept (I know you can’t produce 
all the data) … distill out the important, the core, when you’ve got so 
much heavy technical stuff and potentially heavy commercial stuff and 
clinical stuff all floating in there, what’s the thing at the heart of that, 
what’s the business proposition, what’s the thing you take to an 
investor, what’s the thing you say to a new employee as you’re trying to 
track him into the company or whatever, what’s the distillation of all 
this complexity because we could take a year to tell you what we do or 
we could take five minutes to tell you what we do and I think its my job 
to be able to do the five minute elevator pitch and I don’t mean that 
superficially, I think its get the best out of what we do, so I think that 
communicating as a leadership thing is very important... 
 
INTERVIEWER 
How do you create a climate of innovation? 
 
CEO2 
I think it goes from the very top, make sure that its clear that you want 
that to happen in the organization, you have to draw some sort of 
framework where you say this is a playground…and for instance in that 
sort of group we also tend to keep the managerial structures very flat 
so people don’t have to do lots of management of people, they don’t 
have to worry about appraisals and all this sort of stuff, they do less of 
that than any other part of the organization because it doesn’t work 
very well for many where they hate all that stuff, they don’t do it well 
and if you can keep it as flat as possible, that seems to work very well… 
 
INTERVIEWER 
Are you actively looking yourself for new ideas as a CEO?... 
 
CEO2 
I think more as a facilitator so I think I’m approached quite a lot, so if 
I’m at a conference, just through email, people come to me with what 
do you think about this and I would be an initial screen you know... 
 
INTERVIEWER 
How do you as a CEO actually increase output of R&D ..? 
 
CEO2 
I think in general, output is an important role with the CEO, in all honesty 
I think we struggle to measure it, I think we’re trying again to measure 
it, what the output is and bringing in real benchmarks but I think we 
struggle with that, I think quite honestly what you do as CEO is you 
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create more and more pressure until a time that you think the pressure 
is enough and it becomes negative, if you can’t measure … 
 
INTERVIEWER 
What are your incentives to stimulate innovation? 
 
CEO2 
Nothing formal I think that’s – so people don’t get money, they get 
recognition. 
 
INTERVIEWER 
And how is that shown that recognition? 
 
CEO2 
I think what we’re currently doing is identifying or have identified what 
we call the high performers which are generally the innovators around 
the organization, a lot of them are innovative … with them we’re doing 
on a case by case basis interviews where we identify what makes them 
tick, what do they need, some of them want a hat, some of them want 
some stripes, some of them want 50 Euros a month, some of them want 
a car, some of them don’t want anything except me to pat them on the 
back every day, each of us are turned on by different things like that and 
we’re trying to get at the heart of that innovating group and see what 
they want rather than try and present a 500 Euro bonus for someone 
who comes up with a bright idea, we think that’s all a bit of a plain tool, 
we’re trying to custom design on a person by person basis. 
 
INTERVIEWER 
To what depth are you involved in those discussions....? 
 
CEO2 
I think with a clinical trial I’d be engaged at the beginning when we 
design the format for the trial, when we buy into what we’re trying to 
do and what we’re trying to achieve what the size of the trial is and 
what the consequence of the trial is, understanding and mapping that 
out and once a trial starts I’m generally only involved when things go 
wrong otherwise I’m getting told once a week, once every two weeks  - 
its fine don’t worry, we’re doing exactly what we said we’d do... 
 
INTERVIEWER 
Do you sometimes go down to the labs and to talk to the scientists? 
 
 
 
CEO2 
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Quite rarely mainly because two reasons 1) because we’re working to 
more and more regulated environments and me just walking into a lab, 
it disturbs the flow, it also its what I’ve heard … our CSO did do in the 
past and I wouldn’t do because its more expected that the CSO goes in 
and says what are you doing with that gel and how does that work and 
what’s going on so immediately it makes people a bit more nervous so I 
tend to wait more in the project teams when they’re prepared and they 
seem more comfortable and they know what they’re going to try and 
present to me. 
 
4.2.2 Final CEO interviews  
The operational interview data are presented in Appendix G. The findings are presented 
below and divided in three sections. The first section (4.2.2.1.) presents the raw data 
obtained from the content analysis. The data are presented in five steps. First, the 
distribution of the major themes (attention, attitude, commitment, involvement and 
innovativeness and the ‘CEO other roles’-theme) is presented (see below under 4.2.2.1. 
Content analysis, Distribution of major themes). Second, a number of new subthemes 
that emerged from the interviews will be identified (see below: New subthemes).  Third, 
the relative distribution of subthemes is reported (see below: Distribution of 
subthemes). Fourth, further subtheme categorization is conducted and a number of 
themes are brought together under single themes (see below: Further theme 
categorization). Fifth, the data are analyzed in order to allow the identification of 
subthemes which are worth exploring further (see below: Subtheme analysis). The 
second section (4.2.2.2.) presents interview observations. 
4.2.2.1 Content analysis 
The findings of the content analysis are tabulated in Table 4-1 below. It presents the 
different themes that emerged from the interviews: attitude, attention, commitment, 
involvement, innovativeness and other themes each with their subthemes. For example, 
the major theme attitude, ’ATI’ collects a number of subthemes ‘ATI1’ to ‘ATI9’. New 
themes have also emerged under the major theme ‘CEO-OTH’ as ‘CEO-OTH1’ to ‘CEO-
OTH53’. The table also presents: 
 
Nt:  the number of times the theme or subtheme appears in all interviews 
Ni:  the number of interviews in which the theme emerges 
Ri:  the ratio of the number of interviews in which the theme appears to the total 
number of interviews. It represents the fraction of interviews in which the theme 
emerged 
 
Distribution of major themes 
For each transcript that was analyzed, the frequency of appearance of an a priori theme 
(attitude, attention, commitment, involvement, innovator) and the themes under ‘CEO 
other roles’ are collected and presented in Table 4-1.  For example, in the  
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interview with CEO1, he/she referred to an attitude related theme 12 times (i.e. ATI1, 1 
time; ATI2, 1 time; ATI3, 3 times; ATI4, 1 time; ATI5, 3 times; ATI6, never; ATI7, 2 times; 
ATI8, 1 time; ATI9, never; or in total: 1+1+3+1+3+0+2+1+0 = 12). CEO4 uses 13 ‘CEO-
other’ themes to describe his/her role (i.e. CEO-OTH6, 2 times; CEO-OTH10, 1 time; CEO-
OTH12, 1 time; CEO-OTH19, 2 times; CEO-OTH20, 1 time; CEO-OTH21, 1 time; CEO-
OTH22, 2 times; CEO-OTH23, 1 time; CEO-OTH24, 1 time; CEO-OTH25, 1 time or in total: 
2+1+1+2+1+1+2+1+1+1 = 13 times). The a priori themes of attitude, attention, 
commitment and involvement and their related themes are mentioned respectively 67, 
48, 58 and 47 times in total (see shaded areas in Table 4-1). The theme of CEO 
innovativeness is only mentioned once during the interviews (by CEO9). The data shows 
that: 
 
- all CEOs address the concepts of attitude, attention, commitment and 
involvement in varying degrees, 
- only one CEO (CEO9) referred to the concept of innovator. It was the CEO 
academician/founder of the firm. Overall, no CEO referred to his/her role as the 
driver of new product development, takes control of every detail of the new 
product development process and/or develops his/her idea in order to 
transform/disrupt the market with new products 
- CEOs use a myriad of other themes to describe their role in innovation (CEO-
other: CEO-OTH1 to CEO-OTH53). This indicates that a priori concepts only 
represent a fraction of the role descriptions that are used by CEOs. Especially 
CEO14 was creative in raising themes on his/her role in innovation which were 
not defined earlier. 
New Subthemes 
In the a priori theme of ATI ‘attitude’, 2 new subthemes appeared (the other subthemes 
ATI1 to ATI7 were part of the primary/secondary node structure used to analyze the 
interview transcripts): (ATI8): ‘CEO states processes may stifle innovation’ and (ATI9): 
‘CEO has an inquisitive nature: asking, listening, probing’. They refer respectively to one 
of the CEO’s argument that a culture of innovation is difficult to attain if business 
processes prevent the use of experimentation and the challenging of established 
procedures. ATI9 refers to the attitude of CEO8 who argued that an important task of a 
life science R&D-CEO is to ‘ask questions’ that are ‘inquisitive, probing’ in order to better 
understand the details, the underlying mechanisms or processes of a R&D problem.  The 
CEO underlined that this process of ‘inquiring and probing’ is different from the attitude 
of challenging, but rather an approach that led him/her to uncover hidden ideas and 
propositions that cannot be unveiled by a challenging process that is destined to search 
for the limits of an undertaking rather than the depth of it. Another new subtheme was 
assigned to the theme of commitment and referred to the CEO’s role to secure sufficient 
financial resources and to manage an ideal cash flow for the firm (COM8). Under the 
theme of involvement, four new subthemes appeared.  Subtheme INV7: ‘CEO is involved 
at the start of an R&D project and then delegates it’ referred to the statement made by 
CEOs who argued that involvement is not linked to discussions during the R&D project 
but is
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Themes and subthemes Nt Ni Ri 
ATI ATTITUDE 67 14 0,9 
ATI1 CEO fosters a culture of innovation 1 1 1  1 1  1  1  2 1  3 13 10 0.7 
ATI2 CEO fosters experimentation and accepts failures 1 1 1  1  1      1   6 6 0.4 
ATI3 CEO fosters internal communication 3 3 1 2   1 1        11 6 0.4 
ATI4 CEO fosters the exchange of diverse ideas 1 2 2  1  3 1        10 6 0.4 
ATI5 CEO fosters external collaboration to increase internal innovation 3 1 3  1 1 1 2 1  1 1 1   16 11 0.7 
ATI6 CEO fosters flexibility and adaptability    1    1        2 2 0.1 
ATI7 CEO fosters learning in the organization 2   2    1        5 3 0.2 
ATI8 CEO states that processes may stifle innovation 1 1   1   0        3 3 0.2 
ATI9 CEO has an inquisitive nature: asking, listening, probing        1        1 1 0.1 
ATT ATTENTION 48 14 0,9 
ATT1 CEO sets the direction/goal and vision in which innovation to take place 3  2 2 1 1 3 2 1 3 2  3  3 26 12 0.8 
ATT2 CEO sets the focus and boundaries in which innovation to take place 3 1 2  1 1 2 1 2 1 1 3 2  2 22 13 0.9 
COM COMMITMENT 58 14 0,9 
COM1 CEO hires selects and develops innovative leadership 2  2  1  2 1   1    1 10 7 0.5 
COM2 CEO creates incentives and rewards for the R&D function 1 1 1  1 2 1 1        8 7 0.5 
COM3 CEO prioritizes resources 2 1 1            4 8 4 0.3 
COM4 CEO makes available human and financial resources  1 1  2 1   1   2   1 9 7 0.5 
COM5 CEO empowers R&D to execute on new ideas 1  1  3 1          6 4 0.3 
COM6 CEO creates hierarchical flat organizational structures for innovation 1 2 1 2 2 1 1 1 1 1    1 1 15 12 0.8 
COM7 CEO reduces development risk by hiring expert people and developing options       1         1 1 0.1 
COM8 CEO manages ideal cash flow for LFRD firms    1            1 1 0.1 
 
 
Chapter 4 Findings – the role of the CEO as seen by CEOs 
77 
 
INV INVOLVEMENT 47   
INV1 CEO challenges R&D for efficiency  1  1 1  1    1 2   1 8 7 0.5 
INV2 CEO challenges R&D technically  1        1  2   2 6 4 0.3 
INV3 CEO acts as sounding board 2 1   1 1 1  1      1 8 7 0.5 
INV4 CEO interacts with R&D to solve technical problems             1   1 1 0.1 
INV5 CEO is involved in NPD   2  1   1 1  1    1 7 6 0.4 
INV6 CEO holds frequent formalized meetings with R&D 1   1  1 1 1      1 1 7 7 0.5 
INV7 CEO is involved at the start of an R&D project and then delegates it  1        1   1   3 3 0.2 
INV8 CEO comes up with new innovative ideas       1      1   2 2 0.1 
INV9 CEO evaluates economic viability of R&D project             3  1 4 2 0.1 
INV10 CEO picks up to R&D innovational opportunities             1   1 1 0.1 
INN INNOVATIVENESS 1  
INN1 CEO drives new product development in person         1       1 1 0.1 
INN2 CEO takes control of every detail of NDP                0 0 0.0 
INN3 CEO wants to transform/disrupt the market                0 0 0.0 
CEO-OTH CEO OTHER THEMES 130  
CEO-OTH1 CEO admits limited knowledge in specific R&D area 1      1         2 2 0.1 
CEO-OTH2 CEO admits not driving innovation but rather the direction of innovation                0 0 0.0 
CEO-OTH3 CEO interacts with R&D only in those matters he/she has personal knowledge in              1  1 1 0.1 
CEO-OTH4 CEO should not focus on technology 2         1     2 5 3 0.2 
CEO-OTH5 CEO stresses the importance of strong knowledge in the field of innovation          1      1 1 0.1 
CEO-OTH6 CEO requires R&D data to be simplified for strategic decision and communication 1 1 2 2 1 2   1 1 1 2 1 1  16 12 0.8 
CEO-OTH7 CEO wants R&D to step out of academic thinking   1  1 2          4 3 0.2 
CEO-OTH8 CEO role model is knowledge based          1      1 1 0.1 
CEO-OTH9 CEO aims to obtain respect from R&D                0 0 0.0 
CEO-OTH10 CEO attempts to understand R&D expertise   1 1 1 1          4 4 0.3 
CEO-OTH 11 CEO carries R&D through difficult times                0 0 0.0 
CEO-OTH12 CEO considers it an advantage to be untrained in science   1 1    1        3 3 0.2 
CEO-OTH13 CEO considers himself at a disadvantage as a non-scientist                0 0 0.0 
CEO-OTH14 CEO informs R&D about the company's position                0 0 0.0 
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CEO-OTH15 CEO role model is business driven       1 1        2 2 0.1 
CEO-OTH16 CEO wants to protect R&D from the mundane aspects of running a firm  1    1          2 2 0.1 
CEO-OTH17 CEO acts as a role model for innovation 1  1            1 3 3 0.2 
CEO-OTH18 CEO role is to link R&D to internal & external stakeholders  1     1         2 2 0.1 
CEO-OTH19 CEO reduces risk by fail fast fail cheap  1  2 1           4 3 0.2 
CEO-OTH20 CEO gets information from/discusses R&D with all levels 1 2 1 1  1 1 1       1 9 8 0.5 
CEO-OTH21 CEO role in R&D is not different from CEO role in non-R&D    1            1 1 0.1 
CEO-OTH22 CEO looks for the best possible management team    2            2 1 0.1 
CEO-OTH23 CEO requires persistence and resilience in LFSR    1        2    3 2 0.1 
CEO-OTH24 CEO argues that innovation comes from top down and bottom up 1   1  2          4 3 0.2 
CEO-OTH25 CEO and CSO are innovative forces together   1 1      1      3 3 0.2 
CEO-OTH26 CEO innovates by challenging the organization (time, costs etc)     1   1        2 2 0.1 
CEO-OTH27 CEO argues that innovation also occurs outside R&D 1 1   1    1       4 4 0.3 
CEO-OTH28 CEO argues that R&D should always be one step ahead       1         1 1 0.1 
CEO-OTH29 CEO educates the firm’s environment             1   1 1 0.1 
CEO-OTH30 CEO argues that value is as important as market             1   1 1 0.1 
CEO-OTH31 CEO and R&D should have a relationship of trust and confidence 1    4   1    1    7 4 0.3 
CEO-OTH32 CEO should have firm belief in the product            1    1 1 0.1 
CEO-OTH33 CEO considers patients as innovation drivers            1   1 2 2 0.1 
CEO-OTH34 CEO needs to understands process/risks of R&D              1  1 1 0.1 
CEO-OTH35 CEO needs to understand culture of science              3  3 1 0.1 
CEO-OTH36 CEO needs to know how to lead scientists              3  3 1 0.1 
CEO-OTH37 CEO’s understanding of scientists is more important than being a scientist              1  1 1 0.1 
CEO-OTH38 CEO should have some basic understanding of science          1    1  2 2 0.1 
CEO-OTH39 CEOs of LFRD firms should not be dominant           1   1  2 2 0.1 
CEO-OTH40 CEO needs bottom-up ideas in LFSR firms         1     1  2 2 0.1 
CEO-OTH41 CEO top scientist/top business man/women is ideal         1 1    1  3 3 0.2 
CEO-OTH42 CEO argues that simple messages make for flawed decisions        1      1  2 2 0.1 
CEO-OTH43 CEO – not R&D - should simplify the message               3  3 1 0.1 
CEO-OTH44 CEO should make sure scientists can remain scientists (and not become managers)              1  1 1 0.1 
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CEO-OTH45 CEO should be very flexible               1 1 1 0.1 
CEO-OTH46 CEOs should be/act transparent           1    2 3 2 0.1 
CEO-OTH47 CEO can prevent a R&D knowledge gap by growing from within R&D               1 1 1 0.1 
CEO-OTH48 CEO teaches R&D about business               2 2 1 0.1 
CEO-OTH49 CEO does not need to be a scientist           1    1 2 2 0.1 
CEO-OTH50 CEO has no time to talk to the scientists in R&D         1       1 1 0.1 
CEO-OTH51 CEO balances R&D vision with the Board’s vision             2   2 1 0.1 
CEO-OTH52 CEO challenges R&D and is challenged by R&D           2   1  3 2 0.1 
CEO-OTH53 CEO knows how to challenge R&D because of his experience           1     1 1 0.1 
Nt: Number of times the concept or subtheme appears in the interviews; the number of times an a priori concept emerges during the interviews is presented in a shaded area; Ni: the 
number of interviews in which the theme appears; Ri: the ratio of Ni/Ntotal with Ntotal: the total number of interviews 
 
Table 4-1 The appearance of themes during the interviews with CEOs 
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associated with the involvement at the start of the project after which it is delegated to 
the project team. The involvement of the CEOs is to make sure that the project starts 
with the required direction, boundaries and assumptions. Another subtheme INV8 ‘CEO 
comes up with new innovative ideas’ was raised by 2 CEOs (7 and 13) who argued that 
they can be (and sometimes are) the source of new product development ideas which 
are then left to teams for further development.  Subtheme INV9 ‘CEO evaluates 
economic viability of the R&D project’ and INV10 ‘CEO picks up R&D innovational 
opportunities’ are two new involvement themes. 
Besides the new subthemes (ATI8, ATI9, COM8, INV7, INV8, INV9 and INV10) assigned 
to the major themes, a number of new themes emerged from the interview (CEO-OTH19 
to CEO-OTH53) that were difficult to assign to one of the themes of attitude, attention, 
commitment, involvement or innovation. Some of them were carried from the pilot 
research into the final research (CEO-OTH1 to CEO-OTH16) but were not always 
addressed during the final CEO interviews (no number appears in the respective columns 
and rows), such as CEO-OTH2 (‘CEO admits  not driving innovation but rather the 
direction of innovation’); CEO-OTH9 (‘CEO aims to obtain respect from  R&D’); CEO-
OTH11 (‘CEO carries the scientists and their R&D through difficult times’); CEO-OTH13 
(‘CEO considers himself at a disadvantage as a non-scientist’) and CEO-OTH14 (‘CEO 
informs R&D about the company’s position’). The new subthemes CEO-OTH17 to CEO-
OTH53 are listed in Table 4-1 and are illustrated in Appendix H by means of quotes made 
by CEOs.   
 
Distribution of subthemes  
Table 4-1 presents the frequency of appearance of each subtheme for the a priori 
concepts (ATI1 ... INN3) and for the new roles or themes that emerged from the 
interviews (OTH1 ... OTH53).  For example, the theme of attitude was mentioned by a 
majority of CEOs as a condition sine qua non for innovation to take place. The fact that 
a specified theme does not appear in the interview of a CEO (“0” in the table) does not 
mean that it is not considered important for that CEO, but only that under the given 
circumstances, he/she did not consider it worthwhile to refer to it. As was stated above, 
the main themes attitude, attention, commitment and involvement are addressed but 
the nature of underlying subthemes that support these concepts differ substantially 
among the CEOs.   
 
For example, the subtheme ATI1 ‘CEO fosters a culture of innovation’ appeared in 10 
(Ni) out of the 15 interviews. The subtheme OTH28: ‘CEO argues that R&D should always 
be one step ahead’, was mentioned during one interview (Ni=1; CEO7). Other new 
subthemes also appeared only once such as the subtheme COM8 ‘CEO manages ideal 
cash flow’ (CEO4). Of particular importance for this research is the identification of 
concepts or themes that are shared by all or most of the interviewed CEOs.  Because the 
interviews took place separately and CEOs were not informed about each other’s 
interview content, it is argued that when a theme is raised by all CEOs, the theme must 
have meaning for all CEOs concerned.  This is discussed below under Subtheme analysis. 
 
Further theme categorization 
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The discussion above analyses the data as they emerged from the interviews, i.e; 
without further sub-categorization. However, the data lend themselves to further 
categorization because a number of themes can be linked to each other. For example, 
some themes address the concept of ‘knowledge’ as seen from the perspective from the 
CEO and can be pulled together under the theme ‘CEO knowledge’. They are listed below 
in the table (Table 4-2). In addition, other CEO- OTH themes can be categorized under 
the theme of ‘CEO R&D knowledge complexity reduction, ‘CEO Stakeholders’, ‘CEO 
Interaction at all levels’, ‘CEO Culture of science’ and the ‘CEO Challenger’. 
 
Knowledge. Knowledge is recognized as a central theme by the CEOs and although 
involvement is a knowledge based conception of the role of the CEO, the references 
made by the CEOs to ‘knowledge’ are different from the ‘knowledge’ that was the basis 
for the creation of the concept of involvement. While the concept of involvement 
requires intricate knowledge of either the process and the science that supports the R&D 
activities, the references to knowledge in CEO-OTH1, 3, 5, 8, 10, 12, 34, 38, 47, 49 and 
48 address the concept of knowledge as the source of potential conflict, a problem or as 
a vague point of view, e.g. the presence of limited knowledge (CEO-OTH1), the 
interaction with R&D only in those matters in which the CEO has knowledge (CEO-OTH3), 
the emphasis on the need for knowledge (CEO-OTH5 and 34), the differences in CEO 
opinion whether or not knowledge is actually required (CEO-OTH12, 38, 49), the general 
statement that the CEO role model is knowledge based without further specification 
(CEO-OTH8) and the accumulation of new knowledge either through R&D experience 
(CEO-OTH47) or through attempts to understand it (CEO-OTH10) and finally the 
exchange of knowledge through teaching (CEO-OTH48). In other words, although CEOs 
refer frequently to different knowledge related themes, when taken together they do 
not constitute a homogeneous major theme as there is no agreement amongst them 
about the need for knowledge to run a life science R&D firm. 
 
R&D knowledge complexity reduction. The theme of data simplification (CEO-OTH6) and 
the observation by CEO14 that it is the CEO who should conduct the de-complexification 
step (CEO-OTH43) are categorized in the theme of CEO ‘R&D knowledge complexity 
reduction’. This theme was also observed in big pharma firms (CEO11 and CEO12). 
 
Stakeholders. Because CEOs have to take care of all stakeholders of the firm, a separate 
category is created as ‘CEO Stakeholders’ that includes the themes CEO-OTH18, 21 and 
59.  
 
Interaction at all levels. Some CEOs interact with R&D at all levels within the company 
and CEO-OTH20, 40 and 24 illustrate that attitude.  
 
Culture of science. CEO14 has clear views on the need for leadership of scientists as is 
clearly articulated by the themes CEO-OTH35, 36, 37 and 44 illustrating the need to  
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Nt Ni Ri 
CEO  Knowledge  1  2 2 1 1 1 1 0 3 1 0 0 3 4 20 14 0,9 
CEO-OTH1 CEO admits limited knowledge in specific R&D area 1      1         2 2 0.1 
CEO-OTH3 CEO interacts with R&D only in those matters he/she has personal knowledge in              1  1 1 0.1 
CEO-OTH5 CEO stresses the importance of strong knowledge in the field of innovation          1      1 1 0.1 
CEO-OTH8 CEO role model is knowledge based          1      1 1 0.1 
CEO-OTH10 CEO attempts to understand R&D expertise   1 1 1 1          4 4 0.3 
CEO-OTH12 CEO considers it an advantage to be untrained in science   1 1    1        3 3 0.2 
CEO-OTH34 CEO needs to understands process/risks of R&D              1  1 1 0.1 
CEO-OTH38 CEO should have some basic understanding of science          1    1  2 2 0.1 
CEO-OTH47 CEO can prevent a R&D knowledge gap by growing from within R&D               1 1 1 0.1 
CEO-OTH48 CEO teaches R&D about business               2 2 1 0.1 
CEO-OTH49 CEO does not need to be a scientist           1    1 2 2 0.1 
CEO R&D knowledge complexity reduction 1 1 2 2 1 2 1  1 1 1 2 1 4  20 13 0,9 
CEO-OTH6 CEO requires R&D data to be simplified for strategic decision and communication 1 1 2 2 1 2   1 1 1 2 1 1  16 12 0.8 
CEO-OTH43 CEO – not R&D - should simplify the message               3  3 1 0.1 
CEO Stakeholders  1     1      3   5 3 0,0 
CEO-OTH18 CEO role is to link R&D to internal & external stakeholders  1     1         2 2 0.1 
CEO-OTH51 CEO balances R&D vision with the Board’s vision             2   2 1 0.1 
CEO-OTH29 CEO educates the firm’s environment             1   1 1 0.1 
CEO Interaction at all levels 1 2 1 2  3 1 1 1     1 1 14 10 0,1 
CEO-OTH20 CEO gets information from/discusses R&D with all levels 1 2 1 1  1 1 1       1 9 8 0.5 
CEO-OTH40 CEO needs bottom-up ideas in LFSR firms         1     1  2 2 0.1 
CEO-OTH24 CEO argues that innovation comes from top down and bottom up 1   1  2          4 3 0.2 
CEO Culture of science              8  8 1 0,1 
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CEO-OTH35 CEO needs to understand culture of science              3  3 1 0.1 
CEO-OTH36 CEO needs to know how to lead scientists              3  3 1 0.1 
CEO-OTH37 CEO’s understanding of scientists is more important than being a scientist              1  1 1 0.1 
CEO-OTH44 CEO should make sure scientists can remain scientists (and not become managers)              1  1 1 0.1 
CEO Challenger     1   1   3   1  6 4 0,3 
CEO-OTH26 CEO innovates by challenging the organization (time, costs etc)     1   1        1 1 0.1 
CEO-OTH52 CEO challenges R&D and is challenged by R&D           2   1  3 2 0.1 
CEO-OTH53 CEO knows how to challenge R&D because of his experience           1     1 1 0.1 
 
Table 4-2 Further theme categorizations from CEO interviews 
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understand the culture of science, how to lead scientists and the fact that CEOs should 
make sure scientists can remain scientists (and not become managers). 
 
Challenge. Finally, the CEO is also a challenger as exemplified by the themes CEO-OTH26, 
52 and 53. However, these types of challenges are not part of the involvement theme in 
which ‘challenger statements’ are also included such as INV1 and INV2. The difference 
is that in INV1 and in INV2 these challenges specifically address the R&D function, while 
in CEO-OTH26, 52 and 53, they address the reciprocal challenge CEO-R&D which is 
different from the involvement of the CEO in R&D, the challenge of the firm activities 
with respect to time and costs (i.e. operational challenges at firm level) and the CEO’s 
capability to challenge (which is different from actual challenging) respectively. 
Therefore, these themes were not included under the a priori theme of involvement 
(INV) but treated as separate themes.  
 
Subtheme analysis 
When the data presented in Table 4-1 are analyzed further according to the frequency 
by which they appeared during the interviews (Ni, max = 15, theme emerges in all 
interviews; min = 0, theme does not emerge in an interviews), the following 
observations can be made. The theme COM6 ‘CEO creates … structures for innovation’ 
appears in 12 of the 15 interviews (with CEO1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 14 and 15). It 
implies that the majority of the CEOs are committed to creating organizational 
structures for innovation to take place, such as flat and matrix organizations. The use of 
flat & matrix organizations is a common approach in life science R&D firms seen the 
requirement for diverse experts to become part of R&D project teams and it is therefore 
not surprising that this theme appears in a majority of interviews. The theme ATT2 ‘CEO 
sets the focus and boundaries in which innovation to take place’ appears in 13 of the 15 
interviews. Figure 4-1 shows the number of interviews (Ni) in which these themes 
emerge (ATI1 to CEO-OTH53). 
 
Other literature based a priori themes that appear frequently are themes that refer to 
(in decreasing order): 
 
- the setting of the direction and vision (ATT1; 12/15),  
- external collaboration (ATI5; 11/15),  
- the fostering of a culture of innovation (ATI1; 10/15),  
- the selection and hiring of innovative leadership (COM1; 7/15),  
- CEO challenges R&D for efficiency (INV1; 7/15), 
- CEO holds frequent R&D meetings (INV6; 7/15) 
- CEO acting as a sounding board (INV3; 7/15), 
- the acceptance of experimentation and failures (ATI2; 6/15),  
- the fostering of internal communication (ATI3; 6/15),  
- the exchange of diverse ideas (ATI4; 6/15),  
- the incentives and rewards for the R&D function (COM2; 6/15),  
- CEO is involved in NPD (INV5; 6/15)  
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Figure 4-1 Distribution of individual subthemes emerging during 15 CEO interviews
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Literature based a priori themes
CEO-OTH themes 
CEO-OTH6 CEO requires R&D data to be simplified 
for strategic decision and communication (12 interviews)
CEO-OTH20 CEO gets information from/
discusses R&D with all levels 
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This overview is not unexpected as the different subthemes are intrinsically linked to 
each other: the creation of an innovative organization proceeds through the setting of 
direction and focus, the fostering of a culture of innovation through acceptance of 
experimentation and failure, internal communication through frequent R&D meetings 
and exchange of diverse ideas, selection, hiring, incentivizing and rewarding of 
innovative leadership (Goffin and Mitchell, 2011).  In view of the fact that the firms 
selected for this research are limited in size and therefore allow frequent interaction 
between the top of the organization and the lab-bench, the subtheme of ‘CEO acts as a 
sounding board’ (INV3; 7/15) is also not unexpected. Therefore, the CEO-OTH20 theme 
of ‘CEO gets information from/discusses R&D with all levels’ is not surprising either (see 
Figure 4-1). 
 
However, one could have expected that the CEOs, because of the limited size of the 
firms and the possibility of frequent interactions with R&D, would not raise a theme 
referred to as the ‘requirement for simplification of R&D data for strategic decision and 
communication’ (OTH6). This theme of ‘R&D simplification’ was mentioned in 12 out of 
the 15 interviews and was emphasized strongly during the interviews (Nt 16; see Table 
4-1). It was raised as an important part of their job and it was observed independently 
of their educational status, prior expertise or tenure. The theme was unexpected and 
differed from the other subthemes that appeared in the interviews in that the latter are 
well known innovation concepts (i.e. culture of innovation and structures for innovation 
etc.). It was observed that the CEOs do not take strategic decisions based upon raw data 
but on a knowledge base that was transformed – either by R&D, by discussions within 
the TMT or through an individual appointed to perform this task – into a package that is 
amenable to challenge and decision making. In the case of CEO1 for example, he/she 
argued that he/she expects his R&D head to take the ‘learnings of the TMT with respect 
to the business proposition’ back in the laboratories to make the decision process at the 
level of the TMT more efficient.  This process of transfer of R&D knowledge whereby the 
data are being transferred from one context to another in order to make it useful for 
the CEO to discuss, challenge and take decisions was a recurring theme in the interviews. 
The separation between the CSO – as the ‘scientific superstar’ – and the CEO as the 
‘direction giver’ is raised by many CEOs. It is accompanied by the observation that – 
because of the complexities of modern life science R&D – CEOs are not capable anymore 
to fully grasp the intricacies of the scientific activities conducted in their firms even when 
they were trained as a scientist. CEO2 argues that – even with his scientific background 
(he holds a medical/biological science doctorate) - it is impossible to understand the 
intricacies and complexities of current R&D. In line with CEO1’s observation, CEO2 
requires the R&D teams to re-contextualize their know-how. CEO2 considers this an 
important aspect of R&D management and calls this process ‘complexity reduction’. 
According to CEO2, this is required for two reasons: first, it makes the R&D know-how 
ready to be challenged by the CEO at the same level of challenge as the challenge that 
is given by the CEO to other company functions (finance, IP). Second, the simplified data 
can be used as a business proposition to be discussed with the top management team 
and with outside stakeholders (such as investors). This complexity reduction is a process 
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whereby R&D know-how is transferred into language that the CEO is able to challenge 
so that... 
 
‘I cannot be fooled’ (CEO2). 
 
According to CEO2 the process of complexity reduction is a bimodal concept because it 
is not only important to allow appropriate challenging and to make strategic decisions 
but also to serve the whole company, its shareholders and its internal/external 
stakeholders. The simplified R&D know-how ‘should not only make sense’ to the CEO 
but should also be the basis for ‘story telling’. It means that the complexity reduction 
process serves the ‘story telling’ activity about the firm and its scientific assets. 
According to CEO2, the story telling and the associated internal and external 
communication is one of his/her responsibilities in a life science R&D firm.  
 
CEO4 admits that he is not capable to understand the ‘lyrics’ of R&D (he holds an MBA 
and has no scientific background), but is capable of appreciating the ‘music’:  
 
‘I do not understand the science so I cannot go into the details of the 
science but I know what the key projects are and I try to understand 
what is going on. I always say that I want at least to understand the 
music. I don’t understand the lyrics but I need to understand the music 
and I need to be able to challenge and then I will challenge (R&D) 
people. That is the approach’ 
 
The ‘music-lyrics’ metaphor is explained as follows. The ‘lyrics’ that CEO4 is referring to, 
is the raw R&D data consisting of biotechnological vocabulary that is only open for 
assessment, evaluation and discussion by experienced R&D researchers. These scientific 
‘lyrics’ are incomprehensible for CEO4 and in order for him to make sense of the data, 
he requires them to be communicated, not through the ‘score or the text of the piece 
of music’ but through its essence: the music itself. This ‘music’ can be appreciated or 
criticized by anyone, even by those who do not understand the lyrics or the score. 
Reducing the score and the lyrics of a piece of music to the actual music (what is heard) 
is – fundamentally - a process of complexity reduction. During his interactions with R&D, 
CEO4 wants to understand the basics of the science that takes place in the firm, as to 
make up his mind whether or not this ‘makes sense’.  
 
The interviewed CEOs seem to be capable to extract from a set of complex pieces of 
knowledge that specific information that is important for them to make strategic 
decisions on the condition that the knowledge from R&D undergoes a transformation to 
allow the CEOs to do so. For the CEO to be able to grasp the knowledge that is generated 
in the R&D department, this knowledge needs to be calibrated to the level of the CEO. 
What seems to take place is an equilibration whereby the knowledge levels of both 
parties, the CEO and R&D, find a common base that, on the one hand, retains the core 
of the message that R&D wants to see conveyed and, on the other hand, allows the CEO 
to use his prior knowledge and experience to challenge it. It seems that the prior 
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knowledge of the CEO (either obtained through education or through experience) drives 
the calibration of the message from R&D down to the level of the CEO such that he/she 
can challenge and evaluate it.  Even CEOs with a strong educational science background 
require a de-complexification step seen the pace by which science evolves and the speed 
by which a CEO’s knowledge is out-dated if he/she is not actively involved in the science. 
Because the concept of complexity reduction strongly emerges from the interviews and 
because the majority of the CEOs agreed on its importance, the interview transcripts 
were re-analyzed and the quotes made by the different CEOs compared against each 
other. This is the topic of the next paragraph on interview observations. 
4.2.2.2 Interview observations 
Key interview observations are available in Appendix I. It presents a detailed discussion 
of interview observations during the CEO interviews with a focus on R&D knowledge 
complexity reduction. A table summarizing some of the quotes is introduced in the table 
below. 
 
CEO Conversation on complexity reduction: quotes on complexity reduction of R&D knowledge 
CEO2 ‘I think the other key thing is to be able to reduce this complexity to simple idea...’ 
 
CEO3 
 
‘...if you can’t translate a technical issue to a common sense business language discussion and really 
have a discussion on the principles, on the core of what is really happening there then either – you know 
- there’s a communication gap or you don’t fully understand really what’s behind it....they need to take 
that one extra step of translating a technical conversation to a common sense conversation but I think 
in going through that effort you end up having a much deeper discussion ... I think you have a much 
more robust discussion if you’re able to translate the scientific point to a common sense point...’ 
 
CEO4 ‘I do not understand the science so I cannot go into the details of the science but I know what the key 
projects are and I try to understand what is going on. I always say that I want at least to understand 
the music. I don’t understand the lyrics but I need to understand the music and I need to be able to 
challenge and then I will challenge (R&D) people. That is the approach’ 
 
CEO5 ‘..break it down to the most simple common denominator, simplest form of the issue,  so yes you can 
get bogged down into this miniature but I always try to keep it in a very simple form, simple is better 
for me right always and so I tend to probe in a very simplistic way and try to get to the most simple 
explanation, essentials ... I try to say: if you were talking to your 10 year old son how would you explain 
what you’re doing, what you’re trying to do...” .... “you know if you’re going to a warm buffet and meet 
someone who doesn’t understand anything about science, how would you get that person to invest in 
your company by simplifying what you’re trying to do?’ 
 
CEO6 
 
‘...it only develops by practicing is that we’re able to simplify the problem or the story to the essence so 
that we can look at it from a business point of view so that we can look at the business case and yes 
this role is extremely complex but if you ask the right questions I think you can simplify it to a certain 
level that you can make your decisions’  
 
‘...so one of the things I learned is don’t try to download your complexity on your boards because then 
they go bananas but we’re also training the scientists to not download all their complexity on the 
leadership team’  
 
CEO7 ‘at one time in the future, the chief scientist will know much more than I do and it is he who will then 
need to simplify the data, the same way as I am currently transferring simplified data to the board’ 
 
CEO8 ‘...our chairman knows more about the science than I do, there is no need to simplify the data or reduce 
the complexity of the science I am putting on the table at the board’ 
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CEO9 ‘I’m involved with  people that are doing bioinformatics, who have to simplify what they are discovering 
to me... but they have to make clear to me what they have found and how they came to that process in 
very general terms that I understand so ... I always want to understand it... bring it (the R&D 
knowledge) into convincing digestible pieces of knowledge...’ 
 
CEO11 ‘Look ...  you probably need both kinds of people, very strong in the science but maybe not that good in 
communicating on what they are doing and trying to translate that into what I would call normal 
language that is: such that the marketing guy will understand, the CFO can understand and other 
people can understand what this really means...’ 
 
CEO12 ‘... well I’m a chemist by training so they cannot really catch me totally off guard, so ask silly questions, 
make them explain and ask, ask, ask, if you come to the fifth why usually you get an answer that even 
you understand, that even I understand.. what I want to understand is whether it’s thought through 
and that there is a high conviction level of the fact that we’re doing the right thing, I want to test this 
identification, this belief, emotional bond which is often thought through, well thought through...’ 
 
CEO14 ‘by simplifying things you induce another variable (in the decision making process), the more variables 
you have to deal with the more difficult the decision will be and so the outcome becomes unpredictable.  
Simplification does not remove the variables ... they don’t disappear by this simplification’ 
 
‘... I think its up to the CEO to do the reduction... it’s not up to the scientist, it’s up to you as CEO 
whether you can live with that...’ 
 
 
Table 4-3 Some quotes by CEOs on the topic of reduction of R&D knowledge complexity 
4.3 CEO focus group  
The findings of the focus group research are tabulated in Appendix K and represent the 
main phases of interaction among the 4 CEOs. In general, there were no topics on which 
the CEOs formally disagreed. All CEOs reaffirmed the themes that emerged during their 
individual interviews and during the interviews with their colleagues. Again, the concept 
of CEO innovativeness was not addressed. CEO5 reconfirms the a priori literature 
concept of ‘attention’ by referring to the concept of ‘focus’ but argue that focus is 
difficult, seen the caliber of the scientists working in R&D. This is a re-confirmation of 
the statement made by CEOs (see CEO-OTH4 above) that the focus is on maintaining the 
firm’s competitive edge, and not allowing R&D to explore non-core academic routes. 
Although not explicitly raised during the individual CEO interviews, CEO15 raises the 
topic of ‘R&D motivation’ and argues that it may be improved/ supported through a 
culture of transparency that in turn generates commitment from R&D. CEO5 argues that 
CEO commitment has its counterpart in R&D commitment. Although it is premature to 
argue, this is an interesting idea in that a CEO role behavior such as attitude etc. may 
require its R&D equivalent in order for innovation to flourish, such that CEO 
commitment triggers R&D commitment and vice versa. In addition CEO5 stresses the 
‘learning agility’ as compared to the ‘learning ability’ of the CEO. According to CEO15, 
‘dis-involvement’ in the science by the CEO is useful in order to create a clear vision for 
the future and to create some distance from the science. The need for CEO knowledge 
cannot be agreed upon among the CEOs. While CEO5 argues that it is not required to 
have an understanding of the science, CEO8 is convinced that if the CEO does not have 
knowledge of the scientific principles supporting R&D, ‘you have an issue’. In other 
words, the concept of the need for ‘knowledge’ remains a discussion topic among CEOs 
(and among R&D executives as well, as will be seen in Chapter 5). 
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CEO5 reconfirmed the statement made during the individual interviews in that the 
complexity reduction of R&D knowledge allows the CEO to develop a narrative such that 
story telling inside and outside of the firm can take place. In addition, CEO15 argued that 
the complexity reduction step is crucial in that it allows to focus the R&D function on 
the objectives of the firm’s R&D. By becoming too much emerged in ‘raw R&D’, the risk 
exists that the R&D function looses focus and becomes involved in the science and 
technology itself, drawn as they may be into interesting (but commercially useless) 
scientific opportunities. This was one of the major concerns of the CEOs, i.e. that either 
themselves or the R&D function ‘falls in love with the science and technology’. By 
creating a version of their research from which the complexity is removed, the CEO is 
capable to use this ‘simplified’ version to focus R&D and to rally the whole firm behind 
the idea (CEO5). This message becomes embedded in their mind and allows them – as 
well as the CEO – not to become sidetracked from the major R&D objective.  The 
complexity reduction of R&D knowledge therefore is – according to these 4 CEOs - a 
necessary step to focus R&D. The comments made by CEO5 and CEO15 show the 
importance of the concept of complexity reduction and it seems to be an important 
instrument in the CEO’s arsenal of management techniques to manage his/her firm. This 
was corroborated by all CEOs present in the focus group. CEO dominance was also 
referred to as a CEO characteristic that is incompatible with the management of life 
science R&D firms as corroborated by CEO14 during the individual interviews.  
4.4 Discussion 
4.4.1 Literature based themes 
The findings have showed that the concepts retrieved from the literature on the role of 
the CEO in innovation, i.e. attitude, attention, commitment and involvement in different 
industrial settings can also be found in life science R&D firms and this is illustrated in 
Figure 4-2. The figure presents the themes that emerged from the interviews together 
with the number of times (i.e. the weight (Krippendorf, 2013) by which) they emerged 
from the interview transcripts (Nt in Table 4-1). The literature based a priori themes are 
introduced as shaded boxes. As can be seen, the concept of the CEO as innovator 
(innovativeness) was not supported by the CEOs: they do not consider themselves as 
the drivers of breakthrough and/or disruptive innovations but rather as facilitators of 
innovation. Only one CEO (CEO-founder, CEO9) referred to this theme and considered 
him/herself the driver of breakthrough innovations: 
 
‘Who is the main (product) innovator in the firm? I am’ 
 
The low emergence of CEO innovativeness stands in contrast with the innovativeness of 
CEOs in high-tech design and IT firms where the CEOs are recognized as innovators 
(Dickson et al. 1995). The concept of CEO innovativeness, as a CEO ‘who has original 
ideas, would sooner create something new than improve something existing and often 
risks doing things differently’, as defined by Thong and Yap  (1995), is not observed in 
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these  life science R&D firms. The frequency with which each concept is addressed by 
the CEOs varies. For example, attitude and commitment are more frequently mentio- 
 
 
 
Figure 4-2 Ranking themes according to their emergence during interviews of CEOs 
 
ned by the CEOs than involvement and attention. Although the evaluation of qualitative 
data using quantitative data should be done with utmost caution because 
 
‘it is probably most important to keep their Janus-faced character in 
mind’ (Krippendorff, 2013), 
 
the fact that CEO attitude is on top of the ranking is not surprising as it is also recognized 
and supported by previous research reported in the literature (Chapter 2). For example, 
Damanpour and Schneider (2006) showed the importance of attitude towards 
innovation of the top manager in governmental organizations while Papadakis and 
Bourantas (1998) found attitude to be critical in driving innovation in high technology 
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firms. The theme of CEO commitment (i.e. making available human and financial 
resources, see chapter 3) is not unexpected seen the considerable cash burn in these 
life science R&D firms. The emergence of attention and involvement as a potential driver 
of innovation is corroborated by Yadav et al., 2007 in the banking industry and by Laforet 
and Tan (2006). The presence of CEO involvement as a driver of innovation is 
corroborated by findings by Dickson et al. (1995) who found CEO involvement to be 
important in innovation in design firms.  This is probably caused by the fact that the 
knowledge gap between CEO and the R&D function in these firms is lower (although this 
is a statement not supported by empirical evidence) while there is a clear knowledge 
gap between the CEO and the R&D function in these LSRD firms, as clearly argued by 
CEO3:  
 
‘there is a gap, right?’  
 
Concluding that the concepts of attitude and commitment to innovation are more 
accurate role descriptors for CEOs in life science R&D companies than involvement and 
attention is not possible because the qualitative study was not designed to uncover 
differences in the level of appearance of conceptual roles but rather to ascertain 
whether they could be observed in life science R&D firms. A more in-depth interview 
and longer term observation of the CEOs may lead to convergence of the concepts and 
to a more stabilized pattern in which concepts are addressed in more or less equal 
measure. In summary, the answer to the first research question whether the a priori 
concepts from the literature appear in the context of life science R&D firms can be 
confirmed with the exception of the role of the CEO as innovator.   
 
These a priori role concepts as stated by the CEO are not necessarily perceived as such 
or required by the R&D function. For example, it may be that CEOs are involved in R&D 
but it is not clear whether this has a positive impact upon the R&D workforce’s 
performance or innovative work behavior. The R&D function may require other 
conceptual roles from the CEO than those which are discussed above. In other words, 
there may be misalignment between the CEO’s a priori roles and the roles as perceived 
or expected by the R&D function. This will be explored in Chapter 5. 
4.4.2 New themes 
The second research question addressed the appearance of other (new) themes or 
concepts that emerge during the interview. Besides the literature-based themes of CEO-
attitude, -attention, -commitment and –involvement, CEOs describe their role of 
innovation using a myriad of other themes, indicating that the role of the CEO is still 
much unexplored and that the use of CEO proxies such as CEO age, CEO tenure etc., as 
employed in upper echelon research, provide a rather limited view on the role of the 
CEO. The data show that CEOs use a myriad of other themes that can be used to describe 
their role (Table 4-1). The themes were divided in 6 groups pointing to: 
 
- CEO Knowledge  
- CEO R&D knowledge complexity reduction  
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- CEO Stakeholders 
- CEO Interaction at all levels 
- CEO Culture of science 
- CEO Challenge 
 
and a number of other (granular) themes that were difficult to put into new major 
themes or categories.  
 
It is no surprise that the CEOs consider themselves as key in involving firm stakeholders, 
either internal or external to the firm. It also comes as no surprise that CEOs argue that 
they interact with different hierarchical levels in the firm. This observation is the result 
of the size of the firm (the selected firms were SMEs) and because CEOs have created 
flat hierarchical structures (see COM6; Ni 12; Ni 15). The big-pharma CEOs did not make 
this observation because they are not in a position to approach the different levels seen 
their firm’s size. In addition, CEOs are known as challengers and this also emerges from 
the interviews.  Few CEOs argue that there are specific leadership skills required to lead 
science based firms such as the understanding of the culture of science, or that it is more 
important to understand the culture of science than being a scientist oneself. These 
comments were raised by the CEO who was thoroughly trained academically (two 
doctorates in biomedical sciences and a MBA) complemented with extensive experience 
in leading science-based firms.  
 
CEOs made it clear that knowledge is an important concept and discuss this along the 
need for knowledge complexity reduction. The majority of the CEOs made it clear that 
R&D knowledge is subject to a process of ‘complexity reduction’ before it is transferred 
to a higher echelon in the organization for use in strategic decision making and/or 
communication. The one exception in this regard is CEO8, who did not agree with the 
‘simplification’ or ‘complexity reduction’ step because it was argued that this may lead 
to flawed decision making processes (see Appendix I). One of the major differences with 
the other companies is that the board of the company that is run by CEO8, consists of 
three individuals: CEO8, the chairman and an academic representative.  The chairman 
of the board is fully aware of the intricacies of the science that is conducted in the firm 
and therefore does not require any complexity reduction step. In other words, there 
seems to be a ‘knowledge continuum’ between the R&D labs, the CSO, the CEO and the 
board. In the other firms, the CEOs reported into boards whose members were 
scientifically educated but whose careers took off in positions where extensive 
experience in commerce, investment banking, licensing/business develop-ment, project 
management was accumulated. However, they lacked expertise in the areas of R&D in 
which the firms were involved. In order to convince the board, the R&D message could 
not be transferred as such from the laboratories unless the board “would go bananas”, 
as CEO6 put it (see Table 4-3 and Appendix I).  This process was described by one of the 
CEOs as a process whereby the R&D function needs to put its knowledge into the context 
of a business proposition. The data hereby takes a new form that makes it amenable to 
challenge by the CEO and the TMT and forms the basis for strategic decision making. 
This process of transfer of knowledge from one organizational unit to another one is a 
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process whereby data are moved from one context (the R&D function, with its own 
vocabulary, procedures and routines (Styhre, 2009)) to another context (the TMT) and 
therefore is essentially a process of re-contextualization.  This need for re-
contextualization of R&D knowledge was illustrated by the CEOs in their concern that 
the company’s R&D activities focus too much on the technology itself whereby the R&D 
function would conduct research for the sake of scientific progress instead of being 
driven by market potential. CEOs play a role in innovation by attempting to bridge the 
knowledge gap with R&D and by reducing its complexity and re-contextualizing its 
content.   
 
In Table 4-2, it is clear that CEOs consider knowledge an important element in leading 
their firms. They do not agree however how much of this knowledge is required. As an 
example, CEO4 (he/she holds a MBA from a reputable business school) argues that 
because he/she does not understand the R&D knowledge he is able to ask the right 
questions, while CEO8 (an engineer with extensive consulting experience in a reputed 
consulting firm) argues that because he/she understand the R&D knowledge he is able 
to take the right decisions.  In other words, while the CEOs do not agree on the level of 
knowledge they require in order to be able to absorb the knowledge from R&D, the 
majority of the CEOs agree that there is a need to reduce the complexity of the 
knowledge of R&D to make strategic decisions. This is an unexpected finding and 
therefore deserves further discussion. 
4.4.3 From complexity reduction to CEO absorptive capacity 
The process by which R&D knowledge is transferred to the CEO (and further on to the 
board) is a process of complexity reduction to make sure that the complexity is not 
‘downloaded’ to the CEO (see Table 4-3; CEO6). It was argued that this is an unexpected 
finding in these firms because of their small size but it was also found in big pharma. In 
other words, it seems to point to a generalized characteristic of a CEO’s role in 
innovation in life science R&D firms. As CEO6 and CEO3 argue:   
 
‘... we’re training the scientists to not download all their complexity on the 
leadership team ... they’re forced to crystallize the research reality along 
answers to simple questions’ 
 
‘....they (R&D) need to take that one extra step of translating a technical 
conversation to a common sense conversation ... in going through that 
effort you end up having a much deeper discussion’ 
 
The reduction of the complexity needs to take into account the prior knowledge of the 
CEO. In the case of the CEO accountant (CEO2P, to take the most extreme example, see 
Appendix E), the knowledge had to be transformed by two hired consultants in order for 
CEO2P to understand the knowledge. In other words, the knowledge had to be titrated 
down to the level of the ability of the CEO to absorb the new knowledge from R&D.  
Cohen and Levinthal argue ‘that the ability to evaluate and utilize outside knowledge is 
largely a function of the level of prior related knowledge. At the most elemental level, 
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this prior knowledge includes basic skills or even a shared language but may also include 
knowledge of the most recent scientific or technological developments in a given field’ 
(Cohen and Levinthal, 1990). Cohen and Levinthal argue that an organization’s 
absorptive capacity, i.e. ‘an organization’s ability to evaluate and utilize outside 
knowledge will depend on the absorptive capacities of its individual members’ and thus 
– even more critically - on the absorptive capacity of the CEO as the final decision maker. 
Therefore the theme of the complexity reduction observed during the content analysis 
of the CEO interviews, points to the CEOs’ individual absorptive capacity. As a result, it 
is argued that the CEO’s absorptive capacity is a new major theme. While the CEOs never 
raised the theme of CEO absorptive capacity themselves, they inferred its existence 
through their clearly articulated need for complexity reduction. 
4.4.4 From complexity reduction to R&D focus  
The focus group research was to inquire how CEOs, when brought together, respond to 
the conclusions of the research conducted in the first part during the individual 
interviews. Doing so, this research acts as a validation instrument to evaluate whether 
the observations made by the interviewer sound familiar with the CEOs and whether 
any of the comments raised by themselves generate new ideas or themes that would 
give additional clarification of their roles in innovation. The importance of the concept 
of complexity reduction was not only recognized by the CEO focus group but was also 
strengthened and put into a different perspective. While the concept was originally 
identified as an exercise that took place to equilibrate the knowledge levels between 
CEO and R&D in order for the CEO to be able to value the knowledge, it was now 
strengthened in that complexity reduction is also used to ‘sell the idea to the 
shareholders, to the market and to the employees’ and - as argued by the CEOs - to force 
R&D to focus on what it is actually doing.  In other words, complexity reduction is not 
only an exercise of straightforward simplification in order for the CEO to understand 
what is ‘going on’, it also serves the focus of the project by R&D and the valuation (or 
perception of the value) of the project by other stakeholders.  Doing so the CEO ‘returns’ 
the simplification back to the R&D executives in that he/she uses the simplified message 
to keep the scientists within focus as to prevent them to distract and wander into 
interesting academic opportunities that do not contribute to the firm’s innovational 
strategy (according to the CEOs, a ‘nightmare’).  CEO8 who argued during his/her 
individual interview that the process of complexity reduction was not required in his 
firm, agreed with this interpretation of the use of complexity reduction as an instrument 
of focus. According to CEO15, it is also a training exercise for the CEO, in that he/she 
learns to ask the right questions, to challenge R&D and to generate motivation within 
the R&D team because he/she is only capable to drive the company only if he/she 
understands the science that is taking place. In other words, the CEOs use this 
complexity reduction to focus – manage – the R&D function. The concept of R&D focus 
was not identified as a new theme in its own right as it is a constituent of the literature 
based theme of ‘attention’ (see Chapter 2). However, the process of complexity 
reduction shows how CEOs without prior knowledge of R&D are still able to focus R&D.  
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Although this research project offer some insight into the role of the CEO in innovation 
in life science R&D firms, a number of questions remain unanswered. For example, are 
these CEO role behaviors, as stated by the CEOs, also perceived by the R&D executives 
and do R&D executives perceive the same CEO role behaviors or do they observe other 
behaviors from their CEOs?  The next part of the research project attempts to answer 
these questions. 
4.5 Summary 
The concepts retrieved from the literature and used to research the role of the CEO in 
innovation in other industrial settings, i.e. attitude, attention, commitment and 
involvement are also found in life science R&D firms. Through their positive attitude 
towards innovation, their attention to the future and the resources they make available, 
CEOs facilitate the innovation in their firms and become involved in R&D. CEOs are not 
innovators: they do not consider themselves as the drivers of breakthrough and/or 
disruptive innovation. In order for CEOs to play a role in innovation, they need to make 
considerable use of their absorptive capacity. R&D reduces the complexity of its 
knowledge and titrate it to the level of the CEOs’ absorptive capacity. The CEOs argue 
that this reduction of complexity is also used to keep the R&D function focused on their 
objectives and to keep it aligned with the firm’s objectives such that it does not deviate 
from the firm’s innovational objectives by exploring scientific projects which are not 
commercially interesting. A tabular overview of the findings is presented in Table 4-4. 
 
 
 Themes addressing the role of the CEO in innovation as they emerged 
from individual structured interviews of CEOs 
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Table 4-4 The a priori themes and new themes observed during the CEO interviews 
 
Based on these observations at this stage of the research, the role of the CEO can be 
described as follows: 
  
‘The CEO leads innovation in life science R&D firms by making considerable use of 
his/her absorptive capacity. This allows him/her to bridge the knowledge gap with the 
R&D function and to focus the R&D function without the need to fully understand the 
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intricacies of the science driving the innovation’. In order to further substantiate these 
findings we now turn to the view of the R&D function on the CEO’s role in chapter 5.
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5 Findings - the role of the CEO as seen by R&D 
5.1 Introduction 
The second part of this research continues the exploration by focusing on the role of the 
CEO but now seen through the lens of senior R&D executives. As was observed in the 
literature review on the role of the CEO in innovation, it was found that the R&D function 
- because of its autonomy, competitive knowledge and resistance to managerial 
leadership and practice - is capable to take the firm in a new strategic direction and 
hence possess power that is usually observed (and expected) to reside with the top 
manager. Seen this power, it would be interesting to explore how the R&D function sees 
the CEO in his/her role in innovation. For example, if CEOs argue that they offer direction 
to firm innovation, how does the R&D function perceives this direction setting? Does 
R&D accept such direction from top management? Does it accept and even expect the 
CEO to do this? This chapter presents the results of an investigation of the perceptions 
of 39 senior R&D executives (6 pilot and 33 final) about the role of their CEO in 
innovation. It proceeds as follows.  First, in Section 5.2., an example interview is given 
(5.2.1.) followed by the findings of the final interviews (5.2.2.) which are divided in 2 
parts: the content analysis of the interview transcripts in 5.2.2.1. and interview 
observations in 5.2.2.2.. The data are discussed in 5.3. and summarized in 5.4. 
5.2 R&D interviews 
5.2.1 Example interview  
This section presents an example interview of a R&D executive to offer the reader some 
insight into the point of view of R&D executives. The sample is an extract from an 
interview with RDE1-P, a well known Chief Scientific Officer in the life science industry, 
who combines his job as university Professor with that of CSO and who has accumulated 
rich experience in the management of R&D in life science firms.... 
 
INTERVIEWER  
Thank you for this interview... let me start with the first question.. what 
are the attributes of a chief executive officer in a company like (name of 
the company)?   
 
CSO 
I believe that the CEO has to provide confidence and trust in the CSO 
which has been hired to not only lead a (name of department) in (name 
of company) but initially confronted with history, where history might 
be different from the viewpoint the novel CSO brings on board, so what 
you need to have once you join a company as a CSO is the belief that 
the CEO, if it would turn out that vision might be different than what is 
existing in the organisation, that he or she (the CEO) will listen to that 
novel view.  Second if realising that in this case the CEO has more a 
commercial background and is not fully vested in (name of discipline), 
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I think as well it is the task of the CSO to explain as clearly as possible 
why the given vision will be followed; so it is not so that the CSO has to 
expect that the CEO has a full understanding and a full scope and idea 
what it takes to become innovative in (name of department), it’s the 
task of the CSO I believe, to defend his case towards the CEO and the 
hope is that the perception and the belief and the trust in the CEO is 
there to come to reasonable collaborative teamwork and agreements. 
It’s a question of confidence and I will try to explain that. When I came 
here and we rebuilt the plan for the (name of therapeutic area-) team, 
a number of ideas we had were different from how the CEO but even 
the chairman of the company looked to it and I do recall we had the 
presentation meeting towards the second half of January that both 
said well, ‘woow’ it is an interesting vision, it’s a clear vision but we 
would like not only to hear this kind of vision from you but it might be 
nice that we do organise in the company workshop in which we invite 
some external speakers who are not briefed but which are there to help 
us - management, shareholders/CEO - to have a second opinion, a 
second viewpoint and on one hand you might say well that’s a weird 
kind of control but I enormously appreciated that because that 
convinced me that even while there might have been a gap between 
how it was in the past and how it should be in the future that it was a 
big willingness from people who are a bit further away from the daily 
operations and they wanted to see how that could be translated into 
reality by hearing the vision from a number of external key opinion 
leaders - so what we have done since that day ... we have worked out 
a complete workshop with ten speakers in which we invited top, top 
notch speakers who basically came here and whom we gave freedom 
to give their talk and basically what I then did, is try to summarise what 
we heard, we asked to all speakers the single thing they would 
recommend to (name of company) and then a week and a half later I 
took one step back and I invited to my entire department to collect all 
the things they would have heard which may have been different from 
what I have heard, but just to make sure that we have captured it all... 
we used a big wall with ‘post-its’ which three topics: strategy, 
technology, biology and basically collected all the things which we had 
heard and at the very end that was exactly the same vision as what I 
have presented in January... so I was very happy with that view...... 
 
 INTERVIEWER 
 And you didn’t consider that as distrust from his part? 
 
 CSO 
 No, I find it my task to explain why we do something ... in this company 
basically (name of CEO) had only one single task: get that single drug 
approved, so it sounds impolite (but that’s not the case), this was the 
furthest away from his concerns what happened in my (name of 
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department) because that’s ‘for the future’ ... however now that we’re 
getting pretty close to getting feedback from the (name of health 
authority) and launch, what you will see is ... not only within the 
company but also in the community - and you start to feel that now 
already - people always have looked at (name of company) as that 
company that helps develop that type of (name of drug) but now so 
many people start to ask what is next?.... so the people start to ask 
what is in the pipeline... 
 
 INTERVIEWER 
 How do you perceive the CEO’s leadership characteristics, which kind 
of leadership characteristics do you perceive from the CEO? 
 
 CSO 
 Well he gives on the one hand the flexibility ... he has a quite strong 
controllability but a number of things like how should seating be 
organised, how should the structure of the pipeline look like, he’s pretty 
much involved not about the science but how a department should look 
like and how interaction between different departments should be or 
how interaction between different levels of people should be, just 
something in which he is quite involved .... what we haven’t got and I 
think it gives you a good idea of how things have moved the last few 
months ... so till the end of July the focus was ‘I want that drug 
approved’ ...  so the company here has a management team with the 
nine department heads coming together every two weeks for an hour 
and a half to two hours .... basically it turned out that until the end of 
last month or September even, that these biweekly meetings we 
covered every single topic except topics from the people in the (name 
of discipline) have, very often they were removed from the agenda, of 
course lesser priority ... but (name of CEO) nicely tackled that and 
understood that this was inefficient and we have now since just two 
weeks... that we do not have a company wide management team 
really, we have a meeting ‘en petit comité’ with the CSO and the two 
people you’re going to see this afternoon... so the four of us basically 
now have a biweekly hour and a half get together with the CEO and 
this for the first time – and there was a big need for that - we have an 
opportunity to fill him in with three things - I’ll get back to that in a 
second - and he has a closer look on what really happens in the 
department, the last nine months for obvious reasons is being tackled 
by the installation of an excellent forum, small teams, five people, for 
preclinical and the CSO to really make sure that the gap is closed. 
 
 
 INTERVIEWER 
 That gap is that a gap between new ideas and his role … 
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 CSO 
 No the gap between what is this (name of department) doing and the 
CEO, so now.... 
 
 INTERVIEWER 
 Was this his idea or was it … did you come up and say that we need to 
talk? 
 
 CSO 
 Yes we often asked, can we talk? ...  we both felt that some topics fell 
off the radar and vice versa,  in fact ...  we had not a forum to tackle a 
few things in parallel but because he started to be asked by people 
what is in the pipeline, what is next ... instead of coming to us on an ad 
hoc basis, now we have a forum ... the company understands that on 
one hand (name of discipline) research takes time, takes longer than 
you always think and will not be sufficient to fill the gap in the pipeline 
so for that reason we have a new team which basically looks at 
opportunities which are further developed in the pipeline which we can 
eventually in-license and move quickly into the clinic, so basically what 
we cover in our bi-weekly talk is status of scouting, status of 
predevelopment and organisation. 
 
5.2.2 Final R&D interviews 
The operational interview data (interviewee code, recording nr, duration of interview, 
conversation type, transcript length etc.). are presented in Appendix N. Appendix O 
collects the quotes extracted from the interview transcripts of the R&D executives and 
the arguments used to assign these quotes to specific themes, either the literature-
based a priori themes (ATI, ATT, COM, INV and INN), the themes developed by CEOs 
(CEO-OTH) and to new themes developed by the R&D executives (RD-OTH). Interview 
observations are presented in Appendix P.  
5.2.2.1 Content analysis 
A total of 34 themes previously used by CEOs are shared with the R&D executives (see 
Table 5-1) and 29 new themes are identified as themes exclusively used by RD executives 
(see below Table 5-4). The findings are discussed in the following order: 
i. Themes that are shared by both CEOs and R&D executives (see below: Themes 
shared by R&D executives and CEOs). They are divided in frequent a priori themes 
and less frequent a priori themes and in frequent CEO themes12 and less frequent 
CEO themes. Frequent themes appear in more than 50% of the interviews, while 
less frequent themes appear in less than 50% of the interviews.  
ii. Themes which are used by R&D executives but not used by CEOs (see below: 
Themes used by R&D executives but not used by CEOs) and which are divided in 
                                                          
12 A priori themes are themes extracted from the literature and CEO themes are themes that were developed by CEOs during the 
CEO interviews to describe their roles in innovation (see Chapter 4) 
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frequent themes used by R&D executives but not used by CEOs and less frequent 
themes used by R&D executives but not used by CEOs 
iii. Further theme categorization 
iv. Themes that are only used by CEOs (see below: Themes exclusively used by CEOs 
and not used by RD executives) 
Themes shared by R&D executives and CEOs 
The themes shared by R&D executives and CEOs can be divided in literature based a 
priori themes (ATI, ATT, COM, INV and INN) and themes developed by CEOs (CEO-OTH). 
They are presented in Table 5-1. In this table the following parameters are used: 
 
Nt:  the number of times the theme or subtheme appears in all interviews 
Ni:  the number of interviews in which the theme appears 
Ri:  the ratio of the number of interviews in which the theme appears to the total 
number of interviews. It represents the fraction of interviews in which the theme 
emerged. The closer Ri to 1, the more a theme emerged in interviews, with Ri = 
1 if the theme appears in all interviews and Ri = 0 if the theme did not appear in 
an interview or appeared only marginally (i.e. if in 1 of the 33 interviews or 1/33 
= 0.033 or rounded off as 0.0). 
 
The table shows that the majority of the subthemes shared by CEOs and R&D executives 
are ‘other’ themes (CEO-OTH3, 4 etc...), i.e. 18 of the 34 themes that emerged from the 
interviews or 53%. In addition, 4 subthemes are related to attitude (12%), 2 to attention 
(6%), 3 to commitment (9%), 7 to involvement (21%) and none to innovativeness.  The 
table also presents for each theme the frequency by which it emerges in an interview 
with a R&D executive (RDE7 to RDE33). For example, the theme ‘CEO fosters a culture 
of innovation’ (ATI1) was raised two times (see bold ‘2’’ in the table) by R&D executive 
RDE9.  
 
In order to structure the findings, it was decided to separate themes that appeared in 
more than 50% of the interviews (i.e. Ri> 0.5) from the themes that appeared in less 
than 50% of the interviews (Ri ≤ 0.5). This threshold was established arbitrarily to 
structure the observations as there was no rational argument to choose another 
separation (e.g. 30 vs 70%). The themes that appeared in more than 50% of the 
interviews are termed ‘frequent themes’ while the other themes are termed ‘less 
frequent themes’. It should be emphasized however that the separation between 
frequent and less frequent themes does not imply that less frequent themes are less 
important than more frequent themes but only that the interviewee attaches more 
value to the theme in the given context. In other words, a less frequent theme may be 
important because it may shed light on the appearance of a more frequent theme: it 
may take the single observation of a single R&D executive to explain the appearance of 
strongly emerging themes. The same theme mentioned frequently by different inter- 
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Number of times a concept (left column) shared by CEOs and R&D executives is used by R&D executives RDE7 to RDE39  
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Nt Ni Ri 
ATI ATTITUDE  67  
ATI1   2  1 5 1 1  2 1    1 1 5 2 1 3 2   2 1   1  1 1 1  35 20 0.6 
ATI3              1 1   1     1 1 1 1     2  2 11 9 0.3 
ATI5      1    1 2 1 2  2 1 1 1 3   1 1       1 1   19 14 0.4 
ATI7                    1     1         2 2 0.1 
ATT ATTENTION 55  
ATT1  1  1 1 1 2 2 2 3 2 3 2 3 1 1 3 2  1 1 1 2 2   1  1   1  40 24 0.7 
ATT2  1  1  3 1 2   1 1            2    1  2    15 10 0.3 
COM COMMITMENT 22  
COM1                 1             1  1  3 3 0.1 
COM4   1   1  1    1 1 2   2  1     2    1 1 1    15 12 0.4 
COM6    1  2                 1           4 3 0.1 
INV INVOLVEMENT 25  
INV1           1 1      1     2    1       6 5 0.1 
INV2      1    1       1 1 1  1      1       7 7 0.2 
INV3               1              1     2 2 0.1 
INV5                  1                1 1 0.0 
INV6 1                   3              4 2 0.1 
INV8      2      1                   1   4 3 0.1 
INV9        1                          1 1 0.0 
CEO-OTH: OTHER ROLES DESCRIBED BY CEOs 
CEO-OTH3                  1 1           1 1   4 4 0.1 
CEO-OTH4  1                                1 1 0.0 
CEO-OTH5   1  1     1 1                       4 4 0.1 
CEO-OTH6  1 2  2 2 1 2 3 2 1 2  1 2 1 1 1   3 4   1 2 2 1  1  2 2 41 24 0.7 
CEO-OTH7                  1                1 1 0.0 
CEO-OTH9          1                        1 1 0.0 
CEO-OTH10   1    1         1      1      1   2   7 6 0.2 
CEO-OTH12      1    1          1            1  4 4 0.1 
CEO-OTH17              1         2           3 2 0.1 
CEO-OTH20   1   2 2  1            1  1         1  9 7 0.2 
CEO-OTH22                                1  1 1 0.0 
CEO-OTH25                  1     1           2 2 0.1 
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CEO-OTH31 3  2  2 1  4 1 3 1 2 5 1 3 1  9 5 5 3   1 1  3 8 2 2   1 69 24 0.7 
CEO-OTH34             1 1                    2 2 0.1 
CEO-OTH38  1     1     1    1  1          1  1  1  8 8 0.2 
CEO-OTH39 1     1         1  2                 5 4 0.1 
CEO-OTH41       1     1  1            1        4 4 0.1 
CEO-OTH50              1                    1 1 0.0 
Legend: ATI1: CEO fosters a culture of innovation; ATI3: CEO fosters internal communication; ATI5: CEO fosters external collaboration to increase internal innovation; ATI7: CEO fosters 
learning in the organization; ATT1: CEO sets the direction/goal and vision in which innovation to take place; ATT2: CEO sets the focus and boundaries in which innovation to take place; 
COM1: CEO hires selects and develops innovative leadership; COM4: CEO makes available human and financial resources; COM6: CEO creates hierarchical flat organizational structures 
for innovation; INV1: CEO challenges R&D for efficiency; INV2: CEO challenges R&D technically; INV3: CEO acts as sounding board; INV5: CEO is involved in NPD; INV6: CEO holds 
frequent formalized meetings with R&D; INV8: CEO comes up with new innovative ideas; INV9: CEO evaluates economic viability of R&D project; CEO-OTH3: CEO interacts with R&D 
only in those matters he/she has personal knowledge in; CEO-OTH4: CEO should not focus on technology; CEO-OTH5: CEO stresses the importance of strong knowledge in the field of 
innovation; CEO-OTH6: CEO requires R&D data to be simplified for strategic decision and communication; CEO-OTH7: CEO wants R&D to step out of academic thinking; CEO-OTH9: 
CEO aims to obtain respect from R&D; CEO-OTH10: CEO attempts to understand R&D expertise; CEO-OTH12: CEO considers it an advantage to be untrained in science; CEO-OTH17: 
CEO acts as a role model for innovation; CEO-OTH20: CEO gets information from/discusses R&D with all levels; CEO-OTH22: CEO looks for the best possible management team; CEO-
OTH25: CEO and CSO are innovative forces together; CEO-OTH31: CEO and R&D should have relationship of trust and confidence; CEO-OTH34: CEO needs to understands process/risks 
of R&D; CEO-OTH38: CEO should have some basic understanding of science; CEO-OTH39: CEOs of LFRD firms should not be dominant; CEO-OTH41: CEO top scientist/top business 
man/women is ideal; CEO-OTH50: CEO has (no) time to talk to the scientists in R&D; Nt: Number of times the theme or subtheme appears during the interviews; Ni: the number of 
interviews in which the theme appears; Ri: the ratio of Ni/Ntotal with Ntotal: the total number of interviews. 
 
Table 5-1 Themes shared by CEOs and R&D executives 
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viewees however shows the importance attached to the theme under the given context 
(Krippendorff, 2013). This section starts with the findings of the frequent a priori themes 
shared by R&D executives and CEOs and the less frequent a priori themes shared by R&D 
executives and CEOs, and continues with the findings of the frequent CEO-OTH themes 
shared by R&D executives and CEOs and continues with a discussion on the less frequent 
CEO-OTH themes shared by the R&D executives and CEOs.  
 
Frequent a priori themes shared by R&D executives and CEOs. The frequent a priori 
themes emerging from the R&D interviews are linked to CEO-attitude and attention. For 
example, the attitude-related themes ATI1 (‘CEO fosters a culture of innovation’, Ri 0.6; 
Nt 35; Ni 20) clearly emerges from the interviews. In addition, both CEOs and R&D 
executives find that it is important to have a clear direction and vision in which the 
innovation should take place (ATT1 ‘CEO sets the direction/goal and vision in which 
innovation to take place’, Ri 0.7; Nt 40; Ni 24). Both attitude and attention related 
themes were raised frequently by R&D executives (67 and 55 times during the total 
length of all interviews of 1100 minutes): they are perceived as major CEO roles in 
innovation.  
 
Less frequent a priori themes shared by R&D executives and CEOs. No theme, indicating 
the innovativeness of the CEO emerges from the interviews. R&D executives perceive 
their CEO’s innovativeness as a marginal – even obsolete - phenomenon. There is also 
no other theme (frequent or less frequent) that refers to the innovative character of the 
CEO – or to the need to have an innovative CEO at the helm of the firm. Less frequent a 
priori themes observed during the R&D interviews are, in decreasing order: 
 
- ATI5 (‘CEO fosters external collaboration to increase internal innovation’; Ri 0.4) 
- COM4 ‘CEO makes available human and financial resources’; Ri 0.4) 
- ATI3 (‘CEO fosters internal communication’; Ri 0.3) 
- ATT2 (‘CEO sets the focus and boundaries in which innovation to take place’; Ri 0.3) 
- INV2 (‘CEO challenges R&D technically’; Ri 0.2) 
- ATI7 (‘CEO fosters learning in the organization’; Ri 0.1) 
- COM1 (‘CEO hires selects and develops innovative leadership’; Ri 0.1) 
- COM6 (‘CEO creates hierarchical flat organizational structures for innovation’; Ri 0.1) 
- INV1 (‘CEO challenges R&D for efficiency’; Ri 0.1)  
- INV3 (‘CEO acts as a sounding board’; Ri 0.1) 
- INV5 (‘CEO is involved in NPD’; Ri 0.1) 
- INV6 (‘CEO holds frequent formalized meetings with R&D’; Ri 0.1) 
- INV8 (‘CEO comes up with new innovative ideas’; Ri 0.1 and  
- INV9 (‘CEO evaluates economic viability of R&D project’; Ri 0.0) 
 
It is not surprising that commitment (COM1, 4 and 6) is shared by both CEOs and R&D 
executives as CEO commitment is crucial seen the cash burn in these companies.  
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Frequent CEO themes shared by R&D executives and CEOs. Besides the a priori literature 
themes, Table 5-1 also collects CEO themes which are used by R&D executives to 
describe the roles of their CEOs. The themes 
 
- CEO-OTH31 (‘CEO and R&D should have relationship of trust and confidence’ Ri 0.7) 
and 
- CEO-OTH6 (‘CEO requires R&D data to be simplified for strategic decision and 
communication’ Ri 0.7)  
 
are themes shared by CEOs and R&D executives and which are clearly emphasized. The 
theme addressing the relationship between CEO and R&D based on trust (CEO-OTH31) 
is mentioned 69 times during the interviews while the theme that refers to the 
complexity reduction of R&D knowledge (CEO-OTH6) is mentioned 41 times, indicating 
that both themes are in the top of the R&D executives’ mind when referring to the role 
of the CEO in innovation. This is illustrated in Figure 5-1.   
 
 
 
Figure 5-1 Emergence of trust and complexity reduction during R&D interviews 
During the interviews, the importance of the theme of trust (CEO-OTH31) was clearly 
articulated by the R&D executives13 as is illustrated by RDE7, the CSO of a small biotech 
firm and a world renown scientist (see also Appendix P). He/she has made his/her name 
in industry and in academia in a particular area of biomedical science. However, his/her 
experience in dealing with CEOs has not been without problems.  The fact that one of 
the drugs that were under development did not make it to the market, was - according 
                                                          
13 Note: although trust is a shared theme between CEOs and R&D executives,  CEOs referred to trust in a strikingly lower 
emphasis. This is discussed in detail in Chapter 6. 
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to this CSO - caused by the fundamental problem of the difference in view between CSO 
and CEO. The CEO was a dominant- science educated - individual who managed with 
‘rigidity and control’ and made decisions on his/her own without paying attention to the 
concerns and scientific/medical arguments of the CSO and his/her team. The CSO 
therefore is convinced that an effective CEO in a life science R&D firm. 
 
‘would only work if the CEO had senior scientists who had a very 
good relationship with them and there was a bond of trust’ 
 
The table below (Table 5-2) collects a number of quotes made by the R&D executives on 
the concept of trust. They are extracted from the interview observations in Appendix P. 
 
R&D Quote on trust 
RDE12 ‘...I think certainly trust and belief (by the CEO) in the team is very important’ 
RDE14 ‘...‘trust (from the CEO) is always important’ 
RDE15 ..so I do fully understand the need for a different type of CEO that is more commercially 
oriented which has less R&D or life science experience but should trust us’ 
RDE16 ‘...capturing the complexity so that you (RED16 refers to the CEO) know when you (the CEO) 
can take the right decision also from your (the CEO) own experience and not only because 
your people tell it-  I mean you have to trust your people no problem...’ 
RDE33 ‘...‘I think trust and challenge for me on the CEO level is absolutely essential because you 
can deconstruct any R&D organization if you ask the nasty questions, you just don’t always 
have answers and that’s where the trust part comes in’ 
 
Table 5-2 A number of quotes from R&D executives on trust 
R&D executives also shared the need for complexity reduction of their knowledge with 
the CEOs (CEO-OTH6) and hence recognize the theme of absorptive capacity that was 
identified in Chapter 4. According to RDE33, a senior vice president of a big pharma 
company: 
 
‘....we titrated ourselves or each other really to a middle ground 
where we can talk about value and risk...’ 
 
Another R&D executive, RDE8, is a senior scientist hired by a CEO-accountant (CEO2-P). 
RDE8 only focuses  on the essentials of the R&D message to avoid the CEO to be drawn 
into the details of science and prepares a R&D message that is reduced in complexity. 
He/she compares the transformation of a complex R&D message as ‘a key art’..:  
 
‘I don’t regard simplification as sort of a patronising thing, to 
simplify the science is not something you do to patronise people 
who don’t understand science, ...  to simplify science and its 
objectives is a key commercial art anyway because you know 
what’s key at the end of it is still down to the objectives, the 
value, the time it takes to get there’ 
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The table (Table 5-3) below collects a number of quotes made by the R&D executives on 
the concept of complexity reduction. They are extracted from the interview 
observations in Appendix P. 
 
R&D Quote on complexity reduction 
RDE20 ‘I simplify the message for him to understand and not necessarily because he doesn’t 
understand, I think in particular in my area he’s quite confident but just because I see him 
once a month and if I bother him with the latest analytical problem he will get confused’ 
RDE23 ‘... I would try to adapt to the person and depending if it would be a financial guy you would 
use more financial data at the end of the day you would say look that we could make a 
business plan. ‘ 
RDE27 …‘the language (used in the communication of R&D knowledge between the R&D function 
and the CEO) has to match that of the understanding of the CEO’ 
RDE12 ‘it’s more a responsibility that you have to tell your story to the management team you 
have to make sure that they understand this, ....  you have to translate the project and this 
takes a lot of my time because it’s not my core activity...  it’s a responsibility that I should 
not forget doing ‘ 
RDE14 ‘... you need to reduce it in its complexity in order for them to grasp it quickly, it helps a lot 
because it focuses also the thinking about your own issues ...  I don’t see this as an issue, I 
have to be able to explain this to my wife for example’ 
 
Table 5-3 A number of quotes from R&D executives on complexity reduction 
Less frequent CEO themes shared by R&D executives and CEOs. R&D executives also 
observe that CEOs are mainly interested in those aspects of R&D activities in which they 
can contribute because of personal expertise (CEO-OTH3 ‘CEO interacts with R&D only 
in those matters he/she has personal knowledge in’; Ri 0.1). In addition, some R&D 
executives argue not to focus on technology (CEO-OTH4; Ri 0.1) and want R&D to step 
out of academic thinking (CEO-OTH7; Ri 0.0). According to some R&D executives (RDE9, 
RDE11, RDE16 and RDE17) it is important that a CEO should have strong knowledge in 
the field of innovation (CEO-OTH5 ‘CEO stresses the importance of strong knowledge in 
the field of innovation’; Ri 0.1). However, other R&D executives find it useful to have 
CEOs at the helm of the company who are untrained in science (CEO-OTH12 ‘CEO 
considers it an advantage to be untrained in science’; Ri 0.1). Other shared less frequent 
themes have a more general character such as CEO-OTH9 (‘CEO aims to obtain respect 
from R&D’). The theme CEO-OTH41 (‘CEO top scientist/top business man/women is 
ideal’; Ri 0.1) shows that some R&D executives consider CEOs who thoroughly 
understand the science, have extraordinary business acumen and are capable ‘to make 
money’ using this R&D knowledge, are the ‘ideal’ CEOs for life science R&D firms. Still 
other less frequent themes are in decreasing order:  
 
- CEO-OTH10 (‘CEO attempts to understand R&D expertise’; Ri 0.2),  
- CEO-OTH20 (‘CEO gets information from/discusses R&D with all levels’; Ri 0.2),  
- CEO-OTH38 (‘CEO should have some basic understanding of science’; Ri 0.2) 
- CEO-OTH17 (‘CEO acts as a role model for innovation’; Ri 0.1), 
- CEO-OTH25 (‘CEO and CSO are innovative forces together’; Ri 0.1), 
- CEO-OTH34 (‘CEO needs to understand process/risks of R&D; Ri 0.1) 
- CEO-OTH39 (‘CEOs of LSRD firms should not be dominant; Ri 0.1) 
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- CEO-OTH22 (‘CEO looks for the best possible management team’; Ri 0.0),  
- CEO-OTH50 (‘CEO has (no) time to talk to the scientists in R&D’; Ri 0.0) 
 
Finally, when asked about the ideal CEO for a life science R&D firm, R&D executives 
argue that these CEOs should not act as dominant figures (CEO-OTH39; Ri 0.1).  
 
Themes used by R&D executives but not used by CEOs 
 
R&D executives also use themes to describe the roles of CEOs in innovation that are not 
used by CEOs. These themes are presented in Table 5-4 below. It presents the themes 
(first column) and indicates their frequency in each individual interview and during all 
interviews. The table includes the same parameters Nt, Ni and Ri as in previous tables. 
The data are also are graphically presented in Figure 5-2 below.  
 
 
 
Figure 5-2 The themes exclusively used by R&D executives and their emergence 
 
Frequent themes used by R&D executives but not used by CEOs. The theme RD-OTH21 
(‘CEO learns from R&D and R&D learns from CEO’ Ri 0.5) is a frequently recurring theme 
and is the most frequently used theme by R&D executives. When they argue that they 
teach CEOs about their science, they expect from their CEOs to teach them about 
management, the market and about the place of their research in the overall strategy 
of the firm. R&D executives want to learn from their CEOs in order for them to make 
sense of their research activities and – therefore – to become involved in the  
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Number of times a theme used exclusively by R&D executives emerges from R&D interviews  
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Nt Ni Ri 
RD-OTH1 2           1            1          4 3 0.1 
RD-OTH2 1                                 1 1 0.0 
RD-OTH3 2                        1         3 2 0.1 
RD-OTH4 1                                 1 1 0.0 
RD-OTH5 1                                 1 1 0.0 
RD-OTH6 2         3 6  1 1   1   1 1  1    1     2 2 22 12 0.3 
RD-OTH7  1                                1 1 0.0 
RD-OTH8  4                                4 1 0.0 
RD-OTH9  1     1  2      1                   5 4 0.1 
RD-OTH10  1                                1 1 0.0 
RD-OTH11  1                                1 1 0.0 
RD-OTH12  1                                1 1 0.0 
RD-OTH13  1                                1 1 0.0 
RD-OTH14   1                               1 1 0.0 
RD-OTH15   1  2      4  2  5  1    1 2 2 1      1 3  1 26 13 0.4 
RD-OTH16    1                            1  2 2 0.1 
RD-OTH17    1                              1 1 0.0 
RD-OTH18     1                             1 1 0.0 
RD-OTH19      3 1    4  1     1   2 3 1 1 1 1     1 3  23 13 0.4 
RD-OTH20      1 1 1  1 1  1     2 1  1     1      1  12 11 0.3 
RD-OTH21      3 4  4 1  1 1  1   1 2 2    1   4 1  2 3   31 15 0.5 
RD-OTH22       1                           1 1 0.0 
RD-OTH23         1                         1 1 0.0 
RD-OTH24          1 1               1        3 3 0.1 
RD-OTH25          1 1                       2 2 0.1 
RD-OTH26              2 1                   3 2 0.1 
RD-OTH27              1                    1 1 0.0 
RD-OTH28              1        1 1           3 3 0.1 
RD-OTH29                        1          1 1 0.0 
Legend: Nt: Number of times the concept or subthemes appears in the interviews; Ni: the number of interviews in which the theme appears; Ri: the ratio of Ni/Ntotal with Ntotal: the 
total number of interviews; RD-OTH1: CEO should focus on common good and act beyond personal ambition; RD-OTH2: CEO manages LSRD firms with rigidity and strict control; RD-
OTH3: CEO manages qualitatively and quantitatively; RD-OTH4: CEO should be forceful and full of drive;RD-OTH5: CEO has a strong cultural and literature background; RD-OTH6:  
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CEO should not interfere with the science; RD-OTH7: CEO should balance industrial vs. academic work; RD-OTH8: CEO requires a balanced view of the potential of R&D; RD-OTH9: 
CEO should be capable to evaluate R&D knowledge; RD-OTH10: CEO should be located in proximity of the R&D site; RD-OTH11: CEO makes final R&D decision; RD-OTH12: CEO is a 
good listener;RD-OTH13: CEO is capable to talk the language of scientists; RD-OTH14: CEO should lead scientists, not manage them; RD-OTH15: CEO is a fast learner and has a scientific 
background; RD-OTH16: CEO should involve all levels of R&D; RD-OTH17: CEO is not expected to come up with new ideas; RD-OTH18: CEO should drive R&D not only from a financial 
point of view; RD-OTH19: CEO contributes to R&D by means of his/her experience; RD-OTH20: CEO does not need scientific knowledge (but when it is available it may help); RD-
OTH21: CEO learns from R&D and R&D learns from CEO; RD-OTH22: CEO balances short-term vs. long term innovation; RD-OTH23: CEO is a good communicator;RD-OTH24: CEO 
understand the new product development process and its risks; RD-OTH25: CEO should be willing to take risks in innovation; RD-OTH26: CEO makes sure that innovation is conducted 
in compliance with regulations; RD-OTH27: CEOs should be brought back to scientific reality; RD-OTH28: CEOs should embrace new innovative ideas; RD-OTH29: CEO should make 
time available for R&D. Nt: Number of times the theme or subtheme appears during the interviews; Ni: the number of interviews in which the theme appears; Ri: the ratio of Ni/Ntotal 
with Ntotal: the total number of interviews. 
 
Table 5-4 Themes used by R&D executives but not by CEOs 
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building of an overall strategy of the firm.  Transforming R&D data for transfer to the 
CEO learns the R&D function to think about the business context of their activities 
thereby linking the concept of absorptive capacity with the concept of learning. 
According to RDE33: 
 
‘the data from R&D are being transformed, or modified such that 
it becomes open to challenge, the challenge is to simplify data, 
actually learn R&D, it is the coaching of R&D to become a 
business organization, it’s for me a vital part of what’s 
happening’ 
 
In other words, it is not only the CEO who learns from R&D by means of the de-
complexified knowledge, also R&D executives learn about the CEO’s knowledge by doing 
so. This is clearly exemplified by RDE33: 
 
 ‘the simplification process is also a very valuable process for 
both parties to learn from each other’ 
 
It is not surprising that R&D executives emphasize the concept of learning. As they the 
key knowledge workers in the firm, learning constitutes an essential element of their  
professional responsibility.  
 
Less frequent themes used by R&D executives but not used by CEOs. Less frequent 
themes emerging from the R&D executives are for example: 
 
- RD-OTH15 (‘CEO is a fast learner and has a scientific background’; Ri 0.4),  
- RD-OTH19 (‘CEO contributes to R&D by means of his/her experience’; Ri 0.4), 
- RD-OTH6 (‘CEO should not interfere with the science’; Ri 0.3),  
- RD-OTH20 (‘CEO does not need scientific knowledge’; Ri 0.3)  
 
Other less frequent themes are linked to the availability of the CEO to interact with all 
levels of the R&D organization (RD-OTH16 ‘CEO should involve all levels of R&D’; Ri 0.1) 
which is the mirror R&D theme used by the CEOs (CEO-OTH20 ‘CEO should interact with 
all levels of the firm’). From a viewpoint of innovative ideation, R&D executives expect 
their CEOs to be open for new innovative ideas (RD-OTH28 ‘CEOs should embrace new 
innovative ideas’; Ri 0.1) and dare to take risks (RD-OTH25 ‘CEO should be willing to take 
risks in innovation’; Ri 0.1). The CEO, according to some R&D executives, should be 
capable to evaluate new knowledge (RD-OTH9 ‘CEO should be capable to evaluate R&D 
knowledge’; Ri 0.1 and RD-OTH8 ‘CEO requires a balanced view of the potential of R&D’; 
Ri 0.0) and should not ‘manage’ scientists (RD-OTH14; Ri 0.0). R&D executives refer to 
their CEOs as fast learners having a scientific background (RD-OTH15; Ri 0.4) or as 
individuals with lack of knowledge in the area of R&D (RD-OTH20; Ri 0.3) or having 
acquired knowledge through experience such that they contribute to R&D (RD-OTH19; 
Ri 0.4).  
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Further theme categorization 
The discussion above analyses the data as they emerged from the interviews, i.e; 
without further sub-categorization and as granular themes. However, the data lend 
themselves to further categorization. For example two themes emerged from the R&D 
interviews that address two concepts that are sensitive to R&D scientists in that the role 
of the CEO should exclude him/her meddling with the science (RD-OTH6) and that the 
CEO should not ‘manage’ science (RD-OTH14). They are brought together under the 
theme ‘CEO and science’ (see Table 5-6).  
 
In addition, R&D executives frequently address the concept of knowledge as indicated 
in Table 5-6 (RD-OTH9, 15, 19, 20, 21 and 24). The themes on knowledge used exclusively 
by R&D executives are brought together under the theme ‘CEO knowledge’. The table 
shows that knowledge related themes are strongly emphasized by the R&D executives 
(Nt 100 for all subthemes combined). Both the themes addressing knowledge used 
exclusively by R&D executives and those shared with CEOs are summarized and 
compared in Table 5-5 below.  
 
 
Themes on knowledge shared by CEOs and R&D executives (see Table 5-1): 
 
CEO-OTH3: CEO interacts with R&D only in those matters he/she has personal knowledge in 
CEO-OTH5: CEO stresses the importance of strong knowledge in the field of innovation 
CEO-OTH10: CEO attempts to understand R&D expertise 
CEO-OTH12: CEO considers it an advantage to be untrained in science 
CEO-OTH34: CEO needs to understands process/risks of R&D 
CEO-OTH38: CEO should have some basic understanding of science 
 
Themes on knowledge used exclusively by R&D executives (see Table 5-4): 
 
RD-OTH9: CEO should be capable to evaluate R&D knowledge 
RD-OTH15: CEO is a fast learner and has a scientific background 
RD-OTH19: CEO contributes to R&D by means of his/her experience 
RD-OTH20: CEO does not need scientific knowledge (but when it is available it may help) 
RD-OTH21: CEO learns from R&D and R&D learns from CEO 
RD-OTH24: CEO understand the new product development process and its risks 
 
Table 5-5 Comparing themes on knowledge shared with CEOs and R&D  
During the interviews the need for relevant CEO prior knowledge did not emerge as a 
uniform theme and it was therefore decided to reanalyze the R&D interview transcripts 
in an attempt to find structure in the R&D executives’ view on (the need for) prior CEO 
knowledge.  For example, R&D executives – on the one hand – argue that CEOs should 
profit from a scientific background (RD-OTH15), should understand the risks of R&D 
(CEO-OTH34) and of NPD (CEO-OTH24), should have a basic understanding of science 
(CEO-OTH38) but – on the other hand – find it advantageous for a CEO to be untrained 
in science (CEO-OTH12) or not having scientific knowledge (RD-OTH20). Table 5-8 
presents the results of this analysis and includes a spectrum of knowledge perceptions 
of the R&D executives using quotes made by R&D executives that underpin the 
individual perceptions of knowledge. It could be argued that the 
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Nt Ni Ri 
CEO and science 24 12 0,4 
RD-OTH6 2         3 6  1 1   1   1 1  1    1     2 2 22 12 0.3 
RD-OTH14   1                               1 1 0.0 
CEO knowledge  100 11 0,8 
RD-OTH9  1     1  2      1                   5 4 0.1 
RD-OTH15   1  2      4  2  5  1    1 2 2 1      1 3  1 26 13 0.4 
RD-OTH19      3 1    4  1     1   2 3 1 1 1 1     1 3  23 13 0.4 
RD-OTH20      1 1 1  1 1  1     2 1  1     1      1  12 11 0.3 
RD-OTH21      3 4  4 1  1 1  1   1 2 2    1   4 1  2 3   31 15 0.5 
RD-OTH24          1 1               1        3 3 0.1 
CEO limits of science 5 2 0.1 
RD-OTH8  4                                4 1 0.0 
RD-OTH27              1                    1 1 0.0 
RD-OTH6: CEO should not interfere with the science; RD-OTH8: CEO requires a balanced view of the potential of R&D; RD-OTH9: CEO should be capable to evaluate R&D knowledge; 
RD-OTH14: CEO should lead scientists, not manage them; RD-OTH15: CEO is a fast learner and has a scientific background; RD-OTH19: CEO contributes to R&D by means of his/her 
experience; RD-OTH20: CEO does not need scientific knowledge (but when it is available it may help); RD-OTH21: CEO learns from R&D and R&D learns from CEO; RD-OTH24: CEO 
understands the new product development process and its risks; RD-OTH27: CEOs should be brought back to scientific reality; Nt: Number of times the theme or subtheme appears 
during the interviews; Ni: the number of interviews in which the theme appears; Ri: the ratio of Ni/Ntotal with Ntotal: the total number of interviews 
 
Table 5-6 Further theme categorizations from R&D interviews
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variation in opinion among the R&D executives of the need for CEO prior knowledge is 
caused by the prior knowledge of the CEOs. In other words, R&D executives who report 
to a CEO with limited knowledge in the field of R&D would report a higher need for 
expert knowledge than R&D executives who report to CEOs who have expert knowledge 
in the field. However, a relationship between CEO education and R&D’s need for CEO 
prior knowledge cannot be found. For example, the chief scientific officer who reports 
to a CEO-investment banker does not consider it necessary for the CEO to have scientific 
knowledge. R&D executives who report to scientifically knowledgeable CEOs argue that 
there is no need for that level of knowledge at that level in the company, because 
science develops so fast that it is impossible for him/her to keep track of developments 
anyway. Accordingly, R&D executives who report to CEOs with limited or no scientific 
background do not necessarily perceive this as a disadvantage.  In other words, the 
CEO’s knowledge requirements as seen from the R&D executives perspective do not 
overlap with the CEO’s educational /experience background. This is illustrated in the 
table below (Table 5-7). It lists the R&D executives who argue that there is no need for 
a CEO to have scientific prior knowledge. As is shown, these R&D executives report to 
CEOs who have no scientific background (MBA, economics, law) as well as to CEOs with 
a strong science background (MD, MD/PhD, PhD). R&D executives RDE27 and RDE28 
who report to scientifically well trained CEOs such as CEO9, do not consider this to be 
advantageous and R&D executives such as RDE12, RDE13 and RDE19 who report to CEOs 
with no background knowledge such as CEO3 do not find this to be disadvantageous.  
 
Since the arguments and statements made by the R&D executives and CEOs on the 
concept of knowledge are inconsistent it was decided not to explore the concept of 
knowledge in the context of life science R&D any further as the exploratory approach 
and the interview questions did not allow further elucidation of the concept. Further 
research of this theme will require a separate systematic review of the literature, and 
should take into account the multidimensionality of the concept, the different 
gradations (no knowledge, basic knowledge, expertise knowledge) and the factors that 
constitute the basis (education, experience, R&D specific, business knowledge etc). In  
other words, it requires another and more focused approach that goes beyond the 
objective of this research. 
R&D executives who argue that 
there is no need for a science 
background of the CEO 
CEO to whom the R&D 
executives report 
Background of the CEO 
RDE12, RDE13, RDE14 CEO3 Economics 
RDE17, RDE19 CEO5 PhD science/law degree 
RDE24, RDE25 CEO8 Engineering/ consultant 
RDE27, RDE28 CEO9 MD, PhD immunology 
RDE30 CEO11 (big pharma) Law 
RDE32 CEO12 (big pharma) BSc Science, marketing 
RDE38 CEO15 PhD biology 
 
Table 5-7 Overview of R&D executives who do not need science CEOs and their CEOs 
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Quotes made by R&D executives on CEO prior knowledge perceptions 
NO R&D KNOWLEDGE  NO R&D KNOWLEDGE BUT 
EAGER TO LEARN 
BASIC R&D KNOWLEDGE NPD KNOWLEDGE ONLY PRIOR R&D KNOWLEDGE ON 
THE TOPIC OF RESEARCH 
EXPERT R&D KNOWLEDGE 
CEO has no knowledge on the 
science that governs the R&D 
activities because it is not 
necessary 
The CEO has no or limited 
science background (but makes 
efforts to understand the science 
and that is important for R&D) 
The CEO needs basic knowledge 
on a natural science discipline 
(but not necessarily related to 
the science that governs the 
R&D activities) 
The CEO should have knowledge 
on new product development 
processes and the risks that they 
entail 
The CEO should have  prior 
knowledge on the R&D that 
takes place in the company (i.e. 
when the firm conducts 
immunological research, he/she 
can talk ‘immunology’) 
The CEO should have expert 
knowledge on the science that 
governs the R&D activities  
Comments by R&D executives: Comments by R&D executives: Comments by R&D executives: Comments by R&D executives: Comments by R&D executives: Comments by R&D executives: 
‘The CEO does not need a 
scientific background (RDE12) 
 
‘The CEO  does not to have a 
science background because, if 
you cannot convincingly present 
the opportunity as a scientist 
then it is probably not a good 
opportunity’ (RDE12) 
 
‘It is more important for the CEO 
to have experience in the field 
rather than a relevant academic 
or educational background’ 
(RDE12) 
 
‘CEO experience is more 
important than CEO knowledge’ 
(RDE13) 
 
‘It is not a disadvantage to have 
a non-science CEO because it 
increases the diversity’ (RDE14)  
 
‘The CEO does not need prior 
knowledge on the topic’ (RDE25) 
‘The CEO wants to understand 
what we are doing’ (RDE19) 
 
‘The CEO is learning the science 
and talk s to everybody in order 
to learn about the science’ 
(RDE13) 
 
‘The CEO is very eager to learn’ 
(RDE13) 
 
‘The CEO wants to learn because 
he/she has no knowledge but is 
interest in R&D’ (RDE13)  
 
‘The CEO  always tries to 
understand’ (RDE24) 
 
‘The CEO wants to understand 
what is going on in R&D’ (RDE37) 
‘The CEO needs some knowledge 
about the science’ (RDE16) 
 
‘The CEO  doesn’t need to know 
the ins and outs of the detailed 
science and that’s one of the 
dangers is that when you talk to 
an academic’ (RDE8) 
 
‘It would have helped the 
company if the CEO was 
scientifically trained’ (RDE8) 
 
‘A CEO without any knowledge 
on the science that is conducted 
and is only knowledgeable  
about the finance is 
catastrophic’ (RDE11) 
 
‘A non-science CEO needs to be 
controlled in order to prevent 
him/her to make the wrong 
conclusions’ (RDE17) 
 
‘A CEO understands (and should 
understand) the basics of our 
R&D’ (RDE18) 
‘The CEO  should certainly be 
familiar with the processes 
involved in drug development, 
understand the risk (commercial, 
technical etc)’ (RDE17) 
 
‘A CEO understands the process 
and risks of new product 
development’ (RDE19) 
 
‘A CEO is knowledgeable about 
the new product development 
process’ (RDE20) 
 
‘A CEO had the knowledge to 
steer the development in the 
company’ (RDE26) 
 
‘A CEO needs process knowledge 
(what is achievable? What are 
the risks?)’ (RDE31) 
 
‘A CEO needs to understand how 
R&D is progressing’ (RDE37) 
 
 
‘I think it is important the CEO 
has prior knowledge because he 
is the one to give us direction; so 
if he does not understand where 
we want to go he will not give us 
a direction ... if he’s not 
convinced he will give us much 
less or not adequate budget’ 
(RDE9) 
 
‘A CEO has a good high-level 
understanding of the science 
projects in our firm’ (RDE17) 
 
 
‘Prior knowledge of the CEO 
leads to faster decision making’ 
(RDE19) 
 
 
‘The need of prior knowledge 
depends on how good R&D 
operates’ (RDE278) 
 
 
‘A CEO with expert knowledge 
need to take a step back from 
the science’ (RDE17) 
 
‘A CEO  with expert knowledge 
and interferes with the science 
will risk losing all his scientists’ 
(RDE17) 
 
‘Good scientists do not make 
good CEOs’ ( RDE17) 
 
‘A CEO with ‘CSO knowledge’ 
cannot be a good CEO’ (RDE20) 
 
‘A CEO and I could discuss the 
science problems and the pros 
and cons of the approach’ 
(RDE27) 
 
‘A CEO  who understand the 
science is more capable in 
securing money’ (RDE37) 
 
Table 5-8 Spectrum of CEO science knowledge as perceived by R&D executives 
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The concept of learning appears frequently during the interview with the R&D 
executives. They refer to learning as dyadic exchange of knowledge whereby both actors 
exchange data and learn from each other. In order to obtain a good understanding of 
what R&D executives mean by ‘learning’, the R&D transcripts were reanalyzed to look 
for quotes and arguments that specifically address the concept of ‘learning’. Table 5-9 
offers an overview of the ‘learning’ concept as it emerged during the interviews. It is 
clear that the learning process covers both learning of CEOs by R&D and R&D by CEOs.  
 
LEARNING PROCESSES BETWEEN R&D AND CEO 
CEO to R&D R&D to CEO Learning each other 
‘...his experience, his previous 
experience from other companies is 
definitely also something that we can 
learn from, that’s what I’m doing for 
the moment so he learns me how to 
develop starting from an idea to go to a 
product so I also see that as a learning 
curve from his experience yes because 
most of the time it’s a start up like we 
are so we are coming from the 
academic world and we don’t have the 
idea from how to develop something 
out into the market so it’s a learning 
curve and he’s definitely there and has 
a leading role’ (RDE37) 
 
‘...and I learnt a lot from the CEO’ 
(RDE37) 
 
‘Well its each time a bit different with 
another CEO, in the case of this CEO it 
is again learning in a very intense way 
on how to structure and focus our 
business and our activities, at the same 
time he is very friendly, he can laugh, 
he can party and he thinks he cares 
about patients’ (RDE12) 
 
‘We really learn a lot from him ... how 
our company is placed in the market or 
its connections to others and 
partnering in collaboration there we 
learn a lot of then how these contexts 
– but scientifically really pure the 
science that we do and that goes to the 
scientist’ (RDE25)  
‘...look an accountant without any 
knowledge and -  even worse - without 
any interest who just runs the company 
like he does ....  that’s not good I think, 
that’s not good because I do not learn’ 
(RDE13) 
 
‘I think the much broader picture and 
the strategy ....  I feel our CEO has much 
more experience and has completely 
other ideas about how to manage a 
team and how to do that in parallel 
with the science... managing a team is 
for example one of the things I am 
learning from our CEO much more then 
from the CSO and this I think for me at 
least is very important and welcome’ 
(RDE26) 
‘There is no knowledge gap between you 
and the CEO at this stage.... because also 
for him its important for him to know, to 
have the knowledge because he needs to 
explain it to potential partners to a 
potential investor and he wants to learn 
it, he wants to understand it’ (RDE37) 
 
‘You know I studied philosophy before I 
studied medicine and those are 
problems, the education of the CEO if 
he’d learnt to read a novel properly and 
analyse literature it tells you about 
human relationships, they’d do a lot 
better than going to a business school’ 
(RDE7) 
 
‘He /she is capable of understanding the 
science behind it because to some extent 
he’s a fast learner’ (RDE11) 
 
‘Well we had the case of course with the 
CEO who had no knowledge and who 
was a slow learner, of course that didn’t 
work at all, we have now we have a new 
CEO and he is a science background but 
he’s a fast learner so and he’s really well 
trained’ (RDE11) 
 
‘I think he’s learning a lot, he’s reading a 
lot about what we also exchange all of 
the information with each other, we go 
together to scientific meetings. I join him 
in business meetings and we have 
several people who do that also from the 
marketing team, there’s quite a lot of 
interaction between him/her and his 
team and so he’s learning fast, he has 
already learned a lot about the science’ 
(RDE12) 
 
‘Every time we have these type of 
discussions and need to make decisions 
he’ll be able to understand a little bit 
more about the science behind these 
types of messages, so I don’t see myself 
as a teacher for him that’s not it but it’s 
something that happens in the process 
anyway’ (RDE15) 
 
‘There might be a very small gap but it is 
minor because I think what we also do, 
he/she is also doing reading, business 
development, reach out to pharma 
‘Learning, definitely, that definitely 
goes both ways because you can hardly 
predefine, well unless you go to such a 
high level of methodologic aggregation 
and just talk – that’s I think the most 
abstract you can do and it could be all 
kinds of bullshit behind that, excuse my 
German and finding a level that is more 
appropriate I think that’s the two-way 
learning experience’ (RDE33) 
 
‘I learn from the CEO and the CEO 
learns me’ (RDE12) 
 
‘I expect to learn from the CEO and I 
expect to learn the CEO something that 
you know’ (RDE15) 
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companies, he’s very active in this, also 
for finding out if the programs in which 
we are working if these make sense also 
for a pharma party ... you have to reach 
out to pharma parties and having those 
discussions I’m also involved in this, you 
learn a lot’ (RDE21) 
 
Table 5-9 Learning processes between R&D and CEO 
In addition, R&D executives also refer to the themes of ‘understanding the limits of 
science by the CEO’ (RDE-OTH8 and RD-OTH27, respectively ‘CEO requires a balanced 
view of the potential of R&D’ and ‘CEOs should be brought back to scientific reality’). It 
became clear during the interviews that R&D executives are concerned by the idea that 
CEOS ‘run away’ with the achievements of R&D before these are validated and create a 
hype with the top management team, the board members and - even worse - the 
external stakeholders before they were able to find substantial evidence for their 
findings. These are brought together under the theme ‘CEO limits of science’ (see Table 
5-6). 
 
Themes exclusively used by CEOs and not used by R&D executives 
A number of themes are not shared between CEOs and R&D executives and are not used 
exclusively by R&D executives but are only used by CEOs. Table 5-10 below lists the 
themes that are used by CEOs to describe their roles and which are not shared by R&D 
executives.  The table lists the themes and the following parameters: 
Nt:  the number of times the theme or subtheme appears in all interviews 
Ni:  the number of interviews in which the theme appears 
Ri:  the ratio of the number of interviews in which the theme appears to the total 
number of interviews. 
 
The CEO-specific themes focus on attitude (ATI2 ‘CEO fosters experimentation and 
accepts failure’), ATI4 (‘CEO fosters exchange of diverse ideas’), ATI6 (‘CEO fosters 
flexibility and adaptability’) and the fear that too much procedural impact may stifle 
innovation, ATI8 (‘CEO states that processes may stifle innovation’), commitment 
(COM2 ‘CEO creates incentives and prioritization), COM3 (‘CEO prioritizes resources), 
INV4 (‘CEO interacts with R&D to solve technical questions’), INV7 (‘CEO is involved at 
the beginning followed by delegation’), INV7 (‘CEO picks up innovational opportunities’), 
INN1 (‘CEO drives the innovation him/herself’) and a myriad of other themes as 
presented in the table.   
 
Themes exclusively used by CEOs: 
 
Nt Ni Ri 
ATI2 CEO fosters experimentation and accepts failures 6 6 0.4 
ATI4 CEO fosters the exchange of diverse ideas 10 6 0.4 
ATI6 CEO fosters flexibility and adaptability 2 2 0.4 
ATI8 CEO states that processes may stifle innovation 5 3 0.6 
ATI9 CEO has an inquisitive nature: asking, listening, probing 1 1 0.1 
COM2 CEO creates incentives and rewards for the R&D function 8 6 0.4 
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COM3 CEO prioritizes resources 8 4 0.3 
INV4 CEO interacts with R&D to solve technical problems 1 0 0 
INV7 CEO is involved at the start of an R&D project and then delegates it 3 3 0.6 
INV10 CEO picks up to R&D innovational opportunities 1 1 0.1 
INN1 CEO drives new product development in person 1 1 0.1 
CEO-OTH1 CEO admits limited knowledge in specific R&D area 2 2 0.4 
CEO-OTH8 CEO role model is knowledge based 1 1 0.1 
CEO-OTH15 CEO role model is business driven 2 2 0.4 
CEO-OTH16 CEO wants to protect R&D from the mundane aspects of running a firm 2 2 0.4 
CEO-OTH18 CEO role is to link R&D to internal & external stakeholders 2 2 0.4 
CEO-OTH19 CEO reduces risk by fail fast fail cheap 4 3 0.6 
CEO-OTH21 CEO role in R&D is not different from CEO role in non-R&D 1 1 0.1 
CEO-OTH23 CEO requires persistence and resilience in LFSR 3 2 0.4 
CEO-OTH24 CEO argues that innovation comes from top down and bottom up 4 3 0.6 
CEO-OTH26 CEO innovates by challenging the organization (time, costs etc) 2 2 0.4 
CEO-OTH27 CEO argues that innovation also occurs outside R&D 4 4 0.3 
CEO-OTH 28 CEO argues that R&D should always be one step ahead 1 1 0.1 
CEO-OTH29 CEO educates the firm’s environment 1 1 0.1 
CEO-OTH30 CEO argues that value is as important as market 1 1 0.1 
CEO-OTH32 CEO should have firm belief in the product 1 1 0.1 
CEO-OTH33 CEO considers patients as innovation drivers 2 2 0.4 
CEO-OTH35 CEO needs to understand culture of science 3 1 0.1 
CEO-OTH36 CEO needs to know how to lead scientists 3 1 0.1 
CEO-OTH37 CEO’s understanding of scientists is more important than being a 
scientist 
1 1 0.1 
CEO-OTH40 CEO needs bottom-up ideas in LFSR firms 2 2 0.4 
CEO-OTH42 CEO argues that simple messages make for flawed decisions 2 2 0.4 
CEO-OTH43 CEO – not R&D - should simplify the message  3 1 0.1 
CEO-OTH44 CEO should make sure scientists can remain scientists (and not become 
managers) 
2 1 0.1 
CEO-OTH45 CEO should be very flexible 2 1 0.1 
CEO-OTH46 CEOs should be/act transparent 3 2 0.4 
CEO-OTH47 CEO can prevent a R&D knowledge gap by growing from within R&D 1 1 0.1 
CEO-OTH48 CEO teaches R&D about business 2 1 0.1 
CEO-OTH49 CEO does not need to be a scientist 2 2 0.4 
CEO-OTH51 CEO balances R&D vision with the Board’s vision 2 1 0.1 
CEO-OTH52 CEO challenges R&D and is challenged by R&D 3 2 0.4 
CEO-OTH53 CEO knows how to challenge R&D because of his experience 1 1 0.1 
Legend: Nt: Number of times the concept or subthemes appears in the interviews; Ni: the number of interviews in 
which the theme appears; Ri: the ratio of Ni/Ntotal with Ntotal: the total number of interviews. 
 
Table 5-10 Exclusive CEO themes 
 
5.2.2.2 Interview observations 
A more extended overview of the quotes raised during the R&D interview observations 
is available in Appendix P. It is divided in two parts. The first part discusses the interview 
observations as they relate to the concept of trust, while the second part addresses the 
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process of knowledge complexity reduction as both strongly emerged from the 
interviews. 
5.3 Discussion 
5.3.1 Literature based themes 
The findings in the second part of this research show that the a priori literature based 
concepts of CEO-attitude, -attention, -commitment and –involvement reappear when 
R&D executives are asked about their perception of the role of their CEOs. CEO attitude-
related themes such as the fostering of a culture of innovation, of internal 
communication and external collaboration to increase internal innovation emerged 
from the R&D interviews. This observation is corroborated by similar findings in the 
research literature that show that CEO-attitude is a major factor in innovation 
(Damanpour and Schneider, 2006). In addition, both CEOs and R&D executives find that 
it is important to have a clear direction and vision in which the innovation should take 
place and the boundaries in which this occurs. Another theme that is shared by CEOs 
and R&D executives is the commitment of the CEO to human and financial resources. 
This is not surprising because CEO commitment is crucial seen the considerable cash 
burn in these companies and the continuous resources required to conduct R&D. R&D 
executives also refer to CEO involvement as an important CEO role descriptor, but less 
strongly than CEO attitude and CEO attention.  R&D executives do not perceive their 
CEOs as innovators (see Figure 5-3). This was also observed during the CEO interviews. 
Both R&D executives and CEOs see the role of the CEO as a factor that facilitates life 
science innovation in the firm.  
5.3.2 Other themes 
While the literature based a priori themes constitute approximately 50% of the themes 
emerging from the interviews (Table 5-1), other themes – originally developed by the 
CEOs during their individual interviews - are also recognized by R&D executives as 
important role attributes. Some of these themes are emphasized by the R&D executives 
such as the concept of trust and absorptive capacity (Figure 5-1 and Figure 5-3). Again, 
as was observed during the interviews with the CEOs, the concept of absorptive capacity 
did not emerge ‘as such’ but rather through multiple references to the process of R&D 
knowledge complexity reduction.  
 
Trust 
The concept that R&D executives frequently and strongly elaborate on is the concept of 
trust. During the interviews, the R&D executives not only referred to the CEO’s attitude 
and attention to innovation, they also articulated the need to have their CEOs trust their 
capabilities.  
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Figure 5-3 Ranking of themes according to their emergence during R&D interviews  
 
First, trust is shared by CEOs and R&D executives but, as will be discussed in detail in the 
next chapter, with strikingly different emphasis. Trust has been defined as the 
‘psychological state that comprises the intention to accept vulnerability based upon 
positive expectations of the intensions or behavior of another’ (Mayer et al., 1995).  This 
psychological state goes a step further than a positive attitude towards innovation which 
was defined as the positional stance of openness to innovation. How important and 
relevant it may be for any firm wanting to innovate, in life science R&D firms, this general 
stance does not seem to be sufficient because its positive effect would disappear rapidly 
if trust was not present in R&D’s capabilities. The positive attitude towards innovation 
– accepted by the R&D executives to be a conditio sine qua non - needs to supplemented 
with clear signs of trust role behaviours. The intention to accept vulnerability - which is 
core to the concept of trust - is an indispensable psychological state in life science R&D 
firms seen the impressive failure rates of innovation projects in these firms (Rosier, 
2013). In other words, the attitude of ‘having a positive stance towards innovation’ is 
only a weak position in view of the considerable risks associated with life science R&D 
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firms (ranging from project failure and large financial losses to company death). 
According to the R&D executives therefore, trust is pivotal and therefore frequently 
emphasized. In addition, the concept of trust, as argued by the R&D executives, also 
seem to point to a relationship of trust rather than to a culture of trust. These are 
necessarily linked to each other but in the case of R&D executives this dyadic form of 
trust seems to be a key factor in how they see the role of the CEO. As argued by Dovey, 
‘trust is never an impersonal commodity’ and ‘through inspirational communication, 
knowing and believing in their “followers” and principled personal example leaders 
mould strong interpersonal bonds’. Trust also requires ‘significant face-to-face time’ 
(Dovey, 2010) and is ‘embedded in relationships between people’ (Nahapiet, J. and 
Goshal, S., 1998) In other words, it seems that R&D executives argue that their CEOs 
should clearly accept – or at least share - the vulnerability caused by the high uncertainty 
associated with the activities of the R&D function14. 
 
Second, the concept of trust could have been assigned to the a priori literature of 
attitude in Chapter 3. However, in view of the above and because of its clear and striking 
emergence in R&D interviews, it is argued that it has value in its own right and should 
not be ‘masked’ by the a priori concept of attitude. It is therefore considered a separate 
theme that supplements the more ‘mundane’ and general concept of attitude. This 
research points into the direction that trust is a concept that describes the role of the 
CEO in a life science R&D firm – seen their risk profile - more precisely than the 
generalized concept of attitude.  
 
Third, trust requires learning and is more easily enacted ‘in a culture where change is 
underpinned by openness to learning and self-renewal’ such as a culture of innovation 
(Dovey, 2010). The theme of learning between CEO and R&D is frequently recurring 
theme during the interviews. It shows that learning, i.e. making sure that the CEO 
understands the specialized R&D know-how (and informing R&D about the market by 
the CEO) is an important construct in the mind of R&D executives.   
 
Trust can only develop between two agents if the knowledge available to both is shared 
such that it is open to an understanding for both. It is built ‘through the development of 
shared cognitive frames of reference via participation in a variety of overlapping 
networks’ (Dovey, 2010). Such shared frameworks ‘facilitate the flow of knowledge and 
develops the absorptive capacity of the collective’ (Nonaka and Takeuchi, 1995). When 
two agents discuss a package of knowledge that has been adapted or transformed for 
the party with less knowledge to equilibrate his/her absorptive capacity, then learning 
follows and trust develops. In other words, trust can be developed between two agents 
if knowledge is made available to the agent with less knowledge that is in line with 
his/her absorptive capacity. 
 
 
                                                          
14 This was also observed by the INSEAD researchers Loch et al. (2011) in their working paper ‘Supervising Projects you Don’t 
Understand’ in which they refer to ‘trust’ as a basis of the relationship between CEOs who do not understand the knowledge of 
their top scientific management. This paper became available after the start of the writing process of this thesis. 
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Complexity reduction 
During the interviews, R&D executives address the concept of trust and link this to the 
concept of knowledge such that CEOs with limited or no knowledge will need to show 
trust when they interact with the R&D function.  CEOs with limited prior knowledge in 
R&D have limited absorptive capacity and therefore will need to trust their R&D function 
more than CEOs with considerable prior knowledge. However, even when CEOs have 
considerable knowledge in the R&D taking place in their firms, R&D executives still 
require trust to be present. For example, RDE21 is a chief scientific officer (and a 
university Professor) who reports to a CEO who holds a PhD in molecular biology (CEO6) 
and whom he/she regards high from a scientific point of view (see also Appendix P) 
argues that: 
 
‘I’ve seen other CEO’s in my previous life who didn’t know the 
science so well and I think that is a limitation, if such persons 
completely have to trust their CSO...’ 
 
But even for CEO6, R&D knowledge is simplified by RDE24: 
 
‘I do simplify the message ... I do that yes unless he asks more 
specifics and then I explain in more detail. I speak in a different 
way with him such that the knowledge becomes absorbable and 
speak with him other than I do with my team’  
 
Although R&D executives agree on the need for trust and the fact that complex R&D 
knowledge needs to be simplified, they do not agree on the level of prior knowledge – 
a constituent of absorptive capacity - required from their CEOs. There is a large variation 
of prior knowledge requirements, ranging from no knowledge about the science to 
considerable knowledge of the R&D that takes place in the firm. The interviews did not 
allow – because of time constraints - to explore in detail what R&D executives expect 
from their CEOs when they refer to his/her knowledge.  
 
Based on the results presented above, it can be concluded that – answering the first 
question – that the a priori themes used by CEOs to describe their roles are also 
recognized by R&D executives can be answered positively, with the exception of CEO 
innovativeness. The second research question whether the R&D function uses concepts 
to describe the role of the CEO other than those used by CEOs can also be confirmed. It 
is argued that to be the concept of trust. 
 
The research data above however become increasingly interesting when they are 
contrasted with the CEO interview observations and discussed from the perspective of 
both CEO and R&D. Therefore the discussion of this chapter is continued in Chapter 6. 
5.4 Summary 
The role of the CEO in innovation as perceived by R&D is similar to the role of the CEO 
described by CEOs. The themes shared by CEOs and R&D executives are the a priori 
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literature based concepts of CEO-attitude, -attention, -commitment and -involvement. 
Also, R&D executives do not perceive their CEOs as innovators in their own right, an 
observation which was also made by the CEOs during their interviews. It means that the 
role of CEOs as described by R&D is aligned with the role of the CEO as described by the 
CEOs. R&D executives also recognize the need for complexity reduction and in doing so 
recognize the CEOs’ absorptive capacity as they titrate their knowledge to his/her 
absorptive capacity. R&D executives however forcefully and frequently address the 
concept of trust in their relationship with the CEO.  Because R&D executives clearly 
emphasize the concept of trust (in innovation by R&D) and because it is viewed as a 
considerable component of the role that a CEO should discharge in life science R&D 
firms, it is considered a new theme. Based on these observations at this stage of the 
research, the role of the CEO can further be described as follows:  
 
‘The CEO leads innovation in life science R&D firms by creating a bond of trust with the 
R&D function. This trust bond is formed as a result of the increased understanding of 
the CEO of the knowledge generated by R&D using his/her absorptive capacity and by 
creating a frame of reference in which that knowledge can be shared and understood’.  
 
The key findings are summarized in Table 5-11 below.   
 
 
 Themes addressing the role of the CEO in innovation as they emerged 
from individual structured interviews of R&D executives 
 A priori themes from the literature New themes 
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Table 5-11 The a priori themes and new themes observed during the R&D interviews 
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6 Comparing views of CEOs and R&D executives 
6.1 Introduction 
Both the first and second part of this research offered insight in how CEOs describe their 
role in innovation in life science R&D firms and how R&D executives perceive the CEO’s 
role. Both CEOs and R&D executives share a set of common themes such as the need for 
CEO-attitude towards innovation, attention to the environment and the future and 
commitment to innovation. It was also shown that CEOs emphasize the need to reduce 
the complexity of the R&D knowledge, while R&D emphasizes the need to reduce the 
complexity in view of the CEO’s prior knowledge. As a result of this finding, the concept 
of CEO absorptive capacity was introduced, i.e. the capability of the CEO to absorb and 
evaluate new R&D knowledge based upon his/her prior knowledge. R&D also expects 
the CEO to trust its innovative explorations. While Chapter 4 and 5 presented the 
perspective of the CEOs and of the R&D executives respectively, this chapter attempts 
to contrasts and analyze these perceptions.  It starts with a discussion on theoretical 
saturation (Section 6.2.) and proceeds with a comparative analysis of both observations 
(Section 6.3.) which are summarized in Section 6.4. 
6.2 Theoretical saturation 
In order to compare the data from the research on the CEO and on the R&D executives, 
the collections of themes that emerged from both interviews should be ‘complete’. It 
would be inappropriate to compare both data sets if themes would be missing from any 
collection of themes. In other words, it is necessary to ascertain that theoretical 
saturation is achieved for as well the CEO as the R&D interviews.  
6.2.1 Theoretical arguments 
Theoretical saturation is described as a process whereby a researcher ‘continues to 
sample relevant cases until no new theoretical insights are being gleaned from the data’ 
(Glaser and Strauss, 1967). According to Bryman (cited by Baker and Edwards, 2012), 
‘such an approach to sampling is very demanding because it forces the researcher to 
combine sampling, data collection, and data analysis, rather than treating them as 
separate stages in a linear process’ and ‘the researcher cannot possibly know at the 
outset how many cases he or she will need to collect data from, which causes problems 
when trying to formulate a research proposal’. In the case of interviews of CEOs, the 
problem is also hampered by the difficulty of obtaining access (Yadav et al. 2007). In 
other words, even if it would be possible to theoretically determine the number of cases, 
it is not sure whether the number would be attained in a real life research setting.  Guest 
et al. (2006) (cited by Bryman, 2012) interviewed women in 2 West African countries 
and found that saturation was attained after 12 interviews. According to Bryman, ‘this 
might appear quite a low figure but the sample was quite homogeneous (women at high 
risk of HIV) and the research was tightly focused’. In this case, theoretical saturation 
could be achieved because the sample was tightly controlled within strict boundaries of 
sampling. As few guidelines are available on how to establish theoretical saturation, 
Bowen et al. (2008) (cited by cited by Baker and Edwards, 2012) propose two stages, 
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which they employed during two health related projects, consisting of an initial sample 
of around 10 cases followed by a further three cases to determine if any new themes 
emerge, thereby corroborating Guest et al.’s point of view.  
 
Based upon Guest et al.’s and Bowen et al.’s arguments, it could be argued that the 15 
CEO interviews – which were preceded by 2 pilot interviews - should lead to theoretical 
saturation because the interviewed CEOs constituted a narrowly selected research 
cohort and form a group enclosed within a narrow community of life science R&D firms 
with similar risk profiles and sizes. In line with Guest et al.’s argument, it can therefore 
be assumed that theoretical saturation is obtained after the CEO interviews.  In the case 
of the 33 interviews of the R&D executives, Warren’s suggestion (Warren, 2002) that 
‘the number of interviews need to be between 20 and 30 for an interview-based 
qualitative study to be published’, offers at least theoretical assurance that theoretical 
saturation is reached for the research interviews of the R&D executives. Realizing that 
there is no formal approach that allows the determination of a minimal number of cases 
(Baker and Edwards, 2012) it is argued here that, from a theoretical point of view, 
theoretical saturation is achieved. 
6.2.2 Data analysis 
Seen the amount of data that was extracted from both research projects reported in 
Chapter 4 and 5, it was decided to also test empirically whether the interviews led to 
theoretical saturation. 
6.2.3 Theoretical saturation CEO interviews 
In order to test the hypothesis that theoretical saturation was achieved after the inter- 
views of the CEOs, the data in Table 4-1 and Table 4-2 were rearranged and the number 
of new themes were counted that emerged after each CEO interview. The data were 
then plotted in a graph which is presented below in Figure 6-1. It shows that the number 
of themes that emerge from the interviews start to level off with the number of CEOs 
interviewed although a plateau is not reached: there is still a slight increase in the 
number of themes when the interview of the last CEO is conducted. However, whether 
a continuation of the interviews would lead to fundamentally new themes that would 
jeopardize the conclusions reached in Chapter 4 is doubtful. In light of the observation 
of Guest et al. (2006) that theoretical saturation was achieved after 12 interviews 
because the sample was tightly controlled, it is argued here that theoretical saturation 
was achieved at the end of the CEO interviews, seen the homogeneity of the sample 
(CEOs of small mid-sized firms, in life science R&D). 
6.2.4 Theoretical saturation R&D interviews 
The data in Table 5-1 and Table 5-4 were reorganized and the number of new themes 
were counted that emerged after each R&D interview. This was done as well for the 
themes that were shared by CEOs and R&D executives and for the themes that were 
identified as exclusive to the R&D executives. The data are presented in Figure 6-2.  
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Figure 6-1 Theoretical saturation curve for themes emerging from interviews of 15 CEOs 
 
 
 
Figure 6-2 Theoretical saturation curve for themes emerging from 33 R&D interviews  
 
The curves show that for the interviews of the R&D executives, saturation is achieved 
after approximately 15 interviews when the R&D-exclusive themes are taken into 
account and after approximately 20 interviews when the CEO-R&D shared themes are 
taken into account. Because it is argued that additional interviews would not generate 
new themes that would alter the conclusions and because both the CEO and the R&D 
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saturation curves show the development of a plateau after around 15 interviews, it is 
concluded that theoretical saturation is achieved to a level that allows comparison 
between both collections of themes. 
6.3 Comparing themes and their emergence 
This section addresses the themes that emerged from the structured interviews and the 
R&D executives. It is divided in a section on a priori themes and a section on ‘other 
themes’. 
6.3.1 A priori themes 
It was observed during the CEO interviews and the R&D interviews that the role of the 
CEO in innovation in these life science R&D firms are perceived by both CEO and R&D 
executives by means of a common set of themes, i.e. those which were identified in the 
literature: attitude, attention, commitment and involvement. Both CEOs and R&D 
executives argue that they are crucial components of the role of the CEO (see Figure 
6-3). The emergence of attitude, attention and commitment is not surprising as the 
absence of such role behaviors would be difficult to accept both by CEO and by R&D as 
they constitute the culture, the future and the resources required to innovate. R&D 
executives do not perceive their CEOs as product innovators but rather as facilitators of 
innovation which is also how CEOs perceive themselves. The setting of the goal and 
direction in which innovation should take place (i.e. CEO attention) are clearly 
recognized by both CEOs and R&D executives. During the focus group research, CEOs 
showed how they discharge this role: by using the de-complexified R&D knowledge they 
‘rally the firm behind the idea’ (CEO3) and focus the R&D function.  R&D executives also 
perceive their CEO’s commitment as limited. There is no clear explanation for this 
difference but it may be caused by the fact that the R&D function, seen the continuous 
need for R&D resources, perceive their CEO’s commitment (and his/her capacity to 
resource seen the difficulty of obtaining funding) as limited. 
 
It was observed in the first part of this research that CEOs perceive their involvement as 
limited: during the CEO interviews they refer to NPD involvement only 7 times and 47 
times if all involvement subthemes are taken into account. However, R&D executives 
refer to the involvement of their CEOs much less (in total, 25 times for 33 R&D executives 
and to NPD involvement only once). It points to the direction that CEOs tend to over-
estimate their NPD involvement while their actual involvement as perceived by R&D 
executives is limited. This difference in self-perception by the CEOs with respect to their 
involvement and the perception by the R&D executives about the actual CEO’s 
involvement is difficult to explain. When CEOs perceive themselves as involved in 
innovation while R&D executives do not perceive that behavior, the CEO’s self-
perception may actually be caused by the CEO’s involvement at the start of the NPD 
process after which the CEO ‘lets go’ to allow the R&D executives to proceed with the 
project using their personal insight. This attitude of ‘being involved at the beginning and 
then letting go’ is raised by the CEOs (see INV7 ‘CEO is involved at the start of an R&D 
project and then delegates it’, Chapter 4) and may cause them to perceive themselves 
as ‘involved’, while R&D executives who run the project for many months/years, do so 
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in the absence of the CEO and therefore perceive his/her involvement as limited 
(because they only involve him/her when things go wrong). This in turn may result in the 
R&D executives’ reduced emphasis/emergence of CEO involvement during their 
interviews. In other words, they refer to their R&D projects as if the CEO ‘was not 
around’.  
 
 
 
Figure 6-3 Comparison of themes between CEO and R&D executives 
6.3.2 Other themes  
6.3.2.1 Trust 
While trust is a theme that is shared by both R&D executives and CEOs it appears in 
strikingly different levels (Figure 6-3). Even when caution is required to interpret the 
figures in the table above, it became clear during the interviews of the R&D executives 
that they considered trust a pivotal part of the role that a CEO should play in innovation 
in life science R&D firms. During the R&D interviews it became clear that the concept of 
‘trust’ was a sensitive concept. R&D executives referred to it frequently and it emerges 
‘organically’ during the discussion as if it were a fundamental concept that should be 
articulated clearly for the interviewer to be recognized. It was also observed during the 
2 pilot studies when R&D executives stressed the concept of trust already from the start 
of the interview.  In the mind of most - 24 out of 33 - R&D executives, trust plays a key 
role to describe the role of the CEOs. During the final CEO interviews, the theme of trust 
only emerged in one interview (the interview with CEO5) and only then as a concept 
that ‘passed away’ during the interview, i.e. it disappeared as quickly as it emerged and 
without any of the visual signs that accompanied the concept of trust during the 
interviews of the R&D executives. This indicates that trust seems to point to a specific 
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theme that differentiates the R&D function’s view on the role of the CEO from the CEOs’ 
view on his/her role. The majority of the CEOs do not refer to the theme of trust because 
they do not consider it to be of importance or because they consider it to be a given and 
of such a fundamental nature that it is not worth drawing attention to.  Surprisingly, the 
concept of trust of the CEO in R&D was not reported during the discussions of the CEO 
focus group unless it was brought in the discussion by the interviewer. At this stage, the 
CEOs all seemed to be surprised that the concept of trust was laid on the table. They 
argued that trust is a concept that – in their context at least – is related to the level at 
which they challenge R&D.  The level of trust and of challenge seemed to be related 
(CEO8): 
 
‘…it was very clear that I personally went over the board in trusting her 
too much and still it was not sufficient to her... so therefore I find this 
trust to be very complex... and it’s very difficult to accept data and be 
offered data by R&D with the statement ‘take it at face value’…’  
 
This was also perceived as such by R&D executives (for example RDE33) who argued that 
there is a fine balance between trust and challenge and that challenge can be strong 
without necessarily impacting trust negatively.  
 
‘....what I said at the beginning was that the very difficult balance 
between challenge and trust... so just enough challenge to trigger the 
conscience in the R&D organization ... that we constantly need to 
challenge ourselves, but not challenge to the point where it disrupts 
R&D and innovation, innovative activities that’s what I mean really, so 
it’s really the trust of the CEO into the R&D organization ... it sounds 
like ‘leave it alone it’s a black box’, that’s not what I mean...’ 
 
Nevertheless for R&D, trust was bifocal: it concerned trust by R&D in the CEO (can we 
trust the CEO?) and by the CEO in R&D (does the CEO trust us?).   
 
‘...and yes it also works the other way around: there needs to be 
trust from the R&D side into the CEO that there is a sustainability 
in the approach to innovation …’ 
 
The concept of trust in the CEO is based upon R&D’s concern whether his/her knowledge 
about the market is of value for R&D and whether he/she is capable to take the right 
decisions based upon the knowledge that R&D generates.  
 
It seems therefore that trust – from the viewpoint of R&D at least – is a function of prior 
CEO knowledge. If R&D learns from the CEO about the business context, trust in the CEO 
is developed. If the CEO learns from R&D, the CEO develops trust in R&D. This learning 
process is therefore linked to the CEO’s absorptive capacity whereby knowledge is to be 
transformed to a level whereby both actors can interact in a meaningful way because 
they use a common knowledge base that lies the foundation for trust building. During 
 
 
Chapter 6 Comparing views of CEOs and R&D 
131 
 
the focus group research, CEO15 argued – and this was supported by all present CEOs - 
that the reduction of the complexity of R&D knowledge is not only a ‘simple 
simplification’ of that knowledge but also constitutes a learning exercise for the CEO, in 
that he/she learns to ask the right questions (CEO15), to challenge R&D and to generate 
motivation (CEO15) within the R&D team because he/she is only capable to drive the 
company only if he/she understands the science that is taking place. In other words, it 
seems that in life science R&D firms, knowledge, trust and learning go hand in hand in 
the relationship between CEO and R&D. Because it is impossible for CEOs to keep pace 
with scientific developments, the knowledge gap with R&D remains and the R&D 
function expects the CEO’s role to be one based on trust because he/she is not capable 
– because of time constraints or lack of (prior) knowledge – to fully grasp the details of 
the R&D knowledge which constitutes the innovative edge of the firm. 
6.3.2.2 Absorptive capacity 
The concern for the CEO’s knowledge seems to be a domain (or theme) of the R&D 
executive, which is not surprising as they are the knowledge workers ‘par excellence’.  
Depending upon the R&D executive, the need for scientific knowledge by the CEO ranges 
from the need for CEO expert knowledge, to CEO knowledge on new product 
development processes, to CEO prior knowledge on the topic of research to ‘go along’ 
with the discussion, to CEO basic knowledge, to no science knowledge (but eager to 
learn and understand) and finally to no scientific knowledge at all. It is not clear from 
the research interviews which knowledge requirements need to be fulfilled by the CEO 
in order to ‘satisfy’ the knowledge requirements of R&D. 
 
The theme of CEO absorptive capacity – identified through the process of complexity 
reduction - is the second most frequently mentioned theme by R&D executives (it 
appeared 41 times during the interviews with the R&D executives, see Chapter 5). This 
observation corroborates the findings of the CEO interviews who argued that a de-
complexification step is necessary to bridge the knowledge gap with R&D. R&D 
executives de-complexify R&D knowledge for CEOs who are in need of such de-
complexification step. It is surprising to observe that RDE24, the chief scientific officer 
who reports to CEO8 who argued that such a de-complexification step is not necessary, 
finds the data communicated to CEO8 greatly reduced in complexity in order for CEO8 
to make sense of it. When R&D executives find that such complexity reduction is not 
necessary it is because their CEOs are highly knowledgeable about the scientific R&D 
background. However, their CEOs still refer to the complexity reduction step and even 
CEO8 who argued strongly against the de-complexification step (because it may result 
in flawed decision making), agreed that it is required for CEOs to keep their R&D units 
in focus as to avoid it to become distracted into other topics of interest. The data show 
that the concept of complexity reduction and hence the construct of absorptive capacity 
is supported by the R&D executives. 
While R&D executives address knowledge from the point of view of prior knowledge of 
the CEO (and through this to his/her absorptive capacity), CEOs address his/her prior 
knowledge (his/her absorptive capacity) through the need of the complexity reduction 
process. In other words both CEOs and R&D executives share the absorptive capacity 
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concept but address it from a different angle: the CEO from the need to reduce 
complexity in order to balance R&Ds’ knowledge with his/her prior knowledge and R&D 
executive from the CEOs’ prior knowledge and the effort required to titrate their 
knowledge to the CEOs absorptive capacity. By addressing each others’ knowledge, 
CEOs learn from the R&D executives and by reducing the complexity of their knowledge 
R&D executives learn how CEOs thinks and what he/she knows(about markets, 
opportunities). Doing so both learn from each other.  
6.3.3 Small versus large firms and impact of gender 
No difference could be observed between themes emerging from interviews of CEOs of 
small and large forms and from interviews from R&D executives of small and large firms. 
Both CEOs of the larger firms addressed the concept of knowledge through the theme 
of complexity reduction while the R&D executives stressed the importance of both 
complexity reduction and the need for CEO trust. For reasons of anonymity it is 
impossible to divulge the data, quotes, themes and arguments raised by the (only) 
female CEO. However, based on the data there is no difference observed in the nature 
of the themes that could be assigned to gender. 
6.4 Summary 
CEOs and R&D executives share a number of a priori themes that describe the role of 
the CEO in innovation in life science R&D. The attitude of the CEO, his/her attention to 
the environment and the future and his/her commitment are crucial components of the 
role of the CEO and it is recognized by both CEOs and R&D (Table 6-1). The CEO’s 
involvement in innovation is recognized by R&D executives (‘<’ in the table) but CEOs 
tend to over-emphasize it (‘>’ in the table). Both CEOs and R&D executives do not 
recognize the role of the CEO as the main innovator in the firm. 
Both CEOs and R&D executives refer to the process of complexity reduction and 
therefore share and recognize the concept of CEO absorptive capacity. CEOs and R&D 
executives also share a number of other - newly developed - themes but do so with 
strikingly different emphasis or focus. CEO trust is strongly emphasized by R&D 
executives as a crucial part of the role of the CEO, while CEOs do not - or only marginally 
- use the theme to describe their role in innovation. Although both CEOs and R&D 
executives recognize the concept of CEO absorptive capacity, they differ in the emphasis 
on knowledge and learning. While CEOs refer to general themes of innovation 
management (attitude etc..) when discussing their role in innovation, R&D executives 
refer to the concept of knowledge but they strongly differ in opinion about the need for 
prior scientific knowledge. 
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 Themes addressing the role of the CEO in innovation as they emerged 
from individual structured interviews of CEOs and R&D executives 
 A priori themes from the literature New themes 
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Table 6-1 Comparison of CEO and R&D perceptions about the role of the CEO 
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7 Discussion and conclusion 
7.1 Introduction  
At the end of this thesis it is appropriate to return to the question raised in Chapter 1 
where the overall inquiry of our research was presented as follows: 
‘How does a CEO discharge his/her role in innovation in 
the context of a life science R&D firm?’’ 
More specifically, it was asked whether CEOs play a role in innovation in the research 
and development of drugs, vaccines or diagnostics. It was argued that it is generally 
believed that they do, but also that it is not clear how this is achieved and – if such a role 
exists – how it is discharged. In order to investigate that role, a systematic review of the 
literature followed and it became clear that the study of the role of the CEO in innovation 
was conducted using quantitative surveys whereby CEO characteristics and leadership 
styles were linked to measures of firm innovation. It was then argued that this 
quantitative approach misses valuable information seen its rather unidirectional 
approach and it was decided to take a more inquisitive route by addressing the CEOs 
directly, to include R&D and to take a qualitative rather than a quantitative approach. 
Our objective therefore was to increase our understanding of the role of the CEO by 
asking CEOs directly how they see their role and checked their understanding against 
the perceptions of the R&D function. In other words, our objective was to create an 
understanding on what CEOs do to play a role in innovation in life science R&D firms and 
how this can best be described.   
The following paragraphs discuss the role of the CEO as observed from our interactions 
with CEOs and R&D executives (see below 7.3.) and inquire whether these observations 
can be generalized (7.4.). A separate paragraph uses the observations to develop a 
conceptual framework using Arendt’s CEO-Adviser model (7.5). The chapter ends with a 
final conclusion (7.6) and offers future research avenues (7.7). But first the research 
design is reflected upon in paragraph 7.2.. 
7.2 Reflections on research design 
7.2.1 Purpose, method and outcome 
In Chapter 3. Research design, a table was introduced to link purpose, method and 
outcome (Table 3.6.).  The question what CEOs do to lead innovation in life science R&D 
firms remains unanswered when researchers focus on quantitative survey-based 
research. This is because the actual role remains ‘undiscovered’ or may only be inferred 
or assumed from the relationships between predetermined variables (e.g. 
transformational leadership behavior of the CEO and firm innovation) or from the 
identification of (leadership or demographic) factors that may or may not impact 
innovation. What CEOs ‘actually do’ can only become known if they are asked ‘what they 
do’. A description of the role of CEOs in innovation in life science R&D firms can only 
become known if the CEOs are approached directly through interviews and 
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conversations. Therefore there is a direct linkage between purpose (what do CEOs do?), 
method (asking the CEOs directly through interviews) and outcome (a detailed role 
description). The table below shows that the purpose of the study and the methods are 
aligned with the outcome of the research project in that the original research questions 
are addressed using appropriate methods (Table 7-1). 
Purpose Method Objective Outcome Cumulative outcome 
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To obtain a 
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role of the CEO in 
innovation as seen 
by CEOs 
 
A description of the role that 
CEOs play in innovation in a R&D 
life science setting as viewed by 
the CEOs 
 
a description of the role that 
CEOs play in innovation in a 
R&D life science setting as 
viewed by the CEOs 
 
CEO focus group 
of 4 CEOs to 
which the 
observations of 
the individual 
CEO interviews 
are presented  
To inquire 
whether CEOs 
agree among 
themselves about 
the described role 
by each of the 
CEOs 
To find support by the focus 
group CEOs for the statements 
made individually by the their 
colleague CEOs thereby 
supporting the validity of the 
research observations during the 
individual CEO interviews 
 
Insight of the CEO’s role in 
innovation as seen not only by 
individual CEOs but also 
accepted as core roles by a 
group of CEOs 
Research 
interviews of 33 
R&D managers 
reporting to the 
15 CEOs  
To inquire 
whether the role 
description 
offered by the CEO 
is perceived as 
such by R&D 
To ascertain the validity of the 
research observations during the 
individual CEO interviews by 
using the R&D manager’s point 
of view on the role of the CEO 
thereby avoiding potential bias 
from the part of the interviewer  
 
Insight of the CEO’s role in 
innovation as seen by CEOs and 
corroborated by their R&D 
executives 
Table 7-1 Alignment of purpose, method and outcome 
7.2.2 Limitations 
Although it is argued above that quantitative based surveys would not offer insight into 
the actual role of the CEOs, one of the limitations of this study stems from the qualitative 
approach. The CEOs and their R&D executives have been interviewed during a relatively 
short time period and although they were quite open to interaction and exchange of 
ideas and appreciated the conversation, one should realize that the propositions made 
by both only reflect a fraction of what they could have argued and of what is on their 
mind. Although it was tried to minimize the impact of the limited time span by creating 
well prepared structured interviews, by bringing the CEOs back together in a focus group 
research and by obtaining agreement of as many R&D executives as possible, it should 
be recognized that the data obtained should be viewed in that regard. On the other 
hand, the data were obtained by means of a structured interview developed by means 
of an innovation framework that included as many innovation parameters as possible as 
to prevent potentially interesting concepts to disappear or to not emerge if they were 
present. Although this research is on an exploratory nature it does not diminish the need 
for validity. The focus group research was introduced to ascertain that the conclusions 
of the individual CEO interviews would prove justified.  
 
In addition, while the research introduced a focus group of CEOs to inquire whether the 
data obtained during the individual CEO interviews would be supported during an 
interview session of 4 CEOs (which they did and even reinforced), a focus group research 
with the chief R&D scientists was not conducted and therefore it is not known whether 
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the observations made by the individual R&D interviews would have been supported 
during a focus group of the chief R&D scientists. This could have thrown light on the 
wide range of different opinions among R&D executives about the need for CEO prior 
knowledge.   
7.3 Describing the role of the CEO in innovation 
7.3.1 CEOs make use of their absorptive capacity 
It was found that CEOs need to make considerable use of their absorptive capacity in 
order to be able to play a role in innovation.  They evaluate R&D knowledge after it has 
been reduced in complexity by R&D. Core to the R&D knowledge transfer research and 
its application in the R&D-CEO interface, is the concept of ‘knowledge distance’ which is 
the ‘degree to which the source and recipient possess similar knowledge’ (Cummings 
and Teng, 2003). Knowledge distance is also referred in the narrow sense as cognitive 
distance (Nooteboom, 2010).  According to Cummings and Teng, for R&D knowledge 
transfer, ‘a particular difficulty is that the R&D contexts of the source and the recipient 
can be quite different. The R&D output of the source is often the R&D input of the 
recipient, and there may hardly be any other overlap between the R&D activities of the 
two parties’. In the field of knowledge transfer among firms, Dougherty argues that 
‘shared interpretation of knowledge is essential for collaboration in R&D activities’, 
while Hamel considered that the knowledge distance or ‘knowledge gap’ between two 
parties cannot be too great because too ‘many learning steps will be required if the 
knowledge gap (or distance) is significant’ (Hamel, 1991; Dougherty, 1992).  It is believed 
that overlapping areas of expertise facilitate knowledge transfer (Nonaka and Takeuchi, 
1995). As Hamel (1991, p. 97; cited in Cummings and Teng, 2003) put it, this knowledge 
gap is linked to the concept of learning: ‘if the skill gap between partners is too great, 
learning becomes almost impossible’, as the recipient may be unable ‘to identify, if not 
retrace, the intermediate learning steps between its present competence level and that 
of its partner’. Alignment in terms of knowledge is necessary for knowledge transfer 
(Dinur et al., 1998). In this regards, the concept of ‘absorptive capacity’ was developed 
to study the transfer of know how between two or more organizations, which means 
that firms differ in terms of their ability to learn15 (Cohen and Levinthal, 1990; Lyles and 
Salk, 1996; Szulanski, 1996). Until now absorptive capacity was predominantly explored 
as a phenomenon between organizations. Only a few studies have used qualitative 
approaches in studying absorptive capacity either as a process exploration (Easterby-
Smith et al., 2008) or to gauge impact of top and middle management leadership on 
absorptive capacity (Sun and Anderson, 2011).  
 
The concept of absorptive capacity may also apply in the relationship between R&D and 
CEO.  As we have seen in the outcome of our research some CEOs have knowledge about 
the nature of R&D in the firm while some CEOs have no knowledge. However, in both 
cases, the CEOs argue that the information that is proposed to them needs to be 
simplified, because the nature of the R&D data and the pace at which it develops has 
                                                          
15 The concept of absorptive capacity has been re-defined frequently (Zahra and George, 2002 and Todorova and Durisin, 2007) 
but the original concept of Cohen and Levinthal is used in this thesis. 
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reached a level of complexity whereby even scientifically trained CEOs have difficulties 
understanding the intricacies of the data offered to them.  It may explain why one 
specific CEO (CEO8) had no difficulty in accepting and transferring the raw R&D data as 
his/her absorptive capacity may have been high and in balance with the knowledge 
giver, i.e. the R&D function.  Cohen and Levinthal argue ‘that the ability to evaluate and 
utilize outside knowledge is largely a function of the level of prior related knowledge. At 
the most elemental level, this prior knowledge includes basic skills or even a shared 
language but may also include knowledge of the most recent scientific or technological 
developments in a given field. Thus, prior related knowledge confers an ability to 
recognize the value of new information, assimilate it, and apply it to commercial ends’.  
According to Cohen and Levinthal, an organization’s absorptive capacity ‘will depend on 
the absorptive capacities of its individual members’. This means that it also depends – 
and potentially even more critically – on the absorptive capacity of the CEO. They define 
absorptive capacity as the ability of an organizational member ‘to value, assimilate and 
apply knowledge’ and Mowery and Oxley extend this definition by arguing that 
individual absorptive capacity is a ‘skill needed to deal with the tacit component of 
transferred knowledge and needed to modify this imported knowledge’ (Mowery and 
Oxley, 1995). In this light, Pedrosa and Jasmand have developed the individual 
equivalent of firm absorptive capacity (Pedrosa and Jasmand, 2012) and defined 
individual absorptive capacity as an ‘organizational member’s work-relevant capability 
to identify new knowledge, assimilate it, apply it, and disseminate it to other 
organizational members’.   
 
However, few studies have paid attention to individual absorptive capacities as opposed 
to organizational absorptive capacity. Ko et al. (2005) for example studied the 
knowledge transfer between consultants and their clients, but no studies have been 
conducted to explore the absorptive capacity of CEOs. Also, for knowledge to be 
transferred effectively, knowledge source and recipients require direct and intimate 
interaction (Park et al., 2007). This is the case when CSO and CEO interact because the 
hierarchical difference between both is minimal but is not the case with middle-
management R&D that is considered to be the locus of innovation (Burgelman et al., 
2004). Ko et al. demonstrated that individual user’s absorptive capacity plays a 
significant role in the knowledge transfer.  In their study of perceived absorptive capacity 
of individual users, Park et al. (2007), define individual absorptive capacity as the ability 
of an organizational member to value, assimilate and apply new knowledge. They 
classify user absorptive capacity in three interrelated components: 
 
- The user’s capacity for understanding external knowledge. This component is 
strongly related to the member’s prior knowledge base about the object i.e. 
‘when organization members possess greater prior knowledge, they can absorb 
new knowledge more effectively’  
- The user’s capacity for assimilating knowledge i.e. the user’s ability to internalize 
new knowledge into his or her task environment. This is ‘affected by how 
comfortable the user feels when executing the tasks using the technology’  
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- The users’ capacity to apply the newly acquired knowledge i.e. not only the 
ability to understand and assimilate external knowledge but also the ability to 
exploit and commercialize. 
 
In view of previous research in which CEO demographics and cognitive factors have been 
used to explore the role of the CEO in innovation and which were used to predict firm 
innovational performance, the concept of absorptive capacity  shows considerable 
promise in that it potentially captures demographics and cognition in a single concept.  
As Cohen and Levinthal argue: ’the ability to evaluate and utilize outside knowledge is 
largely a function of the level of prior related knowledge’. This may only be achievable 
by CEOs with long tenure, experience in specific knowledge domains or business areas, 
with age or educational level etc., thereby encompassing these demographics and or 
cognitive capabilities into the concept of absorptive capacity. It can also be argued that 
a certain level of absorptive capacity of a CEO is a conditio sine qua non – at least 
theoretically – for a CEO to become attentive to opportunities in the internal or external 
environment, to become committed to and to become involved or even innovative in 
matters of R&D.  
 
CEOs did not directly refer to the need for prior knowledge and if they did, they strongly 
disagreed among each other. When interviewed about their role in innovation, they 
referred to the process of the complexity reduction of knowledge, needed to have a 
meaningful discussion with R&D. This may explain the differences in opinion among R&D 
executives in their need for prior CEO knowledge. These differences may not be 
explained by differences in actual or perceived prior knowledge of the CEOs but rather 
by the different levels of CEO absorptive capacities perceived by the R&D executives. In 
other words, R&D executives who argue there is no need for their CEO to have strong 
prior knowledge in the field of science, may find their CEOs to have considerable 
absorptive capacity which is not necessarily caused by an appropriate educational 
background in science but by major experience levels or strong intellectual capabilities. 
In other words, CEO absorptive capacity is a concept that not only encompasses prior 
knowledge, experience, education, age but also the CEO’s intellectual and cognitive 
capabilities or as one R&D executive commented during a post-interview talk: ‘our CEO 
is not a scientist, has no experience in R&D but is a smart guy and learns fast’.  
 
Figure 7-1 presents a scheme describing the transfer of knowledge between R&D and 
CEO. At the start of the process, the R&D function has knowledge which is complex (level 
b) and as such cannot be used for decision making by the CEO. The CEO may have prior 
knowledge from previous interactions with R&D or from previous experience but its 
complexity is lower (level a). In order to have a meaningful discussion, CEOs will need to 
base their decisions on knowledge from which the complexity has been removed and 
put in the context of a business proposition. This shared frame of reference is the end 
result of the transfer of knowledge from R&D to CEO.  
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Figure 7-1 Transfer of knowledge between CEO and R&D 
 
During this process, the CEO has learned new knowledge which may be used for future 
evaluations while R&D has learned to put his knowledge in a manner that allows 
evaluation. During the knowledge transfer, the complexity of the scientific knowledge is 
high at the level of R&D, but lower at the level of the CEO as the CEO, seen his/her 
background may only be capable to handle ‘simple’ R&D knowledge. When R&D 
simplifies the knowledge, it does so by ‘titrating’ its knowledge down to the level of the 
absorptive capacity of the CEO until a shared frame of reference is obtained such that 
the CEO and R&D reach a common understanding.  During this process, the CEO has 
increased his absorptive capacity because he/she learned new knowledge that may act 
as prior knowledge for the new interaction with R&D.  
 
7.3.2 CEOs use their absorptive capacity to create trust  
According to Dovey, by creating a shared cognitive frame of reference, trust in newly 
communicated knowledge is built between acceptor and sender because of the 
increased understanding of the shared knowledge while the absorptive capacity of the 
knowledge acceptor for new(er) knowledge improves as a result of the learning process 
(Dovey, 2010). This research has shown that while CEOs refer to knowledge by referring 
to the need for complexity reduction and re-contextualization, R&D executives draw the 
researcher’s attention almost exclusively to the concepts of ‘knowledge’ and ‘trust’. 
While trust is a theme that is shared by both R&D executives and CEOs but with strikingly 
different intensity, the knowledge residing with the CEO seems to be an important 
domain (or theme) of consideration by the R&D executive, which is not surprising as 
they are the knowledge workers ‘par excellence’. Their preoccupation with knowledge 
focuses on the (prior) knowledge of the CEO. Depending upon the R&D executive, the 
need for scientific knowledge by the CEO ranges from expert knowledge, to knowledge 
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R&D-CEO shared frame of reference
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on new product development processes, to prior knowledge on the topic allowing the 
CEO to ‘go along’ with the discussion, to basic knowledge, to no science knowledge - but 
eager to learn and understand - and finally, to no scientific knowledge at all. It is however 
not clear from the research interviews which knowledge requirements need to be 
fulfilled by the CEO in order to ‘satisfy’ the ‘knowledge requirements’ of R&D.  
 
R&D executives link this need for CEO’s prior knowledge to the concept of ‘trust’. When 
a CEO has no knowledge at all about R&D – as was the case with CEO2P - there will be a 
considerable need to trust R&D. While trust is a frequently recurring theme during the 
interviews with R&D executives, it appeared only explicitly during one CEO interview 
(CEO5). No other quotes in the CEO interview-transcripts could be assigned to the 
‘psychological state that comprises the intention to accept vulnerability based upon 
positive expectations of the intensions or behavior of another’ which is the scientific and 
generally agreed definition of trust (Mayer et al., 1995). In other words, during the CEO 
interviews, no CEO referred to his/her vulnerability as a result of the uncertainty 
associated with the activities of the R&D function.  It was as if ‘trust’ was a concept that 
CEOs do not consider worthwhile discussing or mentioning. This is not necessarily 
surprising because others have already observed that CEOs of innovative firms do not 
consider themselves as risk takers. If management decisions are based on perceived 
rather than on actual risks, the CEO of an innovative life science R&D firm may not 
necessarily be a greater risk taker. On the contrary, according to Lefebvre and Lefebvre, 
innovative CEOs may be ‘risk-reducers’ as they appreciate their risky ventures better 
than CEOs who are not engaged in innovative programs and therefore consider 
themselves as ‘risk-cautious’ (Lefebvre and Lefebvre, 1992). Therefore the concept of 
trust – as the psychological state of willing to be vulnerable to the actions (risk taking) 
of others - and accept the risk associated with this vulnerability does not seem to be an 
important factor in their perceived role in innovation. Although the theme of trust 
appears only once during the interviews with CEOs, it does not mean that it is 
unimportant as they will not be able to function if trust with the R&D function were 
broken. However, it is the striking difference by which the concept of trust emerged 
between CEO and R&D executives that makes it worthwhile to draw attention to. When 
R&D executives discuss ‘trust’ they do so by referring to the concept of CEO knowledge, 
a concept used by CEOs indirectly through their reference to the need for complexity 
reduction of the knowledge received from R&D.  From the viewpoint of R&D executives 
‘trust’ seems to be a crucial element in their perception of CEOs.  Because new life 
science knowledge develops fast, individual(s) who are not continuously updated about 
its developments are left behind very rapidly, thereby creating a knowledge gap 
between those ‘who know and those who don’t’. Because CEOs and R&D executives 
develop their knowledge in different fields (market and business vs science and 
technology) their respective knowledge bases will gradually diverge, thereby creating 
what is defined as a knowledge gap.  It is therefore no surprise that R&D executives 
frequently refer to knowledge during their interviews and the potential gap that may be 
created between their knowledge and the CEO’s. While CEOs reflect on generalized 
concepts such as attitude, attention and commitment that impact the firm as a whole, 
R&D executives point to a specific set of concepts that – from their point of view seem 
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to be crucial in their relationship with the CEO. As was argued by the R&D executives, 
the less he/she (the CEO) knows about the science, the more he/she will need to trust 
R&D because he/she will not be able to value their work and proposals because of lack 
of relevant knowledge and the inability to verify and discuss the data. It was observed 
above that by de-complexifying R&D knowledge for the CEO a shared knowledge base 
is created between CEO and R&D. According to Dovey ‘trust is built through the 
development of shared cognitive frames of reference...’ (Dovey, 2010). Therefore R&D 
executives, when referring to knowledge and the reduction of its complexity, refer to 
trust. 
 
This is not contradictory to the data observed during the interviews of the R&D 
executives when some argued that it does not matter what knowledge background the 
CEO has (see Chapter 5 and Table 5-7). Knowledge of the CEO is not limited to scientific 
background knowledge but also to knowledge about the markets and more importantly 
to his/her capacity to absorb new knowledge that R&D executives generate. The more 
prior scientific knowledge the CEO has however, the higher his/her absorptive capacity 
for new R&D knowledge whereby trust is replaced by a process of verifiable data 
exchange and discussion. In other words, if the CEO and the CSO have the same scientific 
knowledge base, the need for trust is limited as the data can be verified, controlled, 
discussed and agreed upon as such. This is the case in start-ups and early life science 
R&D firms.  An attempt is made to structure this relationship between trust, prior 
knowledge and absorptive capacity in Table 7-2.  
 
Science knowledge 
differential between 
CEO and CSO: 
Knowledge CEO = knowledge R&D Knowledge CEO  ≠ knowledge R&D 
CEO-CSO Trust 
relationship: 
Knowledge between CEO and CSO is  a 
continuum: CEO and CSO have the same 
scientific knowledge base; therefore the 
CEO does not need a relationship based on 
trust as both knowledge bases are identical 
and data can be exchanged and verified, as 
is the case in any scientific discussion 
Trust is replaced by an exchange of 
verifiable and challengeable data 
Knowledge between CEO and CSO is 
complementary: CEO and CSO have different 
knowledge bases.  Data exchange and 
verification is hard to achieve. 
Challenge and verification of scientific data is 
possible but only to a limited extent seen the 
limited prior knowledge of the CEO: a trust 
relationship between CEO and R&D is 
required 
CEO absorptive 
capacity: 
Prior R&D knowledge of the CEO is high as is 
his/her absorptive capacity 
Prior R&D knowledge of the CEO is low as is 
his/her absorptive capacity 
 
Table 7-2 Absorptive capacity, trust and prior knowledge 
This research indicates that the complexity reduction of R&D knowledge is a process 
whereby a shared cognitive frame of reference is created that facilitates the flow of 
knowledge between CEO and R&D. This process increases the CEO’s individual 
absorptive capacity and – because of his/her growing understanding of R&D knowledge 
and because of new learning – develops trust in R&D (irrespective of his/her educational 
background or experience). In other words, the knowledge de-complexification step is 
not a simple ‘simplification’ of complex R&D data, it is an instrument that builds trust 
and develops absorptive capacity of the recipient.  
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Papadakis and Bourantas, in their study of the role of the CEO in innovation (Papadakis 
and Bourantas, 1989), already stated that managers should pay particular attention to 
the manner in which technological innovation proposals are presented to the CEO if they 
are to be successful in gaining the CEO’s acceptance. Our research shows that the 
manner in which R&D knowledge is offered to the CEO may not only gain CEO 
acceptance but also generate CEO trust which is, according to Dovey (Dovey, 2009) ‘the 
cornerstone of effective organizational leadership ... (the) significance (of which) in 
creating a milieu to innovate cannot be underestimated’. The fact that R&D executives 
refer to the theme frequently and forcefully shows that trust – from their point of view 
– is an essential element of the R&D-CEO relationship and reflects the need of R&D 
executives to receive clear signals from their CEOs that their relationship in view of the 
innovation is a trustworthy one. This means that although R&D executives are 
considered ‘autonomous’ and require ‘freedom’ to be innovative, trust in their work 
seems to play an essential role that supports that wish for autonomy and freedom. 
 
Trust requires learning and it is more easily enacted ‘in a culture where change is 
underpinned by openness to learning and self-renewal’ such as a culture of innovation 
(Dovey, 2010). From this perspective, the concept of trust could have been assigned to 
the a priori literature of attitude and more specifically to the fostering of a culture of 
innovation, in Chapter 2. However, because its marginal appearance in CEO interviews 
and its clear emergence in R&D interviews, it is argued that the concept of trust has 
value in its own right and should not be ‘masked’ by the a priori concept of attitude. 
While attitude is a general conception that describes the role of the CEO and his/her 
‘positional stance towards innovation’ and his/her ‘tolerance to experimentation and 
failure’, this research points into the direction that trust is a concept that describes the 
role of the CEO in a life science R&D firm more precisely than the generalized concept 
of ‘attitude’ because, as argued by Dovey ‘failure to learn from experience destroys trust 
(i.e. particularly failures seen the low success rate in life science R&D, comment inserted 
by this author)’ (Dovey, 2010). If R&D failures occur but are not learned from by the CEO 
because his/her absorptive capacity does not yet allow him/her to understand the 
underlying complexities of a failure in R&D, his/her trust in R&D will be affected 
negatively. 
 
Because of the R&D executives’ view that CEOs do not necessarily need to have expert 
knowledge, trust becomes an essential element in their relationship. Innovative ideas 
emerging from R&D may be accepted because the CEO‘s absorptive capacity allows 
him/her to correctly value the innovative idea or because he/she has trusts R&D’s 
valuation because he/she does not have the necessary skills.  Innovative ideas may be 
rejected because the CEO‘s absorptive capacity is either high in which case he found the 
proposal not sufficiently of value or low in which case he/she rejects it because he/she 
does not trust R&D.  According to Nooteboom, ‘trust is more needed to the extent that 
the people concerned differ in their cognitive structures and develop ‘cognitive distance’ 
that needs to be crossed if one is to collaborate with the other (Nooteboom, 2010). 
Cognitive distance, according to Nootebom, is as well a problem – because of the need 
to ‘cross the cognitive bridge’ – as an opportunity because of the new insights that can 
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be learned. This was supported by a non-scientist CEO who - when asked what the most 
important characteristic is of a CEO of a life science R&D firm - is his learning agility: 
his/her ability to learn, de-learn and re-learn. The ability to learn, de-learn and re-learn 
reflects the absorptive capacity of the acceptor of the knowledge and the learning 
process that supports it. In the latter case, the problem then is how trust can be built if 
knowledge is not present or cannot be calibrated to a level that data verification is 
possible. In line with Nooteboom, (CEO-) trust in data and (CEO-) verification of data 
then become each other complements and substitutes (Nooteboom, 2010). According 
to Nooteboom, cognitive distance ‘yields both a problem and an opportunity’ and that 
‘the positive side of cognitive distance is that it provides an opportunity for learning’ 
(Nooteboom, 2010).  
 
As stated above, trust has been defined as the willingness to be vulnerable (Mayer et 
al., 1995). This vulnerability is relevant in the highly vulnerable environment of R&D in a 
life science firm. Highly R&D intensive life science firms, depend primarily on the 
innovative R&D scientists in their midst: ‘those capable individuals who unofficially 
sponsor the practices  that lead to the realization of ideas that would normally be 
crushed , in spite of the risk that such informal action holds for their own future within 
their organization (Foster and Kaplan, 2001; Hamel, 2000; Pinchot, 1985; referenced by 
Dovey, 2009).  R&D scientists who innovate make ‘themselves vulnerable either by the 
rejection of their ideas (and associated embarrassment) and the lack of recognition from 
others (through their ideas not being taken seriously)’ (Dovey, 2009).  In this regard, 
R&D scientists face the challenge of their CEOs and associated reputation vulnerability. 
In other words, when R&D executives propose new ideas to their CEOs and top 
management team members, they are vulnerable to embarrassment as one R&D 
executive remarked during a post-interview talk:  
 
‘... we have some great ideas for great new products in the area 
of (therapeutic disease) and if we talk to patients about our 
ideas, they are utterly enthusiastic...  but one cannot imagine 
how terrible it is to become ridiculed by top management when 
making the same proposal in the board room...’ 
 
The challenge that R&D executives receive from their CEOs can be fierce if not 
embarrassing. The interviewed R&D scientists observed that the ‘challenge-trust’ 
balance is a delicate one as too much challenge may disrupt trust (RDE33, see Chapter 
5). Uzzi demonstrated that in case of a good interpersonal trust relationship, the trustor 
does not collect, analyze the data offered to him by the trustee but makes decisions 
based upon limited information but steered by the level of trust available between both 
(Uzzi, 1997).  Trust is a fragile resource in that whilst it is difficult and time-intense to 
create, it can easily and rapidly be destroyed. Trust was linked by the CEOs in the focus 
group to the action of challenge (see Appendix P and Chapter 4) and the question was 
raised in how far a CEO needs to fully trust R&D. The relationship between trust and 
challenge was also raised by R&D executives who argued that the balance between trust 
and challenge is a delicate one, as inappropriate challenge may lead to distrust. As was 
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argued by CEO8 however during the focus group meeting, there is no reason to accept 
R&D statements ‘at face value’ as too much trust may become detrimental for the firm 
and the CEO-R&D relationship. In an interesting series of experiments, Bidault and 
Castello (2010) observed that the effectiveness of innovation runs along an optimum of 
trust below which it starts to appear and above which it starts to decrease. Bidault and 
Castello found that as mutual trust increases between pairs of individuals in an 
experimental setting, the partnership’s creativity went up, reaches a maximum and then 
starts to decline. They coined the creativity that was deployed within the pairs as 
‘partnership effectiveness’. It can be argued that a similar process appears when CEOs 
challenge R&D. At an optimal level of challenge, the creativity that emerges from the 
‘healthy’ challenge leads to new ideas and the detection of opportunities that neither 
CEO nor R&D would have identified in isolation. However, if the level of challenge is low, 
the emergence of new ideas is solely associated with the R&D’s group which may be 
caught or ‘prisoned’ in its own perspective. When CEO-challenge reaches a level that 
R&D perceives as a sign of distrust, both partners leave the room without new ideas or 
opportunity detection but rather with fixed points of view: the CEO with unanswered 
questions and doubts about R&D’s innovativeness and R&D with a feeling of isolation 
and misunderstanding.  When challenge is intense it can be caused either by expert 
knowledge of the CEO or the absence of it. In the first case, challenge may lead to fruitful 
discussions and the detection of alternative ways of thinking as is the case when R&D 
scientists - among each other- create innovation as a result of ‘creative tension’ (Bidault 
and Costello, 2010). On the other hand if intense challenge is not based upon CEO 
expertise knowledge but results from either a poor understanding or even suspicion 
about the value of the proposal and of the rationale and argumentation behind R&D’s 
statements, this may result in distrust from the part of R&D. Bidault and Costello argue 
that ‘trusting partners are more likely to commit the resources needed to implement 
the jointly developed ideas’ thereby linking the concept of trust to the concept of 
commitment (for resources) as was also observed for absorptive capacity (Cummings 
and Teng, 2003).  If it is observed experimentally that there is an optimal level of trust 
required for two partners to innovate and if R&D scientists argue that CEO-challenge 
can either build trust or destroy it, then it becomes clear that the level and extent of the 
challenge that CEOs use to discuss R&D proposals become a critical factor in firm 
innovation. This may also explain the variety of arguments used by R&D scientists about 
the need for CEO-knowledge. As was discussed above, R&D scientists differ in opinion 
about the required level of science-based knowledge of the CEO: ranging from expert 
knowledge to a basic understanding to no knowledge at all. This variety in the need of 
science-based CEO knowledge as perceived by R&D was explained by the variety of the 
R&D’s perception of their CEO’s absorptive capacity.  R&D’s need for science based CEO 
knowledge was driven by its perception of a low CEO’s absorptive capacity while R&D’s 
reduced need for science based CEO knowledge is driven by its perception of a high 
CEO’s absorptive capacity.   
 
In view of the observations made by the CEOs and the R&D executives, the wide variety 
of R&D’s perceptions of the need for science-based CEO knowledge, explained by the 
range of their perceptions of CEO absorptive capacities may be caused by the different 
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ways these R&D executives are challenged by their CEOs. In other words, the way these 
R&D executives are challenged by their CEOs - i.e. whether the challenge creates or 
destroys trust - drive their perceptions of the CEO’s absorptive capacities and their 
perceived needs for science-based CEO knowledge. For example, if R&D is challenged by 
the CEO such that the challenge is experienced as trust-building, because they can easily 
reach a shared frame of reference, then the CEO’s absorptive capacity is perceived as 
high and the need for science-based CEO knowledge is not articulated as important. On 
the other hand, if R&D is challenged by the CEO such that the challenge is experienced 
as trust-destroying, because it is difficult to find a shared frame of reference, then the 
CEO’s absorptive capacity is perceived as low and the need for (science-based) CEO 
knowledge is articulated as important. If CEO absorptive capacity is perceived as high, 
and a shared frame of reference can easily be found, the challenge can be intense and 
severe without creating distrust with the R&D function. This explains why CEOs with 
expert knowledge in the field and high absorptive capacity – such as CEOs in start-up 
firms - can fiercely challenge their R&D function, without the latter becoming distrustful 
of their CEO and – on the contrary – even become more motivated and innovative.  It 
may also explain why firms equipped with excellent scientists and engineers are 
performing below their innovation capabilities because their CEO is not capable to 
challenge his/her scientists in a manner that motivates them, because his/her 
absorptive capacity is low and it proves extremely difficult to find a shared frame of 
reference in which fierce challenge can take place without destroying trust.  In summary, 
CEOs with high absorptive capacity are capable to challenge appropriately and keeping 
a trust relationship with their R&D function. 
 
7.3.3 CEOs use their absorptive capacity to focus R&D 
During the interviews and the focus group discussions, CEOs argued that it is difficult to 
focus R&D and to retain it within boundaries to avoid it to diverge into non-strategically 
(but scientifically interesting) endeavors, seen the wide variety of R&D opportunities 
and the potentially interesting projects that exist within the firm.  The creation and 
retention of focus was considered by the CEOs as a major challenge. The complexity 
reduction process helps CEOs to focus their R&D activities (as became clear during the 
CEO focus group meeting). On the one hand, the complexity reduction of knowledge 
serves the CEO  
- to value the contribution from R&D and to become capable of evaluating it by 
creating an equilibrium of knowledge between CEO and R&D and to 
contextualize the R&D know-how 
- to distill appropriate narratives out of the complex message that can be used to 
share with potential stakeholders and to focus R&D 
On the other hand, the creation of such a simplified message also forces the R&D 
function to think and reflect about their activities and thereby check whether they are 
still aligned with the firm’s objectives and with the R&D vision of the firm.  
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This bimodal character of complexity reduction was also supported by R&D executives 
who argued - along the same lines as the CEOs – that it helped them to keep focus. R&D 
did not see this complexity reduction as a waste of time. On the contrary, it was a 
worthwhile exercise as was stated by for example, RDE16: 
‘...the most important thing … is that if you do an experiment 
there is a certain goal in the experiment so I think the 
presentation of the results should be in the context of why did 
we do this experiment, (for which purpose) it has been intended 
to be used and so what are the results telling us in the big 
context so the presentation is a reductive presentation but it 
has a certain goal it is really what we wanted to do is that 
because we wanted to go there...’ 
 
In other words, the complexity reduction process is more than a simplification or a trust 
generating concept. It is also a focus-generating concept, as well for the CEO (‘ís this 
know-how aligned with our objectives or is its value such that it needs reassessment of 
our objectives?’) as for R&D (’is our R&D and the new ideas that are being generated 
still in line with the company objectives and will it potentially generate value for the 
firm?’). In summary, the complexity reduction task required by R&D for the CEO is 
returned by the CEO to R&D as an instrument of focus.  
 
All this does not mean that CEOs are presented with easy-to-swallow scientific data. As 
argued by CEO5 during this focus research group meeting, the most important 
characteristic of a CEO of a R&D life science firm is his/her ‘learning agility’, i.e. the 
capacity to learn, de-learn and re-learn. While the complexity reduction process is linked 
to the knowledge titration process that takes place between R&D and CEO whereby 
knowledge is transformed such that a shared frame of reference – a point of equivalence 
– is obtained between two actors with different levels of knowledge, it also serves the 
learning process of the CEO about the science that takes place and of the R&D about the 
business context.   
7.4 Generalization of the observed CEO role 
Our research was conducted in life science R&D firms characterized by intensive R&D. It 
means that the generalizability of the results is limited to their context and it may be 
difficult to extrapolate these findings to other industries with fundamentally different 
R&D paradigms such as IT and software development and where R&D investment and 
development time are much shorter than in life science R&D. However, it can be argued 
that the concept of absorptive capacity, the interaction with the R&D function and the 
building of trust and focus through the use of the CEO’s absorptive capacity may prove 
to be a common concept driving the role of CEOs in innovation. Also, the question is 
valid whether the results can be generalized to firms outside of life science R&D firms. 
This research has led to conclusions which are highly relevant for life science R&D firms. 
The fact that these firms are all within a certain size (i.e. SME according to EU EMA 
definition) and that two big-pharma CEOs (more than 1000 employees in R&D) and their 
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chiefs of R&D were introduced without these having a different opinion when compared 
with the other CEOs of the smaller firms, shows that the generalization of the 
conclusions from small to large life science R&D firms can – at least tentatively - be 
accepted. Both the responses from the CEOs of the large R&D firms did not differ from 
those of the small firms: de-complexification of the knowledge was a main theme 
emerging from the interviews. In addition, their R&D chiefs were – as their R&D 
counterparts in the smaller life science R&D firms - primarily concerned about the CEO’s 
knowledge and the trust required by them to interact with R&D. The question is valid 
whether the concepts retrieved from this study are applicable to other industries where 
complex knowledge is generated and complex developments take place. An industry 
that is also challenged by complex knowledge, considerable investments and long 
development times is the aviation industry. The question therefore can be asked 
whether these conclusion of this research are transferable to the aviation industry and 
research in this area may prove interesting. 
 
7.5 The role of the CEO seen through a theoretical lens 
7.5.1 Knowledge transfer 
This chapter aims to put these findings against the background of current theory and to 
develop a conceptual framework of the role of the CEO in innovation in life science R&D 
firms. According to Cummings and Teng, a transfer of knowledge depends on the 
knowledge context, its articulability and embeddedness and the recipient context where 
learning culture and priority to the transfer are being set. In both cases people, roles 
and routines at the level of knowledge giver and at the level of knowledge acceptor 
determine the success of the transfer of the knowledge. Transfer is also steered by the 
context of the relationship between knowledge giver and knowledge acceptor and is 
determined by distance – either physical or organizational- and by contextual 
knowledge, norms and contextual activities (Cummings and Teng, 2003).  Knowledge 
transfer success in the innovation literature, focuses on how knowledge is re-created in 
the recipient whereby transfer involves the re-creation of a source’s knowledge package 
in the recipient (Nelson, 1993). According to Cummings and Teng, the problem with this 
re-creation is that knowledge can be embedded in ‘many different structural elements 
of an organization, such as in the people and their skills, the technical tools, and the 
routines and systems used by the organization, as well as in the networks formed 
between and among these elements’ (Argote and Ingram, 2000). Evidence is available 
that shows that effective re-creation also ‘requires that the knowledge package is made 
accessible to or de-contextualized for the recipient so that the recipient can convert it, 
adapt it or reconfigure it to its localized needs’ (Davadas and Argote, 1995; Dixon, 2000; 
Leonard-Barton, 1988; Moreland et al., 1996).  The literature on knowledge transfer has 
focused primarily on the transfer of R&D know-how between organizations and a 
research model for knowledge transfer was proposed by Cummings and Teng. A 
successful transfer is defined by the degree to which a recipient obtains ownership of, 
commitment to, and satisfaction with the transferred knowledge, a process defined as 
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knowledge internalization and developed within institutional theory (Cummings and 
Teng, 2003; Meyer and Rowan, 1977).  
 
The concept of ownership by the CEO is particularly applicable in the context of transfer 
of R&D knowledge from the R&D function to the CEO where the goal of the transfer is 
for the CEO to make decisions in view of the value creation that it may offer to the firm. 
Knowledge ownership (references cited by Cummings and Teng, 2003) means that 
 
- greater discretion over the knowledge allows a recipient to invest more of their 
own ideas, unique knowledge, and personal style in the knowledge (Pierce et al., 
2001) 
- the intensity of the recipient’s association with the knowledge (i.e. the number 
of interactions involving the knowledge) potentially affects its feeling of 
ownership 
- an individual invests energy, time, effort, and attention in the knowledge 
(Csíkszentmihályi and Rochberg-Halton, 1981) 
 
The second element of knowledge internalization is commitment. Commitment may be 
defined as a facilitating conception, in that it creates the specific circumstances for R&D 
to flourish, either by financial or human resources, infrastructure etc.  The generation of 
science-based knowledge (the raw R&D data) described by one of the CEOs as the 
“lyrics” of R&D, is then recreated as “music” which – according to the CEO, can be 
appreciated and evaluated and constitutes the recontextualized science based 
knowledge (see Appendix I, CEO 4). The concept of R&D knowledge re-contextualization 
is linked to the a priori concepts retrieved from the literature review and used to conduct 
this research project. It shows that the leadership and innovation literature from which 
the a priori concepts were retrieved, is linked to the knowledge transfer literature 
through the a priori concept of ‘commitment’. As was discussed earlier, commitment 
was defined as ‘the act of committing, or putting in charge, to entrust, to bind to a 
certain line of conduct’ (Thatcher and McQueen, 1980) and is therefore linked to action. 
According to Leonard-Barton and Mowday, individuals develop knowledge commitment 
to the extent that ‘they see the value of the knowledge, develop competence in using 
the knowledge, maintain a working relationship or interaction with the knowledge, and 
are willing to put in extra effort to work with the knowledge’ (Leonard-Barton, 1995; 
Mowday et al., 1979). In order for the CEO to make this formal commitment he/she 
requires ‘re-contextualized’ knowledge from the R&D function in order for him/her to 
make strategic decisions.  
 
The third aspect of knowledge internalization is ‘satisfaction’. Recipient satisfaction with 
knowledge is important ‘because it can reduce the recipient’s stress and resistance 
levels in adapting and using the knowledge’ (Leonard-Barton and Deschamps, 1988).  
 
In summary, only when a recipient internalizes knowledge can it be sufficiently 
understood and adapted by the recipient to allow for its effective re-creation and, 
ultimately, its use. Knowledge internalization therefore is an important conceptual 
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approach to study the role of the CEO in innovation as it may potentially show how 
knowledge embedded in R&D is extracted from its context and recreated into a form 
that allows the CEO to take ownership of the data so that it can be discussed at the level 
of the TMT, to become committed to and satisfied with the data so that it results in 
investments and further development. 
7.5.2 Arendt’s CEO-adviser model 
Although it was not developed to understand the role of the CEO in innovation, Arendt’s 
CEO model offers interesting perspectives to understand the role of the CEO in 
innovation (Arendt et al., 2005). According to Arendt et al., two models have been used 
to try to understand top-level organizational decision making.  
The first model addresses the CEO as the unit of analysis and is presented as the ‘CEO 
model’.  However, ‘to the extent that the CEO model  focuses on CEOs as lone decision 
makers ... it is an atomized, undersocialized conception of human action’ that neglects 
‘the CEO’s social context’ (Granovetter, 1985) and ‘CEOs would wield their power and 
make unilateral decisions... despite needing to address multiple, conflicting goals and 
evaluate a myriad options’ (Cyert and March, 1963).  
The second model (the ‘TMT model’) used the top management team as the unit of 
analysis and depicts a decision making process that is shared by the TMT members. The 
concept resulted in a broad range of scientific investigations addressing TMT-conflict, 
TMT-consensus, TMT-demographics and TMT-composition among others.  According to 
Granovetter (Granovetter, 1985 cited by Arendt et al., 2005) this model is an 
‘oversocialized conception’ that ‘does not recognize that TMTs tend to be hierarchical 
decision-making bodies in which involvement is not equal’.  
In view of the two models presented above, Arendt et al. argue that ‘many strategic 
decisions in many firms are neither made by a unilateral CEO nor by a TMT’. This is 
particularly the case in firms where the innovation expertise does not reside with the 
top management team or the CEO but rather in middle management (Burgelman et al. 
2004).  They therefore propose the ‘CEO Adviser model’ which ‘blends individual and 
group decision making... by recognizing that individuals involved in strategic decision 
making may come from anywhere in the firm’s hierarchy and may not be consulted on 
all decisions’ and which, they argue, is ‘more authentic’. The model involves four 
characteristics:  
- the CEO as the principal decision maker,  
- the advisers to the CEO who can be internal or external to the firm,  
- the selection of advisers by the CEO, and  
- the dyadic communication between the CEO and advisers.  
According to Arendt et al., in the CEO Adviser model the CEO solicits information from 
different levels within and outside the organization, yet ‘holds ultimate authority for the 
final decision and is accountable for it’ (Sniezek, 1999), involves a complex social 
information search to identify strategic advisers and involves – according to Arendt et al 
(2005) - considerable CEO Adviser trust (emphasis by this author) and collaboration. 
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According to Arendt et al., the foundation of the CEO Adviser model rests on four 
assertions which are central to the management literature (Arendt et al., 2005): 
- firstly, as the CEO is the final decision maker in the firm, the CEO is ultimately 
responsible for the firm’s strategic decision making and accountable for its 
outcome (Finkelstein and Hambrick, 1996)  
- secondly, the strategic decision making is characterized by ambiguity and 
complexity (Carpenter and Fredrickson, 2001) and is therefore subject to advise 
by the CEO from his/her advisers 
- thirdly, there is a high potential for information overload or overreliance on 
extant mental maps (Cyert and March, 1963) as the ‘type of information 
processed from a firm’s environment is likely to be too great for any one person’ 
(Arendt et al., 2005) 
- fourthly, it is known that top managers rely on advice from social networks that 
include friends, customers, financial institutions, alliance partners, trade 
associations etc. (Collins and Clark, 2003; Gabarro, 1987). 
Arendt’s model is suitable for incorporation of our research results for the following 
reasons.  
First, the model proposes that the CEO is the ultimate decision maker in the firm. This 
argument is independent of the firm’s internal or external environment and therefore is 
also applicable in the context of life science R&D firms. It is the CEO who takes final 
decisions and searches for approval from the board. 
Second, the CEO-Adviser model’s assertion is that strategic decision making is 
characterized by ambiguity and complexity. This is especially true in the context of life 
science R&D where not only a myriad of options are available in setting the course of 
action but where the decision making process is complicated by the potential knowledge 
asymmetry between CEO and (R&D) advisers (Styhre, 2009).  
Third, the ‘type of information processed from a firm’s environment is likely to be too 
great for any one person’ and this generates potential information overload. This applies 
to environments of R&D, where the firm’s operational and market information is 
complemented with a large and complex information data base originating from within 
and made available by the R&D function. For example, the choices that need to be made 
and which have major strategic impact are based upon a varied and complex knowledge 
base requiring careful examination and consideration from a technical, scientific, 
regulatory and marketing point of view.  
Fourth, the model allows the study of the CEO in view of his/her interaction with social 
networks in and around the R&D function because it specifically addresses the 
importance of interaction with a group of advisers to the CEO and the trust required 
between both. This is highly relevant in the context of a life science R&D firm where the 
complexities of science make it highly unlikely for a CEO to take decisions unilaterally. 
Based upon the assumption that the role of the CEO in life science R&D may be driven 
by the interaction with the R&D function, Arendt et al.’s CEO Adviser model offers a 
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conceptual framework that is suitable and appropriate to conduct research in life-
science R&D firms.  
7.5.3 Arendt’s CEO adviser model and R&D 
The research reported above shows that the role of the CEO in innovation is driven by 
his/her absorptive capacity, necessary to have meaningful discussions with the advisers 
– the R&D function - in the firm. These advisers are not limited to the top management 
team but rather extend into the R&D function as was clearly stated by CEOs as by the 
R&D executives during the interviews. The diagram below (Figure 7-2) presents the CEO-
adviser model as proposed by Arendt et al. and is adapted for the environment of a life 
science R&D firm. It consists of 4 distinct steps whereby the CEO 
- gathers information from the different R&D advisers available at all levels in the 
firm. During this research it was shown that both CEOs and R&D executives argue 
that CEOs in these firms look for advice and knowledge at all levels and not only 
at the level of the CSO (step 1), 
 
 
 
Figure 7-2 The creation of a shared frame of reference 
- the CEO, together with the R&D advisers, process and interpret the R&D 
knowledge (step 2), 
- the R&D function, because it has a full understanding of the scientific knowledge, 
its risks and potential opportunities, recommends a decision to the CEO (step 3), 
- the CEO takes a decision (step 4) 
In this process the advisers are described as originating from within the R&D function of 
the firm but they may come from as well inside or outside the firm, as has been reported 
by as well CEOs as R&D executives during the interviews.   
By interacting with the advisers, the CEO can discharge his/her role in innovation, but 
only to the extent allowed by his/her absorptive capacity. It is at the level of information 
gathering and interpreting of information that the CEO’s absorptive capacity becomes 
crucial. In other words, CEOs only play a role in innovation if they bridge the knowledge 
gap with R&D. In order to do so, the complexity of R&D knowledge is reduced and a 
shared frame of reference is created between CEO and R&D as represented in the figure 
above. Doing so, the CEO is capable to evaluate – i.e. process and interpret - new 
CEO
Adviser Adviser
Adviser
R&D
Shared frame of reference
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knowledge even when the knowledge distance with the R&D function is high. The higher 
the CEO’s prior knowledge, the higher his/her absorptive capacity, the less knowledge 
needs to be reduced in complexity. 
7.5.4 The absorptive capacity – innovation cycle 
The research above has shown that CEOs frequently refer to the process of complexity 
reduction in order to have a meaningful discussion with R&D. By making complex R&D 
data understandable to the CEO, the latter develops his/her absorptive capacity to 
absorb new(er) knowledge but also – because of his/her growing understanding of R&D 
knowledge – develops trust in R&D and is able to focus the R&D function. 
 
The diagram in Figure 7-3 shows the linkage between firm R&D knowledge, the 
development of a shared frame of reference, CEO absorptive capacity, R&D focus by the 
CEO and CEO trust in R&D and the resulting impact on innovation. First, R&D knowledge 
(K1) is transferred to the CEO in a firm with minimal innovation (Imin). During this 
transfer process the complexity and science-based context are reduced and de-
contextualized respectively, such that it is equilibrated with the absorptive capacity of 
the CEO (A1) driven by his/her prior knowledge.  This leads to an understanding of the 
CEO of the scientific activities conducted in the R&D function and generates trust (T1) 
from the CEO in R&D as argued by Dovey (2009). This in turn allows the CEO to focus 
R&D, an activity that he/she would not be able to do if he/she would not understand 
R&D knowledge and can only do if he/she makes use of a de-complexified, simplified 
message. This leads to firm innovation because the R&D proposals are embraced by the 
CEO. When R&D continues to engage in innovation, it will transfer its knowledge (K2) to 
the CEO, who has now become more knowledgeable about the science, has developed 
a higher absorptive capacity (A2) and an increased trust (T2) because of his/her 
increased understanding and has become capable to focus – manage – his/her R&D 
function even better and to increase his/her commitment. The CEO embraces the idea 
and the firm innovation potential increases to an even higher level (Imax). By increasing 
his/her absorptive capacity through repetitive cycles of CEO-R&D interaction, the CEO’s 
learning increases as well as his/her trust in R&D, which in turn will be perceived 
positively by R&D and result in innovative behavior. This cycle is presented as the ‘CEO 
absorptive capacity innovation cycle’. 
 
As defined in 2.3.4.2., CEO attention is the ‘act of keeping one’s mind closely on 
something or the ability to do this’. As argued by Yadav et al. (Yadav et al., 2007), the 
attention of the CEO on the future and on internal or external environment impacts the 
speed of detection and development of new technologies and explains why some top 
managers have a greater impact on innovation than others. It is argued that this 
‘attention to the future resulting in a focus on the internal and external environment’ 
(Yadav et al., 2007) is moderated by the CEO’s absorptive capacity. If the absorptive 
capacity of the CEO is high, he/she will be capable to ‘sharpen’ focus and draw the 
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Figure 7-3 The CEO absorptive capacity – innovation cycle 
 
organization’s attention to specific innovative objectives. If the absorptive capacity of 
the CEO is low, he is able to increase it through repetitive interactions with R&D who 
transform complex messages in simple language thereby allowing the CEO to improve 
his/her absorptive capacity and increasing his/her capacity to focus the company on 
strategically promising objectives. In other words, the level of absorptive capacity of the 
CEO will drive the level of focus and - in turn - increase the precision by which financial 
and human resources will be made available. When Papadakis and Bourantas (1998) 
argued that managers should pay particular attention to the manner in which 
technological innovation proposals are presented to the CEO (if they are to be successful 
in gaining the CEO’s acceptance), it should not be forgotten that the creation of the 
‘perfect’ message for the CEO also enables him/her to create the ‘perfect’ focus for the 
firm. At the start of the cycle, CEOs can only focus the firm using a basic absorptive 
capacity leading to minimal or average innovation. However, after several cycles of 
interaction with R&D, the CEO’s absorptive capacity increases and thereby allows 
him/her to sharpen the focus of innovation as his absorptive capacity increases. In 
addition, by developing his/her absorptive capacity, the CEO will also be able to 
appropriately challenge the R&D function without the risk of breaking a valuable trust 
relationship with R&D. 
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number of cycles ; Focus min: the focus that can be realized at the start of the cycle; Focus max: maximum focus after repeti tive cycles
Maximal firm innovation
K1 K2
CEO-R&D knowledge transfer
A2 A1
FminFmax
I max
I min
CEO
TRUST in R&D T2
Minimal firm innovation
T1
CEO 
COMMITMENT CminCmax
 
 
Chapter 7 Discussion and conclusion 
154 
 
7.6 Conclusion 
7.6.1 What is the role of the CEO in innovation in life science R&D firms? 
CEOs play a role in innovation by acting as facilitators. They create a culture of 
innovation where R&D scientists are free to experiment, take risks and exchange ideas. 
They also make available resources and create organizational structures for innovation 
to occur.  These CEO roles are presented in the literature as attitude, attention, 
commitment and involvement. CEOs do not play a role in innovation by becoming 
innovators themselves. However, for CEOs to play a role in innovation by discharging an 
attitude fostering innovation, by becoming attentive and involved in innovation and by 
being committed they need to make considerable use of their absorptive capacity. 
Without this, their role in innovation eventually disappears and will result in 
disengagement and abdication of responsibilities as was shown in the case study 
presented in the introduction (Chapter 1) (Loch et al., 2011). Therefore the first of our 
main conclusions is as follows: 
It is not possible for a CEO of a life science R&D firm to play a role 
in innovation in life science R&D firms without actively employing 
his/her absorptive capacity 
CEOs also make sure that there is clear attention to the future and focus the firm’s R&D 
within well-defined boundaries. CEOs acknowledge the presence of a major gap of 
knowledge between themselves and R&D. They make use of their absorptive capacity 
to bridge the gap and are assisted by R&D that de-complexifies knowledge to a level that 
is in equilibrium with the available absorptive capacity of the CEO, such that a common 
frame of reference is obtained that creates mutual understanding.  This mutual 
understanding allows the focus of the R&D function because, as one of the CEOs argued, 
it, and the whole firm, can be rallied behind a simple idea. Therefore: 
CEOs use their absorptive capacity to develop a frame of reference 
with R&D in which knowledge is shared and understood. This 
shared knowledge allows the CEO to focus the R&D function, even 
when he/she does not understand the intricacies of the science that 
governs the R&D  
 
The trust that is generated as a result of this frame of reference then becomes a source 
for more innovation because the R&D function feels confident that the CEO is capable 
to follow their scientific exploration and developments. Because the CEO has a better 
understanding of the R&D knowledge he/she will be better able to identify new 
innovational opportunities in the market or detect them sooner and as a result: 
Because of the increased understanding of R&D knowledge, 
facilitated by the creation of a shared frame of reference, trust by 
the CEO in the R&D function is created which in turn fosters further 
innovation 
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In short, the role of the CEO in innovation in life science RD firms consists in developing 
his/her absorptive capacity such that he/she is able to focus the R&D function, a 
responsibility the CEO can only take by using de-complexified R&D knowledge in line 
with his/her absorptive capacity such that a common understanding is achieved with 
R&D which leads to CEO trust in R&D, to commitment and hence to innovation.  
7.6.2 Contribution to theory 
7.6.2.1 CEO absorptive capacity in upper echelon research 
In view of previous upper echelon research in which CEO demographics such as age and 
tenure were used to predict firm innovation, the use of individual CEO absorptive 
capacity shows promise in that it captures demographics, cognition, education and 
experience into a single concept thereby offering a more encompassing alternative to 
the use of singular CEO-proxies. Absorptive capacity can be considered a conglomerate 
of education, personal experiences, knowledge generated through successes and 
failures and intellectual capabilities. The concept encompasses a more coherent view 
than the CEO ‘proxies’ used in upper echelon research. As was observed, CEOs play a 
role in innovation by bridging the knowledge gap with R&D. In order to bridge the gap, 
the complexity of R&D knowledge is reduced such that a shared understanding is 
created between CEO and R&D. Doing so, the CEO is capable to evaluate new knowledge 
even when the knowledge distance with the R&D function is high and to identify 
innovational opportunities. This process takes place as the CEO makes use of his/her 
absorptive capacity or ‘the ability of an organizational member to value, assimilate and 
apply knowledge’ (Cohen and Levinthal, 1990). It also includes experience-based 
knowledge, knowledge obtained through education and through other sources.  The 
higher the CEO’s prior knowledge, the higher his/her absorptive capacity, the less 
knowledge needs to be reduced in complexity and potentially the faster innovational 
opportunities can be detected. In other words, the research has shown that CEO 
absorptive capacity is a promising new conceptual instrument to study the role of the 
CEO in innovation. 
7.6.2.2 CEO absorptive capacity and trust  
While CEOs do not refer to their prior knowledge as such when interviewed about their 
role in innovation but rather to the process of complexity reduction in order to have a 
meaningful discussion with R&D, R&D executives refer continuously to the CEO’s prior 
knowledge and the need for his/her trust in their knowledge. In their study of 
organizational trust and knowledge transfer, Nonaka and Takeuchi (1995) argue that 
‘trust is built through the development of shared cognitive frames of reference which 
facilitate the flow of knowledge and develop the absorptive capacity of the collective 
with respect to knowledge transfer’. When R&D knowledge is reduced in complexity, a 
shared cognitive frame of reference is made that facilitates the knowledge flow between 
CEO and R&D. By making complex R&D data understandable to the CEO, the latter 
develops his/her absorptive capacity to absorb new(er) knowledge and – because of 
his/her growing understanding of R&D knowledge – may develop trust in R&D. In 
addition, the CEO uses the simplified knowledge as an instrument of focus for R&D. It is 
argued here that the knowledge complexity reduction process not only ‘simplifies’ 
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complex R&D data, but also builds trust, ‘the cornerstone of effective organizational 
leadership ... (the) significance (of which) in creating a milieu to innovate cannot be 
underestimated’ (Dovey, 2009) and focus the firm’s R&D.  
7.6.3 Contribution to practice 
This research has important implications for managers. CEOs of small and medium sized 
life science R&D firms tend to invest most of their time and management effort into 
generating income to keep their firms afloat because such companies require 
considerable amounts of cash for funding research. At the same time biomedical science 
is progressing at a considerable pace and so current knowledge rapidly becomes 
outdated. In these circumstances, CEOs – even those with a biomedical background – 
who fail to continue learning, will find their capability to evaluate newer knowledge 
decreasing rapidly because their prior knowledge has not kept pace with developments 
in biomedical R&D. This will reduce their absorptive capacity and in turn lead their ability 
to accurately evaluate the business potential of emerging biomedical knowledge. 
Another key implication for CEOs is that they need to constantly refresh their knowledge 
- by a continuous interaction with R&D - if they are to be perceived by R&D as capable 
of driving innovation. If CEOs are not perceived as driving innovation then this will lead 
to R&D de-motivation and reduced output. So in life-science companies, CEOs have a 
real challenge—they must balance their managerial responsibilities with keeping their 
understanding of scientific developments up to a level where they can conduct 
meaningful discussions with R&D. It is also essential for R&D to communicate complex 
knowledge in a manner that makes sense to CEOs.  
 
Based on the knowledge obtained through our research, CEOs are advised: 
 
- to develop their absorptive capacity by increasing their interactions with R&D 
scientists at all levels  
- to let themselves be trained in the knowledge of R&D 
- to train R&D in the business and market 
- to develop a firm specific shared vocabulary between him/herself and R&D 
- not to interfere with everyday practice of R&D 
- to develop the capability of the R&D function to create de-complexified 
messages of their knowledge 
- to use these messages to rally stakeholders behind the idea 
- to return the message to R&D to keep it in focus 
 
Doing so, the CEO will generate: 
 
- personal trust in the capabilities of R&D 
- generate trust of R&D into the CEO 
- create a learning organization that links science to business 
- increase the commitment to sharply focused RD projects 
- innovative power in his/her organization 
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7.7 Future research 
The thesis leads to additional research questions and questions about research 
methodologies.  
 
First, a number of interesting research avenues can be envisaged. For example, how can 
the concept of individual absorptive capacity be better understood? While Pedrosa and 
Jasmand (2012) have offered a definition of individual absorptive capacity as an 
organizational member’s work-relevant capability to identify new knowledge, assimilate 
it, apply it, and disseminate it to other organizational members, is there a need to adapt 
this definition for top management members? This research has shown that identifying 
new knowledge – the first part in Pedrosa and Jasmand’s individual absorptive capacity 
– is possible if there is a shared frame of reference between the knowledge giver (R&D) 
and the knowledge acceptor (CEO). How do CEOs then assimilate the new simplified 
knowledge, apply and disseminate it to other members?  
 
Second, the concept of CEO absorptive capacity also opens interesting research 
perspectives for trust scholars: what is the impact of CEO absorptive capacity on 
perceived trust in R&D?  What is the relationship between CEO absorptive capacity and 
his/her trust in complex R&D projects? What is the impact of CEO absorptive capacity 
on the speed of detection of new opportunities? 
 
Third, the methodologies used to explore the role of the CEOs until now were 
quantitative based. The arguments raised in the literature (Yadav et al., 2007) for the 
use of survey based CEO research and CEO research in general is that CEOs are under 
considerable time pressure which prevents them to engage in qualitative research. 
However, it was experienced during this research, that the CEOs, in contrast to what is 
currently posited in the literature, are quite open to qualitative research and the CEOs 
appreciated and enjoyed the time to discuss their role in innovation. There is, of course, 
the time pressure put on CEOs which make it difficult for them to make sufficient 
interview time available and the risk that interview meetings are cancelled immediately 
prior to the meeting. The direct interaction however proved to be rewarding for both 
interviewer and CEOs who showed great interest in receiving feedback from this 
research. It was also found that in order to be able to approach CEOs for qualitative 
research, it is imperative to find ways of becoming introduced into their networks: the 
majority of the CEOs in this research agreed to the interview because their colleagues 
agreed to the study. Finally, in view of the use of absorptive capacity as a potential 
improved measure compared to CEO demographics, the use of survey based studies 
could benefit from the use of CEO absorptive capacities, as the instruments to measure 
these have now become available (Pedrosa and Jasmand, 2012) 
 
Fourth, another potential perspective for research is related to the requirement of 
transforming complex life science knowledge in simpler terms, not only for reasons of 
popularization of science, but more importantly to allow the early detection of the 
potential value or threats (e.g. ethical) of newly developed life science. Realizing that 
the complexity of science will not decrease but will go hand in hand with its impact on 
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society, the need for a science that studies the decomplexification of highly complex 
matters in life sciences may be needed and may involve not only scientists but also 
linguists. 
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Appendix A. Procedure for the literature reviews 
 
This appendix  presents the approach and structure of the literature review.  It is based 
upon  
 
i. a traditional literature review whereby two literature streams – the innovation 
and the leadership literature – are explored 
ii. a systematic review of the literature 
iii. an exploration of the literature that goes beyond the systematic review of the 
literature 
 
The overall approach to search the literature followed five distinct steps. 
 
- Step 1. The traditional review. The process started with a traditional literature 
review and the exploration of two literature streams. The leadership literature 
was reviewed for research data that address innovation and the innovation 
literature was reviewed for research data that address leadership.   
- Step 2. The extended traditional review. In the traditional review of the 
literature the conceptual leadership literature was introduced and its 
relationship with innovation.  
- Step 3. The systematic review of the literature.  It was then decided to continue 
the literature search by engaging into a formal systematic review of the 
literature. This systematic review of the literature led to a set of papers not 
previously identified and these were added to the collection of research papers. 
- Step 4. Beyond the literature. It quickly emerged that even a systematic review 
would have its limitations in this research because a systematic review using 
specifically selected search terms would miss a key area of leadership literature 
that present leadership theories and concepts that may be of value in 
considering the role of CEO and top management in innovation but have not yet 
been explored. They would not have been identified through a systematic 
review. It was therefore decided to proceed with a literature search looking for 
leadership theories and concepts that would be of value in an innovative setting. 
This allowed the identification of theoretical concepts that were not yet explored 
before and offered potential better insights and research avenues. 
- Step 5. Collecting and reporting the data. The literature data collected through 
the traditional literature review, the systematic review and through a literature 
exploration that went beyond the systematic review resulted in the literature 
data presented below.  
A schematic overview of the general approach is presented in the following diagram 
(note: in the figure below, reference is still made to ‘DBA Project 1’ – see bottom of the 
picture – as this literature review was conducted as part of project 1 of a Doctoral In 
Business Program). 
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Traditional review of the literature 
The traditional review approached the literature by exploring two literature streams: 
the leadership literature and the innovation literature. Journals in both literature 
streams were selected from the Association of Business Schools, Academic Journal 
Quality Guide16. 
The innovation literature on the leadership of innovation 
The following journals were selected based on the ABS-listing of journals in the 
innovation field: 
 
i. Rank 4: Journal of Product Innovation management  
ii. Rank 3:  R&D management  
iii. Rank 2:  Industry and Innovation, Technovation 
iv. Rank 1:  Creativity and Innovation Management,  European Journal of 
 Innovation Management  
                                                          
16 The Association of Business Schools Academic Journal Quality Guide – Journals Classified by Field and Rank, 
March 2008, Edt. C. Harvey, H. Morris and A. Kelly – www.the-ABS-org.uk 
Literature review approach
Traditional literature 
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Leadership literature
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In addition, the following journals which are not referenced in the ABS-listing of journals 
in the field of innovation but are available through the ABI/GLOBAL database were also 
screened:   
 
v. International Journal of Entrepreneurship and Innovation Management 
vi. International Journal of Entrepreneurship and Innovation  
vii. Innovation  
viii. Innovation: Management, Policy and Practice 
 
Journals were screened for articles that contain the term “leader*” in the Citation and 
Abstract part of the article. The following journals were not used in the search: Stanford 
Social Innovation Review, Economics of Innovation and New Technology, Construction 
Innovation. 
The leadership literature on leadership of innovation 
A number of journals carry the term “leadership” or an equivalent term (eg “leader*”) 
in their journal title.  The following journals were selected based on the ABS-listing of 
journals in the innovation field: 
 
i. Rank 4: Leadership Quarterly  
ii. Rank 1: Leadership and Organizational Development Journal 
iii. No rank:  Journal of Leadership and Organizational Studies 
 
In addition, the Journal of Organizational Behavior (Rank 4) which is classified by ABS in 
the same field as “Leadership Quarterly”, was also included in the search.  Some journals 
identified in the Cranfield Library contain the term “leader(ship)” but were removed 
from the search exercise,  as they refer to leadership in the educational or non-profit 
sector or specifically address gender issues and leadership17. Journals were screened for 
articles that contained the search term “innovat*” in the citation and abstract part of 
the article. Journals in the leadership field which are not peer-reviewed or magazines 
focusing on leadership and act as executive fora were not included in the search18. 
General management literature on leadership of innovation 
A search was also conducted in the top-ranking management literature for the search 
terms “leader*” and “innovat*”. A number of high ranking (rank 4) general management 
journals were included in the search: Academy of Management Journal, Academy of 
Management Review, Strategic Management Journal and Administrative Science 
Quarterly. In addition, the ABI/GLOBAL database was searched using the search term 
”CEO” OR “chief executive officer* AND “innovat*”. This search generated articles that 
specifically address matters related to the CEO and innovation. All papers collected 
                                                          
17 Advancing Women in Leadership, Leadership in Health Services, Non-profit Management and Leadership, 
Academy of Educational Leadership, Allied Academies International Conference Academy of Educational Leadership 
Proceedings 
18 Journals such as: Leadership Excellence, Strategy and Leadership, Leader to leader, Leadership in Action 
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through the (extended) traditional literature review were introduced into a RefWorks 
folder. 
Systematic review of the literature  
The goal of a systematic review is to identify research data in the literature that presents 
an answer to a specific research question, using a procedure that is both transparent 
and reproducible (Tranfield et al., 2003). It follows a set of predefined steps as follows: 
 
Identification of the need for a review 
Preparation  of a proposal for review 
Database selection 
Conducting the review 
Selection  of the studies 
Quality assessment  
Search results 
Data extraction 
 
Identification of the need for a review 
The need for further research on the role of the CEO in innovation was put forward by 
Jung et al. (2008) after their research on the impact of transformational leadership styles 
of CEOs on innovation. This paper was identified after a first unstructured screen of the 
leadership literature using database search engines. This led to an additional selection 
of research papers that drew attention to the role of the CEO in innovation and in which 
different visions were articulated. For example, while some argue that the impact of 
CEOs is not very relevant (Burgelman et al., 2004; Christensen and Diehl, 1997) and point 
to the crucial role of middle-level managers in supporting initiatives from operating 
levels, others have put the CEO back in the seat of innovation (Yadav et al., 2007) or 
argue that they have an effect on innovation through their support of individuals and 
teams (Hegarty and Hoffman, 1990; Montoya-Weiss and Calantone, 1994). Still others 
observed a relationship between CEO demographics and R&D spending (Barker and 
Mueller, 2002). This first screen of the literature made it clear that it offered 
inconclusive, diverse and conflicting statements on the role of the CEO and showed 
considerable debate in the scholarly management literature on the impact of CEOs on 
innovation (Eggers and Kaplan, 2009; Damanpour and Schneider, 2006; Papadakis and 
Bourantas, 1998; Elenkov et al., 2005). Therefore, it was decided to conduct a systematic 
review of the literature in order to obtain a clearer picture of what the literature says 
on the relationship of the CEO with the R&D function and how this relationship impacts 
(culture of) innovation. The research question used in this systematic review is:  
 
“What is the impact of the relationship between the CEO and 
the R&D function on the culture of innovation?” 
 
 
Preparation of a proposal for review 
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This research question was developed to allow a systematic review of the literature to 
look for research papers that not only addresses the role of the CEO in innovation  but 
also extends the review to areas that would be left uncovered if the research question 
would be defined too tightly. Therefore the relationship between CEO and R&D is 
included in the question as it is one of the objectives of our research to explore the 
R&D’s view of the CEO. The concept of culture was also introduced to extend the 
systematic review outcome to areas beyond the CEO and R&D. The reason for this 
approach is because the systematic review has its advantages but also limitations. The 
table below presents the steps taken to mitigate the limitations of the systematic review 
of the literature. An overly narrow focus of the systematic review of the literature was 
prevented by addressing two sets of keywords into the research question addressing 
two different literatures, i.e. the leadership literature and the innovation literature. The 
risk of omitting relevant studies was reduced by adding a traditional literature review to 
the systematic review. This approach disclosed areas of the literature that would not 
have been identified by the systematic review alone and offered a broader view of the 
relevant literature in which the research is embedded. 
 
Addressing the limitations of the systematic review of the literature 
Limitations of the systematic 
review  
Steps taken to mitigate these 
limitations in my approach 
Examples of the mitigation in my 
study 
 Overly narrow focus 
 
 Combine two literature streams 
 
In our research both the 
leadership and the innovation 
streams were included through 
the systematic review question 
 Omission of relevant 
studies 
 Combine the systematic review 
of the literature with a 
traditional review of the 
literature 
The systematic review was 
complemented with a bifocal 
traditional review of the literature 
addressing leadership and 
innovation 
 
The review protocol for the systematic review was developed and is presented in the 
table below: 
   
Step Activity 
1 Identify the databases that will be used 
2 Define the search keywords 
3 Develop appropriate search strings 
4 Introduce the search strings into the databases for a search at the level of TITLE and for a search at 
the level of ABSTRACT 
5 Run the search procedure in the database at the level of TITLE and at the level of ABSTRACT 
6 Determine the number of “hits” returned from each database:  
“T (database)” for hits returned for papers carrying the search string in the TITLE of the paper 
“A (database)” for hits returned for papers carrying the search string in the ABSTRACT of the paper 
7 Read the abstract of all papers identified through the database search irrespective of whether they 
have been identified through a TITLE or ABSTRACT search 
8 Select the papers whose abstracts constitute content that is of value for answering the research 
question irrespective of whether they have been identified through a TITLE or ABSTRACT search; 
“paper relevant?” 
9 Note the number of papers whose abstracts constitute content that is of value for answering the 
research question T(database) for TITLE and A(database) for ABSTRACT 
10 Archive all selected papers in each database into a specified “RefWorks” folder 
11 Remove all duplicates 
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12 Count the number of papers - the number of papers is “#” - and constitute the final number of papers 
for further analysis and remove duplicates 
13  Reassess all papers and repeat steps 9 to 12 
14 Count the number of papers - “#” - and constitute the final number of papers for further analysis 
15 Read all papers for their content  
16 Apply exclusion/inclusion criteria to each paper 
17 Archive included papers “#” in a specified “RefWorks” folder 
18  Identify papers cross-referenced in each selected paper 
19 Read the referenced paper  
20 Apply exclusion/inclusion criteria to each paper 
21 Archive referenced papers in the specified “RefWorks” folder 
22 Assess the quality level 
 
The procedure is presented in two schemes on the following page 
 
Database selection 
The databases that were used to search the literature are presented below.   
 
Database Description/rationale (from N. Nikitesh, Ph.D. student, Cranfield 
university) 
ABI/Inform Specifically, ABI/INFORM Trade & Industry™ is a business and 
management database in ABI/INFORM. This provides major trade and 
industry news. It includes in-depth coverage of companies, products, 
executives, trends, and other topics for more than 1,320 publications, with 
over 1,150 in full-text. With ABI/INFORM Trade & Industry, users can study 
and compare specific trades and industries, including telecommunications, 
computing, transportation, construction, petrochemicals, and many others 
EBSCO Provides full text for more than 8,500 scholarly business journals and 
other sources, including full text for more than 1,100 peer-reviewed 
business publications. Coverage includes virtually all subject areas related 
to business. This database provides full text (PDF) for more than 350 of the 
top scholarly journals dating as far back as 1922 (EBSCO Information 
sources) 
EMERALD Emerald is the world’s leading publisher of business and management 
research, with 200 journals and a wide range of serials, series and books in 
management and related fields. Contains full text of 170,000 peer 
reviewed papers from many prestigious journals (Emerald Information 
sources) 
SCIENCE DIRECT Covers over 1700 journals from Elsevier Science and about 60 million 
abstracts from the field of social science Covers 1700 journals from 
SOCIAL SCIENCES 
CITATION INDEX 
Provides journal papers with citation reports and acts as a single route 
access to all Thomson Reuter’s products 
WILEY INTER-SCIENCE 
JOURNALS 
Provides access to more than 3 million articles across 1400 journals. These 
journals cover the full spectrum of science, technology, business, social 
science and the humanities and include many titles at the forefront of 
their fields 
 
In order to conduct the systematic review, a review panel was established that consisted 
of faculty members of Cranfield School of Management and a Cranfield’s University 
library specialist.  Before implementing the procedure and conducting the  
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systematic review, advice was sought from the systematic review specialist (SR 
specialist) and in case of doubt the library specialist was consulted. The review panel is 
presented in the table below. 
 
Expert Expertise Affiliation 
Prof. K. Goffin Innovation, Supervisor Cranfield School of Management 
Prof. A. Kakabadse Leadership, Panel member Cranfield School of Management 
Prof. P. Reinmoller Strategy, Panel Chair Cranfield School of Management 
Dr. M. Szwejczewski Innovation and SR specialist Cranfield School of Management 
Ms. H. Woodfield Library specialist Cranfield School of Management 
 
Conducting the review 
The search terms and search strings are presented in the table below and and are 
combined into search strings using the Boolean operator “AND” or “OR” and were 
introduced into the search engines of several literature databases. The search strings 
were then developed under the assumption that they would generate a number of hits 
available for review.  The keyword “cultur*” was introduced into search string A and B 
after the first database searches. 
 
Area of investigation Search Keywords Target keywords 
The role of the CEO in 
innovation 
 
“CEO”  -  “chief 
executive”  -  “top” – 
“chief”  
chief executive officer, top manager, top 
management 
The role of the top 
management team in 
innovation 
 
“Top” – “top  
management”  - “top 
team” – “TMT” – 
“CTO” – “CSO”  
top management team, top team, TMT, Chief 
Scientific Officer – Chief Technology Officer 
The role of the CEO in 
innovation 
 
“innovat*”   innovation, innovative, innovators, 
innovativeness, innovatively, innovative 
culture, culture of innovation 
Other innovation-related 
terms: R&D, research and 
development, new 
product development and 
technology 
“R&D” – “develop*” -  
“tech*” 
new product development, development plans, 
developability, development projects, 
development ideas, technology development, 
technology implementation, technological, 
R&D, R&D teams, R&D management  
Culture of innovation “cult*” culture, cultural, cults 
 
 
Search strings used for the systematic review 
Code Search string 
A 
 
“CEO”  OR  “chief executive” AND “innovat*” OR “R&D” OR “develop*” OR “tech*” (AND 
“cultur*”) 
B “Top” OR “TMT” OR “CTO” OR “CSO” AND “innovat*” OR “R&D” OR “develop*” OR 
“tech*” (AND “cultur*”) 
 
Selection of the studies 
Reports which were identified through the database searches were submitted to a 
selection process according to inclusion/exclusion criteria. The inclusion/exclusion-
process is conducted according to the criteria below.  From the papers which were 
selected, other papers were retrieved which were referenced in the first paper and 
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addressed the role of the CEO. They were also submitted to the inclusion/ exclusion 
criteria and the quality assessment.  There is also a considerable practitioner’s literature 
on the role of the CEO in innovation. This includes numerous interviews of CEOs, book 
reviews, editorials in magazines and “how to innovate”-articles.  These were not 
included in this review as they do not add to the scientific rigor.  
 
Inclusion and exclusion criteria 
Inclusion criteria Justification: 
Academic papers in peer-reviewed scholarly 
journals, working papers, conference papers, 
theses and dissertations. The ranking of the 
journals was not an inclusion/exclusion criterion. 
Only journals in the English language are included 
Journal papers are the primary academic 
resources on a given subject. Theses and 
academic working papers may offer the latest 
thinking on the subject 
Papers that specifically address and explore the 
role of the CEO in innovation and the impact 
factors on that role 
 
No restriction on industry or geographical areas All data on the relation of CEO and innovation 
irrespective of market or geography may prove 
valuable 
Academic papers that specifically address 
management research 
 
The topic of interest is in the field of 
management and therefore other papers that 
are outside the field of management are of no 
interest 
Exclusion criteria Justification: 
Papers that discus the role of the CEO outside of 
the innovation field 
Numerous papers are published on the role of 
the CEO in firm performance, strategic decision 
making and other factors but not necessarily on 
innovation 
Papers older than 20 years We assumed that the number of papers on the 
role of the CEO in innovation is limited. We 
employed a timeframe of max. 20 years. Papers 
published before 1990 were not taken into 
account. We assumed that older papers, if they 
are valuable, would be referenced in recent 
papers.  
Anonymous papers The absence of a reference to an author makes 
it difficult to address the argument  
Papers or documents that present a personal 
vision on the topic such as editorials, 
considerations, opinions, advisory statements, 
consulting advice, ‘how to innovate’-articles, 
generic and/or consultant ‘recipes’ 
These documents do not add to the academic 
rigor that is required for this systematic review 
Interview of CEOs Although potentially interesting (and 
numerous), these interviews were not withheld 
because they offer a quite ‘glossy’ view on the 
CEO’s role in innovation. They are also not 
scientifically valid interviews conducted as part 
of a qualitative study 
Papers that do not specifically refer to the role of a 
CEO in innovation 
There are several studies that study the role of 
the CEO on corporate culture and firm 
performance. When these studies do not 
include a reference to innovation as a 
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parameter of firm performance, they were not 
included 
Papers, cases or books that refer to the subject 
from a general point of view and do not add to the 
knowledge of the role of the CEO in innovation but 
merely represent an author’s personal experience 
There are numerous cases and books on the 
role of the CEO and upper management in 
innovation but these documents do not add to 
the academic rigor that is required for this 
systematic review 
Scholarly papers addressing innovation with a 
technically applied focus in the areas of biology, 
physics or chemistry and disciplines derived 
thereof 
The topic of interest is in the field of 
management and papers that are inside the 
field of innovation but only address technical 
issues are not of interest 
 
Quality assessment 
The papers were ‘qualified’ using a scoring system by which 7 quality parameters were 
scored between 1 and 3. The 7 quality parameters were:  literature review (A), 
theoretical background (B), methodology and methods (C), data analysis and results (D), 
generalizability (E), contribution to knowledge (F), limitations and potential for future 
research (G) as presented in the table below.  
 
Parameter 
A to G 
Quality Scoring 
Score 1 Score 2 Score 3 
Literature 
review (A) 
Poorly covered 
literature landscape 
Basic coverage of 
literature landscape 
Excellent coverage of 
literature landscape 
Theoretical 
background (B) 
Report does not 
demonstrate 
awareness of existing 
theories and current 
theoretical 
developments 
Reasonably good review 
of theoretical 
background 
Excellent review of 
theoretical background and 
demonstrates a clear link 
of theory with the research 
area and hypothesis; 
reviews and summarizes 
studies previously carried 
out 
Methodology 
& methods (C) 
Rationale for the use 
of a methodology not 
stated. Difficult to 
find link between 
methods used and the 
research objectives 
Reasonably good 
research design with 
acceptable methodology 
and appropriate 
methods used to 
complete the study 
Clear link of the 
methodology used to the 
research question and 
theoretical foundation. 
Methods used are clearly in 
line with what is being 
achieved 
Data analysis 
and results (D) 
Poor data sources, no 
clear explanation of 
the sample used. 
Results are not 
explained very clearly 
in light of research 
objectives 
Reasonably good data 
sources; data sample is 
justifiable; results are 
relevant and in line with 
the objectives of the 
research 
Excellent data sources data 
sample is appropriately 
chosen; analysis results are 
in line with the objectives 
of the research and there is 
a description of how these 
are similar or dissimilar to 
papers from other 
researchers/sources 
Generalizability 
(E) 
Single cases where 
investigation involved 
a particular type of 
innovation 
Countries or industries of 
similar characteristics 
High level of 
generalizability; any 
country or any industry or 
any product 
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Contribution to 
knowledge (F) 
Does not make any 
important 
contribution; 
contribution not 
mentioned in the 
paper 
Builds upon existing 
theory and the 
contribution is 
appropriately positioned 
in the existing body of 
literature 
Contributes further to 
developing existing 
knowledge; develops the 
technique through which 
the research area was 
explained 
Limitations and 
potential for 
future research 
(G) 
Limitations not 
stated although it lacks 
theoretical backing, 
methodological rigor 
and have used poor 
data 
Limitations stated 
but do not explain its 
relevance to understand 
the results of the study; 
future research areas 
not stated 
Limitation of the study 
explicitly stated and clearly 
understood; provides areas 
for further research that 
can enhance understanding 
 
For example, for a given quality parameter such as literature review, a score was 
assigned 1, 2 or 3, indicating a “poorly covered literature landscape” (a score of 1), a 
“basic coverage of the literature (score 2) or an “excellent coverage of the literature 
landscape” (score 3) respectively.  Each quality parameter, A to G, was assessed using 
this scoring system. For all quality parameters combined, the total score (TS) lies 
between 7 (7 x score 1) and 21 (7 x score 3). The total score was then used to categorize 
the papers into three classes along three different levels of scores: TS < 10 for low 
quality, 10<TS<17 for medium quality and TS>17 for high quality. The final scores for 
each paper are collected in table on the next page. For example, Ettlie’s paper (Ettlie J.E. 
, 1990) was given a score of 1 to each quality parameter leading to a total score of 7 
while Bang et al.’s paper (Bang et al., 2006) received a slightly higher score of 8, because 
the literature review was not considered “ poor” but “basic” (a score of 2). On the other 
hand, the Papadakis and Bourantas’ paper (Papadakis and Bourantas, 1998) received a 
score of 13 because the literature review was high quality and could easily be compared 
with the literature reviews of the top papers while the “generalizability” was only poor 
as their study is limited to Greek industrial companies without any reference to size or 
industrial innovation capabilities. The table below lists the papers with increasing quality 
(from 7 to 21) and identifies the papers which were also identified through a traditional 
review of the literature (“TR” in the table and indicated by means of a red square). The 
quality appraisal distribution for the papers identified is as follows: 
 
Quality appraisal of the papers retrieved from the systematic review 
Low 1 Number of papers: 3 
  
Al-Qirim, N. (2007), "The adoption of e Commerce communications and applications 
technologies in small businesses in New Zealand", Electronic Commerce Research & 
Applications, vol. 6, no. 4, pp. 462-473. 
 
Bang, N. J., Kyeong, S. H. and Myung, J. L. (2006), "Determining factors for the adoption 
of e-business: the case of SMEs in Korea", Applied Economics, vol. 38, no. 16, pp. 1905-
1916. 
 
Ettlie, J. E. (1990), "What makes a manufacturing firm innovative?", Executive, vol. 4, 
no. 4, pp. 7-20. 
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Medium 2  Number of papers: 34 
 
 
 
Barker, V. L.,III and Mueller, G. C. (2002), "CEO characteristics and firm R&D spending", 
Management Science, vol. 48, no. 6, pp. 782. 
 
Beal, R.M. and Yasai-Ardekani, M., (2000), “Performance implications of aligning CEO 
functional experiences with competitive strategies”, Journal of Management Vol. 26, 
no.4, p.733. 
 
Berson, Y., Oreg, S. and Dvir, T. (2008), "CEO values, organizational culture and firm 
outcomes", Journal of Organizational Behavior, vol. 29, no. 5, pp. 615-633. 
 
Calantone, R. J., Vickery, S. K. and Dröge, C. (1995), "Business Performance and 
Strategic New Product Development Activities: An Empirical Investigation", Journal of 
Product Innovation Management, vol. 12, no. 3, pp. 214-223. 
 
Carbonell, P. and Rodríguez-Escudero, A. (2009), "Relationships among team's 
organizational context, innovation speed, and technological uncertainty: An empirical 
analysis", Journal of Engineering and Technology Management, vol. 26, no. 1/2, pp. 28. 
 
Daellenbach, U. S., McCarthy, A. M. and Schoenecker, T. S. (1999), "Commitment to 
innovation: The impact of top management team characteristics", R & D Management, 
vol. 29, no. 3, pp. 199. 
 
Damanpour, F. and Schneider, M. (2006), "Phases of the Adoption of Innovation in 
Organizations: Effects of Environment, Organization and Top Managers1", British 
Journal of Management, vol. 17, no. 3, pp. 215. 
 
Datta, D. K. and Guthrie, J. P. (1994), "Executive Succession: Organizational Antecedents 
of Ceo Characteristics", Strategic Management Journal, vol. 15, no. 7, pp.569-577. 
 
Datta, D. K., Guthrie, J. P. and Rajagopalan, N. (2002), "Different industries, different 
CEOs? A study of CEO career specialization", Human Resource Planning, vol. 25, no. 2, 
pp. 14. 
 
Dechow, P. M. and Sloan, R. G. (1991), "Executive incentives and the horizon problem", 
Journal of Accounting & Economics, vol. 14, no. 1, pp. 51-89. 
 
Deeds, D. L., DeCarolis, D. and Coombs, J. (2000), "Dynamic capabilities and new 
product development in high technology ventures: An empirical analysis of new 
biotechnology firms", Journal of Business Venturing, vol. 15, no. 3, pp. 211. 
 
Dickson, P., Schneier, W., Lawrence, P. and Hytry, R. (1995), "Managing design in small 
high-growth companies", The Journal of Product Innovation Management, vol. 12, no. 
5, pp. 406. 
 
Elenkov, D. S., Judge, W. and Wright, P. (2005), "Strategic leadership and executive 
innovation influence: an international multi-cluster comparative study", Strategic 
Management Journal, vol. 26, no. 7, pp. 665. 
 
Elenkov, D. S. and Manev, I. M. (2005), "Top Management Leadership and Influence on 
Innovation: The Role of Sociocultural Context", Journal of Management, vol.31, no. 3, 
pp. 381. 
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Green, S. G. (1995), "Top management support of R&D projects: A strategic leadership 
perspective", IEEE Transactions on Engineering Management, vol. 42, no. 3,pp. 223. 
 
Judge, T. A. and Bono, J. E. (2000), "Five-factor model of personality and 
transformational leadership", Journal of Applied Psychology, vol. 85, no. 5, pp. 751. 
 
Kickul, J. and Gundry, L. (2001), "Breaking through boundaries for organizational 
innovation: New managerial roles and practices in e-commerce firms", Journal of 
Management, vol. 27, no. 3, pp. 347. 
 
Kitchell, S. (1997), "CEO characteristics and technological innovativeness: A Canadian 
perspective", Revue Canadienne des Sciences de l'Administration, vol. 14,no. 2, pp. 111. 
 
Laforet, S. and Tann, J. (2006), "Innovative characteristics of small manufacturing 
firms", Journal of Small Business and Enterprise Development, vol. 13, no. 3, pp.363. 
 
Lefebvre, E. and Lefebvre, L. A. (1992), "Firm Innovativeness and CEO Characteristics in 
Small Manufacturing Firms", Journal of Engineering and Technology Management, vol. 
9, no. 3,4, pp. 243. 
 
Lefebvre, L. A., Mason, R. and Lefebvre, E. (1997), "The influence prism in SMEs: The 
power of CEO's perceptions on technology policy and its organizational impacts", 
Management Science, vol. 43, no. 6, pp. 856. 
 
Lin, C., Lin, P., Song, F. M. and Li, C. "Managerial Incentives, CEO Characteristics and 
Corporate Innovation in China’s Private Sector", Journal of Comparative Economics, vol. 
In Press, Accepted Manuscript. 
 
Ling, Y., Simsek, Z., Lubatkin, M. H. and Veiga, J. F. (2008), "The impact of 
transformational CEOs on the performance of small- to medium-sized firms: Does 
organizational context matter?", Journal of Applied Psychology, vol. 93, no. 4, pp. 923. 
 
Lynskey, M. J. (2004), "Determinants of Innovative Activity in Japanese Technology-
based Start-up Firms", International Small Business Journal, vol. 22, no. 2, pp.159. 
 
Miller, D. and Toulouse, J. (1986a), "Chief Executive Personality and Corporate Strategy 
and Structure in Small Firms", Management Science vol.32, no. 11, pp. 1389. 
 
Miller, D. and Toulouse, J. (1986b), "Strategy, Structure, CEO Personality and 
Performance in Small Firms", American Journal of Small Business, vol. 10, no. 3, pp.47. 
 
Papadakis, V. and Bourantas, D. (1998), "The chief executive officer as corporate 
champion of technological innovation: An empirical investigation", Technology Analysis 
& Strategic Management, vol. 10, no. 1, pp. 89. 
 
Scherer, F. M. and Huh, K. (1992), "Top Managers' Education and R&D Investment", 
Research Policy, vol. 21, no. 6, pp. 507. 
 
Simsek, Z. (2007), "CEO tenure and organizational performance: an intervening model", 
Strategic Management Journal, vol. 28, no. 6, pp. 653-662. 
 
Thong, J. Y. L. and Yap, C. S. (1995), "CEO characteristics, organizational characteristics 
and information technology adoption in small businesses", Omega, vol. 23,no. 4, pp. 
429-442. 
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Tyler, B. B. and Steensma, H. K. (1998), "The Effects of Executives' Experiences and 
Perceptions on their Assessment of Potential Technological Alliances", Strategic 
Management Journal (1986-1998), vol. 19, no. 10, pp. 939. 
 
Wu, W., Chiang, C. and Jiang, J. (2002) “Interrelationships between TMT management 
styles and organizational innovation”, Industrial management, vol. 102, no. ¾, pp. 171. 
 
Yadav, M. S., Prabhu, J. C. and Chandy, R. K. (2007), "Managing the Future: CEO 
Attention and Innovation Outcomes", Journal of Marketing, vol. 71, no. 4, pp. 84. 
 
Young, G. J., Charns, M. P. and Shortell, S. M. (2001), "Top manager and network effects 
on the adoption of innovative management practices: A study of TQM in a public 
hospital system", Strategic Management Journal, vol. 22, no. 10, pp. 935. 
High 3 Number of papers: 8 
 
 DeTienne, D. R. and Koberg, C. S. (2002), "The impact of environmental and 
organizational factors on discontinuous innovation within high-technology industries", 
IEEE Transactions on Engineering Management, vol. 49, no. 4, pp. 352. 
 
Eggers, J. and Kaplan, S. (2009), "Cognition and Renewal: Comparing CEO and 
Organizational Effects on Incumbent Adaptation to Technical Change", Organization 
Science, vol. 20, no. 2, pp. 461. 
 
Jung, D. I., Chow, C. and Wu, A. (2003), "The role of transformational leadership in 
enhancing organizational innovation: Hypotheses and some preliminaryfindings", 
Leadership Quarterly, vol. 14, no. 4,5, pp. 525. 
 
Jung, D. (., Wu, A. and Chow, C. W. (2008), "Towards understanding the direct and 
indirect effects of CEOs' transformational leadership on firm innovation", Leadership 
Quarterly, vol. 19, no. 5, pp. 582. 
 
LING, Y., SIMSEK, Z., LUBATKIN, M. H. and VEIGA, J. F. (2008), "Transformational 
Leadership's Role in Promoting Corporate Entrepreneurship: Examining the Ceo-Tmt 
Interface", Academy of Management Journal, vol. 51, no. 3, pp. 557-576. 
 
Makri, M. and Scandura, T. A. (2010), "Exploring the effects of creative CEO leadership 
on innovation in high-technology firms", The Leadership Quarterly, vol. 21,no. 1, pp. 75-
88.  
 
Swink, M. (2000), "Technological innovativeness as a moderator of new product design 
integration and top management support", The Journal of Product Innovation 
Management, vol. 17, no. 3, pp. 208. 
 
Wu, S., Levitas, E. and Priem, R. I. (2005), "Ceo Tenure and Company Invention Under 
Differing Levels of Technological Dynamism", Academy of Management Journal, vol. 48, 
no. 5, pp. 859. 
 
Search results 
The table below collects the number of papers (“hits”) returned after introduction of the 
search strings in the databases.  
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i. The first column includes the search strings, starting with search strings A and B 
and an additional set of 5 search strings developed during the search process.  
i. The second column includes the number of hits returned by the database after 
introduction of reviewed) papers that carry the search terms in the paper’s titles.  
ii. The third column includes the number of hits returned by the database after 
introduction of the search string in the database search engine which was asked 
to identify scholarly (peer reviewed) papers that carry the search terms in the 
paper’s abstracts. 
iii. The data representing the number of hits in the second and third column contain 
2 numbers; the top number is the number of hits returned by the database 
search engine and the bottom number is the number of papers obtained after 
application of the inclusion/exclusion criteria 
As an example, inserting search string 1 ”CEO” AND “innovat*” in the ABI/Inform 
database returned 16 papers that carry these two terms in the title. Of these 16 papers, 
10 were withheld after application of the inclusion/exclusion criteria.  When the 
originally developed search string “CEO”  OR  “chief executive” AND “innovat*” OR 
“R&D” OR “develop*” OR “tech*” was introduced in the database, it returned 93 papers 
combining these terms in the title, and 32 were retained for further evaluation. Papers 
which passed the inclusion/criteria selection, were exported to a RefWorks archive 
folder identified as “Project 1 CEO/TMT/INNOV ABI/Inform”. 
The originally developed search strings A “CEO”  OR  “chief executive” AND “innovat*” 
OR “R&D” OR “develop*” OR “tech*” and B “Top” OR  “TMT” OR “CTO” OR “CSO” AND 
“innovat*” OR “R&D” OR “develop*”, returned a high number of papers that carry a 
search term  or a combination of search terms in the abstract section of the paper: 3282 
and 8239 respectively. As this number is too large for a review within an acceptable time 
period, we did not evaluate these abstracts, and NE (Not Evaluated) is added in the table. 
In order to generate an acceptable number of papers carrying the search terms in the 
abstract section we simplified search strings A and B by removing 
 
 
SEARCH RESULTS 
 
Search string: Hits in 
TITLE 
Hits in 
CITATION & 
ABSTRACT 
ABI/INFORM (Proquest) - number of scholarly journals 
Search string A: “CEO”  OR  “chief executive” AND “innovat*” OR 
“R&D” OR “develop*” OR “tech*” 
93 
32 
3282 
NE 
Search string B : “Top” OR  “TMT” OR “CTO” OR “CSO” AND 
“innovat*” OR “R&D” OR “develop*” 
53 
29 
8239 
NE 
Additional set of search strings developed during the search process:   
Search string 1. “CEO”  AND “innovat*”  16 
10 
386 
74 
Search string 2. “Top management team” OR “TMT” AND “innovat*”  13 
13 
146 
57 
Search string 3. “CEO” AND “R&D”  7 124 
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7 33 
Search string 4. “CEO” and “CTO” OR “CSO” 1 
1 
17 
5 
Search string 5. “CEO”  OR  “chief executive” AND “innovat*” OR 
“R&D” OR “develop*” OR “tech*” – DISSERTATIONS (titles and 
abstracts) 
7 
4 
230 
28 
Number of references returned through search 189 903 
Number of papers after application of inclusion/exclusion criteria  96 197 
Total number of papers in RefWorks (folder “ Project 1 
CEO/TMT/INNOV ABI/Inform) after duplicate check 
225 
EBSCO (Business Source Complete) - number of scholarly journals 
Search string A: “CEO”  OR  “chief executive” AND “innovat*” OR 
“R&D” OR “develop*” OR “tech*” 
>5k 
NE 
>50k 
NE 
Search string B : “Top” OR  “TMT” OR “CTO” OR “CSO” AND 
“innovat*” OR “R&D” OR “develop*” 
>100k 
NE 
>500k 
NE 
Additional set of search strings developed during the search process:   
“CEO” AND “innovat*”  18 
9 
225 
50 
“Top management team” OR “TMT” AND “innovat*”  219 
61 
516 
134 
“CEO” AND “R&D”  5 
5 
53 
22 
“CEO” and “CTO” OR “CSO” 28 
0 
126 
3 
Number of references returned through search 270 920 
Number of papers after application of inclusion/exclusion criteria  75 208 
Total number of papers in RefWorks (folder “Project 1 
CEO/TMT/INNOV BESCO”) after duplicate check 
167 
EMERALD DATABASE number of scholarly journals 
“CEO”  AND “innovat*”  
0 
185 
20 
“top  management team”  AND “innovat*”  
0 
81 
16 
Number of references returned through search 0 266 
Number of papers after application of inclusion/exclusion criteria  0 21 
Total number of papers in RefWorks (folder “Project 1 
CEO/TMT/INNOV EMERALD”) after duplicate check 
21 
SCIENCE DIRECT  DATABASE 
“CEO”  AND “innovat*”  7 
4 
35 
17 
“top  management team ” AND “innovat*”  4 
4 
18 
12 
Number of references returned through search 11 53 
Number of papers after application of inclusion/exclusion criteria  8 29 
Total number of papers in RefWorks (folder “Project 1 
CEO/TMT/INNOV SCIENCE DIRECT”) after duplicate check 
19 
SSCI DATABASE 
“CEO”  AND “innovat*”  21 
8 
285 
57 
 “top  management team”  AND “innovat*”  9 
9 
141 
69 
Number of references returned through search 30 426 
Number of papers after application of inclusion/exclusion criteria  17 126 
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Total number of papers in folder “Project 1 CEO/TMT/INNOV SSCI” 
after duplicate check19 
109 
WILEY INTERSCIENCE JOURNALS  DATABASE 
“CEO”  AND “innovat*”  5 
2 
353 
25 
“top  management team”  AND “innovate*” 5 
4 
373 
26 
Number of references returned through search 10 726 
Number of papers after application of inclusion/exclusion criteria  4 76 
Total number of papers in folder “Project 1 CEO/TMT/INNOV WILEY” 
after duplicate check 
73 
 
the Boolean  operator “OR” and the terms “develop*” and “tech*”, which generated 
a search result that is too broad because of the use of “develop*” in contexts such as 
“development of a test method” or “development of a new market” and the use of 
“tech*” in contexts such as “technological markets”, “technologists”, “technical know 
how”, “technicians” etc..  When the search term “tech* was removed from search string 
A, the search still returned 2503 hits. When the search term ‘tech*” and “develop*” 
were removed, the number of hits was 660. The search was continued using search 
strings 1 to 5, because they showed more discriminative power while keeping the 
original keywords such as “CEO”, “CTO”, “CSO”, “innovat*” and “R&D” in the search 
strings, specifically addressing our topic of the role of the CEO in science-based 
innovation. As the ABI/Inform database allows for a search of dissertations we 
introduced search string 5 into the database search engine to look for relevant 
dissertations (10th row). After having introduced all search strings into the database for 
a search at the level of title and at the level of abstract, and after having applied the 
inclusion and exclusion criteria, a number of  96 papers carrying the search terms in the 
title and 197 papers carrying the search terms in the abstract were identified . These 
papers were transferred into the RefWorks’ “Project 1 CEO/TMT/INNOV ABI/Inform”-
archive and screened for duplicates. Applying this duplication test on the data, resulted 
in a collection of 225 papers. The same procedure was introduced in the EBSCO 
(Business Source Complete) database and resulted in 167 relevant papers. The relevant 
papers obtained from the EBSCO search was collected in a RefWorks archive entitled 
“Project 1 CEO/TMT/INNOV EBSCO”.  In addition to the ABI/Inform and the EBSCO 
research, three additional databases were searched for relevant papers: EMERALD, 
SCIENCE-DIRECT, Social Sciences Citation Index and WILEY Interscience Journals. 
 
Finally, the papers collected in RefWorks archives “Project 1 CEO/TMT/INNOV 
ABI/Inform”, “Project 1 CEO/TMT/INNOV EBSCO”,  “Project 1 CEM/TMT/INNOV 
EMERALD” and  “Project 1 CEO/TMT/INNOV SCIENCE DIRECT” were transferred in a new 
RefWorks archive entitled “Project 1 CEO/INNOV All databases” and checked for 
duplicates.  The list of papers obtained by searching the SSCI and WILEY databases were 
collected in archives as a pdf file and identified as “Project 1 CEO/TMT/INNOV SSCI” and 
a folder “Project 1 CEO/TMT/INNOV. These lists were then compared with the list of 
                                                          
19 The searches in SCIENCE DIRECT and WILEY could not be directly transferred to Ref Works and were introduced in a pdf-file and 
stored separately 
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papers available in “Project 1 CEO/INNOV All databases” and checked manually for 
papers that were either duplicates or which were not “catched” previously through the 
ABI/Inform-, EBSCO-, EMERALD- and SCIENCE DIRECT-searches.  This resulted in a 
collection of 405 papers. This collection of 405 papers was then tested for duplicates. 
This resulted in a collection of 360 papers. Each abstract of these 360 papers was then 
reviewed one by one for their relevance for our review. A collection of 132 scholarly 
(peer reviewed) papers were retained for further scrutiny and were then transferred in 
a final archive in RefWorks entitled: “Project 1 CEO/INNOV Final List”. Subsequently, 
each of the 132 research papers were read and those that actually discussed the role of 
the CEO in innovation and factors that impact on this role such as CEO characteristics 
(demography and personality characteristics), context, the top management team, 
compensation, perception, attitude towards innovation etc.  etc. were retained for data 
extraction and further study. This resulted in a final list of 45 relevant papers. We have 
also entered search strings A and B with the inclusion of the keyword ”cul*” in order to 
find papers that specifically study the role of a CEO in an R&D setting and the impact of 
that on culture of innovation in R&D settings.  The output of this search was limited and 
no valuable papers were retained. 
 
Data extraction 
The papers collected through the traditional and the systematic review are not be 
discussed ‘on their own’ as if they were disconnected from the rest of the literature, 
instead, they were rearranged according to specific topics which constitute the 
backbone of this literature review. This data categorization was conducted after a 
thorough analysis of each paper. This allowed the paper to be assigned to a category of 
research addressing a topic of the role of the CEO in innovation (see Chapter 2). 
 
Comparing and separating the traditional review vs the systematic review 
The figure below shows that 209 papers were retrieved from both the traditional 
literature review (196 papers) and the systematic literature review (45 papers). The 
systematic literature review allowed the identification of 16 papers which were also 
identified through a traditional review of the literature.  There is no difference in the 
quality distribution of the papers which were identified both by traditional and 
systematic review and the papers identified only by the systematic review of the 
literature. In both cases the percentage of papers in the medium quality group is 82%, 
while the percentage of high quality papers identified through the traditional and the 
systematic review is 18 and 17% respectively.  When studying the literature references 
of the top quality papers retrieved by the traditional review of the literature (Jung et al. 
2003; Jung et al. 2008 and Makri and Scandura, 2010), there is no reference to the 
papers which were additionally retrieved as a result of the systematic review (Swink, 
2000; Detienne et al., 2002; Wu et al., 2005; Ling et al., 2008; Eggers and Kaplan, 2009). 
This illustrates the efficiency of the systematical review in exploring the literature more 
deeply and more refined then a traditional review. The traditional literature review 
however offers a more expanded view of the literature in that it offers the environment 
in which the data retrieved from the systematical review are to be positioned. The 
traditional review opened a larger field of data that were helpful in putting the granular 
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data of the systematic review into perspective. Also, the traditional review of the 
literature generated papers that  approached the problem from a fresh perspective such 
as the CEO-adviser model (Arendt et al. ,2005) and the 
 
 
 
 
 
close and distant leadership concept  (Waldman and Yammarino, 1999). These papers 
can only be found in the literature environment of the topic at hand but it is these papers 
that enriched the thinking about the role of the CEO in innovation.  In summary, while 
the systematic review offered a deep knowledge of a very specific topic and extended 
the knowledge beyond the raw traditional reviews of the literature, the latter offered a 
mental map of the overall literature 
 
Beyond the systematic review of the literature 
Following the argument that it would be worthwhile to conduct a search for leadership 
theories which have not yet been used in an innovative setting, another review of the 
literature was undertaken to look for leadership theories which have not yet been used 
in innovative settings.  Three documents were used as a source of reference on 
leadership theory: 
 
29 papers
16 papers180 papers
16 papers identified by 
SR and TR  
29 papers identified by 
SR only
180 papers identified 
by TR  only
TRADITIONAL 
REVIEW
SYSTEMATIC
REVIEW
High Q Medium
Q
Low Q
3 13 0
Q3/TOTAL = 18%
Q2/TOTAL = 82%
Q1/TOTAL = 0%
High Q Medium 
Q
Low Q
5 21 3
Q3/TOTAL = 17%
Q2/TOTAL = 82%
Q1/TOTAL = 1%
QUALITY LEVEL QUALITY LEVEL
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i. Leadership: Current Theories, Research, and Future Directions (Avolio et al., 
2009)  
ii. Leadership theory and Practice (Northouse, 2010) 
iii. Essence of leadership (Kakabadse and Kakabadse, 1999) 
 
These sources were used as reference documents to inquire which of the theories 
presented could be of value to understand the role of the CEO in an innovative setting. 
The goal of the section is not to offer a comprehensive overview and analysis of untested 
theories and models, but instead to explore alternatives in the research into the role of 
the CEO in innovation, without trying to achieve completeness either through scope or 
through depth. 
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Appendix B. Upper echelon theory – Overview of the 
literature data 
 
The upper echelon perspective has led to a wide variety of research that was conduc-
ted in an attempt to link CEO characteristics to different measures of innovation. 
 
Education and innovation 
CEOs have different functional and educational backgrounds (Gupta and Govindarajan, 
1984) and backgrounds in science or engineering are associated with progress, 
invention, and improvement (Wiersema and Bird, 1996). It is therefore reasonable to 
believe that CEOs with science and engineering backgrounds have more potential to 
foster innovation than CEOs with other educational histories.  The literature links the 
attained educational level ‘cognitive ability, capacity for information processing, 
tolerance for ambiguity with propensity or receptivity for innovation’ (Bantel and 
Jackson, 1989; Hambrick and Mason, 1984; Datta and Guthrie, 1994a). It can thus be 
hypothesised that the higher the top management’s  educational level the more it will 
foster innovation. For example, in a study of the banking industry, Bantel and Jackson 
(Bantel and Jackson, 1989) found that more innovative banks are led by top managers 
with relatively higher levels of education. In addition, top managers' education levels 
have been linked empirically with the need to change the status quo and to implement 
strategic change (Wiersema and Bantel, 1992). This is also true for the CEO’s team; 
Bantel and Jackson argue that more innovative firms tend to have more highly educated 
management teams and Pfeffer posits that R&D companies are best served by 
individuals with advanced training and education (Pfeffer, 1985). Several researchers 
have looked into the impact of prior education of CEOs on measures of innovation as 
will be reported in the following section.  
 
CEO education and R&D spending 
R&D spending is considered a measure of innovative effort and has therefore been used 
frequently to assess the impact of CEOs (Adams et al., 2006). Hayes and Abernathy 
(Hayes and Abernathy, 1980) attributed the ‘short-sighted’ investment policies in the 
1980’s in the USA and the declining growth of the US economy, to the increasing number 
of specialists in law and finance at the top levels in US companies. This generated an 
interest among scholars in studying the relationship between educational background 
and innovation.  Scherer and Huh analysed data over a period of 17 years on R&D 
expenditures and looked for a relationship between the educational background of CEOs 
for 221 research-intensive U.S. corporations and R&D expenditures (Scherer and Huh, 
1992). They found that, when controlled for profitability and the industrial fields in 
which the firms operate, a science or engineering degree was linked to more intensive 
R&D expenditure.  Barker and Mueller (Barker and Mueller, 2002) took this research 
further and investigated the effect of CEO characteristics on firm R&D spending. They 
collected data from the business reports of 172 firms and found a significant effect of 
CEO’s education on R&D spending in the firm, even when they controlled for corporate 
strategy, ownership structure and other firm attributes. For example, they observed that 
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once a CEO has a university degree, the education received above this level did not play 
a role in R&D spending. The presence of a science degrees has an important influence 
on R&D spending in the firm. Having a CEO with a business degree as a formal education 
did not influence R&D expenditure, whilst CEOs with a legal degree impacted R&D 
expenditure negatively. Lynskey (Lynskey, 2004) approached the role of the CEO in high-
technology start-up firms by looking into the effect of the level of CEO education on the 
number of patents issued and new products developed. It was observed that managerial 
characteristics did not influence the number of products, but CEOs who held a post-
graduate university degree and who were members of networks with other researchers, 
led companies owning a higher number of patents, but not necessarily a higher number 
of new products.  Using a World Bank survey of 1,088 private manufacturing firms 
covering the period 2000 to 2002, Lin et al. (2002) observed that the level of CEO 
education and professional background were positively linked to a firm’s innovation 
effort.  Firms headed by a CEO with a university education combined with  a professional 
background  tended to invest more in R&D projects and manage firms with higher R&D 
intensity. Kitchell (Kitchell, 1997) found that CEOs trained in engineering had a 
significant positive effect on technology adoption.  
 
Datta and Guthrie (Datta and Guthrie, 1994b) showed that R&D-intensive firms were 
more likely to hire CEOs with technical backgrounds whilst the level of education of the 
CEO was positively associated with higher R&D intensity, corroborating other results in 
companies but contradicting results obtained in public organizations by Damanpour and 
Schneider (Damanpour and Schneider, 2006). Other data by Young et al. (Young et al., 
2001) showed that better-educated managers are more skilled in identifying innovations 
from the stream of ideas to which managers are exposed. In summary, several studies 
support the idea that CEOs’ education and science and engineering degrees positively 
impact innovation. Tyler and Steensma (Tyler and Steensma, 1998) found that technical 
education and perceived technological emphasis by the firm, risk orientation and 
previous success with collaborative activities moderated an executive’s weighing of 
alliances. Top executives with a technical education focused more on an item of 
information that represented an opportunity for the firm than did executives without a 
technical education. Technically trained executives did not focus less on information 
related to threats than executives with non-technical education. These findings suggest 
that undergraduate technical education has a greater impact than technical work 
experience on the extent to which executives focus on the technological opportunities 
associated with technological alliances. 
 
CEO age and tenure  
The nature of R&D innovation is such that it is subject to a high degree of freedom – the 
freedom to take a selected scientific approach to an issue at hand, to hold different 
views on how problems may be solved and to choose different directions in developing 
products. This means that CEOs who run companies where decisions are made on the 
basis of scientific data should be sufficiently open to risk-taking and adopt an attitude 
conducive to open-mindedness and a free exchange of ideas (Hambrick et al., 1992).  
According to Hambrick (Hambrick, 1987), it is expected that in high-discretion situations, 
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chief executives tend to be relatively young.  The question whether the age of CEOs 
impacts upon the innovational output (or culture) of a firm is a long-standing one and it 
is argued that younger CEOs have greater open-mindedness, exchange ideas more freely 
and are more willing to take risky approaches to firm growth. As stated earlier, 
Damanpour and Schneider’s data do not support these claims but this inconsistency may 
be due to the fact that their study was conducted in not-for profit organizations. The 
results presented by Young et al. (Young et al., 2001) are consistent with earlier research 
showing that younger and better-educated top managers are more inclined to adopt 
innovations. Younger managers may have less of an emotional commitment to a 
particular way of managing and thus are more receptive to new ideas. R&D spending, 
for example, is higher when CEOs are younger and have career experience in output 
functions such as sales/marketing and R&D/engineering (Barker and Mueller, 2002). 
Kitchell found that the effect of the CEO’s age is negative-curvilinear, meaning that the 
older the CEO is, the less inclined he/she is to engage in high-risk innovation ventures. 
 
Other studies found the effect of CEO tenure on innovation to be positive and highly 
significant  (Miller, 1991). This finding supports Hayes and Abernathy's view (Hayes and 
Abernathy, 1980) that constant job change among corporate CEOs may reward the 
individuals involved, but the resulting short-term focus, inadequate information 
processing and lack of commitment might seriously detract from technology 
advancement for the corporation. CEOs spend less on R&D during their final years in 
office (Dechow and Sloan, 1991) although other data show that when CEOs stay with 
the firm longer, the investment in R&D increases, possibly because the CEO has collected 
experience and can shape the R&D to fit his/her own vision (Barker and Mueller, 2002). 
In other words, CEOs spend R&D dollars for R&D in a specific field of science and 
engineering only if he/she feels comfortable with the nature of the scientific or 
technological aspects of the market. Young et al. (Young et al., 2001) did not observe a 
significant effect of tenure, which confirm the inconclusiveness of the empirical research 
addressing this demographic variable. 
CEO experience  
As part of the factors that contribute to CEO strategy formulation, previous work 
experience may be a determining factor. On the basis of a data set of 101 small 
manufacturing firms, research supports the hypothesis that the positive effect of prior 
experience of a CEO on firm performance increases when the firm emphasizes 
innovation differentiation (Beal and Yasai-Ardekani, 2000). R&D spending is higher when 
CEOs have career experience in output functions such as sales/marketing and 
R&D/engineering (Barker and Mueller, 2002). In pharmaceutical biotech companies the 
effect of a CEO’s experience in managing commercial R&D facilities positively impacts 
the R&D capabilities of the firm (Deeds et al., 2000).  When CEOs have manufacturing 
experience, they engage more in innovative manufacturing facilities and technology 
policies. The background of the CEO is translated into strong technology-driven 
manufacturing plants and in a hiring policy to attract technical talent (Ettlie, 1990).  In 
line with these observations, it was shown that top executives' experiences and 
perceptions influence their attitudes toward technological alliance formation.  For 
example, Tyler and Steensma showed that executive experiences and perceptions 
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influence their assessments of potential technological alliances (Tyler and Steensma, 
1998).  Hambrick, Black and Fredrickson (Hambrick et al., 1992) observed that 
companies with intensive R&D tend to have CEOs with technical (e.g. R&D) experience. 
Datta and Guthrie examined this relationship at the time of succession between CEOs 
and found that R&D-intensive firms select CEOs with technical (R&D, engineering or 
manufacturing) experience (Datta et al., 2002). The replacement of top executives is an 
important step in triggering innovation in such a situation (Nutt and Backoff, 1997; 
Chaganti et al., 2001). In more innovative companies, the CEO’s background was in 
either sales and/or management accounting, whilst the CEO in less innovative 
companies had an engineering background (Laforet and Tann, 2006). CEOs trained in 
engineering had a significant effect on technology adoption (Kitchell, 1997) which is 
consistent with the view of Lefebvre and Lefebvre (1992) that CEOs' functional 
experience is important and with Ettlie's observations that CEOs with an engineering 
background implement an aggressive technology adoption policy (Ettlie, 1990). CEOs 
with international work experience have a positive, highly significant and curvilinear 
effect on corporate innovativeness: it allows managers to be exposed to different 
approaches in management, products and innovation. Increased and continual 
international exposure, however, prevents CEOs from ‘settling’ and focusing on specific 
innovation tasks, which may explain the curvilinear relationship (Ettlie, 1990) 
Daellenbach et al. observed a relationship between the technical orientation of the top 
management team and CEO, on the one hand and above-average R&D intensity, on the 
other hand (Daellenbach et al., 1999). 
 
Summary of the granular research data using the upper echelon perspective 
The following conclusions can be drawn: 
 
i. CEO demographics are much less important than CEO attitude and personality in 
driving innovation and they are a poor predictor of innovation. CEO attitude 
towards innovation and the appropriate organizational environment are more 
important drivers of innovation. New product introduction is driven by CEO 
personality to a greater extent than by organizational and environmental 
characteristics.  
ii. Although at first sight, CEO demographics do not predict discontinuous 
innovation, the latter decreases with the age of the firm but more rapidly with 
older CEOs; decreases with the size of the firm but more rapidly with long-
tenured CEOs; it increases with the number of intra-firm linkages but more 
rapidly with younger CEOs, all of which shows that CEO demographics may play 
a role but that this role is context-driven.  
iii. Increasing CEO tenure increases a firm’s inventiveness during a first phase but 
inventiveness starts to decrease with prolonged CEO tenure. In very dynamic 
environments, the longer the CEO tenure, the more dramatic the decline of a 
firm’s inventiveness, whilst in low-dynamic environments, the increase in CEO 
tenure increases a firm’s inventiveness, which, however, levels off with long CEO 
tenure.  
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iv. Better educated managers are more skilled in identifying innovations from the 
stream of ideas to which managers are exposed. CEOs’ education and in 
particular science and engineering degrees impact positively on innovation. 
v. Younger (and better educated) top managers are more inclined to engage in 
change initiatives and adopt innovations. R&D spending is higher when CEOs are 
younger and have substantial firm stock and career experience in output 
functions such as sales/marketing and R&D/engineering. 
vi. The effect of CEO age is negative-curvilinear and significant, in that the older the 
CEO, the less inclined he/she is to engage in high-risk innovation ventures. 
vii. CEOs spend less on R&D during their final years in office. When CEOs stay with a 
firm longer, the investment in R&D increases. However, a significant effect for 
tenure was not found further, which adds to the conflicting empirical research 
addressing this demographic variable. 
viii. CEO tenure indirectly influences performance through its direct influences on 
TMT risk-taking propensity and a firm’s pursuit of entrepreneurial initiatives. 
CEO education and experience 
The following conclusions can be drawn: 
i. When controlled for profitability and the industrial areas in which the firms 
operate, a science or engineering degree is linked to more intensive R&D 
expenditure.  
ii. A CEO with a business degree does not influence R&D expenditure, whilst a CEO 
with a legal degree influences R&D expenditure negatively.   
iii. Managerial characteristics do not influence the number of products developed, 
but CEOs who hold post graduate university degrees and who are members of 
networks of other researchers lead companies owning a higher number of 
patents, but not necessarily a higher number of new products. 
iv. Firms headed by a CEO with a university education combined with a professional 
background  tend to invest more in R&D projects and manage firms with higher 
R&D intensity than firms led by CEOs who were once a government official. A 
background in engineering has a significant effect on the extent to which a CEO 
adopts a new technology.  
v. R&D-intensive firms are more likely to hire a CEO with a technical background, 
whereas the level of education of the CEO is positively associated with R&D 
intensity.  
vi. R&D spending is higher when CEOs have career experience in output functions 
such as sales/marketing and R&D/engineering. In pharmaceutical biotech 
companies the effect of a CEO’s experience in managing commercial R&D 
facilities has a clear and positive impact on the R&D capabilities of the firm. 
When CEOs have manufacturing experience, they are more willing to engage in 
substantial innovative improvements into manufacturing facilities and to adopt 
a significantly more aggressive manufacturing technology policy of implementing 
strategies. 
vii. Companies with intensive R&D tend to have CEOs with technical (e.g., R&D) 
functional experience. R&D-intensive firms select CEOs with technical (R&D, 
 
 
Appendix B 
209 
 
engineering or manufacturing) experience. In more innovative companies, the 
CEOs tend to have a background in either sales or management accounting or 
both, whilst in less innovative companies the CEO tends to have engineering 
background. 
viii. CEOs with international work experience have a positive, highly significant and 
curvilinear effect on corporate innovativeness 
ix. There is a relationship between technically orientated TMT and CEOs with an 
above-average R&D intensity. CEO flexibility is associated with risk-embracing 
decision-making.  
x. CEOs who exploit differences in background and perspectives within their TMT, 
are able to channel these differences into creative discussion and debate 
regarding the assessment opportunities for their organization. 
CEO Leadership 
The following conclusions can be drawn: 
i. There is a positive relationship between the transformational leadership style of 
the CEO and the innovation within the organization, whilst environment 
(uncertainty and competition) and firm-level characteristics (innovational 
climate, formalization, centralization and empowerment) have moderating 
effects on the aforementioned relationship. 
ii. CEO transformational leadership is positively associated with, and accounts for,  
additional variance in risk propensity, which in turn is related to corporate 
entrepreneurship. 
CEO attention, involvement, innovativeness and perception 
The following conclusions can be drawn: 
i. The impact of a CEO is a function of his/her attentional focus:  product launch is 
accelerated when attention is directed to a new emerging technology and 
delayed when attention is directed to the existing technology. When a CEO 
focuses his/her attention on an emerging technology, the CEO’s impact is also 
dependent on the level of organizational orientation a firm has toward the 
affected industry. The accelerative impact of a CEO’s attention to a new 
opportunity matters more when firms have greater capabilities with reference 
to this technology. 
ii. CEOs  with an internal locus of control tend to pursue more product innovation, 
tend to be more future-oriented, and tend to tailor their approaches to the 
circumstances facing their firms than CEOs who have an external locus of control.  
iii. The performance of an NPD-strategy and of the elements that constitute this 
strategy (such as customisation, new product introduction, design innovation, 
product development cycle time, product technological innovation, product 
improvement, and original product development) is linked to the importance 
that the CEO attaches to that activity. 
iv. In the more innovative companies, the CEO is much more involved in developing 
new products and ways of working than in the less innovative companies. 
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v. Lack of top management commitment seems to necessitate effective cross-
functional communication flows if new product development is to proceed 
properly. 
vi. A CEO’s flexibility and perseverance play a substantial role in driving innovation. 
Data suggest that a CEO’s flexibility predict innovation adoption. 
vii. CEO innovativeness is a significant factor in the adoption of technological 
innovations such as the use of external e-mail in SMEs. 
viii. Small businesses with CEOs who are more knowledgeable about IT are more 
likely to adopt IT. 
ix. CEO  perception  – and not factual environmental data– seems to be potential 
driver in the development of a technology policy and innovation realization. 
x. If a CEO perceives the environment as dynamic, the positive effect of a 
technology policy on realized innovation efforts (i.e. R&D investments, internal 
innovations such as adoption of IT or improved manufacturing technologies and 
searches for and evaluations of external technology) will increase. If, however, 
the CEO perceives his/her environment as hostile, the realized innovation efforts 
with reference to R&D and internal innovation will be dampened. 
xi. Executives who perceive their firms as emphasizing technology and who have 
scored successes with previous technological alliances, attach more importance 
to opportunity-based information and less importance to threat-based 
information than executives who perceive their firms as placing less emphasis on 
technology and having had been less successful with previous technological 
alliances.  
TMT and board relationship 
The following conclusions can be drawn: 
i. Board involvement in decisions made by the CEO results in an inverted U-shaped 
relationship to NPI performance; board involvement is linked to a poorer 
performance of new product introduction in conditions of greater market 
instability; social ties between board and CEOs have an inverted U-shaped 
relationship with NPI performance. 
ii. CEOs draw on the functional differences between management team members 
to enhance the opportunity-assessment process and tap into the diversity of 
perspectives present within their TMTs in order to foster openness and creative 
exploration. 
The tables below present an overview of the literature data of the impact of CEO 
characteristics on innovation and an overview of the data obtained by Damanpour 
and Schneider (2006) and Papadakis and Bourantas (1998) 
 
Effect of CEO personality, demographics and experience on innovation parameters 
Variable Context CI $ P NP DI IA TA  
CEO personality 
Flexibility MMWF        Kitchell 
Flexibility SF ni       Miller & Toulouse 
Perseverance MMWF        Kitchell 
Risk taking MMWF     ni   Kitchell 
Attitude towards risk SMF        Lefebvre & Lefebvre 
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Proactive attitude SMF        Lefebvre & Lefebvre 
Need for achievement SF ni       Miller & Toulouse 
Internal locus of control SF        Miller & Toulouse 
Internal locus of control SMF        Lefebvre & Lefebvre 
External search for information SMF        Lefebvre & Lefebvre 
Internal search for information SMF        Lefebvre & Lefebvre 
Futurity SMF        Lefebvre & Lefebvre 
Analytical ability SMF        Lefebvre & Lefebvre 
Strategic awareness SMF        Lefebvre & Lefebvre 
CEO demographics 
Tenure 
Higher tenure RDF        Barker & Mueller 
Higher tenure CMF  m      Lin et al. 
Higher tenure PH      ni  Young et al. 
Tenure SMF ni       Lefebvre & Lefebvre 
Years in the sector SMF ni       Lefebvre & Lefebvre 
Tenure BIO IU       Wu et al. 
Age 
Young age RDF   ni ni    Barker & Mueller 
Young age MMWF     C   Kitchell 
Young age PH        Young et al. 
Young age CEOs        Tyler & Steensma 
Experience 
Finance /accounting experience RDF  ni      Barker & Mueller 
Finance /accounting experience SMF        Lefebvre & Lefebvre 
Legal career experience RDF        Barker & Mueller 
Productions/operations experience RDF        Barker & Mueller 
Engineering/production experience SMF        Lefebvre & Lefebvre 
HR experience SMF        Lefebvre & Lefebvre 
Manufacturing experience SMF        Ettlie 
Technical background CSF        Datta & Guthrie 
Technical background CEOs        Tyler & Steensma 
Administration experience RDF  ni      Barker & Mueller 
Marketing experience RDF        Barker & Mueller 
Marketing experience SMF ni       Lefebvre & Lefebvre 
Engineering/R&D experience RDF        Barker & Mueller 
R&D experience JSU   ni ni    Lysnkey 
Education 
Number of business degrees RDF  ni      Barker & Mueller 
Legal degree(s) RDF        Barker & Mueller 
Nr of science-engineering degrees RDF        Barker & Mueller 
University degree JSU    ni    Lysnkey 
Graduate degree PH        Young et al. 
Research network JSU    ni    Lysnkey 
Experience as CEO JSU   ni ni    Lysnkey 
Education level RDF  ni      Barker & Mueller 
Education level CSF        Datta & Guthrie 
Education level SMF        Lefebvre & Lefebvre 
Experience as R&D manager BIO        Deeds et al. 
Education as an engineer MMWF        Kitchell 
CEO college education CMF        Lin et al. 
CEO professional experience CMF        Lin et al. 
CEO political connection CMF        Lin et al. 
Other 
Higher value of stock holdings RDF        Barker & Mueller 
CEO founder JSU   ni ni    Lysnkey 
CEO close to retirement LC        Dechow & Sloan 
Immigrant status MMWF        Kitchell 
International work experience MMWF        Kitchell 
 Increased 
innovation 
 Decreased 
innovation 
 No impact  
Legend: CI: corporate innovativeness; $: R&D spending; P: number of new patents; NP: number of new products; ni: no impact; 
m: marginal; DI: discontinuous innovation: C: relationship is curvilinear; IA: innovation adoption; CI: corporate innovation level; 
IU: inverted U relationship; TA: positive evaluation of technological alliances; SMF: small manufacturing firms; PH: public 
hospitals; CEOs: sample of CEOs graduated from a US university; BIO: publicly traded US biotech companies; LC: large firms (in 
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case of Dechow: 405 firms in 14 SIC industry classifications); SF: small firms; MMWF: machinery and metal working firms; CMF: 
Chinese manufacturing firms; RDF: R&D firms; JSU: Japanese start-up; CSF: CEO succession firms 
 
Summary Damanpour and Schneider (2006) and 
Papadakis and Bourantas (1998) 
Innovation parameters 
Variable IN AD IM NPI SPI IPI IPP DI ATC 
Environmental factors          
 Urbanisation    - - - - - - 
 Community wealth    - - - - - - 
 Population growth    - - - - - - 
 Unemployment rate - - - - - - - - - 
 Environmental dynamisms - - -      - 
Organizational characteristics          
 Structural organicity - - -     - - 
 Complexity of the organization    - - - - - - 
 Firm size    - - - -  - 
 Economic health -   - - - - - - 
 Unions present in firms    - - - - - - 
 External communication    - - - - - - 
 Rational analytical decision-making - - -     - - 
 Use of consultants - - -     - - 
 Firm age - - - - - - -  - 
 Improvisation culture - - - - - - -  - 
 Experimentation culture - - - - - - -  - 
 Transitioning - - - - - - -  - 
 Firm orientation to existing technology - - - - - - - -  
CEO personality          
 Need for achievement - - -     - - 
 Goal of reputation - - -     - - 
 Goal of power - - -     - - 
 Locus of control - - -     - - 
 Attitude to risk  - - -     - - 
 Favouring competition    - - - - - - 
 Entrepreneurial attitude    - - - - - - 
 Attention - - - - - - - - FO 
CEO demographics          
 Tenure - - -     F/
D 
- 
 Formal education - - -     - - 
 Age    - - - - F - 
 Gender    - - - - - - 
 Education    - - - - - - 
 Tenure in position    - - - - -  
 Tenure in management    - - - - -  
  Stat. significant  Stat. Insignificant 
Legend: IN: innovation initiation; AD: innovation adoption decision; IM: innovation implementation; NPI: new product 
innovation: SPI: significant product introduction; IPI: incremental product innovation; IPP: innovation of the production 
process; DI: discontinuous innovation: ATC: adaptation to technical change; F: CEO demographics age and tenure play a role 
when firm size, age and intra-linkages are taken into account; FO: impact of CEO on technical reorientation depends on firm 
orientation towards existing technology; -: not measured; D: environmental dynamisms moderates the effect of tenure 
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Appendix C. Alternative theories for the study of the 
CEO 
 
The role of the CEO in innovation was approached in the literature through the lenses 
of upper-echelons and transformational theory and by exploring the role behaviors that 
were topic of previous research. However, whether these approaches provide the most 
appropriate background for understanding the role of the CEO in innovation is a valid 
question. At the start of the literature review it was realised that a systematic review 
based on specifically selected search terms would miss a key area of the leadership 
literature that addresses leadership theories and concepts that may be of value in 
elucidating the role of the CEO in innovation, but were not yet explored. The objective 
of this section is not to attempt to offer a comprehensive overview and analysis of 
untested theories and models, but instead to explore alternatives in the research into 
the role of the CEO in innovation, without trying to achieve completeness either through 
scope or depth. Two sources were used: ‘Leadership’ by Northouse (Northouse, 2010) 
and a recent review paper by Avolio (Avolio et al., 2009). The table below presents an 
overview of the leadership theories presented in these works, a reference in the review 
article to “innovation”, the number of hits retrieved from a database search 
(ABI/Inform) in which the theory was referred to (in the title) and the citation/abstract 
in the paper. The table shows that various leadership theories are not or very rarely used 
in the context of innovation. 
 
Authentic leadership.  The concept of authentic leadership is still in its initial stages of 
development and is emerging in the social sciences (Northouse, 2010). It holds promise 
for explaining the underlying processes by which authentic leaders and followers 
influence work outcomes and organizational performance.  Authentic leadership has 
four components: self-awareness, internalised moral perspective, balanced processing 
and transparency.  The development of this kind of leadership is a complex process 
whereby leaders are perceived by followers as trustworthy and believable. It is thought 
to be a lifelong process that is influenced by critical life events and tries to determine 
what is truly good for the leader, the followers and the organization.  Whether this 
theory has the potential to yield insight in an innovative context is doubtful as its tenets 
do not contain specific factors and determinants that might prove useful for an 
organization’s quest to become more innovative.  
New-genre leadership is a leadership perspective that contains the transformational 
leadership behavior that is quite well studied in the context of innovation at the team 
level. However, it is used sparingly at the level of the CEO and top management.  Further 
studies are definitely required to explore the effect of transformational leadership and 
the diffusion of this leadership style throughout the organization (Avolio et al., 2009) 
Complexity leadership.  In traditional leadership theory, the units of analyses are the 
leader, the leader and the follower and the leader and the group. The fundamental unit 
of analysis in complexity leadership is the ‘Complex Adaptive System’ or ‘CAS’ (Avolio et 
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al., 2009). In complexity leadership, three leadership roles are identified: adaptive 
(engaging others in brainstorming to overcome challenges), administrative (formal 
planning) and enabling (minimising bureaucratic constraints).  This form of leadership is 
studied by means of micro-observations (i.e. daily interactions through real-time 
observation), meso interactions (the use of social network analysis in which one 
examines a group of agents and how they are linked over time) and macro interactions 
(whereby historical analysis of longer lasting events is conducted). This theory may offer 
interesting perspectives for understanding the role of the CEO in the context of R&D as 
it may elucidate the relationship between the CEO and the R&D function through an 
analysis of events that occur on a day-to-day basis or over longer time periods with the 
aim of determining how both actors interact. 
Shared, collective or distributed leadership is an emergent state whereby leadership is 
developed over time by teams and team members. Avolio studied shared leadership by 
rating the teams instead of the team leaders (Avolio and Bass, 1995). The value of using 
shared leadership in an attempt to study the role and impact of a CEO in innovation is 
rather limited because the unit of analysis from which the theory proceeds is a team or 
a group of individuals.  
Followership and leadership:  the follower-and-leader concept proposes a social 
constructionist theory to describe the relationship between leadership and followership 
(Avolio et al., 2009). This theory may offer interesting perspectives on the role of the 
CEO in innovation as it may show how leaders (CEOs) are perceived by their followers 
(innovators, R&D function) as regards their effectiveness in leading innovation and how 
this perception translates into innovational output or performance.  
Servant leadership. This leadership theory refers to the leader’s values, namely integrity, 
empathy, competence and agreeableness and their effect on the followers’ attitude, 
satisfaction, concern for the safety of others, commitment etc. This theory has nothing 
to recommend in terms of its suitability of researching innovation and the role of the 
CEO. 
Spirituality and leadership. Spiritual leadership is defined as leadership that is comprised 
of the values, attitudes and behaviors that are necessary to intrinsically motivate one’s 
self and others so that they have a sense of spiritual survival thanks through calling and 
membership (Avolio et al., 2009).  
Discretionary leadership. According to Kakabadse and Kakabadse (1999), the under-lying 
assumption of discretionary leadership is that irrespective of the nature and qualities of 
every human being, leaders are only leaders when filling a leadership role. A 
discretionary role is one whose major elements are determined by the role of the 
occupant, i.e. in this case, by the leader, whilst the role of the middle-manager is 
prescribed by structured tasks. The operational latitude that a CEO has depends on the 
environmental conditions and organizational characteristics. In highly turbulent 
environmental conditions, his/her discretionary power is more limited than it is with 
environmental conditions of relative calmness. This means that the impact of the CEO 
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on innovation is not driven only by the leadership behavior or by the mere fact of his/her 
top position but also by his/her discretionary freedom.  
Close and distant leadership. In addition to the theoretical perspectives offered above, 
the literature also presents alternative views that may be useful as testing ground for 
the study of the role of the CEO in innovation. Waldman and Yammarino present a 
theoretical model of CEO charismatic leadership in organizations and show how this 
leadership behavior can impact organizational performance (Waldman and Yammarino, 
1999). The authors base their model on the ‘mixed-effect’ model of Klein (1994) 
whereby CEO leadership behavior affects individual employee effort, but also group 
performance or organizational performance. In their description of the model for 
studying the role of charismatic leadership, the authors propose the concept of “close 
and distant” leadership as a means of understanding the dynamics of CEO leadership. 
Waldman and Yammarino state that future research involving top leaders should be 
geared towards the collection of leadership data from both close and distant followers. 
In addition, the authors argue that leadership can either cascade from higher to lower 
echelons or – alternatively – can bypass directly to lower echelons (Yammarino et al., 
1998). 
Role based leadership is leadership whereby leadership roles are sorted into four distinct 
types: legitimate (the leader is publicly appointed to lead the team), social (defined as 
the role played by the individual who undertakes to build a network of relationships with 
other team members), tasks (leaders who play a role by allocating responsibility for 
delivering a specific task) and macro (the role played by the individual – a senior 
manager –who leads on the basis of a “macro” view of the organization (Sheard and 
Kakabadse, 2007). Sheard and Kakabadse developed the role-based leadership model 
maintaining that by ‘recognising the roles of others and by becoming aware of the range 
of roles that are available to the self, executives learn to modify their behavior to take 
account of the situation’. CEOs may then learn to modify their behaviors to take into 
account the peculiarities of the R&D context.  These concepts may offer valuable 
perspectives for the study of the role of the CEO in an innovational context as it permits 
the study of that role by analysing it in a structured way and by moving away from the 
search for causal demographic or personality factors which has dominated the research 
into the role of the CEO in innovation during the previous decades.  In other words, 
studying the actual role of CEOs is an interesting alternative to the upper-echelon and 
transformational frameworks. 
Although leadership and the inﬂuence tactics that leaders use affect a follower's 
willingness to engage  in creative ventures (Mumford et al., 2002), research into leader 
inﬂuence on creativity and innovation has been scarce  (Mumford et al., 2002; 
Cummings and Oldham, 1997; Tierney et al., 1999). Most studies in strategic leadership 
that looked at this subject (Jung et al., 2008; Elenkov et al., 2005) have  used traditional 
conceptualizations of transactional and  transformational leadership (Bass, 1985) to 
capture CEO leadership characteristics. Although these conceptualizations can be used 
to investigate the relationship between CEOs and followers, strategic leadership in the 
context of high-technology ﬁrms, and firms with extensive R&D capabilities, requires  
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constructs that bear on the  effectiveness of a CEO in fostering not only invention and 
innovation but also  commercialisation of the inventions and developed products.  There 
is a need to reﬁne the constructs that measure creative leadership not only to reﬂect 
the CEO's ability to commercialize existing knowledge and derive proﬁt from it, but also 
to create knowledge (Makri and Scandura, 2010). In other words, constructs - or a set of 
constructs - are needed that allow a more encompassing view of the role of the CEO 
then leadership style alone. As discussed above, Elenkov  et al. observed that strategic 
leadership behaviors increase the executive’s influence on innovation, whilst Jung et al. 
(2008) found transformational leadership to be valuable in fostering innovation in firms.  
According to Makri and Scandura, the multifactor leadership questionnaire used in 
studies using the transformational leadership perspective, does not fully capture the 
unique challenges of the CEO of a high-technology ﬁrm in that it reﬂects only 
relationships between leaders and  members.  According to these authors, the role of 
the CEO in a high-technology ﬁrm is more related to the creation of a culture that 
supports innovation than to direct interactions with employees. Therefore, Makri and 
Scandrura introduced two new leadership concepts, which were termed creative and  
operational to describe the role of a high-technology CEO.  Introducing two dimensions 
of strategic leadership was meant to suggest that an effective leader is one who is able 
to simultaneously invent, develop, and commercialize: 
 
i. The operational component of the CEO’s strategic leadership concept addresses 
the ability of a CEO to ‘to sense new market needs, develop new  concepts for 
products and services, and  increase the knowledge diversity in the firm by 
diversifying into new  products/markets via  mergers, alliances or  acquisitions’ 
(Kuhn, 1970). A successful operational leader identifies important but not yet 
clearly recognizable and future opportunities, acts as a ‘knowledge scout’ whilst 
playing a role as ‘boundary spanner’ of the firm.  The role of a CEO in innovation 
also depends upon the ability of the CEO to drive the inventions through the 
development pipeline, to allow these to be introduced into a manufacturing 
environment and to market and sell them. Therefore the operational leadership 
component of strategic leadership in an innovative setting takes into account 
resources needed and communications necessary to guide the new product 
through the pipeline and onto the market. Makri and Scandura state:  
 
‘A CEO who exhibits characteristics of operational 
leadership would have an external focus when it comes to 
innovation and would be skilled  at communicating with the 
external environment and  broadening the ﬁrm's 
knowledge-creation opportunities by external knowledge 
acquisition’ 
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Leadership 
theory: 
Definition  (as presented  in the literature) Reference to 
“innovation” in  
source review 
article 
Use of theory in 
innovational 
setting 
– No of hits in 
title- in scholarly 
journals 
(ABI/Inform) 
Use of theory in 
innovational context 
– No of hits in citation 
& abstracts - in 
scholarly journals 
(ABI/Inform) 
Authentic 
Leadership 
A pattern of transparent and ethical leader behaviors that encourages openness in sharing information needed to 
make decisions and in which followers’ inputs are accepted 
no 0 6 
New genre 
leadership 
Leadership emphasizing charismatic leader behavior, visionary, inspiring, ideological and moral values, as well as 
transformational leadership such as individualized attention, and intellectual stimulation 
no See Chapter 2 See Chapter 2 
Complexity 
leadership 
The fundamental unit of analysis in complexity leadership is referred to as a complex adaptive 
system, or CAS, composed of interdependent agents that can operate simultaneously on the basis of certain rules 
and localized knowledge that governs the CAS, whilst also being able to adapt and emerge on the basis of 
feedback from the system 
no 2 85 
Shared  
leadership 
A  dynamic, interactive influence process among individuals in groups which the objective is to lead one another 
to the achievement of group or organizational goals or both. This influence process often involves peer, or lateral, 
influence and at other times involves upward or downward hierarchical influence 
no 0 85 
Collective 
leadership 
no 0 42 
Distributed  
leadership 
no 0 22 
Leader 
Member 
Exchange 
The central principle in LMX theory is that leaders develop different exchange relationships with their followers, 
whereby the quality of the relationship alters the impact on important leader and member outcomes. Thus, 
leadership occurs when leaders and followers are able to develop effective relationships that result in mutual and 
incremental influence  
no See Chapter 2 See Chapter 2 
Follower 
and 
leadership 
A social constructionist theory to describe the relationship between leadership and followership. It is argued that 
leadership is significantly affected by the way followers construct their understanding of the leader in terms of 
their interpretation of his/her personality, behaviors, and effectiveness 
no 5 81 
Leadership 
substitutes 
The substitutes-for-leadership theory focuses on situational factors that enhance, neutralize, and/or totally 
substitute for leadership. For example, a group of people engaged in electronic brainstorming using technology, 
such as a group decision support system, may operate as though there was a participative leader who was leading 
the group, but in fact, leadership comes from the operating rules for using the system in order to become 
engaged. 
no 0 9 
Servant 
leadership 
Ten characteristics representing a servant leader: (a) listening, (b) empathy, (c) healing, (d ) awareness, (e) 
persuasion, ( f ) conceptualization, ( g) foresight, (h) stewardship, (i ) commitment, and 
( j ) community building 
no 0 7 
Spirituality 
leadership 
The research on workplace spirituality also now includes a focus on spiritual leadership—defined as “comprising 
the values, attitudes, and behaviors that are necessary to intrinsically motivate one’s self and others so that they 
have a sense of spiritual survival through calling and membership” 
no 0 6 
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Cross 
cultural 
leadership 
The examination of leadership in multicultural contexts no 0 26 
Discretio-
nary 
leadership 
Leaders are only leaders when filling a leadership role and managerial work is categorized as prescribed, namely 
structured, leaving the individual little room to exercise judgment, and discretionary, whereby considerable 
judgment is necessary in order for the individual to function effectively in the role.   
no 0 1 
Role based 
leadership 
Theory 
Leadership roles are categorized along four distinct types: legitimate, social , tasks and macro.   no 0 0 
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ii. The second component of CEO strategic leadership in an innovative setting is 
creative leadership. Creative leaders are more apt to develop human and social 
capital and also to create an environment that fosters innovation (Mumford et 
al., 2002). Creative leaders are capable of stimulating creative subordinates 
intellectually, and offer support for and trust in potentially high-risk projects. By 
doing so, they allow individual initiatives and possibly integrate activities from 
different fields of expertise in the firm (Mumford et al., 2002). This allows the 
development of a culture of innovation which has been shown to be an 
important driver of innovative activities (Scott and Bruce, 1994; Jung et al., 2008; 
Bain et al., 2001; Jung et al., 2003).  ‘High-technology ﬁrms beneﬁt from CEOs 
who are capable of  fostering  innovation by catalyzing and  exploiting the  talents 
of the ﬁrm's technical professionals. These (successful) CEOs are very 
collaborative, open-minded and energetic. Even though these seem like 
universally ideal qualities for a CEO, they appear to be particularly important in 
the  high-technology ﬁrm which has to deal with rapid and  discontinuous 
change, with value creation being dependent on a staff of high-grade technical 
professionals’ (Hambrick et al., 1992).   
Makri and Scandura’s view of a CEO who is successful in innovation is linked to two 
aspects of new product innovation: exploration and exploitation. The challenge in 
innovation in high tech companies resides in the ability to shift from knowledge creation 
and exploration to knowledge application and exploitation. Makri and Scandura suggest 
that for high-technology ﬁrms, effective leadership calls for a CEO who is adept at 
fostering invention internally by catalysing and supporting the talents of the ﬁrm's 
technical professionals and encouraging both science-based and technology-based 
initiatives. Effective leadership calls for a CEO who can also simultaneously create 
opportunities for new  knowledge creation and  existing knowledge application by 
identifying and  exploiting opportunities in the  external environment. This highlights 
two important skill sets that a CEO should possess: that of a creative leader, who is 
people-centred and focuses on internal knowledge development and exploration and 
that of an operational leader, who is constantly on the lookout for new opportunities 
that can be exploited. 
Conclusion 
When the role of the CEO in innovation was studied, research was conducted in an 
attempt to identify CEO-factors that that might impact innovation, such as the CEO’s 
educational background. However, trying to understand the role of the CEO through this 
approach reduces the role of the CEO to a search for causal factors and it does not 
elucidate the roles that CEOs play in R&D and how these can be understood. The review 
of the literature did not identify a research paper that presents research conducted in 
an attempt to understand the actual role of the CEO. However, the literature identified 
a number of role descriptions If the objective is to understand the roles that CEOs play 
in innovation we need to switch our approach away from the search for predictive 
factors.  The literature has learned that: 
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- role behaviors of CEOs such as his/her attitude towards innovation, attention to 
the future, commitment to projects, involvement in innovation and even 
innovativeness may offer an interesting avenue to understand the role of the 
CEO 
- a number of theoretical frameworks call for a role based research perspective 
such as the role based theory of leadership developed by Sheard and Kakabadse 
(2006) and the exploitation/exploration roles proposed by Makri and Scandura, 
posited to be necessary for high tech CEOs 
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Appendix D. Literature study of behavioral role concepts 
of CEOs in innovation 
The following is a comprehensive overview of the behavioral role concepts of attitude, 
attention, commitment, involvement and innovativeness as studied in the literature on 
the role of  the CEO in innovation. 
 
Attitude towards innovation. Perhaps the most influential people, affecting innovation 
and change in organizations are top executives (Damanpour and Schneider, 2006).  
Studies of organizational innovation have shown ‘that senior executives influence the 
adoption of innovation by creating a favorable climate toward innovation’ (Damanpour, 
1991;Dewar and Dutton; 1986; Hage and Dewar, 1973). Therefore top manager’s 
attitude toward change influence organizational climate conducive to innovation’  
(Ekvall, 1996; Hoffman and Hegarty, 1993; West and Anderson, 1996, cited by 
Damanpour and Schneider, 2006).  Hage and Dewar observed that leader factors were 
more important in predicting innovative output than organizational factors (Hage and 
Dewar, 1973, cited by Damanpour and Schneider, 2006).  According to Ekvall and 
Arvonen (1991) and Yukl (1999), cited by Damanpour and Schneider (2006): 
 
‘In addition to task-oriented and employee-oriented behaviors, 
studies of leadership behavior have found a third dimension, often 
referred to as change-oriented behavior. This leadership 
dimension entails an executive who takes long-term perspectives, 
describes appealing visions, encourages and accepts new ideas 
and forges agreements and approvals with people inside and 
outside of the organization to initiate and implement change’  
This third dimension is referred to as the ‘attitude towards innovation’. A positive 
attitude towards innovation facilitates the adoption of innovation by creating a 
favorable climate for innovation (Damanpour, 1991; Dewar and Dutton, 1986; Hage and 
Dewar, 1973).  Organizations led by managers with unfavorable attitude towards 
innovation are most likely not to develop structures and administrative processes 
required for innovation and do not encourage their members to develop new perceptual 
frames for innovation (Damanpour and Schneider, 2006). Bang Nam Jeon, in their study 
of the adoption of e-business in SMEs in Korea, argue that the ‘role of CEOs, who are 
well equipped with knowledge and positive attitudes toward innovation, in adopting 
and expanding e-business by SMEs cannot be overemphasized’ (Bang Nam Jeon et al., 
2006). Bang Nam Jeon et al.’s study of the determining factors of e-business adoption 
defines ‘attitude’ as a composite factor containing ‘CEO innovativeness 1’ and ‘CEO 
innovativeness 2’ defined respectively as  the ’CEO’s eagerness to acquire relevant 
information and skill’ and  ‘the extent to which the CEO feels urgency for a PC training 
program’. This is in contrast with Damanpour and Schneider (2006) and strategic 
leadership researchers, who defined ‘attitude favoring innovation’ as a change oriented 
behavior that facilitates the adoption of innovation by creating a favorable climate for 
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innovation. This different interpretation of the concept of ‘attitude’ illustrates the need 
for a clear definition.  
 
Attitude towards risk. A ‘favorable attitude and willingness to accept occasional failures 
as a natural component of business positively affects new product performance’ 
(Menon et al., 1997; cited by Sanzo et al., 2012). Transformational leaders, it is argued, 
are characterized by risk-taking behavior (Conger and Kanungo, 1988) and CEOs who are 
transformational leaders are hypothesized to create innovational firm output (Jung et 
al., 2008).  Kitchell already suggested that the risk-taking culture of an organization or 
of an individual is positively associated with innovativeness (Kitchel, 1997). In addition, 
innovations are characterized by intrinsic risk and uncertainty (Howell and Higgins, 
1990). Because innovation is an activity that entails risk, Papadakis and Bourantas 
looked for a relationship between a CEO’s attitude towards risk (risk propensity) and the 
level of technological innovation in manufacturing enterprises (Papadakis and 
Bourantas, 1998). The authors did not observe a statistically significant relationship 
between a CEO’s risk attitude and innovation.  Kitchell observed that CEOs’ flexibility 
and perseverance are significant factors in driving innovation, corroborating previous 
studies (Lefebvre and Lefebvre, 1992; Miller and Toulouse, 1986b; Kitchell, 1997; Miller 
and Toulouse, 1986a). Flexibility was shown to be the best predictor of innovation 
adoption, which supports Miller and Toulouse's view that flexible CEOs foster a culture 
that is conducive to innovation adoption (Miller and Toulouse, 1986). The positive effect 
of perseverance is not surprising as innovation activities demand time and effort if they 
are to result in profitable outcomes. However, risk-taking does not play a substantial 
role in driving innovation and, according to Kitchell, this finding ‘cannot be explained by 
the fact that innovative companies are more experienced and knowledgeable adopters 
of new technology, so that for them, the perceived level of risk is not that high’. If 
management decisions are based on perceived rather than on actual risks, the 
innovative CEO may not necessarily be a greater risk taker. On the contrary, innovative 
CEOs may be ‘risk-reducers’ as they appreciate their risky ventures better than CEOs 
who are not engaged in innovative programs and therefore consider themselves as risk-
cautious (Lefebvre and Lefebvre, 1992). These observations with respect to risk taking 
are in line with  Dougherty and Heller argument that  innovation can be considered an 
‘illegitimate action’ that ‘owing to inertial and rigidity forces’ either ‘violate the existing 
regime of thinking and acting’ or ‘fall into a vacuum where no shared understanding 
exist to make them meaningful’ (Dougherty and Heller, 1994). In other words CEOs can 
be innovative while acting as strong risk reducers. This is in line with Padadakis and 
Bourantas argument that ‘technological innovations should confirm with existing beliefs 
and practices in order to gain acceptance’ and that ‘managers should pay particular 
attention to the manner in which IT proposals are presented to the CEO’ and conclude 
that ‘the attitude of the CEO towards the specific innovation is of crucial importance’. 
One can therefore hypothesize that R&D management, seeking  approval from the CEO 
will need to transform innovational R&D proposals to proposal that not only shows 
opportunities for the firm but also reduces the risk profile accepted by the CEO and falls 
within shared understanding.  
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Attitude towards technological innovation. In a study of small businesses, Thong and Yap 
observed that CEOs who have a more positive attitude towards adoption of information 
technology are more likely to adopt information technology (Thong and Yap, 1995) 
supporting Rogers' model of an individual's innovation-adoption process (Rogers, 2003). 
According to Rogers, the development of a favorable or unfavorable attitude towards 
innovation takes place before a decision is made to adopt the innovation and depends 
upon the perception of the CEO towards the innovation (Thong and Yap, 1995). The 
perception of the positive effects of innovation in general or of the positive effects of an 
innovational technology drives the attitude of the CEO towards the adoption of an 
innovational culture or an innovational technology. The concept of attitude therefore 
has two dimensions: either a CEO has a favorable attitude towards innovation as a factor 
that drives firm growth or he/she has a favorable attitude towards a specific 
innovational technology that is presented to him/her.  In both cases, the CEO’s attitude 
can be conceptualized as a positional stance of the CEO about the need for innovation, 
the innovational culture that is required for innovation to take place and the uncertainty 
that is associated with the innovational path and /or technology. As Thong and Yap 
argue in the context of information technology (IT): 
 
 ‘(the) formation of a favorable or unfavorable attitude towards an 
innovation takes place before a decision to adopt is made. In the case 
of a small business, the chief decision-maker is the CEO. Hence, the 
CEO's perception of the adoption of IT is of prime importance. As IT 
is a new innovation to the CEO, he or she has no way of knowing 
whether it will be superior to existing methods of operations. A 
degree of uncertainty exists as adoption of IT is risky, and each CEO 
will perceive the degree of risk or uncertainty associated with IT 
differently. If the CEO perceives the benefits of IT adoption to 
outweigh the risks, then the business is more likely to adopt IT’ 
 
This is in line with Damanpour and Schneider’s argument in that the CEO’s discretion to 
drive innovation (initiation, adoption and implementation) is shaped by his/her 
attitudes toward innovation in general. This means that the CEO attitude is the starting 
point from which innovation takes off in the organization. In both Damanpour and 
Schneider’s, Papadakis and Bourantas’ and Thong and Yap’s research, the concept of 
attitude is defined as a characteristic of the CEO that identifies him/her as an individual 
who is inclined to create an innovative culture that allows innovation to take place. A 
favorable attitude towards innovation or to a technological innovation is based upon the 
perception of the positive impact of innovation by the CEO who is then inclined or 
convinced to adopt the technology. In Damanpour and Schneider’s study, attitude was 
defined as a CEO characteristic that challenges the status quo in public organizations by 
instilling ideas of competitive and entrepreneurial behavior. In Papadakis and 
Bourantas’ study, attitude towards risk was hypothesized to impact on innovation. At 
first glance, the concept of attitude as used by Damanpour and Schneider and the 
concept of attitude as used by Papadakis and Bourantas and Thong and Yap differ 
because the former uses the concept of attitude as a positional stance of the CEO 
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towards innovation in general while the former use the concept of attitude as a 
positional stance towards a specific technological innovation. In the case of Damanpour 
and Schneider, attitude concerns the perception and belief that innovation will drive 
firm growth while Papadakis and Bourantas and Thong and Yap 
refer to attitude as the belief and perception that a specific technology will do the same. 
In both cases however, the belief in the positive effect of innovation in general or the 
adoption of an innovational technology is based upon the inherent acceptance of the 
risk intensity of an innovational undertaking and the culture that will have to drive these  
undertakings. Attitude in the context of innovation, therefore, is the positional stance 
of a CEO who agrees that a culture of innovation is required to grow the firm either 
through the implementation of innovational thinking in the firm and/or through the 
exploration and use of innovational technologies. 
 
Attitude and perception. CEO  perception and not factual environmental data, seem to 
be potential drivers in the development of a technology policy and innovation 
realization. Perception seems to be an important parameter driving the decision-making 
process of a CEO (Lefebvre et al., 1997). If a CEO perceives the environment as dynamic, 
the positive effect of a technology policy on innovation efforts (i.e. R&D investments, 
internal innovations such as adoption of IT or improved manufacturing technologies and 
searches for and evaluations of external technology) will increase. If, however, the CEO 
perceives his/her environment as hostile, the realized innovation efforts of R&D and of 
internal innovation will be dampened whereas the external orientation will increase. 
The practical implications are that misread and/or misinterpreted environments will 
result in an inadequate technology policy. This in turn will translate into suboptimal 
allocation of resources, which could be detrimental to the overall performance or 
survival of a firm. It also means that environmental facts and the interpretations of these 
facts by the CEOs may influence R&D efforts. According to Lefebvre et al., a CEO's 
personal view of the world acts as a prism through which data from the environment 
passes and is differentially weighted to form patterns that make sense to the CEO. 
Different CEOs interpret the same external environment differently, and these different 
interpretations lead to the formulation and enactment of distinctive technology policies 
and to different innovative actions. In another study by Tyler and Steensma (1998), it 
was found that executives who perceived their firms as emphasizing technology and 
who had been successful with previous technological alliances, attached more 
importance to opportunity-based information (i.e. the significance of technology for 
strategy and the potential for learning) and less importance to threat-based information 
associated with performance risk (i.e. the potential for decreased development risk, the 
availability of technological substitutes and the total expected cost of development) 
than executives who perceived their firms as placing less emphasis on technology and 
who had been less successful with previous technological alliances. Executives who 
believed that their firms emphasized technology also focused more on information that 
could be related to threats associated with relational risk (i.e. the favorability of a 
potential partner's history of co-operation) than executives who did not have this belief. 
Likewise, executives who perceived their firms as having been successful with previous 
technological alliances focused less on information that could be related to threats 
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associated with relational risk (i.e. the number of potential partners) than executives 
who did not have this perception. The table below summarizes a number of quotes and 
statements made by researchers on the concept of attitude and the context in which it 
is used, but who do not delve deeper in its effect or significance for innovation. 
 
Attitude is defined as ‘the state, condition or conjecture of a person, as likely to have a 
certain result’ (Thatcher and McQueen, 1980). The attitude of a CEO in the context of 
innovation can be defined as follows: A positive attitude in the context of innovation, is 
the position or stance of a CEO towards the positive effect of innovation on the growth 
and future of the company and his/her acknowledgment of the conditions that need to 
be met in order to achieve innovation and which are likely to have a certain result. The 
attitude of a CEO can be positive (or negative) towards factors that are known to foster 
innovation such as open communication, exchange of diverse ideas, acceptance of 
failure, hiring and selection of innovative people (Goffin and Mitchell, 2010).  Attitude is 
a ‘positional’ conception and starts from the personal point of view an individual CEO 
has towards innovation. The CEO understands that innovation is necessary for a 
company to grow and be competitive and understands it is necessary not only in R&D 
but in all functions of the company. Although attitude is defined as ‘the state, condition 
or conjecture of a person which is likely to generate a certain result’, it does not on itself 
result in action. In order for an attitude to have effect and result in innovative outcome, 
attitude will need to be transformed into action. In the case of R&D firms, this action – 
such as the conduct of R&D - will not materialize unless information is collected in order 
to take strategic R&D decisions. This information- collecting effort, either from the 
internal or the external world, is done by drawing  attention to pertinent information 
(Tyler and Steensma, 1998). 
CEO attention  
In studying of the role of the CEO in innovation, it is important to understand how a 
CEO’s attention to innovation plays a role in new product development processes (NPD), 
in strategic innovative reorientations or in other innovation-related activities in the firm.  
Studies have been conducted to gain an understanding of this attentional aspect of the 
CEO. Attention is defined as ‘the noticing, encoding, interpreting and focusing of time 
and effort by organizational decisions makers’ (Ocasio, 1997) or as ‘the act of keeping 
one’s mind closely on something or the ability to do this; the mental concentration or 
mental readiness for such concentration’ (Thatcher and McQueen, 1980). Attention to 
innovation is translated into time and effort that is used by the CEO to focus on 
innovation. Noticing innovation is the starting point from which  other innovation 
related actions are derived such as commitment to or involvement in  
innovation. When attention is referred to as defined by Ocasio, attention  is the noticing 
and interpreting of internal or external factors in the environment and the future, as 
these terms imply time and effort on the part of the CEO. The concept of attention is 
also linked to perception and sense making of CEOs.  According to Tyler and Steensma 
(1998), in a study exploring the perceptions of top managers on their 
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Datta and 
Guthrie, 1994 
CEOs, are presumed to have a generalist's view (Hambrick and Mason, 
1984) are individuals who are usually functionally specialized (Gupta, 
1984)and bring to the job knowledge, attitudes and skills which are 
partly shaped by experience in their primary functional area. 
Attitude and 
functional 
specialization 
Young et al., 
2001 
Organizational tenure raises conflicting points of view as to its impact 
on a top manager's attitude toward change and innovation. One point 
of view is that increasing tenure leads top managers to become stale 
and resistant to change (Boeker,1997a; Buchholtz and Ribbens, 1994). 
Top managers with long tenure in their respective organizations are 
likely to have obligations to existing organizational constituencies that 
have vested interests in the status quo. The other point of view is that 
with increasing tenure top managers become betterable to manage 
the organizational, political, and cultural challenges associated with 
the adoption of an innovation (Kimberly and Evanisko, 1981;Meyer 
and Goes, 1988; Arndt and Bigelow, 1995).As a result, managers are 
more willing to engage in change efforts and to adopt innovations. 
Although both points of view have theoretical merit, one of the most 
recent and carefully conducted studies addressing the issue supports 
the position that with increasing tenure managers become less willing 
to change (Boeker, 1997a). 
Attitude and CEO 
tenure 
Kitchell, 1997 CEOs who have had experience working with foreign nationals in 
different cultures are also likely to be broader minded and more 
receptive to new ideas. Hence the general impact of international 
work experience is hypothesized to be positive. However, Canadian 
managersare also increasingly reluctant to accept overseas transfers 
because of the problems of reintegration and benefits of having two 
incomes in the family. Hence the question of whether the benefits of 
international work experience are subject to diminishing returns is 
worth exploring. It is possible that several years of overseas work 
experience are critical for developing an outward looking and 
cosmopolitan mind-set. But once these psychological 
attitudes are funned and an interest in international events developed, 
additional years of international work experience among CEOs may 
contribute only marginally to corporate innovativeness. 
Attitude and 
international work 
experience 
Lefebvre et 
al. (1997) 
With respect to technology policy, the prism effect resulting from 
CEOs' biases cannot be ignored, as technological choices and 
investments are greatly influenced by managerial attitudes (Ginsberg 
and Venkatraman 1992) and personal characteristics and personality 
traits of CEOs(Lefebvre and Lefebvre 1992). 
Attitude and 
perception 
Detienne and 
Koberg 
(2002) 
Upper echelon theory argues that the composition, biases, values, and 
perceptions of top managers are important in creating an environment 
favorable to innovation. “It is expected that in high-discretion 
situations, chief executives will tend to be relatively young” ([26, p. 
396]). CEO age is linked to risky strategies that favor innovation. 
Younger managers typically have less commitment to the status quo 
and adopt favorable attitudes toward a greater risk orientation that 
favor innovation. By virtue of their personal characteristics, managers 
will vary in the degree to which they develop and promote different 
types of innovation. 
Attitude and age 
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assessment of potential technological alliances, ‘differences in noticing may lead to 
perceptual differences as the decision-maker focuses less attention on certain stimuli 
while other stimuli dominate his or her attention. Perceptual differences due to sense 
making occur as the decision-maker frames the context of the decision, predicts possible 
outcomes, and forms causal attributions’. Thus, during the perceptual process, the 
potential exists for the executive's cognitive models or understandings to influence not 
only what information is noticed, but also the meaning attributed to that information.  
In their study on CEO values, organizational culture and firm outcomes, Berson et al. 
(2008), argue that ‘self-direction involves an emphasis on making one’s own choices, on 
free thought, and on learning, creating and exploring’ and ‘have been shown to guide 
individuals’ attention and action towards intrinsically rewarding intellectual 
opportunities (Van Dijk and Kluger, 2004).  Calantone et al. (1995) provided evidence 
that the ‘degree of importance placed on an activity by the CEO affected the level of 
performance of that activity, as well as the ultimate financial performance of the firm’. 
These authors conclude that ‘only by focusing top management attention on the 
importance of an activity will the discretionary effort occur to achieve the desired 
outcome’. In this study the concept of attention was defined as the degree of 
importance placed on a certain activity.  Using longitudinal data over a period from 1990 
to 2004, Yadav et al. (2007), in their study of CEO attention to the future, found that the 
level of focus of the CEO on the future and on the internal or external environment, as 
inferred from a psycholinguistic analysis of CEO’s letters to shareholders, influenced the 
process of innovation. The level at which internet technology was used to develop 
internet banking systems and the breadth of the deployment of this technology were 
measured after a given period of tenure of the CEOs during which the detection, 
development and deployment of the internet banking system took place. The extent to 
which the CEO focused on future and external events – gave attention to these events - 
correlated with the speed of detection and development of the technology. The CEOs’ 
attention to the future was a ‘critical driver of innovation even when the target of 
innovation was not innovation per se but simply future events and external events in a 
generic sense or when the innovation outcomes occur far in the future (sometimes 
several years in the future)’. The authors propose an attentional explanation for why 
some top managers have a greater impact on innovation than others.  
 
According to Yadav et al. ‘scarce resource for many firms is no longer information; it is 
processing capacity to attend to information. Attention is the chief bottleneck in 
organizational activity, and the bottleneck becomes narrower and narrower as we move 
to the tops of organizations” (Simon 1973, p. 270)’. In addition, Yadav et al. argue that:  
‘Detection, development, and deployment require the awareness of 
external opportunities and the anticipation of future events. 
Therefore, CEO attention must have a temporal and a spatial 
component that increases such awareness. Combining these insights, 
we argue that the discretion CEOs exercise on temporal attention 
(e.g., emphasis on events that have yet to occur) and spatial attention 
(e.g. emphasis on events that have a locus outside the company) are 
predictive of firm innovation outcomes. When CEOs focus their 
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attention on the future and on external entities, their 
communications and actions reflect this focus and serve to drive 
employees’ attention to events and opportunities in the future and 
outside the firm. In turn, this leads to quicker detection by the firm 
of new technologies and technological opportunities. A greater 
attention to events in the future and to external objects also leads to 
greater preparedness for actions in the future, enabling quicker 
development and more extensive deployment of innovations based 
on these new technologies. In contrast, greater attention to internal 
objects leads to slower detection of new technologies, slower 
development of initial products based on these new technologies, 
and less extensive deployment of innovations.’ 
Also, what top managers pay attention to shapes how they decide and act (Cho and 
Hambrick 2006, Kaplan et al. 2003, Ocasio 1997). According to Eggers and Kaplan (2009):  
‘Technological change provides opportunities for incumbent firms to 
renew themselves, but these opportunities are generally fraught 
with uncertainty. Where information about the direction of change 
is ambiguous, it is not clear that the CEOs of all firms that stand to 
gain from the change would be aware of its potential. It is also 
possible that other factors competing for the CEO’s limited attention 
may distract from the emerging opportunity. Under circumstances 
where the change would require substantial investments with risky 
payoffs, an understanding of CEO attention may help explain which 
firms would take advantage of this opportunity and when they would 
do so (Barr, 1998)’ 
In addition, Kaplan et al. (2003) showed that ‘CEO attention to an emerging technology 
is associated with the subsequent investment in the development of such technical 
capabilities’. In other words, attention by the CEO is the prerequisite for a CEO to 
consider committing the firm’s resources to the innovation. This means that CEO 
attention to the information available (in the marketplace or in the firm) will impact CEO 
attitude; thereby clearly distinguishing both concepts from each other.   
 
Attention is defined as ‘the noticing, encoding, interpreting and focusing of time and 
effort by organizational decisions makers’ (Ocasio, 1997) and ‘the time and effort that a 
CEO is willing to take to become informed about the potential opportunities that exist 
within and outside of the firm in view of future innovations (Yadav et al, 2007). The CEO 
looks for external and internal innovative ideas and for future opportunities and market-
technology linkages. He/she sets the boundaries of the innovational project/work and 
the direction and the focus. Attention therefore, is a ‘forward-looking’ conception in 
that it collects data and information to bring the company into a next stage of growth. 
The ‘forward looking’ attribute to attention is used by Yadav et al. (2007) to determine 
the relationship between attention to the future and innovational output. If a CEO has 
a positive attitude towards innovation which results in a culture of innovation, and if 
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he/she has given attention to the environment (either internal and external) in order to 
identify opportunities for growth, he/she will need to decide whether the opportunities 
deserve investments. If the CEO argues that this is the case, he/she will become 
committed to the innovative project. 
CEO commitment  
According to Carbonell and Rodriguez (2009), ‘managerial attention to building 
supportive governance systems and infrastructural support is a critical step in enhancing 
innovation speed’. This ‘attentional’ perspective is linked to the ‘supportive’ element of 
innovational activities in the firm. According to Carbonell and Rodriguez (2009), ‘top 
management support refers to the amount of support given by top management to the 
NPD project’. Top management support can be made visible in a variety of ways: ‘by 
acting as an executive sponsor, helping a team to surmount obstacles, providing 
encouragement to a team, maintaining open channels of communication with people 
involved in NPD, streamlining decision-making processes, and providing adequate 
capital and human resource’ (Gupta and Wilemon, 1990; Smith and Reinertsen, 1992; 
cited by Carbonell and Rodriguez (2009) and ‘by and large, existing research indicates 
that top management support plays a positive role in accelerating innovation speed’ 
(Mabert et al., 1992; Emmanuelides, 1993; Kessler and Chakrabarti, 1996; cited by 
Carbonell and Rodriguez (2009).  
 
The literature refers to a firm’s commitment to innovation by referring to the level of 
R&D spending as a measure of the firm’s commitment (Daellenbach et al., 1999). On the 
other hand, ‘commitment’ is also used to refer to leaders with ‘vision, enthusiasm, 
future oriented external opportunities for inward investment and information 
gathering’ (Laforet and Tann, 2006). The complex and long-range nature of technological 
innovation makes commitment particularly important to the R&D organization (Starling, 
1991). Empirical research distinguishes between two dimensions of top management 
commitment:  the (financial) support by top management and its positive attitude 
towards risk (Sanzo et al., 2012). According to Llorens et al. commitment means that top 
management fully supports innovation activities (Llorens et al., 2004: cited by Sanzo et 
al., 2012) by making available appropriate funds and resources for each innovation 
project (Cooper and Edgett, 2004; Swink, 2000; cited by Sanzo et al., 2012) and by 
accepting the risky nature of innovation projects (Menon et al., 1997;  cited by Sanzo et 
al., 2012).  The attitude towards risk – as discussed in the previous section therefore is 
linked to the concept of commitment. Top management that shows an unfavorable 
attitude towards risk, will not be inclined to offer valuable and scarce firm resources to 
innovation.  
 
The NPD literature shows the key role of top management in new product success 
(Cooper and Edgett, 2994; Gupta and Willemon, 1990; Swink, 2000; cited by Sanzo et 
al., 2012). Performance of an NPD-strategy and of the elements that constitute this NPD 
strategy, such as customization, new product introduction, design innovation, product 
development cycle time, product technological innovation, product improvement, new 
product development, and original product development, are linked to the importance 
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assigned to that activity by the CEO. The relationship between a firm's performance on 
a specific NPD activity and the importance assigned to that activity by the firm's CEO 
drives the NPD strategy.  The vision and focus on these NPD activities start with the 
recognition by the CEO of their strategic value and with the assignment of appropriate 
staff and technical resources to the performance of these activities, i.e. with the 
commitment of resources to each of them (Calantone et al., 1995). These activities 
ensure that the organization is sufficiently flexible to accept the changes in 
responsibilities for coordination and leadership that are necessary during different 
stages of the NPD process.  In contrast with ‘CEO attitude’ which is a general positional 
stance towards innovation and with ‘CEO attention’ which is an ‘explorative’ concept in 
that the CEO looks for opportunities, CEO commitment takes the role of the CEO a step 
further in that he/she now is committing to the innovation by making available 
resources, either human or financial – for the innovation to take place.  The impact of 
the support from top management (the full team as opposed to the CEO alone) on the 
speed of innovation had a more positive effect on innovation speed under conditions of 
high-technology novelty and high technological turbulence (Carbonell and Rodríguez-
Escudero, 2009).  
 
Lack of top management commitment seems to require effective cross-functional 
communication flows for New Product Development (NPD). Projects that received top 
management support were less likely to be terminated but did not necessarily develop 
in profit-makers for the company, suggesting that the choice of projects by top 
management is not effective (Green, 1995). In NPD, greater top management support 
was associated with better time-based performance of NPD projects; however, data 
suggest that higher levels of top management support in NPD were ineffective in 
securing good financial performance in high-technology environments (Swink, 2000).  
According to Green (Green, 1995), ‘top management is enjoined to look at the needs 
and capabilities of the firm, the resource commitments represented by lines of research, 
and the commercial potential of projects and choose where to place their limited time 
and resources’.  
Commitment therefore is ‘the act of committing, or putting in charge, to entrust, to bind 
to a certain line of conduct’ (Thatcher and McQueen, 1980). Commitment in the context 
of innovation can therefore be defined as: ‘the willingness by the CEO to make human 
and financial resources available to conduct innovative projects in the firm, to develop 
processes that foster R&D output and to allow operational freedom in R&D in order for 
it to achieve its goals and to create incentives and reward’s.  Commitment therefore is 
a “facilitating” conception, in that it creates the specific circumstances for R&D to 
flourish, either by financial means, human resources, facilities, equipment etc.   
CEO involvement  
According to Elenkov et al. (2005), ‘both theoretical discussions and empirical 
investigations have indicated that organizational acceptance and promotion of 
innovation require top management support and involvement (e.g., Drucker, 1985;   and 
Hitt, 1999; Jassawalla and Sashittal, 2000; cited by Elenkov et al., 2005). The act of 
involvement is ‘to connect by way of natural result or consequence, to blend’ (Thatcher 
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and McQueen, 1980). This ‘blending’ is at the core of the concept of CEO involvement 
and presents the CEO as a participant in the innovative activities of the firm. It requires 
the CEO to take a step beyond the level of attitude ( a positive stance towards innovation 
in general), attention (the collecting of information from internal and external sources 
to feed innovation) and commitment (the willingness to make available resources to 
innovation), as these roles may be played ‘outside’ of the innovation project, while the 
role of a CEO who becomes involved in innovation requires the blending of the CEO with 
the innovational activities, projects, discussions and understandings of the project and 
knowledge of the underlying technologies.  According to Swink (2000), ‘top managers 
should draw a note of caution regarding their close involvement in high technologically 
innovative development efforts’ as the results of this and other studies ‘suggest that top 
managers may sometimes do more harm than good’ and they ‘rarely influence 
product/market innovations directly because their involvement may be 
counterproductive if perceived as ‘micro-management’ (Elenkov and Manev, 2005). 
 
On the one hand, it has been shown that there is relatively rare involvement of top 
management in specific projects (Markham et al., 1991; cited by Green, 1995), but on 
the other hand, in small, high-growth (packaging) design firms, CEOs were deeply 
involved in design decisions (Dickson et al., 1995).  Although it is not clear whether this 
involvement leads to more successful products, the majority of the firms studied by 
Dickson et al. consider the involvement of their CEOs to be important and the CEOs 
argue that the knowledge base of their managers should be considerable, thereby 
linking involvement in a (design) project with the knowledge of the features of a design 
project. The CEOs' involvement in product/service design seems to be a significant 
predictor of investment in product/ service but it is not a significant predictor of the 
level of sales revenues generated by new products. The absence of such a relationship 
indicates that CEO involvement alone was not enough to guarantee financial success in 
new product development (Dickson et al., 1995). In the case of intranet adoption, CEO 
involvement appeared to be the only factor to have a significant impact (Al-Qirim, 
2007b). Laforet and Tann observed that in more innovative companies the CEO was 
found to be much more involved in developing new products and ways of working than 
in less innovative companies. Such involvement was defined as ‘innovation leadership’. 
In 75 percent of the cases of the more innovative companies, the CEO came across as 
the project-champion and was observed to evaluate new ideas for products, whereas 
the NPD team evaluated innovation processes.  
 
In contrast with ‘CEO commitment’, a role concept that allows the CEO to invest in 
innovation by making available human and financial resources, the role 
conceptualization of ‘CEO involvement’ takes the CEO to the next level of engagement 
in innovation, i.e. by becoming part of the innovation project through the interaction 
with the innovators and discussing the innovation project. This requires an increased 
level of knowledge into the area that is subject of innovation, as was shown in the field 
of information technology (Bang et al., 2006): CEO involvement seems to be the key 
factor in the adoption of e-business by SMEs in Korea.  
 
 
 
Appendix D 
232 
 
Green (1995) found evidence that top management is an active player in individual R&D 
projects. However, such involvement of top management ‘may cross the line between 
support and become meddling, however, where they begin to micro-manage projects’. 
In Green’s study, ‘behaviors that might be seen as more meddling in character, i.e., 
exerting influence over project level decisions and monitoring project performance, 
were seen by R&D personnel as part of a larger support construct that included 
behaviors where top management took a role in informing and supporting the project. 
This finding suggests that even though top management might increase their control 
over the project that control was not seen as autocratic or meddling’. Thus, Green 
concludes: ‘at least, it appears that when top management chose to be involved at the 
project level they were seen as adopting a shepherding posture in managing 
innovations’. There is no evidence in this study, however, that top management’s 
involvement in specific R&D projects, resulted in picking ‘winners’ (Green, 1995). 
According to Papadakis and Bourantas (1998), in incremental product innovation the 
role of the CEO appears to be insignificant. Results suggest that technological innovation 
of this nature is accommodated within the existing departmental decision-making 
mechanisms, with minimal involvement of the CEO. Here, our data suggest that the main 
influence emerges from outside consultants and from changes in the external 
environment.   
 
Involvement in the context of innovation is ‘the engagement of the CEO to take part in 
the discussions and idea generation of new opportunities in R&D and which requires 
prior in depth knowledge about the R&D innovational project‘. Involvement is a 
‘knowledge’ conception as it requires prior expertise in the field of R&D in which the 
firm is engaged.  
CEO innovativeness  
The term ‘innovativeness’ appears in a number of papers discussing the role of the CEO 
in innovation. It is frequently used to describe the innovative character of an 
organization (‘firm innovativeness’ or ‘corporate innovativeness’) but it is rarely used to 
describe the innovative behavior of a CEO. Thong and Yap and Al-Qirim use the term 
CEO innovativeness (Thong  and Yap, 1995; Al Qirim, 2007). Thong and Yap define CEO 
innovativeness as the characteristic of a CEO who is ‘an entrepreneur figure who is 
crucial in determining the innovative attitude of a small business’. They add: ‘This is 
because the CEO's qualities are the determinants of the overall management style of 
the business. In fact, the rate at which a small business changes depends not only on 
factors like business size or market forces, but also on the abilities and inclinations of 
the CEO and the extent to which he is able or prepared to devolve management. It is the 
role adopted by the CEO that determines the innovativeness of the business’. Thong and 
Yap illustrate CEO innovativeness as a CEO who has original ideas, would sooner create 
something new than improve something existing and who often risk doing things 
differently. In addition, they specifically distinguish between ‘CEO attitude’, ‘CEO 
knowledge’ and ‘CEO innovativeness’.  According to Thong and Yap,  Kirton (1984) 
contended that ‘everyone is located on a continuum ranging from an ability to do things 
better to an ability to do things differently … and … called the two extreme ends of the 
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continuum adaptors and innovators respectively. The adaptor CEO would seek solutions 
that have already been tried and understood. The innovator CEO would prefer solutions 
that change the structure in which the problem is embedded - in other words, solutions 
that have not been tried out and are therefore risky’. 
 
In looking for reasons for slowness in adopting technological innovations in small and 
medium-sized enterprises, researchers looked, among organizational, technological and 
environmental factors, for the impact of entrepreneurial factors defined as CEO 
innovativeness and involvement (Al-Qirim, 2007b; Al-Qirim, 2007a). The data suggest 
that CEO innovativeness was the only significant factor in the adoption of technological 
innovations. This observation shows the importance of an innovative CEO as far as the 
adoption of innovations is concerned. As a result of the central role of the CEOs in SMEs 
and the impact of their innovativeness, it became clear that they were responsible for 
the introduction of new technology into their firms. In line with Thong and Yap (1995), 
CEO innovativeness is the characteristic of a CEO that ‘makes him or her an 
entrepreneurial innovator in his/her own right, drives the product development 
program personally, takes control of the development detail and is trying to 
transform/disrupt the market with new products’. Innovativeness therefore is an 
‘entrepreneurial’ conception, characterized by risk taking, perseverance and flexibility 
(Kitchell, 1997)’. 
 
Overview of papers in which CEO role conceptualizations are used. The table below lists 
the research papers in which conceptualizations of the role of the CEO in innovation 
were used. These concepts are attitude (CEO attitude or ‘CEO ATI’), attention (CEO 
attention or ‘CEO ATT’), commitment (CEO commitment or ‘CEO COM’), involvement 
(CEO involvement of ‘CEO INV’) and innovativeness (CEO innovativeness or ‘CEO INN’). 
Not all papers address the concept of attitude with the same focus and depth. The 
impact of CEO attitude in public organizations for example was explored in detail by 
Damanpour and Schneider (2006) and weighed against environmental factors while 
others refer to attitude as an important factor in driving innovation without exploring 
the impact of the concept. Yadav et al. (2007) researched the attention given by the CEO 
to opportunities in the internal and external environment to investigate its impact on 
innovational output. Other authors such as Thong and Yap (1995) have used CEO 
attitude as well as CEO innovativeness, while Al-Qirim (2007) use CEO involvement and 
CEO innovativeness as independent variables in their research. Still other authors make 
reference to these concepts while not using them in their research project but 
emphasize their importance. Those papers that address the concept as the main topic 
in their research are identified by a ‘+’ in the shaded cell in the table. For example, 
attitude of the CEO was specifically addressed by Damanpour and Schneider (2006), by 
Papadakis and Bourantas (1998) and by Thong and Yap (1995). Other papers that 
address attitude of the CEO towards innovation but do not research the concept, are 
only indicated by a ‘+’ in the table cell. The table also presents the number of papers 
addressing the concept and the papers that only mention the concept (2 bottom rows).   
 
Paper CEO CEO CEO CEO CEO 
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ATI ATT COM INV INN 
Ettlie, J. E. (1990) - - - - + 
Bang, N. J., Kyeong, S. H. and Myung, J. L. (2006) + - - + + 
Al-Qirim, N. (2007) - - - + + 
Dickson, P., Schneier, W., Lawrence, P. and Hytry, R. (1995)  - - - + - 
Laforet, S. and Tan, J. (2006) - - + + - 
Simsek, Z. (2007)  - - (1) - - 
Datta, D. K. and Guthrie, J. P. (1994) + - - - - 
Calantone, R. J., Vickery, S. K. and Dröge, C. (1995) - + + - - 
Green, S. G. (1995)  - - + + - 
Kitchell, S. (1997) + - - - - 
Young, G. J., Charns, M. P. and Shortell, S. M. (2001) + - (1)   
Carbonell, P. and Rodríguez-Escudero, A. (2009) - + + - - 
Thong, J. Y. L. and Yap, C. S. (1995)  + - - - + 
Tyler, B. B. and Steensma, H. K. S. (1998)  + + + - - 
Daellenbach, U. S., McCarthy, A. M. and Schoenecker, T. S. (1999) - - + - - 
Damanpour, F. and Schneider, M. (2006) + - + - - 
Lefebvre, L. A., Mason, R. and Lefebvre, E. (1997) + - + - - 
Papadakis, V. and Bourantas, D. (1998) + - - + - 
Lynskey, M. J. (2004) - - - - - 
Yadav, M. S., Prabhu, J. C. and Chandy, R. K. (2007) - + - - - 
Berson, Y., Oreg, S. and Dvir, T. (2008) - + - - - 
Lefebvre, E. and Lefebvre, L. A. (1992) + - - - - 
Elenkov, D. S., Judge, W. and Wright, P. (2005)  - - - - - 
Elenkov, D. S. and Manev, I. M. (2005) - - - + - 
Swink, M. (2000) - - + + - 
Wu, S., Levitas, E. and Priem, R. I. (2005) - - - - - 
DeTienne, D. R. and Koberg, C. S. (2002) + - - - - 
Eggers, J. and Kaplan, S. (2009) - + - - - 
Makri, M. and Scandura, T. A. (2010)  + - - - - 
Number of papers addressing the concept: 12 9 8 11 4 
Number of papers studying the concept (shaded) 3     
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Appendix E. Procedure for the interviews of the CEOs  
Seen the difficulty of approaching CEOs and obtaining their agreement to engage into 
academic research, it was decided to select the first two CEOs who agreed to collaborate 
as pilot cases. By coincidence, the CEOs had very different backgrounds. One of them 
had a long international career as CEO of life science R&D firms and was medically 
trained. The other one had a long career in business/finance and became CEO only 
recently. The reason why this is mentioned at this stage of our exploration is that in the 
literature, the CEO’s educational and experiential background is used to explain the 
impact of the role of the CEOs on innovation. The following sections present the 
approaches followed, the findings, a discussion of the findings and a conclusion with 
respect to the findings and the interview methods. Finally, a comparative analysis is 
presented. 
The first pilot case was conducted by means of an open, conversation-like interview with 
the objective to obtain a “feel” for the interview of a CEO and to gauge whether this 
approach would lead to interesting data on the role of the CEO in innovation and could 
be used for additional (final) exploratory work. An open-ended interview is based upon 
psycho-analytical theory, the content of which is free and non-directive and proceeds in 
an open manner constantly under the ‘evenly-hovering’ attention of the interviewer 
(Kvale and Brinkman, 2009). The question that opened the conversation was as follows: 
‘Have you ever, in your previous years, had the need to reflect 
upon your role as a CEO in research and development or 
innovation in general?’ 
Starting from this question the interview proceeded without a specific direction to 
address an a priori concept but rather to obtain a good understanding of what the CEO 
considered to be his role in innovation in a life science R&D firm. The questions and 
answers were transcribed and checked for completeness. As it was possible to obtain 
interest from 15 CEOs of small-medium sized life science R&D firms, it was decided to 
initiate our research project with 2 pilot studies to obtain a ‘feel’ for these ‘elite-
interviews’. Therefore, the research project is divided into two subprojects: a pilot 
research project and a final research project. The following section presents the pilot 
research and includes the conclusions as well from a content point of view as from a 
methodological pint of view.  Based upon the pilot research data and the selected 
methodology, we then discuss whether we can take this approach forward into the final 
research interviews.  
According to Pettigrew ( 1990), ‘given the limited number of cases which can actually be 
studied, it makes sense to choose cases such as extreme situations and polar types in 
which the process of interest is ‘transparently observable’’.  Or, with Eisenhardt (1989): 
‘while the cases may be chosen randomly, random selection is neither necessary , nor 
even preferable’. In view of the comments made above with respect to the high degree 
of variation of innovational settings under which the role of the CEO was explored, and 
the potentially ‘over-generalized’ conclusions which were reached, the selection of 
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cases to conduct the research becomes particularly sensitive and important. Therefore, 
the basis upon which the cases were selected for this research need to be clearly put 
forward. The following inclusion criteria were used: 
 
Inclusion criteria: 
 
- The cases should be firms involved in life science R&D because it is important, as 
a researcher, to have knowledge and understanding of a specific innovational 
environment. As stated by Stebbins: “Field based research requires the 
researcher to have the right understanding of the environment in order to be 
able to ask the right questions” (Stebbins, 2001). It is hardly possible to try to 
understand the role of the CEO in a given industry – let alone in a group of 
different industrial environments – without an understanding of the nature of 
that industry and the challenges it faces.  
- The firms should have a clear internalized R&D function headed by a director/VP 
R&D or a CSO. This is an important criterion, because in firms that conduct R&D 
and which are headed by CEOs who act as CSOs (which is often found in micro 
R&D firms and start-ups) the question about the role of the CEO is obsolete as 
he/she is taking up the role of innovator him/herself. Therefore, the decision was 
taken to explore the role of the CEO in innovation in an environment where the 
CEO has the discretion not to play that role.  
- The selected firms have to be small and medium sized, in line with the EMA 
definition of SMEs. Their total workforce should be between 10 and 50 (small) 
and between 50 and 250 (medium). In these companies the role of the CEO may 
be more pronounced and better observable than in major corporations (Miller 
and Toulouse, 1986).  The definition of SMEs is given by the European 
Commission Recommendation 2003/361/EC as follows:  
o The category of micro, small and medium-sized enterprises (SMEs) is 
made up of enterprises which employ fewer than 250 persons and which 
have an annual turnover not exceeding EUR 50 million, and/or an annual 
balance sheet total not exceeding EUR 43 million. 
o Within the SME category, a small enterprise is defined as an enterprise 
which employs fewer than 50 persons and whose annual turnover and/or 
annual balance sheet total does not exceed EUR 10 million. 
- Cases were selected whereby the educational backgrounds of the CEOs differ. 
Companies should be led by CEOs with a science/medicines background or by 
CEOs with a strong finance/investor background, thereby maximizing differences 
between CEOs while maximizing similarities between firms. This case 
differentiation may lead to the observation that a priori conceptual roles 
identified in the literature occur in some firms while not appearing in others 
because CEOs with a scientific/medical background approach R&D through a 
different conceptual role. 
 
The following exclusion criteria are used:  
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- the selected cases (firms) are such that the innovation is generated by internal 
research and development only. This criterion excludes firms that innovate by 
acquiring other (more innovational) firms and therefore exclude major 
pharmaceutical companies and hence the big-pharma firms 
- Micro enterprise -  defined as an enterprise which employs fewer than 10 
persons and whose annual turnover and/or annual balance sheet total does not 
exceed EUR 2 million – are also excluded 
 
In order to select companies for our research, three databases were consulted : 
 
- the MEDTRACK database: a worldwide database which allows the selection and 
description of companies in the life science industry 
- the European Medicines Agency (EMA) database for the selection of life science 
based R&D SMEs in Europe 
- the FlandersBio database for the selection of Flemish life science based R&D 
SMEs  
 
The DATAMED database was consulted by means of the following search procedure: 
 
Step Action Comment 
1 Select industry hub The industry selected was the life science R&D based family of 
companies 
2 Select companies with a clear 
therapeutic category: “cancer 
drug R&D” 
This subset was selected as there are many companies actually looking 
into the discovery and development of new drugs for the treatment of 
cancer (most life science R&D firms are engaged in cancer research as 
this is a potentially highly profitable market and because there are many 
different types of cancers each of them requiring different therapeutic 
approaches. 
3 Select non-US public companies 
operating in Europe 
In order for the research to proceed at a cost efficient level and to 
reduce costs of travel, companies were selected that have their HQ and 
laboratories located in the European continent 
4 Download the excel sheet with 
the list of companies and their 
administrative data 
By administrative data is meant: address, city, state, phone, website, 
contact and title 
5 Select countries by means of the 
country filter 
Country selection: Belgium, France, Switzerland, The Netherlands, UK, 
Denmark, Sweden, Norway, Austria, Finland, Ireland, Italy and Spain 
7 Remove “Big Pharma” Big Pharma was removed from our research (see exclusion criteria) 
8 End result R&D firms 
9 Screen companies for: R&D spending, sales data, employees, R&D spending per employee 
and R&D comparison with industry average 
10 Download selected companies 
and print out overview 
This excel sheet forms the basis for further manual selection of 
companies based upon number of employees 
11 Remove all companies with less 
than 50 employees and more 
than 250 employees 
A SME is a firm with more than 50 and less than 250 employees 
(definition of SME by the European Medicines Agency)  
12 Select from the list of companies 
those companies with a clearly 
defined CSO position 
See inclusion criteria 
13 End result: 20 SMEs involved in cancer drug R&D 
 
If the MEDTRACK database was searched for non-cancer drug R&D companies, an 
additional three companies could be selected and they were added to the list of 
companies selected through the steps identified in the table above. The total number of 
companies selected through the MEDTRACK database is 20. Using the EMA research 
database a further attempt for company selection was carried out using the search 
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functionality of the EMA website (ww.ema.org). This did not result in additional 
companies. Using the FlandersBio database a search procedure was carried out using 
the search functionality of the Flanders Bio website (ww.flandersbio.org). This resulted 
in 5 new life science R&D companies that were approached. Additional life science R&D 
companies were approached through the existing CEO network in Flanders (Hertz and 
Imber, 1995). This resulted in an additional life science R&D company to join the 
program. The companies were first approached by means of an email message 
explaining the reason for the research project and how the outcome may prove useful 
for the CEO’s management and the firm’s innovative output.  This was later followed-up 
with a phone-call to the CEO’s secretary asking for a short introductory talk with the 
CEO. Most emails were not replied to but were then followed-up with a reminder email. 
One approach that proved useful was asking a CEO who had agreed to collaborate in the 
project to identify other CEOs, an approach which was also supported and proven useful 
by Hertz and Imber who studied elites (Hertz and Imber, 1995). Finally, 15 CEOs agreed 
to join the research project. The CEOs are listed in the table below. 
 
Company Company 
size 
CEO  
age  
(yrs) 
CEO 
gender 
CEO nr Country Date interview 
T SME >50 Male CEO1 P Belgium February 17, 2012 
A2 SME >50 Male CEO2 P UK February 23, 2012 
C SME >50 Male CEO1 Belgium March 8, 2012 
A1  SME >50 Male CEO2 Belgium March 14, 2012 
B SME 40-50 Male CEO3 Belgium March 21, 2012 
T SME 40-50 Male CEO4 Spain March 27, 2012 
A3  SME 40-50 Male CEO5 Switzerland April 12, 2012 
A4 SME 40-50 Male CEO6 Netherlands April 20, 2012 
C SME >50 Male CEO7 Belgium April 23, 2012 
R SME 40-50 Male CEO8 Belgium April 24, 2012 
S  SME 40-50 Male CEO9 Netherlands May 4, 2012 
O SME >50 Male CEO10 France April 23, 2012 
J  Big pharma >50 Male CEO11 Belgium October 4, 2012 
G  Big pharma 40-50 Male CEO12 Germany July 12, 2012 
O SME 40-50 Male CEO13 Belgium November 26, 2012 
A5 SME 40-50 Male CEO14 Belgium November 27, 2012 
P SME 30-40 Female CEO15 Belgium November 7, 2012 
 
Preparing for the interview 
In order to prepare for the interviews, a thorough understanding of the scholarly subject 
is required as well as the background knowledge of the fields and careers of the 
interviewees (Kvale and Brinkman, 2009). This is important for two reasons: it illustrates 
to the interviewee that the interviewer has a sincere interest in the management of 
these firms by showing knowledge about the previous experience accumulated by the 
CEO and the history of the firm. The information of the CEO is available through the 
company’s website and therefore is an interesting source to become familiarized with 
the educational and experiential background of the CEO.  In addition, before each visit, 
the annual reports of the companies (if available) were analyzed to understand the R&D 
pipeline and its successes and failures.    
 
 
 
Operational procedure 
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According to Yin (Yin, 2009), ‘this process of data collection (i.e. the case study approach) 
leads to the need to have explicit and well-planned field procedures’. The procedural 
approach for conducting this qualitative research is as follows. 
 
Step Action 
1 After having obtained the agreement of the CEO to engage in this research project, send a “thank you” 
letter (see Appendix) 
2 Arrange with the CEO’s secretary to find an appropriate date for a interview meeting within a three months 
time frame (agree for approx. 1,5 hr meeting time) 
3 Once a date is set, send a letter to the secretary with a detailed modus operandi for the meeting and the 
broader context under which the meeting will take place. More specifically, include in the letter: 
- Confirmation of the day and time 
- The fact that: 
o the interview will be recorded and transcribed 
o all data will be anonymized 
o a copy of the anonymized transcript will be returned 
o the results of the qualitative study will be made available to all CEOs 
4 Three days before the interview, check the recording equipment, assure sufficient power,  make yourself 
fully accustomed to the use. 
5 The day of the interview: collect all materials: paper/pencil,  recording equipment, an example of the 
literature review as a gift to the CEO. 
6 Upon entering the executive office, offer the secretary a sincere thank you for the arrangement of the 
interview 
7 Before the interview: 
- ask the CEO for agreement of the recording, stressing anonymity. 
- Explain how the interview fits into the research project and explain the next steps: 
o Treatment of the interview data 
o The goal of the data to develop working hypotheses 
o The involvement of the R&D function 
- Stress the fact that this research will help the firm to become more effective in R&D by 
informing the CEO about the needs of the R&D function from a CEO point of view to improve 
their output 
- Send a package to the CEO informing him/her about the approach that will be taken 
8 Conduct the interview 
9 After the interview, ask the CEO to appoint an individual (HR or COO or CSO or another individual 
appointed by the CEO) to continue the next research project in the R&D group 
10 Two days after the interview, send: 
- a ‘thank you” letter to the CEO confirming that we appreciate that we can continue our research 
together with his/her R&D team stressing that we will offer feedback on the data and inform 
him/her of further developments 
- a ‘thank you“-email to the secretary informing her about the outcome of the interview 
11 Conduct template analysis 
 
IRB approval and informed consent 
The study was approved under the Cranfield’s School of Management ethical approval 
procedure. All CEOs agreed to sign an informed consent form, formally stating the 
volunteerism in participating in the study. 
 
Interview recording, transcription and transcription checks  
The interviews are recorded (Olympus LS11) and subsequently transcribed and 
submitted to template analysis. Each interview was transcribed immediately after each 
interview and was checked carefully for a correct transcription. This was repeated 
several times until it was assured that each sentence, phrase or question was 
transcribed correctly. A final check consisted of going through the tape while reading 
the text and the transcription was considered finalized only if there was full 
synchronization between the spoken words, phrases and questions and the 
transcription. In general this took 3 to 4 times until the transcription was finalized.    
Triangulation 
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According to Patton, there are different triangulation approaches (Patton, 2002): 
triangulation of data (data triangulation), among different evaluators (evaluator 
triangulation), of perspectives to the same data set (theory triangulation) and of 
methods (methodological triangulation). Stebbins argues, taking the explorer’s point of 
view, that ‘both qualitative and quantitative data may be gathered during exploration’. 
In other words, although in most exploratory studies, qualitative data predominate, they 
are augmented where possible and desirable with such descriptive statistics as indexes, 
percentages and frequency distributions’ (Stebbins, 2001, p6) and from a viewpoint of 
the validity of exploratory research results: ‘exploration validity is…resolved… by using 
different methods to examine the same group or activity (known as triangulation), 
asking key informants to comment on the familiarity and reasonableness of 
observations, and finding recurrent evidence for each generalization’ (Stebbins, 2001, 
p26). The provision of multiple evidence or triangulation will be increasingly important, 
the more critical the assertions that will be made (Partington, 2003, p. 125). In our case, 
triangulation would include the collection of documentary evidence such as meeting 
minutes, agendas, personal notes and comments and other data besides the interview. 
However, at the start of the interview it was not clear whether the CEOs who already 
agreed to accept an interview and a subsequent survey in their R&D units (and by 
accepting this have shown their willingness to commit themselves and their firms to this 
research project ), would also accept the collection of documentary evidence such as 
personal agendas, meeting minutes etc. It was decided not to jeopardize the 
recruitment of the CEOs by asking them to make their agendas and meeting minutes 
available on top of their commitment and run the risk of having them refrain from 
participation because of an inappropriate request (at least from their point of view). As 
is known, CEOs are considerably difficult to recruit for this type of research (Yadav et al., 
2007). It was therefore decided to let the decision to ask for these documentary data 
depend on the personal interaction that developed during the interview. The 
conclusions of each transcript were shared with the interviewed CEOs to assess the 
correctness of the interpretation because exploratory researchers should increase the 
validity of their research by discussing the generalizations with the people they are 
investigating to determine if these ideas ‘have a familiar ring’. In other words, that they 
are considered plausible in the eyes of the respondents (Stebbin, 2001, p48). 
 
Categories  and text analysis 
According to Kvale and Brinkman ‘categorization is a form of coding whereby the 
meaning of long interviews is reduced to a few simple categories. The categories can be 
developed in advance or they can arise ad hoc during the analysis; they may be taken 
from theory, or from the vernacular, as well as from the interviewee’s own idioms’ 
(Kvale and Brinkmann, 2009, p203). In addition, categorization can provide an overview 
of large amounts of transcripts and facilitate comparison and hypothesis testing.  In this 
research project, categorization is performed through the use of concepts which were 
retrieved from the literature. These concepts form the basis upon which interviews were 
analyzed. Each interview is transcribed and analyzed by means of NVivo software 
whereby statements, opinions, arguments (I.e. “quotes”) made by the CEO are assigned 
to these concepts thereby allowing categorization to take place. The a priori concepts 
are defined as primary nodes in the NVivo software. To each primary node, a number of 
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secondary nodes was assigned. These secondary nodes act as a starting point for the 
NVivo analysis. An overview of the primary/secondary node (PSN) structure which was 
introduced in NVivo before the start of the text analysis is presented below. Each 
secondary note is codified by means of a code (ATT1, ATT2, ATI1 .... INN3)  for future 
data retrieval and analysis. Statements, opinions and arguments which were raised by 
the CEOs during the interviews (i.e. the “quotes” made by the CEO) were assigned to a 
specific primary or secondary node. For example, the quote “I want to make sure diverse 
ideas are shared” is assigned to the secondary note ATI3 “CEO fosters the exchange of 
ideas”. To the primary/secondary node structure an additional primary node (or 
category) was added which was entitled: “CEO other”. This primary node “CEO other” 
was used to collect quotes that could not be assigned to the primary nodes attitude, 
attention, commitment, involvement and innovator or to any of the secondary nodes. 
These quotes are codified as ‘CEO-OTH1, CEO-OTH2 … CEO-OTHn’ etc and abbreviated 
as ‘OTH1, OTH2... OTHn’. 
 
Data collection: NVivo analysis of the pilot interviews. Using the primary/secondary node 
structure presented below, the transcript of the first pilot interview (TCP1) was 
analyzed. The quotes made by the CEO were assigned to the secondary nodes. As a 
result of the analysis, a new primary/secondary node structure, PSN1 was developed 
that included new categories assigned to the primary node “CEO other”. This new 
primary/secondary node structure PSN1 (that includes the primary/secondary nodes 
linked to the a priori concepts and the new themes assigned to the primary node “CEO 
other”) was subsequently used for the analysis of the second pilot interview transcript 
(TCP2). This transcript analysis leads to a new primary/secondary node structure PSN2. 
A schematic representation of this approach is presented in the figure below. The 
primary/secondary node structure PSN2 was then used to analyze the transcripts of the 
final interview transcripts (TCF1, TCF2 etc.), see below). 
 
 
 
 
TCP2
NVivo
Start of the 
analysis: primary/ 
secondary nodes 
structure PSN 
based upon the 
literature 
PSN2
PSNL TCP1
Analysis of 
TCP1 and 
TCP2: 
transcripts of
pilot 
interviews
NVivo
CEO pilot 1 CEO pilot 2
Primary/secondary nodes structure 
PSN2  that emerged  after analysis of  
2 pilot interviews
 
 
Appendix E 
242 
 
 
 
Data presentation and discussion. After NVivo analysis, the number of quotes obtained 
for each secondary node were added for each category: CEO attitude, CEO attention, 
CEO commitment, CEO involvement, CEO innovation and CEO other roles. For example, 
if the number of quotes obtained for ‘CEO sets the direction in which innovation to take 
place (ATT1)” is 7 and the number of quotes obtained for “CEO sets the 
focus(boundaries) in which innovation to take place (ATT2)” is 4, then the number of 
quotes for ‘CEO attention (ATT)’ is 11. This approach was used for 2 pilot interviews and 
15 final interviews.  
Quoting respondents 
ATTENTION
CEO identifies 
opportunities 
for future  growth
CEO  sets the direction in 
which innovation to take 
place
CEO  sets the focus 
(boundaries) in which 
innovation to take place
ATTITUDE
CEO acknowledges 
the positive effect of 
innovation on growth
CEO fosters a 
culture of 
innovation
CEO  fosters 
experimentation and 
accepts failure
CEO  fosters internal 
communication
CEO  fosters the 
exchange of diverse ideas
CEO  fosters external 
collaboration to increase 
internal innovation
CEO  fosters flexibility and 
adaptibility
CEO  fosters learning in the 
organization
COMMITMENT
CEO commits resources 
to innovation
CEO  hires, selects and develops 
innovative leadership
CEO  creates incentives and 
rewards for the R&D function
CEO prioritizes resources
CEO  makes available human 
and financial reosurces
CEO empowers R&D to 
execute on new ideas
CEO  creates hierarchical, flat 
organizational structures for innovation
INVOLVEMENT
CEO involvement in R&D 
practice
CEO  challenges R&D for efficiency 
CEO challenges R&D technically
CEO  acts as a sounding board
CEO interacts with R&D to solve technical problems
CEO  is involved in NPD
INNOVATOR
CEO acts as the company 
leading innovator
CEO drives new product development in person
CEO  takes control of evey detail of NPD
CEO wants to transform/disrupt the market
A PRIORI CONCEPT (category):
Nvivo parent nodes - Themes
NVivo child nodes: subthemes
ATT1
ATT2
ATI2
ATI3
ATI4
ATI5
ATI6
ATI7
COM1
COM2
COM3
COM4
COM5
COM6
INV1
INV2
INV3
INV4
INV5
INN1
INN2
INN3
Code:
ATI1
CEO holds frequent formalized meetings with R&D INV6
Starting concepts and themes pilot interview 1 
CEO OTHER CEO other To be completed during text analysis
OTH&, 
OTHé, …OTHn
P
C
N
L
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According to Stebbins (2001, p45), ‘interviewee testimonials play only an illustrative role 
in ... exploratory research, it follows that exact quotations of them are by no means 
always necessary in such work. Because, most of the time, the respondents quoted are 
not personally identified, verbatim accuracy is, in reality unimportant. As long as it 
illustrates the generalization and conveys what the respondent meant to say, the 
quotation can, in fact, be a paraphrase of his or her original statement’.  The transcripts 
of the interviews in this study were accurately transcribed in order to catch the reality 
of the situation; the hesitations and sometimes long periods of silence were therefore 
included in the transcript. The reproduction of the quotes in this report are not 
verbatim, but are used to illustrate the message of the CEO without deviating from the 
original statement. 
 
Pilot interview of CEO1 
Pilot interview findings pilot interview CEO1 
The data obtained from the text analysis are presented in a bar chart below. It presents 
the number of times a theme emerges from the interview. New themes also emerged 
from the interview that could not be assigned to any of the major of subthemes. It is 
clear from this graph that CEO attention (ATT) and CEO commitment (COM) are 
frequently mentioned during the interview. CEO attitude (ATI) and CEO involvement 
(INV) are less frequently mentioned, while CEO innovator (INN), the concept that refers 
to the CEO as the leading innovator in the firm, is not mentioned. The individual 
subthemes are also introduced in the chart, together with the new themes that emerged 
from the interview. The table below presents an overview of new themes. 
 
Theme 
(codified) 
Theme 
(statement) 
COM 7 CEO reduces development risk by hiring expert people 
CEO-OTH1 CEO admits limited knowledge in a specific R&D area 
CEO-OTH2 CEO admits not driving innovation but rather the direction 
of innovation 
CEO-OTH3 CEO interacts with R&D only in those matters he/she has 
personal knowledge in 
CEO-OTH4 CEO should not focus on technology 
CEO-OTH5 CEO stresses the importance of strong knowledge in the 
field of innovation 
CEO-OTH6 CEO takes strategic decisions based on simplified data 
CEO-OTH7 CEO wants R&D to step out of academic thinking 
CEO-OTH8 CEO role model is knowledge based 
 
New themes emerging from the first pilot interview 
 
The majority of the statements by the CEO are assignable to the concept of attention 
and more specifically to the theme “CEO sets the direction in which innovation to take 
place” (ATT1) and to the theme of “focus”: “The CEO sets the focus (boundaries) in which 
innovation to take place” (ATT2). The CEO of this firm considers external collaboration 
to be important for innovation to take place (ATI5), the hiring, selection 
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and development of innovative leadership (COM1) as well as the rewarding of top 
scientists (COM2).  Empowerment of the R&D function (COM5) is another important  
innovation driving factor. This CEO attempts to reduce the risk of the firm’s R&D by 
expanding the scientist pool in the company. This is a serious commitment on the part 
of the CEO and it was therefore assigned to the concept of commitment as an additional 
conceptual theme (COM7). Besides the a priori concepts, a number of new roles 
appeared that are either linked to CEO knowledge (OTH1, 3 and 5) and to the fact that 
the CEO stresses that he does not drive innovation but rather direction of the innovation 
(OTH2). The CEO argues that focus should be directed to the market and not to the 
opportunities that the firms’ research may bring to the academic field of expertise 
(OTH7) neither to the available technology (OTH4). Finally, the CEO argues that strategic 
decision making should be a “simple process” (‘it is not rocket science’). 
Discussion pilot interview CEO1 
It became clear that the CEO stressed the importance of the need for a direction in which 
the company needs to develop its R&D projects and on focusing on the selected 
objective: 
 
‘ ...what I do drive is the direction...where I want innovation to 
happen..’  
 
 ‘ I am not driving innovation, I am driving the direction of 
innovation’ 
 
During the interview the CEO stressed repeatedly that his main responsibility is the 
setting of the direction (in this case a specific therapeutic area) and, within this specific 
therapeutic area, to focus on a specific disease condition. It was made clear by the CEO 
that this strategic R&D orientation cannot be made by the R&D function as it lacks an 
important strategic information source which is the link between available R&D 
capabilities in the firm and the market (medical) need. This notion of a “market-R&D 
linkage” is an important parameter that drives his strategy. This strategic decision 
making (direction, focus, orientation) is not about the future of the research or an 
academic objective that can be achieved but about the future of the company, the 
markets it will serve and the medical needs it will meet. There is, according to the CEO, 
a continuous tension between the CEO’s strategy and vision and the R&D function 
whereby the latter should be controlled as not ‘to lose itself’ in academic objectives. The 
R&D function and its leadership should therefore be continuously be pulled into 
alignment with this vision. What is needed according to this CEO is a vision of the future, 
and thereby clearly refers to the literature concept of “attention to the future” as 
proposed by Yadav et al. (2007).  
 
 
 
 
 
Appendix E 
245 
 
 
 
Themes from the first pilot CEO interview 
 
The analysis resulted in the identification of a number of quotes and statements which 
are reflective of the CEO’s commitment to innovation. This is illustrated by his conviction 
that outstanding scientists should be rewarded but that a reward system by means of 
financial incentives alone is not sufficient for the R&D function:  
 
‘How do we reward them? It’s by giving them their freedom” 
It is also illustrated by his commitment to make additional human resources available to 
the R&D function, not only to make R&D successful but also to minimize risk. By making 
available resources for the conduct of innovative R&D projects, risk reduction can be 
achieved though the availability of expertise and functional support in middle-
management (defined by the CEO as the “second row”).   During the interview, the CEO 
did not refer to the capital intensive nature of life science R&D, very likely because he 
considers this as a fact of life in life science R&D firms. The need for effective innovative 
human resources (‘ creative out of the box thinkers’) was considered a top priority.  The 
CEO referred to the fact that he empowers the R&D function and is not willing to control 
it’s activities as long as the direction of innovation is clear. This empowerment of R&D is 
also caused by the fact that the CEO recognizes that his knowledge in the day-to-day 
0 2 4 6 8 10 12 14 16 18
ATI Attitude
ATI1 CEO fosters a culture of innovation
ATI2 CEO fosters experimentation and accepts failures
ATI3 CEO fosters internal communication
ATI4 CEO fosters the exchange of divers ideas
ATI5 CEO fosters external collaboration to increase internal innovation
ATI6 CEO fosters flexibility and adaptibility
ATI7 CEO fosters learning in the organization
ATT Attention
ATT1 CEO sets the direction in which innovation to take place
ATT2 CEO sets the focus and boundaries in which innovation to take place 
COM Commitment
COM1 CEO hires selects and develops innovative leadership
COM2 CEO creates incentives and rewards for the R&D function
COM3 CEO prioritizes resources
COM4 CEO makes available human and financial resources
COM5 CEO empowers R&D to execute on new ideas
COM6 CEO creates hierarchical flat organizational structures for innovation
COM7 CEO reduces development risk by hiring expert people
INV Involvement
INV1 CEO challenges R&D for efficiency
INV2 CEO challenges R&D technically
INV3 CEO acts as sounding board
INV4 CEO interacts with r&D to solve technical problems
INV5 CEO is involved in NPD
INV6 CEO holds frequent formalized meetings with R&D
INN Innovator
INN1 CEO drives new product development in person
INN2 CEO takes control of every detail of NDP
INN3 CEO wants to transform/disrupt the market
OTH Other roles
OTH1 CEO admits limited knowledge in specific R&D area
OTH2 CEO admits not driving innovation but rather the direction of innovation
OTH3 CEO interacts with R&D only in those matters he/she has personal …
OTH4 CEO should not focus on technology
OTH5 CEO stresses the importance of strong knowledge in the field of …
OTH6 CEO takes innovation decisions based on simplified data
OTH7 CEO wants R&D to step out of academic thinking
OTH8 CEO role model is knowledge based
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R&D activities is too limited to direct R&D lab activities or to become engaged in 
technical discussions.  The CEO argues that there is frequent interaction with the R&D 
function but that this interaction is not driven by his expertise in laboratory experiments. 
However, the notion of involvement by the CEO in innovative activities was strong in 
that knowledge was considered an important CEO asset. The CEO referred to his 
innovation-relevant knowledge as bimodal. First, the CEO possesses knowledge 
common to two subgroups in R&D: clinical science and intellectual property. These are 
the two fields of expertise in which the CEO interacts (is capable to interact) with the 
R&D function, ‘because that’s what I understand’.  Beyond this knowledge base of 
clinical science and IP, the CEO’s knowledge base is too limited to interact with and 
contribute to other disciplines in R&D such as laboratory research. In other words, the 
CEO only interacts with those R&D groups that have a knowledge base shared by the 
CEO and is involved in R&D only to the extent that he has knowledge about specific 
topics in R&D.  Therefore, the CEO stated that it is not he who drives innovation but 
rather takes the strategic direction in which to move the R&D function’s activities: 
 ‘ ... and that is why I don’t drive innovation...’  
 
Second, the CEO has expertise knowledge of the market which is needed to make the 
market-R&D linkage and to address medical needs. This knowledge can be defined as 
knowledge about the competitors and their R&D projects. This CEO also referred to the 
‘technology trap’ in that CEOs ‘may fall in love’ with their technology and may risk losing 
track of the market potential that lies outside of the technology track. This is 
corroborated by the CEO’s statement that the scientific activities in the firm should serve 
a market, not academic knowledge. When asked whether he has a role model in this 
regard, he referred to previous CEOs with whom he worked during the earlier periods 
of his career whereby the CEO to whom he reported was - and still is- known by his 
extensive knowledge about the market (need) and the R&D projects running at his own 
and at other firms. This ‘knowledge’ - considered to be an important factor that drives 
the role of the CEO in innovation  - is a strategic knowledge base that allows the CEO to 
take decisions and point to the direction in which innovation needs to be steered. This 
is different from the knowledge which was defined in the literature - specifically in IT 
firms - where the knowledge base is specific knowledge that resides within the R&D 
function (Dickson et al., 1995; Laforet & Tann, 2006; Bang et al. 2006; Thong and Yap, 
1995). The notion of knowledge that links market need to technology is crucial, and he 
clearly showed great respect and even awe for his role-model-CEO who ‘knows’: 
 
‘this guy knows a lot, ... he knows a lot (stresses: “ a lot” ) ... and 
that’s why management at (name of the firm) knows a lot, 
because it’s embarrassing your chairman knows more than 
you..., ... he knows, he does know... I recently spoke to him .... 
and the guy knows, he knows the projects ... we talked on one 
of our projects .. he knew... I think is very important in life 
sciences in my opinion...” 
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This notion of knowledge is not simple market know how (which the CEO stated you can 
‘simply buy’) but knowledge that links both the internal know-how and R&D to meet 
medical needs.  
 
Although attitude towards innovation can have very different themes ranging from the 
general concept of creating a culture of innovation to fostering learning in the 
organization, this CEO considers external collaboration to be crucial for two reasons. It 
elevates the internal know how by exposing the firm’s R&D to outside expertise and it 
motivates the R&D function. The CEO stated that innovation cannot be sustained when 
it takes place within the boundaries of the firm: innovation can only be of value when it 
transgresses the firm boundaries and if it promotes collaboration, exchange of know-
how with the outside world and organizational learning. The concepts of 
experimentation and failure acceptance, flexibility and adaptability, and exchange of 
ideas did not emerge during the conversation. This may be explained by the fact that 
the CEO considers these attitudes to be obvious in life science R&D firms that it is not 
worthwhile to draw attention to them. This may explain why the concept of attitude 
does not surface during the conversation. Any indication of entrepreneurial 
innovativeness with this CEO was not identified in this case.  The CEO did not indicate 
that he is the (sole) driver of innovation in the firm, is developing products that will 
transform or disrupt the market or is taking control of every detail of the new product 
development. 
 
There are a number of themes that appeared during this interview and which are 
considered “new” because they do not fit into any of the a priori concepts. Some of 
them have been discussed above such as the technology trap, the limited knowledge of 
all aspects of and interaction with R&D, the fact that he does not drive innovation but 
the direction of innovation and the topic of personal scientific and market knowledge. 
The CEO argues that strategic decision making should be simple (OTH6) in that the link 
between the available internal R&D know-how and the medical (market) need should 
not be considered “rocket science” and that “you do not need a lot of research 
documents to make a decision”. This infers that the CEO takes strategic decisions based 
upon a number of simple and clear R&D arguments and links these to medical need upon 
advice from outside parties. 
Interview observations pilot interview CEO1 
The following preliminary observations can be drawn from this first pilot study: 
 
- the CEO’s knowledge about the innovation in his firm is situated in specific areas 
and it is only in these areas that the CEO interacts with R&D and engages in 
technical discussions 
- in the other areas of R&D where the CEO has only limited or no knowledge, he 
interacts with R&D but does not engage in technical discussions  
- the CEO’s knowledge consists of a thorough understanding of the linkage 
between R&D capabilities and the market/medical need, 
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- the CEO takes strategic decisions which are reduced to the essentials so that it 
does not become a ‘rocket science’ .  
- the CEO takes a healthy distance from available technologies in the firm to avoid 
become entangled in its promises rather than in its applicability  
- the CEO minimizes project risk by extending the number of people associated 
with R&D 
 
Although these observations are preliminary and can hardly be generalized, there are 
interesting to keep in mind for the final interviews. At this stage of our research it is 
important to evaluate whether the methodological approach that was taken, is 
acceptable for future interviews. This is discussed in the following section. 
Criticism on the interview method pilot interview CEO1 
Although the interview style used during the first pilot interview showed interesting 
conclusions, (which should be treated carefully seen the singularity of this interview), it 
is clear that a potential comparison (or contrasting) of the CEO’s outputs with the output 
of other CEOs would potentially prove to be difficult as the variations in content could 
be high and therefore difficult to include in a comparative study.  There are also other 
concerns with this approach. First, it consisted of open questions that led the CEO to 
enter the field of personal experiences of sometimes irrelevant topics such as the 
description of a personnel issue and the uncomfortable situation that was created. As 
only 60 minutes of interview time is available it is imperative that it is used efficiently 
without reducing the potential richness of the stories told by the CEOs. The question 
should therefore be asked whether the open conversation interview is the most 
appropriate use of the researcher’s and the interviewee’s time. Second, in her study of 
Nobel laureates, Zuckermann (Zuckerman, 1972, referenced in Kvale and Brinkman, 
2001) argue that her background knowledge of the laureates’ fields and careers 
legitimized spending the time for the interview but also required the ‘necessity of her 
being very precise in her questions to this intellectual elite’. She argued that this was an 
important contributing factor in the success of her study. Therefore, the approach that 
was taken in this first pilot interview was reexamined and the open interview was 
redesigned into a focused interview consisting of precise questions. It was therefore 
decided to develop a number of to-the-point questions for the second pilot interview. 
Pilot interview of CEO2 
 
It was observed during the first interview that a conversation-like interview on the role 
of the CEO in innovation was not an approach that could be sustained for our final 
research.  It was therefore decided to develop precise questions as will be discussed. 
Interview questions pilot interview CEO2 
The objective of the interview approach for this second pilot interview is to obtain 
improved control of the proceedings of the interview in order to obtain as much 
information as possible during a 60 minute time period while allowing further 
investigation of the concepts or themes that the CEO develops. As was stated above, in 
the case of elite interviews, the need for precise questioning is important as well as the 
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assurance that the interviewee understands that the interviewer has sufficient 
knowledge on the topic to be able to become a partner in the conversation. In other 
words, by asking precise questions, based upon prior knowledge of the firm, the 
technology and the overall life science R&D context, the interviewed CEO should find 
the interview an intellectually stimulating event. It was assumed that when this 
objective is realized, a stimulating conversation will result that allows rich data to be 
generated.  
Precise questions were developed along four major approaches:  
- a general approach in which the CEO is asked about his personal view on the 
(attributes of) the role and leadership of CEOs in innovation (questions 1 and 2),  
- a specific approach in which it is explored how the CEO is engaged in R&D either 
through investment decisions, interaction (intensity) with R&D and through the 
exploration of the CEO’s view on his/her role versus the role of the chief scientist 
(question 3 to 11) and on  
- the attributes of an “ideal” CEO in innovation (question 12). 
The following 12 questions were developed. 
1. A question addressing the CEO’s personal vision on the role of the CEO in 
innovation: 
What do you think are the attributes of the role of a CEO in a life science R&D 
firm?  
 
2. A question on what the CEO considers important leadership characteristics in 
innovation: 
What are in your opinion the major leadership characteristics of a CEO in a life 
science R&D firm? 
 
3. A question gauging the commitment of the CEO in innovation: 
What are your driving factors to invest in, make available resources and support 
R&D? 
 
4. A question on the relationship with R&D and the potential knowledge gap: 
How do you bridge the gap between the scientific/ biomedical knowledge in R&D 
and your general management’s knowledge? 
 
5. An open question stressing the role of the CEO vs the role of the CSO: 
How do you describe your role as CEO in R&D vs the role of your CSO? 
 
6. A question on how the CEO may drive innovation personally: 
How do you as a CEO actually increase the output of R&D? 
 
7. A question on involvement of the CEO in R&D discussions: 
How much time and effort do you make available to obtain information from your 
R&D team in percentage? 
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8. A question on involvement of the CEO in R&D discussions: 
How many times per week or month do you interact with R&D? 
 
9. A question to gauge the knowledge base of the CEO in the interaction with the 
R&D function: 
During those interaction, what is the topic of discussion? 
 
10. A question to understand the importance the CEO attaches to multilevel 
exchanges: 
With whom do you interact with R&D? 
 
11. A question about the willingness of the CEO to engage in R&D discussions: 
Are those interactions ad-hoc or formally planned? 
 
12. A question about the role model of the CEO to inquire about the ideal situation 
he/she looks upon as efficient innovation driving: 
Have you seen CEOs who were particularly effective in driving R&D, and why do 
you think they are?  
 
As the interview period is limited to 60 minutes, an average of 2 minutes response time 
per question is available.  However, the interviewer was not limited by this restriction 
and delved into more detail when a topic of interest was addressed. When the CEO 
answered the question, ‘second questions’ (Kvale and Brinkman, 2009) were asked to 
obtain a better understanding of the answer or to request more detail or explanation.  
Findings pilot interview CEO2 
The data obtained from the content analysis are presented in a chart below. On the one 
hand, it was found that the CEO rarely refers to the theme of ‘attitude’, such as fostering 
a culture of innovation as only 3 quotes in the transcript referred to the theme of 
attitude. On the other hand, 7 quotes referred to CEO attention, 8 to CEO commitment, 
none to CEO involvement and CEO innovator. However, 21 themes emerged from the 
interview that could not be assigned to any of the previous themes and were therefore 
coded as ‘OTHx’ in the chart below. It is clear from this chart that CEO attention and CEO 
commitment are recurring items during the discussion. CEO involvement in R&D practice 
describing the actual interaction between CEO and the R&D function is absent. The 
theme of ‘CEO innovator’ is not mentioned.  Some of the 8 themes that emerged during 
the first interview were also identified in this interview (i.e. CEO-OTH1, CEO-OTH2, CEO-
OTH4, CEO-OTH6 and CEO-OTH7) together with a set of new themes identified as CEO-
OTH9, CEO-OTH10, CEO-OTH11, CEO-OTH12, CEO-OTH13, CEO-OTH14, CEO-OTH15 and 
CEO-OTH16. Although it is clear from the chart that the CEO considers the setting of 
direction/focus (ATT1 and ATT2), the commitment to look for financial resources to 
continue R&D (COM3) and the prioritization of the resources (COM4) as important 
aspects of his role, a majority of 
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statements cannot be assigned to an a priori concept. As this CEO has a purely 
financial/business background he encounters difficulties to grasp the intricacies of R&D 
(CEO-OTH13) but on the other hand considers it an advantage to be untrained as a 
scientist (CEO-OTH12). The CEO makes the point that his major role is to assure sufficient 
financial means and that he wants to protect R&D from the more mundane aspects of 
running a life science R&D firm that is continuously looking for additional financial 
means (CEO-OTH11 and CEO-OTH17). This makes the CEO argue that he deserves 
respect from R&D - although he cannot interact nor contribute to their work - because 
his contribution lies in the fact that he is supporting R&D financially and adds value to 
their work by looking for commercial value (CEO-OTH9). 
Discussion pilot interview CEO2 
While the previous CEO decided to hire innovative individuals as a source of creating 
innovation and reducing risk, this CEO argued that the climate of innovation should be 
nurtured by making available sufficient financial resources to conduct R&D, stating that 
if there are sufficient resources, the innovational culture will be generated automatically 
and flourish. Whether this approach is driven by the fact that this CEO has a pure 
business background with no previous exposure to scientific and/or medical activities is 
a matter of speculation. It was clear that attention to drivers of innovational culture in 
this firm such as open communication, exchange of ideas, interaction with external 
partners was poor.  The role of the CEO in innovation on the other hand was clearly 
related to the ‘setting of a direction’ and to ‘confine’ these activities towards the 
company’s goals. When asked what was meant by ‘setting direction’ of R&D and how he 
- a CEO with a strong financial background – sets the direction of R&D, the CEO 
apologized for having used the term ‘direct’ and corrected himself by stating that the 
setting of the direction in fact is a combined effort in which the scientific expertise in the 
company and his financial expertise allows the setting of boundaries in which the 
research can take place: 
 
‘I don’t direct ... I put up a set of rules within which we 
have to operate and using the scientific resources and 
some of my own knowledge we arrive at where we 
should spending money .. 
The topic of R&D knowledge – or absence of it - came to the surface during the 
discussion and two points of view surfaced. On the one hand, the CEO clearly considers 
his financial expertise a positive factor in the management of a R&D company but 
realizes that his absence of scientific knowledge on the research topics which were 
required to run this type of company has been a ‘very humbling experience’. He admits 
that he does not have good insight into the R&D work that is carried out in the company. 
On the other hand, the need to rely on the scientific expertise of his CSO has a major 
advantage – at least from his point of view - in that he does not have to ‘second-guess’ 
the CSO’s decisions seen the expertise and reputation of the latter. 
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Themes from the second pilot CEO interview 
 
 
Theme 
(codified) 
Theme 
(statement) 
CEO-OTH9 CEO aims to obtain respect from R&D 
CEO-OTH10 CEO attempts to understand R&D 
CEO-OTH11 CEO carries the scientists and their R&D through difficult times 
CEO-OTH12 CEO considers it an advantage to be untrained as a scientist 
CEO-OTH13 CEO considers himself at a disadvantage as a non-scientist 
CEO-OTH14 CEO informs R&D about the company’s position 
CEO-OTH15 CEO role model is business driven 
CEO-OTH16 CEO wants to protect R&D from the mundane aspects of running 
 a firm 
 
New themes emerging from the second pilot interview 
 
0 5 10 15 20 25
ATI Attitude
ATI1 CEO fosters a culture of innovation
ATI2 CEO fosters experimentation and accepts failures
ATI3 CEO fosters internal communication
ATI4 CEO fosters the exchange of divers ideas
ATI5 CEO fosters external collaboration to increase internal innovation
ATI6 CEO fosters flexibility and adaptibility
ATI7 CEO fosters learning in the organization
ATT Attention
ATT1 CEO sets the direction in which innovation to take place
ATT2 CEO sets the focus and boundaries in which innovation to take place 
COM Commitment
COM1 CEO hires selects and develops innovative leadership
COM2 CEO creates incentives and rewards for the R&D function
COM3 CEO prioritizes resources
COM4 CEO makes available human and financial resources
COM5 CEO empowers R&D to execute on new ideas
COM6 CEO creates hierarchical flat organizational structures for innovation
COM7 CEO reduces development risk by hiring expert people
INV Involvement
INV1 CEO challenges R&D for efficiency
INV2 CEO challenges R&D technically
INV3 CEO acts as sounding board
INV4 CEO interacts with r&D to solve technical problems
INV5 CEO is involved in NPD
INV6 CEO holds frequent formalized meetings with R&D
INN Innovator
INN1 CEO drives new product development in person
INN2 CEO takes control of every detail of NDP
INN3 CEO wants to transform/disrupt the market
OTH Other roles
OTH1 CEO admits limited knowledge in specific R&D area
OTH2 CEO admits not driving innovation but rather the direction of …
OTH3 CEO interacts with R&D only in those matters he/she has personal …
OTH4 CEO should not focus on technology
OTH5 CEO stresses the importance of strong knowledge in the field of …
OTH6 CEO takes innovation decisions based on simplified data
OTH7 CEO wants R&D to step out of academic thinking
OTH8 CEO role model is knowledge based
OTH9 CEO aims to obtain respect from R&D
OTH10 CEO attempts to understan R&D expertise
OTH 11 CEO carries R&D through difficult times
OTH12 CEO considers it an advantage to be untrained in science
OTH13 CEO considers himself at a disadvantage as a non-scientist
OTH14 CEO informs R&D about the company's position
OTH15 CEO role model is business driven
OTH16 CEO wants to protect R&D from the mundane aspects of running a …
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This, according to the CEO, is an advantage of a non-science CEO.  However, this 
knowledge factor has another implication. In order for the CEO to make strategic 
decisions, he requires the presence of an individual (‘X’) besides the CSO who is capable 
of translating the expertise knowledge into a market environment. In other words, the 
complex data that are being brought to him by the scientific elite in his company requires 
translation into the strategic arena by an individual who is capable of recreating the 
‘biology know-how’ into a ‘marketable know-how’.  
The CEO knowledge base has two components: the CEO acceptance of the CSO’s point 
of view and the CEO’s need to have an expert (‘X’) available to translate the scientific 
and technical data into a ‘language’ that is amenable to decision making.  This is 
illustrated in two statements, one with respect of the CSO and one with respect to ‘X’: 
‘I couldn’t do my job only with the CSO because he could tell me 
this and I’d have to believe it .... he wouldn’t deliberately 
mislead me,  but he wouldn’t perhaps have in mind these other 
considerations that X brings to it... I couldn’t do my job without 
It (referring to X)’ 
The interaction with R&D therefore is of particular interest to the CEO. He admits that 
his interaction with the R&D group is limited but stresses the point that this interaction 
is important as it is necessary for him to ascertain that the CEO gains their respect and 
that he is capable of taking them along the growth path of the company. Again, it is 
argued by the CEO that this interaction cannot possibly be based upon scientific 
exchanges or intellectual discussions with the scientists but on the premise that he can 
add value to the business. The CEO does this by allowing them to carry out their research 
with appropriate financial funding and within certain confines and by making sure that 
they are protected from the more mundane and perhaps ‘less welcome aspects of being 
part of the company, particularly a public company’. In addition, by looking for the 
commercial opportunities the CEO is capable of increasing the value of the company and 
thereby recognizes the work of the R&D function. 
The CEO argues that his major concern is the linkage between the science and 
commercial viability and market opportunities. This linkage between medical need and 
scientific potential is the major driver for doing research and committing resources to 
the R&D function. Finally, the CEO argues that there is a danger in being (too) close to 
the technology and thereby losing oversight and commercial opportunities because ‘one 
has to be able to change track’. The CEO is committed to the R&D function by making 
available rewards to the R&D function but this is limited to classical approaches used for 
non-scientific resources (i.e. by using share options and other monetary rewards). There 
is no mention of adapting a reward system to allow operational freedom, a ‘scientist of 
the year award’, or other incentives beyond the monetary approach. 
Evaluation of the approach pilot interview CEO2 
As a result of the first pilot interview it was decided to engage in an interview approach 
whereby the open-ended interview technique is replaced by a more focused interview 
style with more precise questions. It was assumed that by taking this approach there 
 
 
Appendix E 
254 
 
would be more control on the course of the interview in that it avoids irrelevant and 
deviating excursions such as the tensions with a specific individual, a historical reflection 
on the origins and founders of the company, the greatness of the founder etc. The 
approach that was taken in the second interview proved to be efficient in that it allowed 
a much more focused and continuous attention-directing approach which did not impact 
negatively on the interaction with the CEO. During the second interview it was stated by 
the CEO that the interview was an intellectually interesting exchange of ideas that he 
was keen to have. Therefore, asking direct and precisely focused questions would not 
hamper the output of the CEO’s points of view and vision on his role in innovation. Also, 
taking a more structured question-by-question approach allows for a comparative 
analysis among the interview transcripts. 
Conclusion of the pilot interviews of CEO1 and CEO2 
Although it is too early in this phase of the research program to compare both CEOs, it 
may be worthwhile to reflect on similarities and differences between these two top 
managers. This is presented in the bar chart below. At first glance both CEOs reflect a 
similar ‘role pattern’: “CEO attention” (setting direction and giving focus) and CEO 
commitment (facilitating R&D) are both more pronounced when compared to CEO 
involvement (actual interactions with R&D). For both CEOs the ‘attitude to innovation’ 
is poor, probably because this is considered a fact of life for a CEO in a life science R&D 
company and therefore both do not consider it necessary to draw attention to it. 
Involvement is low for both CEOs. For CEO1 (the science-based CEO), involvement in 
R&D is limited to those aspects of R&D into which he is personally trained or has 
accumulated experience. For CEO2 (the finance-based CEO), involvement is not relevant 
as he is not able to contribute in the area of R&D seen his previous expertise and 
educational background.   This is also reflected in the role model that is used by each 
CEO. CEO2 considers his CEO role model a business-driven CEO (OTH16) while CEO1 
considers a knowledge-driven CEO a role model (OTH8).   
 
There is a clear difference between the educational and experiential backgrounds of 
both CEOs, but it is clear that CEO1 only uses the knowledge that he gained either 
through education or through personal experience, in those areas of R&D that he is 
acquainted with. Outside the fields of his own personal expertise and experience, the 
science-based CEO’s approach towards R&D does not differ from the approach of CEO2. 
Both feel that their knowledge into the details of the science is insufficient to drive 
innovation. CEO1 argues that he does not drive innovation because the core R&D 
activities are conducted by a specialist R&D function in which he does not have sufficient 
know-how to play his role and states that ‘I do not drive innovation’ while CEO2 states: 
‘I don’t direct (R&D)’.  Both do so for the same reason: the absence of relevant R&D 
expertise either in a specific area (CEO1) or in no area (CEO2). Both CEOs have a clear 
view on the nature of the R&D function in their firms and consider the market-science 
relationship the driver of R&D. Irrespective of the educational background or experience 
of the CEO both CEOs found it necessary to translate the complex data in their R&D 
groups into a more ‘manageable’ format that allows to make strategic decisions. CEO1 
does this by using part of his knowledge, combining this with the output of his R&D 
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function, linking this with market data and simplifying this so as not to generate ‘rocket 
science’. CEO2 uses a specifically designed individual to translate the CSO’s data into a 
format that allows him to make strategic decisions.  
Both CEOs argue that there is a danger in becoming to close with the technology. CEO1 
argues that too much focus on the technology may drive a firm into academic research 
path without generating commercial value, while CEO2 argues that by linking up 
intensively with a technology the danger exists that the company gets ‘stuck’ with the 
technology and cannot move swiftly into another area. There is a difference in the 
approach used by both CEOs in incentivizing the R&D function. CEO1 not only employs 
share options as an incentive but also ‘empowers’ the R&D function and creates 
operational freedom. CEO2 only uses monetary rewards. 
According to Yin, ‘interviews will be guided conversations rather than structured 
queries’ and ‘(the) actual stream of questions in a case study interview is likely to be 
fluid rather than rigid’ (Yin, 2009, p106). Two possible interview techniques are 
proposed by Yin (Yin, 2009, p107): the in-depth interview and the focused interview.  
During in-depth interviews, respondents can be asked about the facts of the matter as 
well as their opinions about events. The interview may therefore take place over an 
extended period of time, not just in a single sitting. Focused interviews, on the other 
hand, constitute a time-limited conversation that is likely to follow a set of questions 
derived from a study protocol. According to Flick (2004, p204), this type of interview 
‘unite a high degree of openness and non-directivity with a high level of concreteness 
and the recording of detailed information; (together with narrative interviews,) it is 
therefore superior to other interview variants’.  Central to the focused interview is the 
‘focusing on a subject or topic of conversation determined in advance… and the attempt 
to collect reactions and interpretations in an interview with a relatively open form’ (Flick 
et al., 2004, p205). It is one of the goals of the focused interview to give interviewees 
‘an opportunity to invoke points of view that had not been anticipated’ (Flick et al., 2004, 
p205). Four criteria for a qualitative focused interview are defined: 
- Scope: the spectrum of the problems addressed should not be too narrow: this 
however is a matter of personal interpretation on what ‘narrowness’ means in 
view of the proposed interview. In our case, in which CEOs will be asked about 
their role in innovation, the topic of the interview is sufficiently broad to allow 
the respondent to allow ‘maximal opportunity’ to react to the ‘stimulus situation’ 
- Specificity: the topics and questions that are posed in the interview should ‘be 
dealt with in a specified way’, i.e. the respondent should not generate “general 
feelings or global assessments” and evaluations, but should generate ‘concrete 
memories that relate to the particular topic’. It is essential in our interviews that 
the CEOs are not asked for theoretical or global views on their role in innovation, 
but rather on their actual, concrete real life roles in innovational R&D. 
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Comparison of the themes emerging from the 2 pilot interviews 
- Depth: the interview should appropriately address ‘the dimension of depth’: 
interviewees should be supported in ‘presenting the affective, cognitive and 
value-related meaning which a particular situations have for them’. It is 
important in our research to gauge how CEOs feel about their role in innovation: 
do they consider that role – even if ‘played’ efficiently – worthwhile, 
cumbersome, heavy? 
- Personal context: ‘the personal context in which the analyzed meanings and 
reactions are located must be adequately recorded’. According to Merton et al., 
‘this is a precondition for the interpretation of any non-anticipated reactions to 
the communicative contents that formed the basis of the interview’. It is for 
example necessary to try to understand why, for some CEOs, the responsibility 
and accountability of their firm’s R&D programs may come as a burden.  Is it 
because of their previous experiences, their growth path in their firms? 
0 5 10 15 20 25
ATI Attitude
ATI1 CEO fosters a culture of innovation
ATI2 CEO fosters experimentation and accepts failures
ATI3 CEO fosters internal communication
ATI4 CEO fosters the exchange of divers ideas
ATI5 CEO fosters external collaboration to increase internal innovation
ATI6 CEO fosters flexibility and adaptibility
ATI7 CEO fosters learning in the organization
ATT Attention
ATT1 CEO sets the direction in which innovation to take place
ATT2 CEO sets the focus and boundaries in which innovation to take place 
COM Commitment
COM1 CEO hires selects and develops innovative leadership
COM2 CEO creates incentives and rewards for the R&D function
COM3 CEO prioritizes resources
COM4 CEO makes available human and financial resources
COM5 CEO empowers R&D to execute on new ideas
COM6 CEO creates hierarchical flat organizational structures for innovation
COM7 CEO reduces development risk by hiring expert people
INV Involvement
INV1 CEO challenges R&D for efficiency
INV2 CEO challenges R&D technically
INV3 CEO acts as sounding board
INV4 CEO interacts with r&D to solve technical problems
INV5 CEO is involved in NPD
INV6 CEO holds frequent formalized meetings with R&D
INN Innovator
INN1 CEO drives new product development in person
INN2 CEO takes control of every detail of NDP
INN3 CEO wants to transform/disrupt the market
OTH Other roles
OTH1 CEO admits limited knowledge in specific R&D area
OTH2 CEO admits not driving innovation but rather the direction of innovation
OTH3 CEO interacts with R&D only in those matters he/she has personal knowledg …
OTH4 CEO should not focus on technology
OTH5 CEO stresses the importance of strong knowledge in the field of innovation
OTH6 CEO takes innovation decisions based on simplified data
OTH7 CEO wants R&D to step out of academic thinking
OTH8 CEO role model is knowledge based
OTH9 CEO aims to obtain respect from R&D
OTH10 CEO attempts to understan R&D expertise
OTH 11 CEO carries R&D through difficult times
OTH12 CEO considers it an advantage to be untrained in science
OTH13 CEO considers himself at a disadvantage as a non-scientist
OTH14 CEO informs R&D about the company's position
OTH15 CEO role model is business driven
OTH16 CEO wants to protect R&D from the mundane aspects of running a firm
CEO1 CEO2
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It was learned from the first pilot study that an open-ended, non-structured interview is 
a risky interview approach as the CEO offered data which would be difficult to structure 
against other interview outputs. Also, the open-ended interview approach allowed the 
CEO to color the conversation with ‘war stories’.  The second pilot study was more 
structured and used pre-conceived questions based on the literature concepts and 
offered an overview of responses that would be easier to contrast with the output of 
other CEOs. It also allowed to address concepts around the role of the CEO in innovation 
such as development of innovation culture, role of the CEO, leadership characteristics 
thereby offering the CEO a structure in which he could put down his/her ideas and 
opinions. As a conclusion, focused interviews have a number of advantages such as the 
‘possibility of combining the possibility of a reserved, non-directive management of a 
conversation with an interest in very specific information and the opportunity for an 
object-related explanation of meanings’ (Flick et al., 2004, p206). It was therefore 
decided that a more directive and focused approach will be used for the final interviews. 
Final CEO interviews 
During the pilot research an NVivo primary/secondary node structure was developed 
that formed the basis for the further analysis of the final interview transcripts. The 
primary/secondary node structure developed during the two pilot interviews was used 
as a starting point for the textual analysis for the final CEO interviews is presented below. 
  
ATI Attitude 
ATI1 CEO fosters a culture of innovation 
ATI2 CEO fosters experimentation and accepts failures 
ATI3 CEO fosters internal communication 
ATI4 CEO fosters the exchange of diverse ideas 
ATI5 CEO fosters external collaboration to increase internal innovation 
ATI6 CEO fosters flexibility and adaptibility 
ATI7 CEO fosters learning in the organization 
ATT Attention 
ATT1 CEO sets the direction/goal and vision in which innovation to take place 
ATT2 CEO sets the focus and boundaries in which innovation to take place  
COM Commitment 
COM1 CEO hires selects and develops innovative leadership 
COM2 CEO creates incentives and rewards for the R&D function 
COM3 CEO prioritizes resources 
COM4 CEO makes available human and financial resources 
COM5 CEO empowers R&D to execute on new ideas 
COM6 CEO creates hierarchical flat organizational structures for innovation 
COM7 CEO reduces development risk by hiring expert people and developing options 
INV Involvement 
INV1 CEO challenges R&D for efficiency 
INV2 CEO challenges R&D technically 
INV3 CEO acts as sounding board 
INV4 CEO interacts with R&D to solve technical problems 
INV5 CEO is involved in NPD 
INV6 CEO holds frequent formalized meetings with R&D 
INN Innovator 
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INN1 CEO drives new product development in person 
INN2 CEO takes control of every detail of NDP 
INN3 CEO wants to transform/disrupt the market 
OTH Other roles (from the pilot studies) 
OTH1 CEO admits limited knowledge in specific R&D area 
OTH2 CEO admits not driving innovation but rather the direction of innovation 
OTH3 CEO interacts with R&D only in those matters he/she has personal knowledge 
in 
OTH4 CEO should not focus on technology 
OTH5 CEO stresses the importance of strong knowledge in the field of innovation 
OTH6 CEO requires R&D data to be simplified for strategic decision and 
communicaton 
OTH7 CEO wants R&D to step out of academic thinking 
OTH8 CEO role model is knowledge based 
OTH9 CEO aims to obtain respect from R&D 
OTH10 CEO attempts to understand R&D expertise 
OTH 11 CEO carries R&D through difficult times 
OTH12 CEO considers it an advantage to be untrained in science 
OTH13 CEO considers himself at a disadvantage as a non-scientist 
OTH14 CEO informs R&D about the company's position 
OTH15 CEO role model is business driven 
OTH16 CEO wants to protect R&D from the mundane aspects of running a firm 
 
Data collection: NVivo analysis of the final interviews. The primary/secondary node 
structure PSN2 developed after the second pilot interview formed the basis for the 
NVivo analysis of the final interviews.   In this study, a total of 15 interview analyses were 
conducted. Before the interview, the above list of themes was introduced into the node 
structure of the NVivo software.  After each interview the audiofile (*.wav) was 
transcribed and checked for completeness. At the end of the transcript analyses all 
transcripts were reanalyzed again using the primary/secondary node structure PSNn, 
obtained after the last transcript analysis, to ascertain that all themes were retrieved 
that emerged during the interviews, as presented in the diagram above. 
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Appendix F. From research questions to interview 
questions 
 
The interview questions were developed from two angles: on the one hand, the 
pentathlone framework for innovation (Goffin and Mitchell, 2010) was used to develop 
the content of the questions, while the nature of questions was driven by Stebbins 
discussions on questioning in exploratory research mode (Stebbins, 2001, p23). Based 
upon these two starting points, questions were developed that explored the 
‘innovational world’ in which the CEO discharges his/her role, realizing that the extent 
of the list of questions should be minimal and taking into account the fact that these 
individuals only have a limited timeframe available for research interviewing. The 
approach is presented in below.  
 
 
 
 
 
The pentathlon of innovation offers a suitable framework to develop interview 
questions and to explore the world of innovation in which these CEOs operate. These 
five basic principles are linked to the concepts of ideas, culture, prioritization, strategy 
and implementation. These innovation themes are introduced into the interview 
questions. At the same time, Stebbins (2001) argues that ‘researchers ... look for the five 
Ws... (and) ...try to generalize about who (is doing (thinking, feeling) what to (with, for, 
about) whom and when and where this action takes place’ (italic by Stebbins). The 
overall approach linking both Goffin and Mitchell’s and Stebbin’s approach  is presented 
in the figure below. 
 
Development of interview questions. Interview questions were developed that open up 
the conversation between the interviewer and the interviewee. The interview starts 
with an ‘introductory question’ or ‘opening question’, because they ‘may yield 
spontaneous, rich descriptions where the subjects provide what they have experienced 
as the main aspects of the phenomena investigated’ (Kvale and Brinkmann, 2009).  The 
opening question addresses the role of the CEO in innovation: ‘What do you think are 
the attributes of the role of a CEO in a life science R&D firm?’. It has two purposes: firstly, 
it allows the interviewee to spontaneously refer to his/her personal experiences and 
CEO’s view 
categorized 
according to a 
priori concepts
Interview 
Questions
CEO’s Mindmap
Personal view on 
his/her role in
innovation
Role requirements of the CEO
Leadership requirements
Driving factors for R&D
Time/effort in R&D
Climate of innovation
General innovation
Ideas: origin and exploitation
Investment decisions 
Resources
R&D output
Incentives
Risk management
Knowledge management
Role models
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secondly allows a friendly atmosphere to be established between interviewer and 
interviewee. In addition, it does not inquire deeply into the personal experiences from 
the start. This is followed by a second question that is also of a general nature but looks 
into the role of the CEO innovation from another angle and inquires about the leadership 
characteristics of the CEO: ‘What are in your opinion the major leadership characteristics 
of a CEO in a life-science R&D firm?’ 
 
 
 
 
Leading from these two opening questions, the interview protocol passes along a set of 
questions that focuses on the actual discharge of that role in an R&D environment and 
how this role could effectively be played. The goal of the interview is to let concepts 
emerge from the interview. As a result of the answers given to these questions, the 
interviewer attentively explores the worldview of the CEO by gauging for specific a priori 
concepts paying attention not to lead questions that may generate a role concept such 
as CEO commitment, CEO innovativeness etc.  Finally, the interview leads to questions 
whereby it is explored how the CEO-interviewee actually increases the R&D output in 
your firm, thereby looking for ways in which the interaction with R&D is used as a driver 
for increased innovation. In preparation of the interview a number of additional 
questions were developed that explores the interaction with the R&D function in more 
detail.  
 
One note on leading questions. According to Kvale and Brinkmann (2009), ‘in contrast 
to common opinion, the qualitative research interview is particularly well suited for 
employing leading questions to repeatedly check the reliability of the interviewees’ 
answers, as well as to verify the interviewers’ interpretations’. Because this interview is 
part of an explorative study, the decisions was taken to confine the interview to the 
questions listed below but nevertheless to inquire further with non-preconceived 
questions in order to reach a better understanding of the statements made by the CEOs.   
Goffin & 
Keith (2010)
Innovation 
pentathlon 
concepts
Content of 
interview
questions
Nature of 
interview
questions
Stebbins 
(2001)
“who, why, 
what, when, 
whom?”
INTERVIEW QUESTIONS
RESEARCH QUESTIONS
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In the following list of exploratory questions, the pentathlone framework concepts of 
idea generation, prioritization, implementation, strategy and culture have been 
introduced. Each question is followed by a code that indicates whether the question is 
of a general nature (G), or addresses a specific pentathlone theme (P). For example, the 
first two questions of the interview are general and introductory questions and they are 
therefore followed by the code “G”.  The third question Q3 addresses the origin of the 
innovation and therefore is followed by the code “P-idea”, the fourth question Q4 
addresses the culture of innovation and therefore is followed by the code “P-culture”.  
There are 7 “what”-questions, 11 “how”-questions and 6 “why”-questions which in 
some cases have been put together in a single question. 
The questions are presented below. 
Q1. What do you think are the attributes of the role of a CEO in a life science R&D 
 firm? (G) 
This is the introductory question which allows to take the discussion further.  
 
Q2. What are in your opinion the major leadership characteristics of a CEO in a life 
science R&D firm? (G). This question tries to explore the CEO’s attitude towards 
innovation. For example, the CEO response may be that he/she creates a climate 
open to discussion, ideas etc. Others may argue that is the ability to take risk, to 
instill trust. Three additional questions follow: 
 
Q3 What is in your opinion the most important driving force for R&D 
innovation in the organization and why? (P-idea) 
Q4 How do you create a climate of innovation and why? (P-culture) 
Q5 Is an innovational climate important even in R&D firms which should 
be, by definition, innovative because of the nature of the work? (P-
culture) 
 
Q6 How much time and effort do you make available to obtain information from 
your R&D team in percentage? (G) 
This question addresses attention of the CEO to R&D information (internal and 
external) that he/she can use to develop new ideas for establishing a future for 
the company. Three additional questions are asked: 
 
Q7 How are new ideas developed in R&D? (P-idea) 
Q8 How do you identify new ideas in your firm and exploit those ideas? (P-
idea) 
Q9 Are you actively looking yourself for new ideas in the organization? (P-
idea) 
 
Q10 What are your driving factors to invest in, make available resources and 
support R&D? (P-prioritization). This question tries to gauge the CEO’s 
commitment towards innovation in R&D;  several sub-questions can be asked 
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related to rewards, resources, identification of innovators, incentives to 
innovation and coping with risk. Three additional questions are asked: 
 
Q11 How do you as a CEO actually increase the output of R&D? (P- 
implementation) 
Q12 What are your incentives to stimulate innovation in R&D? (P- 
implementation) 
Q13 How do you live with and manage the risk associated with R&D? (P- 
implementation and P-prioritization) 
 
Q14 How do you bridge the gap between the scientific/ biomedical knowledge in 
R&D and your (general management’s) knowledge? (G). This question tries to 
assess the level of CEO knowledge  that allows him/her to engage in detailed 
NPD discussions. Three additional questions are asked: 
 
Q15 With whom and how frequently (times/w, m, y) do you actually discuss 
R&D, and why? (P- implementation and P-prioritization) 
Q16 To what depth are you involved in the NPD discussions and why? (P-
culture and organization) 
Q17 What is your role in advancing new product development? (P-culture 
and organization) 
 
Q18 How do you describe your role as CEO in R&D vs the role of your CSO? (P 
strategy). This question tries to explore how the CEO seems him/herself in view 
of what is to be considered/expected to the major innovator of the firm, i.e. the 
CSO. Three additional questions are asked: 
 
Q19 Who takes R&D decisions and why? (P- strategy) 
Q20 Who decides on the final product design and why?  (P- strategy) 
Q21 Who is the most important driver in new innovations in your firm? (P-
idea, P- strategy) 
 
Q22 Have you seen CEOs who were particularly effective in driving R&D, and why 
do you think they are? (G) 
 
During each visit of the 15 CEOs, the protocol was adhered too as to generate 
comparable transcripts which were based upon the same set of inquiries. Although our 
research is not a case study, Yin’s argument is valid that ‘questions are posed to you, the 
investigator, not to an interviewee’ as ‘the protocol questions are your reminders 
regarding the information that needs to be collected , and why’ (Yin, 2009). The main 
purpose of these questions is to keep the investigator ‘on track’ as for our data collection 
to proceed. The interview form is added below. 
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Appendix G. Operational data of the CEO interviews 
The table below presents the operational interview data: interviewee code, recording 
nr, duration of interview, conversation type and transcript length. 
 
Interviewee 
R&D executive 
Recording 
Nr. 
Duration 
(in min) 
Conversation Transcript* 
(nr of pages) 
CEO1P 0060 & 0061 63 face-to-face 32 
CEO2P 0062 49 face-to-face 22 
CEO1 0063 75 face-to-face 37 
CEO2 0064 72 face-to-face 30 
CEO3 0065 56 face-to-face 24 
CEO4 0062 57 face-to-face 24 
CEO5 0068 & 0069 & 0070 71 face-to-face 30 
CEO6 0071 55 face-to-face 26 
CEO7 0072 52 face-to-face 20 
CEO8 0073 & 0074 75 face-to-face 26 
CEO9 0075 54 face-to-face 26 
CEO10 0067 69 face-to-face 0 
CEO11 0120 35 face-to-face 15 
CEO12 0113 50 face-to-face 18 
CEO13 0147 54 face-to-face 24 
CEO14 0141 56 face-to-face 23 
CEO15 0135 54 face-to-face 23 
  997 min 
15.5 hrs 
 400 pages 
*A4, Calibri, 12 font size, 1,5 line space; **: interview not transcribed (CEO mixed French-English speaking). 
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Appendix H. New subthemes from final CEO interviews  
New 
Subtheme: 
 
Description: Description as raised by the CEO (examples) 
CEO-OTH17 CEO acts as a role model 
for innovation 
“...here you know the leaders of the company are role models for the rest of 
the company,  so how we behave, what we do, our actions speak louder than 
words, so there I think ... being good citizens and examples of innovation you 
create then people copy you, they follow you, they do what you do and then it 
infects the company...” (CEO3) 
 
CEO-OTH18 CEO links R&D to 
internal and external 
stakeholders 
“... and telling stories to different people to help them understand the other 
sides of the business, helping the finance people understand what the hell 
commercial people are doing and in that we’re providing a link and a theme for 
things going forward so obviously the development of that theme and that 
strategy is a key part of the job but then linking it between the different 
partners internally and externally and obviously what different people want in 
terms of the story and how the scientists will think we spend too much time 
talking about cash and money because most people spend too much time 
about technical issues you know and its really developing, distilling that story, 
telling it again and it’s really about storytelling, this leadership role is all 
about...” 
(CEO2) 
 
CEO-OTH19 CEO reduces risk by fail 
fast fail cheap 
“...I think the only thing you can do is that again you try to put into place the 
mechanism so that you learn as quickly as possible when you’re going to fail, so 
if you’re going to fail, fail quickly” 
(CEO4) 
 
CEO-OTH20 CEO gets information 
from all levels of the 
organization 
“...I get it from other levels, I talk to other people as well and they will be in as 
part of that meeting, so I’ll see them all and I’ll watch a lot of the interaction, 
my decisions are based on to some extent what I think of what they’re saying 
to each other, they’re having a discussion in front of me and that’s very 
illuminating on a lot of what I see so and I will have spoken to people before 
we even get into the meeting, there’ll be a lot of background information 
provided before we go into the meeting and when I want to discuss that I’ll go 
and talk to the individual project or scientist...”  
(CEO2) 
 
CEO-OTH21 CEO role in R&D is not 
different from CEO role 
in non-R&D 
“I have managed various established businesses, which for me had nothing to 
do with managing innovation and I’ve managed an R&D start-up. I think that 90 
percent is the same” 
(CEO4) 
 
CEO-OTH22 CEO looks for the best 
possible team 
“...is to insure that you have the best possible team” (when asked what is 
important to be a CEO of a life science R&D firm” 
(CEO4) 
 
CEO-OTH23 CEO requires persistence 
and resilience in LFSR 
“I think there is persistence. People will look for someone who will keep on 
trying. You know, in this science it’s almost impossible to get it right the first 
time. You’re going to hit a lot of bumps on the road and you need someone 
who can steer the boat around the rocks. That goes back to flexibility, which 
we mentioned before.” 
(CEO4) 
 
CEO-OTH24 CEO argues that 
innovation comes from 
top down and bottom 
up 
“... I think that the driving force  is probably a mixture of a bottom-up desire to 
keep doing things creatively and coming up with new ideas, ... I think that if the 
atmosphere is right then it happens...keep looking for ways of improving ... On 
the other hand, there’s the relentless need of the company and therefore a 
top-down approach to being creative, cutting corners, doing more with less, so 
I think you need that combination. Then you can force innovation” 
(CEO4) 
 
CEO-OTH25 CEO and CSO are 
innovative forces 
together 
“... Yes so he/she (CSO) and I play really complimentary roles because lets say 
(CSO) wants to innovate on the technology, on the base technology ... he wants 
to push the technology really to the next level, finding ways to make it better, 
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cheaper, faster - right - so he is actively searching ... inside and outside the 
company for the next thing...  On my side I want to innovate or go to market 
strategy so on the commercial side, I’ll give you one example we have this 
beautiful touch screen monitor ... so I said to the team ... look I want to find a 
way to connect more deeply with our customer..;” 
(CEO3) 
 
CEO-OTH26 CEO innovates by 
challenging the 
organization 
“...I think it’s a big advantage not being a scientist; I can ask for things that a 
scientist would not dare to ask for. I think it’s a subtle way of creating 
innovation and I’m not sure even if you were to ask the question people would 
realise it, but I think there’s a lot of push from this inquiring approach that 
forces people to innovate...” 
(CEO4) 
 
CEO-OTH27 CEO argues that 
innovation also occurs 
outside R&D 
“...sure yes absolutely you have people in the IT department who bring in 
systems and to improve the R&D productivity right so they influence what 
happens in R&D like for example we have new systems in place for the E-lab 
notebook and how do you manage data and so that the data integrity is 
maintained and systems in place so those kind of things were non existent into 
the old hand written lab note books and we changed all of that into an IT based 
system where every data that is collected is automatically launched into the E-
lab notebook and is stored, archived and so on, so that improves the 
productivity of the scientists because they don’t have to sit and write lab note 
books and get witness and all that stuff, done automated steps to innovation 
from the IT side into that” 
(CEO5) 
 
CEO-OTH28 CEO argues that R&D 
should always be one 
step ahead 
“...You need to be a step ahead always in innovation and research and the 
challenge is to get out of the nothing presented here syndrome of people being 
stuck on certain patterns without being able to look and decide which” (CEO7) 
CEO-OTH29 CEO educates the firm’s 
environment 
‘...it’s a huge challenge first of all to get the idea accepted because many 
people think hey they can’t do anything against viruses so it’s a young domain 
physiology in human medicine as well so we have to actually educate people 
which is nice, we have to educate governments and all kinds of authorities...’ 
(CEO13) 
 
CEO-OTH30 CEO argues that value is 
as important as market 
‘...We have a shared ownership, everyone here is proud because we’re the 
only and the first ones and the ones with good technology and good ideas and 
we are going to make a difference so everyone shares a little bit that feeling so 
of course in the end our investors want money and of course to survive we 
need income, there’s always some things that I need to perfect but on the 
other side there’s let’s say we’re not rambles but anyway we’re sharing some 
kind of a common belief that is far more important than the market that we 
may address at the end’ (CEO13) 
 
CEO-OTH31 CEO and R&D should 
have a relationship of 
trust and confidence 
‘... you want to delegate but effective delegate its like trust but verify right so 
you want to have enough trust in your people and hire the right people to do 
their respective functions but at the same time have a good way of holding 
them accountable for the timelines, for deliverables, for the projects...’ (CEO5) 
 
CEO-OTH32 CEO should have firm 
belief in the product 
‘Like the core rationale why they came to certain conclusion recommendations 
or decisions, what I want to understand is whether its thought through and 
that there is a high conviction level of the fact that we’re doing the right thing, I 
want to test this identification, this belief, emotional bond which is often 
thought through, well thought through’ (CEO12) 
CEO-OTH33 CEO considers patients 
as innovation drivers 
‘...oh the patient is the main innovation driver’ (CEO12) 
CEO-OTH34 CEO needs to 
understands 
process/risks of R&D 
‘...make sure you’re well informed and you’re well surrounded and so on top of 
everything you’ve mentioned just to make sure that its alright on the record, 
you also have to understand the correct risk in supply science and when I talk 
about risk, so ability, high failure rate..’ (CEO14) 
CEO-OTH35 CEO needs to 
understand culture of 
science 
‘..so you need to understand culture, you don’t have to be or to be part of that 
culture but at least you need to understand they’re different cultures so these 
are people who are sometimes a bit difficult to manage in a team format for 
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example, they are individuals and have a pretty strong individual opinion, their 
opinionated and you have to be able to deal with that CEO14 
 
CEO-OTH36 CEO needs to know how 
to lead scientists 
you have to know how to lead an organization of scientists so in that way you 
have to understand their typical characteristics and business they’re dealing 
with because they are leading or guiding scientists, its not the same as guiding 
IT engineers, it’s a different breed I think, like its different to lead an 
organization of …. CEO14 
 
CEO-OTH37 CEO’s understanding of 
scientists is more 
important than being a 
scientist 
So I think as a CEO in a life science R&D firm you have to understand the life 
science itself, I’m not saying you have to be a scientist yourself but at least you 
need to have a thorough understanding of what life science means CEO14 
 
CEO-OTH38 CEO should have some 
basic understanding of 
science 
‘It is important to have some basic understanding of the science that is being 
conducted..’ (CEO10) 
 
CEO-OTH39 CEOs of LFRD firms 
should not be dominant 
I mean in terms of downward management you have to adapt to that, it 
doesn’t work to implement things, you know top down approach in my opinion 
but that’s my personal opinion it just doesn’t work with these people, the only 
way to convince them to do something is to let them understand (CEO14) 
 
CEO-OTH40 CEO needs bottom-up 
ideas in LFSR firms 
Unfortunately its very much top down, the broad things are top down, I 
basically steer or sell what we focus on and obviously then the bright ideas 
come from the bottom out of approaches but unfortunately its not very often 
that it’s the other way round, its not that the research and development – and 
I think we should do this or and all the time that I’ve been here I think that’s 
happened once or twice (CEO9) 
 
CEO-OTH41 CEO top scientist/top 
business man/women is 
ideal 
Most important role I think is that you ensure the continuation of the company 
so in that sense I think important attributes are risk, mitigation, making sure 
that financials are in order and make sure that you continuously have enough 
cash available to support your research and development.  I think it obviously 
requires a lot of different skills which you would like to have in one person but 
specifically in life science that is almost impossible because it requires so many 
skill sets (CEO9) 
 
CEO-OTH42 CEO argues that simple 
messages make for 
flawed decisions 
‘I do see that and it happening but I find it very, very dangerous with 
simplification you lose some of the richness and might lead to completely the 
wrong discussions (CEO8) 
 
CEO-OTH43 CEO – not R&D - should 
simplify the message 
‘...its up to the CEO to do the reduction its not up to the scientist’(CEO14) 
 
CEO-OTH44 CEO should make sure 
scientists can remain 
scientists (and not 
become managers) 
‘... make sure that they become team players and everything but also make 
sure that they remain scientists and not managers chewing a message that is 
appropriate to the leader, that’s wrong I think...’ (CEO14) 
 
CEO-OTH45 CEO should be very 
flexible 
I think first of all you need to be extremely flexible, you need to be able to, I 
mean your days are always different, certainly if you’re CEO of a very small 
company that means ok you end up doing quite a lot, you end up even making 
coffee at some point so doing almost everything, you go to finance with the 
budget, business development, guiding the R&D, you basically are consumed 
with all these tasks and final decision making as well so I think in that respect I 
believe you need to be quite open minded and quite flexible as well’ (CEO15) 
CEO-OTH46 CEOs should be/act 
transparent 
‘I realise when I came back to here Belgium that because of their open policy 
people were committed, they know everything, I don’t have to wonder what is 
the CEO doing, I knew what he was doing because there was very open 
communication’ (CEO15) 
CEO-OTH47 CEO can prevent a R&D 
knowledge gap by 
growing from within 
R&D 
‘...there is no gap because I grew from the science’ CEO15 
CEO-OTH48 CEO teaches R&D about 
business 
‘...what you definitely see as well is that some people pick up extremely fast 
and these are the scientists with the business mind’(on the question how the 
firm teaches its scientist about business) (CEO15) 
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CEO-OTH49 CEO does not need to be 
a scientist 
‘...That gap can be bridged but they cannot sit in their ivory tower, if they’re 
too consumed that what they need to do day to day without showing a clear 
interest or challenge what the team is providing I think you have a problem, I 
think there needs to be a good interaction but I don’t think you need to have a 
scientific background to lead the company sufficiently’ (CEO15) 
 
CEO-OTH50 CEO has no time to talk 
to the scientists in R&D 
‘So what I think is important and what I do in practice is different, I think 
managing and motivating people is very important but I find myself that I have 
less and less time to do that, managing the company in a practical sense takes 
more and more time so in daily reality I am much more involved with my 
industrial partners and management board than I am with the employees of 
the company’ (CEO9) 
 
CEO-OTH51 CEO balances R&D vision 
with the Board’s vision 
‘… and as a CEO in many of my roles in my career actually I’m also more or less 
trying to represent, let’s say if I’m talking to the investors I’m defending my 
team so whatever they decide if we go in a certain direction and its mainly 
driven by what’s living here in the scientific team I’ll defend that to the 
investors but on the other side if the investors have a certain request for 
something like something through their network or they want to see 
something changed in our company they want more focus, less projects 
whatever, I’ll try to defend the investors versus my people so I’m always 
moderating … it works nicely’ (CEO13) 
 
CEO-OTH52 CEO challenges R&D and 
is challenged by R&D 
‘...so its influencing, its managing, its challenging people, challenging the 
organization but also be challenged and accept the fact that you’re going to be 
challenged because I think its this both way communication that is very 
important to being successful here’ (CEO11) 
 
CEO-OTH53 CEO knows how to 
challenge R&D because 
of his experience 
‘...when I talk to scientists I always tell them up front is look I’m not a scientist, 
don’t ask me questions about how a protocol of a clinical study has to be 
written but don’t try to fool me either because I will figure it out because I’ve 
been doing this for such a long time, I know what questions to ask ..’ (CEO11) 
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Appendix I. CEO Interview observations 
The positive attitude of CEO1 towards innovation is reflected in the many references to 
the creation of an environment that is supportive of innovation. The culture of 
innovation in the firm of CEO1 is supported by means of experimentation and failure 
tolerance (ATI2), an intense internal communication and appropriate organizational 
structures  (ATI3), the exchange of diverse ideas (ATI4), the external collaboration to 
increase internal innovation (ATI5) and the learning activities that build the innovational 
culture (ATI7). This positive attitude towards innovation is corroborated by the high 
number of commitment related statements such as the formal commitment of CEO1 to 
drive innovation by hiring selecting and developing innovative workforce (COM1), the 
creation of incentives and rewards for R&D (COM2), the creation of appropriate 
organizational structures (COM6) to allow intense communication and exchange of 
ideas to take place (ATI4). However, these two conceptions of the role of the CEO in 
innovation (attitude and commitment) do not shape the involvement of the CEO in the 
actual practice of R&D. The involvement in R&D is low as CEO1 is not involved in new 
product development processes which are led by project teams operating in a matrix 
structure.  His involvement in R&D therefore is limited to a sounding board for the 
scientists (INV3): 
 
‘that’s why I think being the sounding board there and just to say well ...: 
“by the way have you thought about this? ... or maybe you should talk to 
this person’ 
 
CEO1 is trained as a scientist but admits that his current knowledge is not sufficient to 
keep up with the intricacies of modern life science research in order for him to get 
involved in the every day discussion that take place in the R&D function. To the question 
to what depth he is involved in the research, he responds:  
 
‘I am not an expert , you know ... I’m not an expert ... but because I am not 
an expert, I can bring in this different angle, this different perspective on 
looking upon things and sometimes try to make suggestions..’ 
 
He considers the absence of detailed knowledge of the content of the R&D not as a 
disadvantage. The interaction with R&D takes place either during ad hoc meetings or 
through formalized meetings where decisions are taken a.o. with respect to project 
prioritization (COM3). The formalized meetings where CEO1 is involved in discussing the 
R&D projects are the top management team (TMT) meetings.  When R&D projects are 
put on the agenda of these TMT meetings CEO1 argues that spanning a bridge between 
the complexities of R&D know how and the general management knowledge residing in 
the top management team, is difficult. The core of the problem according to CEO1 is 
that this R&D know-how misses the business proposition that is required by the other 
members of the TMT in order for them to make sense of the R&D message: 
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 ‘I recognize it’s sometimes difficult, it’ sometimes very difficult ... also, 
some colleagues (referring to R&D) they ... they love what they are doing , 
they love the technology, they love the projects but they have no affinity or 
a limited affinity with what’s happening sometimes in the market place’ 
 
CEO1 expects that the R&D representative in the top management team (TMT) shares 
this concern with the R&D function in order for it to transform their know-how into a 
message or proposition that “makes sense” at the level of the TMT. This process of 
“translating” R&D know how into a message that makes sense to non-scientists and can 
be used in a different environment outside the context of R&D, is a challenge that is 
shared by other CEOs. CEO1 does not refer to the concept of “simplification of R&D” as 
was made by the other CEOs, but the interview made clear that there is a bridge 
between the knowledge contextualized within the R&D group and that same knowledge 
in the context of the top management team. During the pilot studies, the CEOs argued 
that the strategic business decisions need to be based upon information that should not 
be considered “rocket science” (Pilot CEO1) or that an individual may be required to 
translate the raw R&D data into a practical, business and market oriented propositions 
(Pilot CEO2). These CEOs do not take strategic decisions which are based upon raw data 
but on a knowledge base that was transformed – either by R&D, by discussions within 
the TMT or through an individual appointed to perform this task – into a package that is 
amenable to challenge and decision making. In the case of CEO1, he argued that he 
expects his R&D head to take the “learnings of the TMT with respect to the business 
proposition” back in the laboratories to make the decision process at the level of the 
TMT more efficient.  This process of transfer of R&D knowledge whereby the data are 
being transferred from one context to another in order to make it useful for the CEO 
and the TMT to discuss, challenge and take decisions was a recurring theme in the 
interviews. 
 
A theme that was also identified during the pilot studies is the argument made by CEO1 
that a too high focus on technology seems to be a risk factor for an innovative life science 
R&D firm:  
 
‘I want to avoid that we become too much technology driven ..” and “I am 
intrigued by science ...  without too much falling in love with the science 
because that’s always the risk’  
 
This is linked to the CEO’s concern that the science conducted in the R&D function may 
become too much disconnected from market needs. The reason for being “careful” with 
the technology is CEO1’s  concern that the R&D function – because it is peopled with 
highly educated, young and bright individuals - deviates from the firm’s main strategy 
and instead start to focus on the “progress of science”.  The concept of attention, (giving 
direction to the company and focusing on specific R&D goals) was not frequently 
stressed by this CEO. This may be explained by the fact his firm is a subsidiary of a major 
corporation that puts forward the major objectives in view of direction and focus.  As 
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this is the case, the “remaining” responsibilities of this CEO are to create an environment 
for innovation to occur, and to be committed to innovation.  
In contrast with the other CEOs, CEO2 makes a sharp distinction between the ‘R’ and the 
‘D’ in the company. The firm develops novel therapies and a selected group of 
individuals (“R”) experiments with new ideas (which eventually may fail) while the other 
group (“D”) is subject to strict budgetary and timeline control (i.e. the drug development 
group that is under pressure to reach targets and milestones). The environment that is 
being proposed as conducive to innovation is one where the real innovators are 
protected and can experiment with new ideas within specific boundaries and budgetary 
restrictions. As stated during the previous interview CEO2 also proposes to keep a 
“healthy distance” form technology. What is needed in a life science R&D firm is a CEO 
who  
 
‘doesn’t love the technology too much,  who is able to say ‘no’ as well as 
‘yes’ because ‘ that is where it goes wrong with people who fall in love with 
the technology’ 
 
CEO2 finds support for this point of view in the experience he accumulated leading start-
up firms where the founder of the company drove the technology. On the question 
whether the CEO has experienced CEOs who were particularly efficient in driving 
innovation, this CEO argues that he has not met such CEOs but – on the contrary - has 
observed CEOs who have not been successful in driving R&D and give the reason why 
this is the case: 
 
‘...because they’ve been real scientists themselves and ...  what you need to 
be is someone who doesn’t love the technology too much ... I have to be 
able to say no as well as yes and I think that where I’ve seen it go wrong is 
with people who fall in love, its why very often the early stage leaders  of 
companies have to be moved at some point because they’ve fallen 
completely in love with their technology and they’re no longer objective ...  
they bring in people like me later on who are hopefully still passionate but 
one step away ... so I think you see people where they’re more dispassionate 
(and) where they bring fantastic CSO’s who do love the technology ...  that’s 
fine as long as it’s a counter balance which I think the CEO then has to 
provide where they’re prepared to say no it doesn’t work, not good enough 
or there’s something better out there and so I think it’s getting that 
juxtaposition of the super CSO and the CEO who brings a little bit more 
balance, that’s his job he has to measure some other thing’ 
 
The separation between the CSO – as the “scientific superstar” – and the CEO as the 
“direction giver” is raised by many CEOs in this research. It is accompanied by the 
observation that – because of the complexities of modern life science R&D – the CEOs 
are not capable anymore to fully grasp the intricacies of the scientific activities 
conducted in their firms even when they were trained as a scientist. CEO2 argues that – 
even with his scientific background (he holds a medical/biological science doctorate) it 
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is impossible to understand the intricacies and complexities of current R&D. In line with 
CEO1’s observation, CEO2 requires the R&D teams to re-contextualize their know-how. 
CEO2 considers this an important aspect of R&D management and calls the process 
“complexity reduction”. According to CEO2, this is required for two reasons: first, it 
makes the R&D know-how ready to be challenged by the CEO at the same level of 
challenge as the challenge that is given by the CEO to other company functions (finance, 
IP). Second, because the simplified data can be used as business proposition to be 
discussed with the top management team and with outside stakeholders (such as 
investors). This complexity reduction process is a process whereby  R&D know-how is 
transferred into language that the CEO is able to challenge so that ‘I cannot be fooled”: 
 
‘.... yes I’m a PhD in science but I stopped science very soon after I did a PhD 
so I would never call myself a scientist ...  I think one of my most important 
functions ...  is to make sure that the scientists in the company believe I 
understand what they’re doing. One of the things a CEO has to be able to 
do is that everybody should be very, very afraid of trying to tell him anything 
that’s not true about the science, not that I can compete with these people 
in the science but I can tell when I’m being told rubbish, I can tell when there 
isn’t support to the idea and I think that allows me to challenge not just the 
finance guy, not just the commercial guy but also any science that is 
presented to me, or all clinical data that’s presented to me, ....  most 
importantly I think the ability to be confident to say I don’t understand what 
you just told me, tell me again until I do and we’re not leaving the room 
until you do...I take three times to understand it but if I don’t get it by the 
third time it’s their fault, there’s something wrong about their logic. I think 
that what all those need is to be sure that the leader in the organization 
can challenge them equally effectively, if I couldn’t do it with the science it’s 
a bit like me saying well I don’t understand finance’ 
 
According to CEO2 the process of reducing complexity is a bimodal concept because it is 
not only important to allow appropriate challenging and to make strategic decisions but 
also to serve the whole company, its shareholders and its internal / external 
stakeholders. The simplified R&D know-how “should not only make sense” to the CEO 
and the TMT but should also be the basis for “story telling”: 
 
‘I think the other key thing is to be able to reduce this complexity to simple 
ideas, one of my current themes in the organization is that the technical 
people will come and present me with a new idea and it will be 35 power 
point slides set and by number 3 I’m already twitching .... the idea that you 
can’t reduce half a pager to one or two slides, an important idea or concept 
.... I think the ability to help people package these things for whatever 
audience it may be and distil out the important, the core, when you’ve got 
so much heavy technical stuff and potentially heavy commercial stuff and 
clinical stuff all floating in there: what’s the thing at the heart of that? 
what’s the business proposition? what’s the thing you take to an investor? 
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what’s the thing you say to a new employee as you’re trying to track him 
into the company?  what’s the distillation of all this complexity because we 
could take a year to tell you what we do or we could take five minutes to 
tell you what we do? ... and I think it’s my job to be able to do the five minute 
elevator pitch so I think that communicator as a leadership thing is very 
important. So I do a lot of the internal communication as well as external 
and talking to people like the scientists, help them understand that side of 
the world to explain why it is that happens and what it is that we have to 
do in order to get support from the rest of our stakeholders so it’s really 
making sense of the world and telling stories to different people to help 
them understand the other sides of the business, helping the finance people 
understand what the hell commercial people are doing and in that we’re 
providing a link and a theme for things going forward. So obviously the 
development of that theme and that strategy is a key part of the job but 
then linking it between the different partners internally and externally and 
what different people want in terms of the story and how the scientists will 
think we spend too much time talking about cash and money because most 
people spend too much time about technical issues you know and its really 
developing, distilling that story, telling it again and it’s really about 
storytelling, this leadership role is all about, again people define that story’ 
 
It means that the “complexity reduction process” serves the “story telling” activity about 
the firm and its scientific assets. According to CEO2, the story telling and the associated 
internal and external communication is one of the key points of his role in a life science 
R&D firm. This priority for communication is clear from the number of times the CEO 
reflects on internal communication (ATI3). These factors are linked to the need for 
implementing appropriate structures to communicate effectively (COM6).  
The third interview took place with a CEO who leads a firm that is developing advanced 
screening systems for the early detection of disease states. CEO3’s view on innovation 
in the firm is that top management needs to act as a role model in innovation in that 
“the leaders are role models for the rest of the company, so that our actions speak 
louder than our words...” Innovation comes first top down and then “infects” the 
company, whereby the selection and recruitment of innovative individuals is a 
requirement for innovation to percolate through the organization. When asked about 
the knowledge distance between the R&D team and himself, he argues that this is a 
problem: 
 
‘....there is a communication gap right and so the language that you use to 
explain something is different between the science with the vocabulary gap 
in particular...’ 
 
The vocabulary gap between R&D and the CEO can however be bridged. The CEO 
argues that the scientists in R&D should make an effort to translate the essentials 
of their work into a message that can be communicated to top management: 
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‘... the essence of what it is that you’re discussing is simple, even if it’s a 
technical issue and if you can’t translate a technical issue to a common 
sense business language discussion and really have a discussion on the 
principles, on the core of what is really happening there then either – you 
know - there’s a communication gap or you don’t fully understand really 
what’s behind it and so I find it maybe puts a little bit of a challenge on the 
scientists, it requires them to spend a little bit more time communicating, 
they can’t quickly just – here is a report right....  they need to take that one 
extra step of translating a technical conversation to a common sense 
conversation but I think in going through that effort you end up having a 
much deeper discussion, you don’t have a superficial buzz word, technical 
driven discussion, you really get to the heart of the issue, the root cause, 
the root challenges and so I think you have a much more robust discussion 
if you’re able to translate the scientific point to a common sense point, so I 
think in the end result its actually very powerfully helpful for the teams ... it 
just requires a little bit more energy for them...’ 
 
This approach is similar to the approach which was used by the previous CEOs who 
argued that if the scientist cannot convince them about the value of the project, he 
(CEO2) will “quit after three attempts” because then “there is something illogic in the 
message that is being brought”. CEO3 argues that the context of the R&D message is an 
important part of the efficiency of the communication: 
 
‘.... let me take the extreme example, assume somebody is trying to fool you 
on an issue ... and they come with a scientific explanation, right, which 
you’re missing as a context in which that exist...  so if somebody wants to 
then explain me to go (into the direction of) X and you miss the overall 
context where X is one of 100 different things ... so why X versus Y? ... if you 
don’t know that 99 other scientific approaches are available, then you’re 
missing that context, so you rely on the individual to explain ... that context 
to you, you don’t have that base context’ 
 
The concept of context seems to be an important parameter for CEO3 to appreciate the 
message received from R&D. The context under which the R&D data have been collected 
is different than the context under which they will be used and will show its value. During 
this transfer process of R&D data is “reconfigured” into a context where it’s usefulness 
and potential value is shown to the CEO. CEO3 agrees that this is not an easy job, 
realizing his non-scientific background (he was an investment banker prior to his job as 
CEO), however, he/she considers this also to be an advantage for him/her as he/she can 
get right to the core of the problem: 
  
 ‘...and so that’s the one disadvantage you have as a CEO with a non 
scientific background:  when a scientist is trying to explain something to 
you, they’ve a greater ability of narrowing the discussion to a topic that 
they want to discuss and not really providing the full picture on the table 
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... and here you know I need ... the right people in the company: ...  
individuals that are really not trying to get their point approved but 
really are trying to think from the company perspective so people who 
are leaders who know that you need to bring this broad context or 
having the discussion in a good way...  so it’s really you rely more heavily 
on your scientists so there the talent search that you talked about is even 
more important and secondly I use ...  scientific advisors, if it’s really an 
important question, I bring other people to look at it, ask their advice so 
you bring scientists in to help you, so I think there you have to be a little 
bit careful on that one weakness that you have as a non scientist, there 
are huge advantages but there’s disadvantages as well’ 
 
The fourth interview (CEO4) was conducted with a CEO who has a very specific view on 
leading a life science R&D firm in that he considers the leadership of such a firm not 
different from any other firm. When asked whether he could easily switch from this type 
of company to another company outside of life science R&D, his answer is positive 
because the “fundamentals” would still apply: choosing the right strategy, insuring that 
you have the best possible team, having a mixture of flexibility and discipline and finally, 
in case of a small biotech company, ensuring careful cash flow management: 
 
‘I have managed various established ... businesses, which for me had 
nothing to do with managing innovation and I’ve also managed an 
R&D start-up. I think that 90 percent is the same... You need to take 
the time to learn at least the music that is going on. You need to ensure 
that you have the right team below you, especially in the area in which 
you feel you’re less competent ... the 10 percent is about the 
adjustment you have to make. ... You need to take the time to learn at 
least the music that is going on...’ 
 
Innovation can “be forced upon” an organization by means of two approaches: by 
continuously challenging the status quo of R&D and of the organization and by hiring 
the scientists to people the R&D function in order to come up with the most innovative 
scientific approach.  Innovation can be initiated by both the CEO and the CSO: each of 
them have the task to innovate from a business perspective and through the scientific 
objectives (OTH26), respectively . In addition, in order for innovation to occur, 
communication should be fostered through all layers of the organization (ATI3).  When 
CEO3 is asked about his relationship with the R&D function, he uses the metaphor of 
the “lyrics” and the “music”:  
 
‘I do not understand the science so I cannot go into the details 
of the science but I know what the key projects are and I try to 
understand what is going on. I always say that I want at least 
to understand the music. I don’t understand the lyrics but I need 
to understand the music and I need to be able to challenge and 
then I will challenge (R&D) people. That is the approach’ 
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CEO4 admits that he is not capable of understanding the “lyrics” of R&D (he holds an 
MBA and has no scientific background), but is capable of appreciating the “music”. The 
“music-lyrics” metaphor is explained as follows. The “lyrics” that CEO4 is referring to, is 
the “hard R&D data” consisting of biotechnological vocabulary that is only open for 
assessment, evaluation and discussion by experienced R&D researchers. These scientific 
“lyrics” are incomprehensible for CEO4 and in order for him to make sense of the data, 
he requires them to be communicated, not through the “score or the text of the piece 
of music” but through its essence: the music itself. This “music” can be appreciated or 
criticized by anyone, even by those who do not understand the lyrics or the score. 
Reducing the score and the lyrics of a piece of music to the actual music (what is heard) 
is – fundamentally - a process of complexity reduction. During his interactions with R&D, 
CEO4 wants to understand the basics of the science that takes place in the firm, as to 
make up his mind whether or not this “makes sense”:   
 
‘The idea is to go down the organization and to have meetings 
with the actual teams, who will explain what they are doing, ..  
one is for me to understand the music a little bit better. I will 
not follow the (R&D) leaders, that I know, but at least I will 
know a little bit better’” 
 
The message conveyed by CEO4 illustrates his/her need to have data extracted from 
R&D that is of such a nature hat it can be challenged appropriately.  CEO4’s involvement 
in R&D is limited to the challenging of the R&D function for “efficiency”, not for 
technicalities or scientific opportunities,  i.e. by a search for alternative approaches that 
may cut time and spend less financial and human resources. CEO4’s technical 
involvement in R&D is not possible because of lack of technical know how. Even for 
CEO2, who was capable to differentiate “rubbish from science” because of his scientific 
background, the intricacies of the R&D know how are so complex that a simplification 
step was required, in other words: even for CEO2, the “lyrics” needed to be reduced to 
the “music”. This limited involvement in the actual R&D practice, i.e. in the details of the 
R&D, is applicable to all CEOs interviewed as they are not involved in the day-to-day 
activities of the R&D function. For example, CEO1 stated that this is left to the team (“I 
am not involved”) while CEO2 is only introduced at the start of the project after which it 
is delegated to the R&D team and who is “generally only involved when things go 
wrong”. 
 
CEO5  manages a pharmaceutical company that develops new therapies based upon a 
novel molecular biology technique and holds a Ph.D. in molecular biology. When asked 
how he manages the information flow from R&D, he states that one should:  
 
‘..break it down to the most simple common denominator, simplest form of 
the issue,  so yes you can get bogged down into this miniature but I always 
try to keep it in a very simple form, simple is better for me right always and 
so I tend to probe in a very simplistic way and try to get to the most simple 
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explanation, essentials, one of the things that we’re trying to accomplish, 
you know what is the end goal of whatever you’re trying to accomplish and 
what are the hurdles along the way that you are encountering and how can 
we overcome all these hurdles and what can I do to help overcome that, 
maybe we don’t have the right expertise in house, you go out and get KOL’s, 
key opening leaders or consultants or people who have done this before, 
encountered something similar and can encourage them to think’ 
‘I spend a lot of time with my business development people, communication 
person and so on in trying to synthesize all of that body of information into 
a very simple form for the investors to understand, if we start talking to 
investors about ... they just get lost so we can simplify it, dumb it down to 
a point where its very simple concepts to simplify, that’s my job and that’s 
the job of our communications people and the business development 
people’ 
 
CEO5 expects the R&D function to modify their know-how in such a way that it 
is reduced to its most simple form in order for him to make the strategic decision 
process easier:  
 
‘... I try to say: if you were talking to your 10 year old son how would you 
explain what you’re doing, what you’re trying to do...” .... “you know if 
you’re going to a warm buffet and meet someone who doesn’t understand 
anything about science, how would you get that person to invest in your 
company by simplifying what you’re trying to do?’ 
 
CEO6 uses similar arguments when asked how he transfers knowledge from the lab into 
the management team meeting. The only approach that allows him to take strategic 
decision is to reduce the science into a less complex dataset that allows the TMT to take 
decisions. CEO6 argues that he wants his R&D team to prepare for this simplification 
step: 
 
‘The key is to the leadership team can simplify the case ... it’s easy to get 
lost in complexity … And raw data, I think what we’re quite good at it but it 
only develops by practicing is that we’re able to simplify the problem or the 
story to the essence so that we can look at it from a business point of view 
so that we can look at the business case and yes this role is extremely 
complex but if you ask the right questions I think you can simplify it to a 
certain level that you can make your decisions and you can also 
communicate to even less sophisticated people also the board about your 
complexity, your decisions’  
 
and to change the R&D function’s behavior in that regard: 
 
‘...so one of the things I learned is don’t try to download your complexity on 
your boards because then they go bananas but we’re also training the 
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scientists to not download all their complexity on the leadership team so 
they know which questions we will ask, so they’re forced to crystallize the 
research reality along answers to simple questions, they’re always the same 
questions, they know that, they know them by heart’ 
 
CEO6’s need for technology simplification is linked with his concern for the marketability 
of the technology developed in his biotech firm and again – as observed above with 
other CEOs, his/her concern that the technology will “take over” : 
 
‘Now biotech .... is a typical technology push, what I mean by that is you 
have the creativity, you have the ideas, you don’t need to stimulate them, 
they are already there and the big question is finding out as soon as possible 
whether that innovative idea is relevant for the markets ... so if you talk 
about the role of the CEO as of day 1, one of the things I have been doing in 
(name of company)  is I have been testing the market as soon as possible 
on the relevance of the idea which we had internally because a big pitfall of 
a technology push company is that the scientists are then offered the 
technology of the products, you work two, three, four years, you come out 
to discover there’s nobody waiting for that product and I think that’s a 
typical problem for biotech companies, they wait too long with a 
confrontation with the market, so when I talk about creating the vision of 
the company one of the things I have been doing as of day 1, even before 
we had a business plan is going out to talk to customers or potential 
customers and understand if I would deliver this, is it of interest to you or 
what do you expect me to do in order to make it of interest to you and 
feeding back that feedback to the lab, to the R&D organization, focusing 
them on delivering something which is relevant..’ 
 
The 7th CEO’s main objective is to set the direction and focus of the innovation to take 
place (ATT1, ATT2)  and therefore considers himself to be the main driving force for 
innovation in the firm. Innovation in R&D is a matter of setting ambitious goals to the 
R&D function and to develop appropriate organizational structures to allow internal 
communication to take place. CEO7 argues - as was the case with the previous CEOs - 
that the R&D function should be “pulled out” of their academic thinking and look to the 
market needs and to interconnect among each other and with the outside R&D 
community. The latter approach is required seen the academic pool from which the R&D 
scientists are recruited and it allows them to act in line with their expertise and 
experience.  CEO7 states that he is capable to increase the output of R&D when the 
teams are challenged from a managerial point of view and not necessarily from a 
technical point of view. There are no specific incentivizing approaches for the R&D 
function besides the use of spot-bonuses for exceptional efforts. With respect to final 
decision making, CEO7 argues that even if the process is more or less “democratic”, the 
ultimate and final decision is taken by the CEO and therefore it is he who takes the 
ultimate and final decision. The fact that a decisions is taken by input from all members 
of the TMT, it does not mean that the final decision is a decision made by the TMT: it is 
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a decision made by the CEO. The CEO gets the information and input on his decision 
from all levels in the organization: from the VP R&D, from the R&D managers and from 
individual scientists.  
CEO7 realizes that even with his/her medicines/biology background there is a difficulty 
of technical challenge of the R&D function seen the fast developments in the area of 
R&D.  CEO7 states that the need for transferring knowledge from the R&D group to him 
and from him to the board requires a stepwise simplification approach that will increase 
and become more important as the company will grow. This simplification process goes 
hand in hand with a “synthesizing” approach whereby the data are structured and 
presented in a format that allows appropriate communication either within the 
company or to outside share/stakeholders. This process of R&D knowledge transfer 
currently takes place from the chief scientist to the CEO and to the board. It will probably 
– according to CEO7 - develop into a process whereby the chief scientist will transfer 
simplified data from the R&D function to the CEO: 
 
‘at one time in the future, the chief scientist will know much more than I 
do and it is he who will then need to simplify the data, the same way as I 
am currently transferring simplified data to the board’ 
 
CEO8 is an atypical CEO in that he has received a business education (MBA), has 
extensive experience with an international reputed business consulting firm, has no 
prior biology/medical professional or educational background but nevertheless runs a 
company that develop drugs for the treatment of a number of diseases. In addition, he 
does not (want to) use the title of Chief Executive Officer but rather that of “Managing 
Director” as that is what he is actually doing: giving direction to the firm and manage the 
strategy towards the goals he has put forward (the vision). His position with respect to 
the need for a culture of innovation is not different from the arguments used by the 
other CEOs. However, his approach in dealing with the R&D function and the data that 
they deliver is essentially different from the other CEOs. When asked how he bridges the 
knowledge gap between the knowledge available in R&D and his general management 
knowledge, he argues that such a bridge does not exist. While some CEOs refer to the 
scientific data and their complexity in terms of a metaphor of “music and lyrics”, or 
require the data to be “simplified” i.e. that it be submitted to a process of complexity 
reduction, this CEO assures that he is fully capable of understanding the science that is 
taking place in his firm and is also fully capable of transmitting the original, non-
simplified message, because  
 ‘...our chairman knows more about the science than I do, there 
is no need to simplify the data or reduce the complexity of the 
science I am putting on the table at the board’ 
 
The danger of simplification, he argues, is that it may potentially lead to a flawed 
decision making process because it removes the richness of the data and may lead to 
the wrong conclusion. If a board has to make decisions based upon R&D data, it will first 
need to be elevated – educated - to a level of scientific knowledge such that the raw 
data can be communicated in its ‘original’ format. CEO8 argues that the process of 
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accepting, evaluating and transmitting R&D data is - at most - a process of synthesis 
backed up with the raw data but not a process of simplification. When asked about the 
difference between a CEO and a CSO in this firm, the CEO ‘holds and knows all the 
scientific details and data’, and argues that the CSO is capable of handling and discussing 
everyday lab-practices and the scientific details and concepts but is not assessing, 
screening market environments. In this firm, therefore, there seems to be a “R&D 
continuum” from the R&D laboratories over the leadership team into the board. CEO8 
accepts that the situation may change when the company will grow and that this transfer 
process may have to change. This was also raised by CEO7. Although the findings in this 
interview may not corroborate the observations made on the concept of transfer of R&D 
knowledge in the other firms, it points to the impact of the context under which this 
transfer takes place. In some firms, this knowledge bridge may be large and a complexity 
reduction process is required, while in other firms, this knowledge bridge is minimal and 
the knowledge transfer is – at most – an exercise in a “synthesis of R&D data”.  
 
CEO9 is the young CEO of a life science diagnostics company and has received a top 
science education (biomedicine and medicine). Nevertheless he/she argues that since 
the time that stopped doing research and became involved in the company, he/she has 
never been able to keep track of new scientific developments and to keep pace with the 
work of the scientists in the lab. Since he/she became CEO of the firm, it has become 
virtually impossible to understand the knowledge generated in the lab, even with his/her 
remarkable background: 
 
‘...a specific disease and specific genes ... that’s where I have my 
knowledge and can place them into a context and see if it’s logical or 
if it works ... so if they come up and say: ... based on our analysis of 
50,000 process on a 1,000 patients we use these kinds of analysis...  I 
don’t even know what it is, I don’t know how to spell what they’re doing 
but at the end... that’s where I tap in, its logical what’s happening here 
and so it doesn’t really matter that I have that specific knowledge, …’ 
‘I’m involved with  people that are doing bioinformatics, who have to 
simplify what they are discovering to me... but they have to make clear 
to me what they have found and how they came to that process in very 
general terms that I understand so ... I always want to understand it.’ 
 
He/she argues that there is a specific skill set associated with the capability of 
a scientist to be able to explain complex things: 
 
‘... what has always intrigued me is the following : ...  if you go to a 
lecture of a PhD student that has started two years ago, it is impossible 
to understand what he’s saying, it’s impossible and nobody really 
understands ... the head of department tries to understand what he’s 
saying ... if you would go to another floor and meet a Noble Prize 
winner who is giving an overview over the work he has been doing in 
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the last few years - although its far more complex what he has seen 
and what he has done - almost everybody can understand it..’ 
 
It is therefore important to: 
 
‘... bring it (the R&D knowledge) into convincing digestible pieces of 
knowledge...’ 
 
CEO10 is the founder CEO of a R&D company who has left the world of science already 
10 years ago and has since then been involved in strategic matters and giving the 
direction and focus to the company. He/she has recently hired a chief scientific officer 
who is looking for alternative ways for identifying promising new therapeutic molecular 
leads. Using the same arguments as CEO9, he/she requires the data of his scientific 
teams to be heavily reduced in complexity for him/her to make sense in order to 
discover the underlying strategic information that allows him to proceed with the firm 
into a certain direction.  
 
CEO11 and CEO12 are both CEOs of a major pharmaceutical firm. They were introduced 
into this research to compare their roles in innovation versus the roles in the CEOs. 
CEO11 has a legal background but was a business development manager since the 
beginning of his career. When he/she was appointed CEO of the firm, he/she argued in 
a local newspaper, when confronted with the question whether he/she will be able to 
interact with the R&D team: 
 
‘... they will not fool me..’ 
 
thereby repeating the argument of CEO2 who argued that  ‘I cannot compete with these 
people in the science but I can tell when I’m being told rubbish, I can tell when there isn’t 
support to the idea...’. These CEOs seem to be capable to extract from a set of complex 
pieces of knowledge that specific information that is important for them to make 
strategic decisions on the conditions that the knowledge from R&D undergoes a 
transformation to allow the CEOs to value the knowledge. According to CEO11: 
 
‘... I don’t have a scientific background. First of all I think what you have 
to do is to recognise for yourself what it is you know and what it is you 
don’t know and especially from a scientific point of view, surrounding 
yourself with good people who complement the knowledge you are 
lacking, people who have strong scientific training, who have insights, 
... and who can help you to understand what it is from a pure scientific 
point of view what’s going on and then asking questions towards your 
scientists ... when I talk to scientists I always tell them up front:  look 
I’m not a scientist, don’t ask me questions about how a protocol of a 
clinical study has to be written but don’t try to fool me either because 
I will figure it out because I’ve been doing this for such a long time, I 
know what questions to ask and sometimes I ask questions because 
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based on ignorance by which they are taken by surprise because its not 
a question that they will expect from a scientist …’ 
 
CEO11 uses his/her experience as a basis for his/her capability to evaluate R&D 
knowledge. The prior knowledge that resides in the CEO is not science or scientific 
management but experience in how the science can be used for economic objectives. 
These remarks are comparable to those of CEO4 who argued along the same lines that 
it is an advantage not to be a scientist as it allows the CEO to ask the ‘right’ questions, 
i.e. those that R&D does not expect. As was argued by previous CEOs, CEO11 requires 
R&D scientist to be able to decomplexify their knowledge: 
 
‘Look ...  you probably need both kinds of people, very strong in the 
science but maybe not that good in communicating on what they are 
doing and trying to translate that into what I would call normal 
language that is: such that the marketing guy will understand, the CFO 
can understand and other people can understand what this really 
means...’ 
 
For the CEO to be able to grasp the knowledge that is generated in the R&D department, 
this knowledge needs to be calibrated to the level of the CEO. What seems to take place 
is a titration whereby the knowledge levels of both parties, the CEO and R&D find a 
common ground that, on the one hand, retains the core of the message that R&D wants 
to see conveyed and, on the other hand, allows the CEO to use his prior knowledge and 
experience in order for him/her to challenge it. It seems that the prior knowledge of the 
CEO (either obtained through education or through experience) drives the calibration of 
the message from R&D such that the CEO can challenge and evaluate it.  Even CEOs with 
a strong educational science background require a decomplexification step seen the 
pace by which science evolves and the speed by which a CEO’s knowledge is out-dated 
if the CEO is not actively involved in the science.  
 
Another CEO of a large pharmaceutical corporation that was included in the interviews 
was CEO12. In contrast with CEO11, CEO12 is an academically trained chemist with a 
pharmaceutical marketing background.  The fact that he/she has a scientific background 
creates self-confidence when interacting with the RD team: 
 
‘... well I’m a chemist by training so they cannot really catch me totally 
off guard, so ask silly questions, make them explain and ask, ask, ask, 
if you come to the fifth why usually you get an answer that even you 
understand, that even I understand.. what I want to understand is 
whether it’s thought through and that there is a high conviction level 
of the fact that we’re doing the right thing, I want to test this 
identification, this belief, emotional bond which is often thought 
through, well thought through...’ 
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The CEOs of the large pharmaceutical firms seem to use the same approach used by 
CEOs of SMEs. It seems that CEO background and not firm size seem to be an important 
role in trying to assess the value of the R&D knowledge. 
 
CEO13 is the CEO of a small highly R&D intensive company with a strong scientific 
background in organic chemistry although he/she currently runs a small R&D company 
involved in developing antiviral compounds. He/she argues: 
 
 ‘..I’m not going into depth into the science, I’m just trying to understand enough 
so I can sell the idea’ and ‘I’m trying to understand as much as possible that I feel 
that is necessary for my investors to be comfortable with it or to invest in it or – 
so its kind of a translation’ 
 
CEO13 considers this simplification step required for him/her to communicate the 
knowledge to the board because  
 
‘...a lot of them are actually totally unaware of what happens in biology or 
virology’ 
 
CEO14 is a bio-medically and medically trained CEO of a small R&D firm that develops 
new drugs in a specific therapeutic area.  He/she beliefs that a CEO of small life science 
R&D firms should – first of all – know how to lead scientists because scientists are ‘very 
different from other people’.  When a CEO fully understands the implications of leading 
scientists, there is no need for a CEO to be a scientist: 
 
‘... you have to know how to lead an organization of scientists so in that 
way you have to understand their typical characteristics, it’s not the 
same as guiding IT engineers, it’s a different breed I think,  like its 
different to lead an organization of sales folks, so you need to 
understand culture, you don’t have to be or to be part of that culture 
but at least you need to understand they’re different cultures so these 
are people who are sometimes difficult to manage in a team format. 
For example, they have a pretty strong individual opinion, their 
opinionated and you have to be able to deal with that, it doesn’t mean 
you have to accept that but at least you have to be able to realise that 
and then maybe bring them into some kind of framework that is 
optimal for the company and may not correspond entirely with what a 
scientist would like but at least you have to be able to communicate...’ 
‘...a scientist is not a team player, by definition is not a team player, a 
true scientist is not a team player at all, you don’t find new things 
playing in a team...’   
 
However, in contrast with other CEOs who argue that R&D knowledge needs to be 
simplified when it reaches the top of the organization and in contrast with CEO8 who 
argues that such simplification is not necessary, CEO14 offers a third angle to this 
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concept of complexity reduction in that it does not need to be conducted by the 
scientists but on the contrary by the CEO him/herself. According to CEO14 this approach 
will avoid the CEO to make the wrong decisions, which was one of the arguments of 
CEO8 why such simplification step is quite risky. CEO14 argues: 
 
‘by simplifying things you induce another variable (in the decision  
making process), the more variables you have to deal with the more 
difficult the decision will be and so the outcome becomes 
unpredictable.  Simplification does not remove the variables ... they 
don’t disappear by this simplification’ 
 
According to CEO14 this complexity reduction step is to be conducted by the CEO 
him/herself rather then by R&D. CEOS should not be afraid to ‘dive into’ the complexity: 
 
‘... I think its up to the CEO to do the reduction... it’s not up to the 
scientist, it’s up to you as CEO whether you can live with that or 
whether you go back to the scientists and say what the hell is going on, 
that’s up to you but the fear of hearing a message you can’t deal 
with..., it’s so easy to decide on a single message versus multiple 
messages, versus complexity...’ 
 ‘There is a certain machismo in this business ...  as a CEO you have to 
understand everything and then you decide right away....:, if that’s 
your behavior, complexity doesn’t fit into that kind of behavior unless 
you are extremely smart and willing to take risks, ... but I’m willing to 
take the risks, yes I will take decisions if they ask them, yes I will deal 
with complexity...’ 
‘The point is if the scientist will reduce complexity before they discuss 
it with you because they think that you won’t like it, ...  it’s your fault 
because it’s their perception that you want to have it like this, that 
means that you have told me things in the past that are not right,( I 
have to make sure as a CEO) that ...they remain scientists and not 
managers chewing a message that is appropriate to the leader, that’s 
wrong I think’ 
 
According to CEO8 and CEO14 the complexity reduction of R&D know how should not 
proceed for two reasons: first, there is the risk of taking the wrong decision because the 
simplification has removed some key variables which were required to make the right 
decisions, and secondly, if a complexity reduction has to take place it is not the scientist 
but the CEO who should do the complexity reduction.   
CEO15 is an atypical CEO as he/she grew from within the R&D function into the CEO 
position, and therefore there is no knowledge gap observed at all at all between the R&D 
function and his/her knowledge base. 
 
‘...that’s basically because I grew out of that environment and I think 
that it’s an advantage as a CEO ... you understand it really well 
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because I’ve also noticed that if you’re too close to what you’re doing 
you sometimes don’t see the bigger picture’ 
 
CEO15 however argues: 
 
‘I think I would say from my end, there is no gap because I grew from 
the science, what I have to be very careful with is (and what)  I want 
to avoid, (is that) there is a gap from the other side so I know what 
they’re doing really well but I want them to be involved as much as 
they can to also see the business side of things so that they can help 
things think through ...’ 
 
In other words, the knowledge gap that – until now – was identified as a gap in scientific 
knowledge between CEO and R&D, is also a gap in ‘business and market’ knowledge that 
may help to arm the scientists with the necessary knowledge to steer and make sense 
of their R&D activities. In other words, the knowledge gap is bifocal, either it is science - 
based from the perspective of the CEO or its business - based from the perspective of 
R&D. 
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Appendix J. Procedure for the focus group research 
All 15 CEOs were invited to attend the focus research group, realizing that it is ‘important 
to recruit to cover for no-shows’ (Morgan, 1997). The CEOs were invited using a letter 
of invitation in which the objective of the meeting was explained. Of the 15 CEOs who 
were invited 5 agreed to join the focus group. On the day of the focus group meeting, 
one CEO informed that he/she was not able to make it. This led to a final research focus 
group of 4 CEOs.  Other CEOs were also interested to attend the focus group but were 
not available at the specified date and time. An attempt was made to create a second 
focus group but the availability of the CEOs proved to be a difficult problem: only 2 CEOs 
could make themselves available for the secondly proposed date. Because this number 
is considered to be too small for a focus group, the second focus group meeting was 
cancelled. All 4 CEOs were part of the first group of CEOs and also agreed to have their 
senior scientists interviewed. The table below lists the 4 CEOs who joined the focus 
group. CEO1 changed company since the first interview and – at the time of the focus 
group research -  acted as the CEO of a major R&D organization with 814 R&D scientists. 
The other CEOs were still managing the same company as during their first interviews. 
It may be appropriate seen the size of the focus group and the interaction of these CEOs 
to have a short description of the four CEOs.  
 
Characteristics of the CEOs participating in the Focus Group Research 
Life 
science 
R&D 
Firm 
CEO  CEO age 
range 
CEO educational 
background  
CEO  
experience 
Number of 
scientists in 
R&D 
Country 
C CEO1 40-50 Science 
Business 
development 
approx. 800 Belgium 
B CEO5 30-40 Economics 
Investment 
banking 
approx. 200 Switzerland 
R CEO8 30-40 Engineering 
Management 
consulting 
approx. 30 Belgium 
P CEO15 30-40 Science 
Chief Scientific 
officer 
approx. 20 Belgium 
 
CEO1 is a soft-spoken, experienced top manager with a highly developed scientific 
academic career which then changed to a business development position and 
subsequently to a CEO position of two life science R&D companies. He is known to 
interact strongly with all levels of the R&D organization and argues that most of 
innovative work comes from the ‘bottom’ of the R&D function and that that level should 
be highly regarded as to their input in innovation.   
 
CEO5 is known by his collaborators as a highly intelligent, sharp and fast learner and 
although he does not have a biomedical background, he knows the language of science 
through his earlier research work in the social sciences. He has major experience in 
investment banking.  His remarks are sharp and to the point and his interest in acting as 
an effective CEO of a science firm sounds sincere. 
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CEO8 has no bio-medical background and came from a major consulting firm; CEO8 
showed sincere interest in the topic of research and has read the systematic review of 
the literature with great interest. It is clear from the communication with CEO8 that 
he/she likes to reflect on his responsibilities and his/her job and – during the interviews 
with CEOs – was the only CEO who argued that complexity reduction is not necessary 
and eventually may lead to flawed decision making. 
CEO15 is known as a very efficient manager who grew from the R&D group of his/her 
company. His/her collaborators respect his/her because of his/her dedication, interest 
in R&D activities and continuous wish to foster communication within the company. 
He/she argues that, as he/she grew from R&D, it would be a mistake as a CEO to keep 
on meddling with the science as this ‘blurs’ his/her vision for the future. 
The size of the focus group 
According to Morgan (1997), the size of a focus research group is based upon as well 
‘practical and substantive considerations that help to clarify the basis for the rule of 
thumb size that specifies a range of 6 to 10’.  According to Morgan, a focus group below 
6 may be difficult to sustain a discussion, above 10, it may be difficult to moderate one. 
However, Morgan argues that ‘one should not feel imprisoned by either this low or 
upper boundary’ and that ‘groups of 3 highly involved participants would have been 
unmanageable at size 6’. In the case of CEOs who are individuals with very clear point of 
views and are capable to articulate their points of view quite strongly and with 
conviction, the presence of 4 CEOs was considered a focus group size that was 
manageable from the point of the moderator. Above 4, and certainly at a group size of 
6 or higher it would become quite difficult to moderate a group of independent, mature 
and very articulate – opinionated – individuals. 
 
Determining the interview content 
According to Merton et al. (1990) the goal is ‘to construct an interview that covers the 
particular topic at hand while generating observations that satisfy the four criteria’ 
mentioned above. Because focus group meetings generally last about 1-2 hours, it is 
recommended to develop a guide that structures the activities with the focus group 
(Morgan, 1997). According to Morgan, the most common form of guide is based directly 
on questions because ‘the very act of asking questions signals the moderator’s basic 
control over the content and direction of the group’s discussion’. Therefore the focus 
group was informed about the agenda that would guide the discussion. The CEOs were 
informed before the start of the meeting as follows: 
 
- Step 1. The interviewer presents the data of the research obtained via the CEO 
interviews in a condensed fashion as to allow the CEOs to become informed 
about the conclusions. The time foreseen for this session was 10 minutes. 
- Step 2. The CEOs are asked whether the conclusions obtained could be 
supported by their own experience and whether they resonate with their 
experiences. The time foreseen for this discussion was 30 minutes 
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- Step 3. Finally, the CEOs were asked the following plenary question: ‘What is in 
your opinion the most  important challenge for you as a CEO in leading R&D in a 
life science R&D firm’ 
It was agreed with the CEOs that the overall sequence should be respected. All CEOs 
agreed with the proposed guide. 
Meeting site 
According to Morgan (1997), the site is a particularly import aspect of focus group 
research, as the site ‘must balance the needs of participants and the needs of the 
researcher; there is little use for sites where participants will not be comfortable or 
where it is not possible to record the session’. Therefore, it was decided that the meeting 
should take place in an environment that is suitable for the elite level of the 
interviewees. The Faculty Club of the University of Leuven was selected because it was 
at an appropriate distance from the headquarters of 3 firms and for one CEO to fly in 
directly from the airport. The meeting started at 7 pm with a short reception for each 
other to meet, followed by a light dinner. Afterwards the CEOs were informed about the 
guide as discussed above. 
 
Recording, videoing and transcription 
The discussion was recorded using an Olympus LS11 digital recorder but was not 
videoed. The text was transcribed word by word but, because of the complexity of the 
interaction, it was reproduced in a condensed way in order to extract the data while the 
audiotape was also used as the source of content analysis. It was (re)listened several 
times to understand and appreciate the dynamics of the interaction. The meeting took 
1hr and 20 min. 
 
Data analysis 
The transcript was analyzed as follows. The transcript was introduced into a tabular 
overview in which the CEO comments (CEO5, CEO15, CEO8 and CEO1) were introduced 
in chronological order and accompanied with comments from the interviewer (3rd  
column).  
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Appendix K. Focus group research observations 
CEO CEO comment Comments by focus group moderator 
CEO5 One of the other important parts of the so-called 
simplification of the idea is that it goes beyond the 
ability of the CEO to understand the complex data 
coming out of R&D but even more importantly, that it 
allows: 
- The selling of the idea to the shareholders 
- The selling of the idea to the market 
- The selling of the idea to the employees and to be 
able to rally people behind the idea. 
In other words you can only drive the idea if you can 
make it simple, because if you describe it in a detailed 
‘raw’ way, people will get lost and loose the value of the 
idea 
CEO5 reconfirms the statement made 
during the interviews of CEO2 that the 
complexity reduction step not only 
serves to balance the absorptive 
capacity of the CEO, but also the 
latter’s narrative using the 
transformed version of the complex 
R&D knowledge as the basis for story 
telling inside and outside of the firm 
CEO15 Well there is another important characteristic to that 
simplification process, in that it forces the R&D groups to 
focus on what they are actually doing: by forcing them to 
put the knowledge in simpler terms , it generates focus: 
i.e. what are we doing and what is the objective of what 
we are doing in a way that ‘OK now I see it...’   
What I have also found is – and I grew out from the R&D 
myself – that by doing so - the CEO is not only capable to 
understand the science that takes place but even more 
important to ask the right questions to R&D and it’s that 
training exercise that is very important – It is also one of 
the big challenges of a small company and that is to keep 
the team motivated because this is  a good driver 
because bonuses is only a short term driver – one of the 
motivational drivers is also to be challenged 
This is also corroborated by the R&D 
individuals who argue that it is 
important to keep the link between 
their research and the larger context in 
which it is conducted. Knowledge 
reduction is therefore also a ‘sense 
making’ process for R&D. The 
comments made by CEO5 and CEO15 
show the importance of the concept of 
knowledge reduction. It seems to be an 
important instrument in the CEO’s 
arsenal of management techniques to 
run his firm and involve R&D. 
 
 
CEO1 A CEO can also not be too dominant especially with  
scientists... 
CEO dominance was also referred to as 
a CEO characteristic that is 
incompatible with life science R&D 
firms as corroborated by CEO14. The 
need for ‘CEO science understanding’ 
was raised by R&D executives but not 
clearly defined (see Chapter 6). 
Although gender impact was not a 
focus of the research, the CEOs 
considered this an important 
parameter for further investigation. 
CEO15 That’s true because you will suffocate them 
CEO8 ...some R&D executives require basic understanding of 
the CEO with respect to the science. That is a very low 
requirement... they are more looking for brainpower 
than for scientific insight 
CEO15 How many female CEOs were represented? 
CEO1 55% of all employees in life science are women... 
CEO8 In our company alone that is 80%... 
CEO15 The reason is that probably you will find a gender 
difference 
 At this point the moderator changed to the topic of trust 
as it appeared during the interviews with the R&D 
Executives 
CEO8 The question is to know about what trust we are talking. 
Is it trust in the CEO but in what? 
At this point CEOs refer to the balance 
between trust and challenge as was 
raised by R&D executives during R&D 
interviews. The trust- challenge-
distrust relationship seems to be a 
sensitive topic between CEO and R&D. 
According to CEOs, challenge is 
required, while R&D executives agree 
with the positive aspects of challenge 
but question when challenge starts to 
create the perception of distrust.  
 
CEO1 Making sure that he is the right person to bring in the 
money, to approach the market... for the company to 
survive  
 
Talking about trust there is a complementarity between 
the level of trust and the knowledge that resides in the 
CEO 
 
CEO8 The trend is in trusting the CEO doing the right thing... 
it’s not necessarily saying that the CEO is trusting me I 
think this is the most complex issue... Trust of the CEO 
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towards the team – I find it also very normal to challenge 
people that when you come along and you start asking 
questions: can you show me the data – but some people 
interpret this as a lack of trust – some people really think 
that if I come with this it should be fine and why 
question it? 
 
CEO1 There is a very thin balance between trust and control – 
just from my experience : we were taken over by (name 
of company) that’s a company – a multinational – 
typically where .. they manage not by trust but by 
control. They manage ... by definition, they do not trust 
anyone... and typically, so my boss who was a senior VP 
at (name of the company), when I was telling him, he 
was at least checking data related to numbers or figures 
with five other colleagues to make sure whether this is 
consistent 
 
CEO8 What I find a bit difficult, it’s almost checking... 
CEO1 That is , that’s how they work... by definition, they 
don’t....trust 
CEO8 That sounds – that is very clear to me as being 
wrong...that if somebody is telling you something you’re 
gonna check it with somebody else 
CEO1 That’s typically... in these firms 
 
It is clear from the discussions with the 
CEOs that the concept of trust is a 
difficult concept and that it is not clear 
where the balance can be found 
between trusting R&D and let R&D 
proceed and where the CEO should 
become involved and to challenge 
thereby risking the development of 
feelings of distrust within R&D. CEO8 
considers challenge a ‘conditio sine qua 
non’ for dealing with R&D. 
CEO8 For example, a person that we fired – (we lost every 
single client) because we had quality issues and quality 
issues that she/he was hiding and frankly, I fired her/him 
and he/she literally said I will never work anymore for a 
CEO who does not trust me a 100%... and there it was 
very clear that I personally went overboard in trusting 
her too much and still it was not sufficient to her... so 
therefore I find this trust to be a very complex hmm... 
it’s very difficult to accept data and be offered data by 
R&D with the statement ‘take it at face value’... 
 
CEO15 From my experience, in my company which is a high 
research company, so there is not that much routine... I 
had similar issues; somebody masked results, but what I 
have noticed in our company what helps I believe is that 
I never challenge what comes out...I challenge it up 
front...we do it with a project management system: 
when we have investment review. Before the project is 
actually conducted and people are not personally 
attacked by it...because you discuss every possible 
outcome, the whole experimental design. We do that as 
a team and the result that comes out is nothing 
‘personal’ anymore; if you say ok... and that helps what I 
found certainly with very difficult experiments..it’s a 
complex matter and that people did not find personally 
attacked if you are challenging up front; were the 
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statistics right? .... but really take the challenge upfront 
(instead of after the facts) 
CEO8 Let me give you the following example, there is a 
business developer who comes to me and says .. you see 
I talked to a number of CROs at this conference and a big 
competitor and they told me that they are 10 % cheaper 
then we are... I want us to drop our prices.. what do you 
do?  
 
CEO15 If you are indeed not getting new business in.. 
something is wrong... 
In general, I remember at some point a business 
developer in our company was coming back saying you 
know... we definitely have no competitive prices.. and 
yeah it was easy to trust him...because we were not 
getting the business in...something was wrong...but the 
technology was strong...it was probably overpriced.. 
CEO5 It’s a common conversation with sales lower our prices it 
is all about the margin... 
CEO8 We were getting business in... The concept of challenging is not only a 
matter of the act of ‘challenge’ itself, it 
is also a matter of ‘how’ the challenge 
is taking place 
CEO5 Maybe I could throw another element in here. I think it’s 
really  how you have the conversation... its not about 
what you are challenging it, it really is how you bring it... 
and there is really a communication style element to it... 
and to make it even more complex .. what I learned he 
last year there are major cultural differences and the 
Flemish culture is really on the one end of the spectrum 
– it’s actually similar to the Japanese culture believe it or 
not... and you have another dimension of sensitivity to 
the question how the questions get asked.. You have to 
be very polite that is important and especially as a CEO, 
if you ask a question it is really  amplified in the Flemish 
culture...If you ask the same question in the United 
States, in Germany in the UK you get very different 
responses – so that was really an interesting experience 
to me culturally, particularly in Flanders .. You have to be 
very polite... 
CEO15 Yes, I saw that as well ... well, I have not worked as a CEO 
in the States but I led an operational team in the States 
and for me it was a night and day difference compared 
with Belgium – I found that the average scientist in 
Belgium performs at a higher level but I believe that ... 
they are more negative ... they love to complain, they 
love drama, and their commitment to the company is 
lower than what I observed in the States.. In the US you 
are in the company, you believe in it..., you go for it.. you 
don’t constantly scrutinize the decisions and I believe 
that is completely different here in Flanders... The whole 
team wants to think through the entire process.. and 
scrutinize every single component of it.. whether they 
are in the right position to do so, it does not matter... 
they all have their opinion on everything...every single 
topic that happens in the company. In the US, I did not 
experience that... So for me it was much easier to lead a 
team in the States than it is here in Belgium... 
The concept is trust disruption may be 
culture driven 
CEO8 I think it also differs among people, I have people where 
I can be extremely straight and ask questions and then 
there are other people where I .. 
CEO15 Yes I agree, I do not want to generalize but I found in the 
States everybody was more inclined to go along with the 
company – wasn’t questioning every single thing all the 
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time... and  I think it’s the Flemish mentality sitting 
beneath our church and watching what everybody else is 
doing... and criticize what everybody else is 
doing..without acting ourselves.. and to some degree 
that kills innovation and I think that is also linked to the 
company culture as well.. 
CEO5 The major challenge for a CEO of a life science R&D firm 
is focus, focus because we have so many great people in 
our organization and excellent scientists that it is difficult 
to choose from the different opportunities from creative 
bright minds in the firm... 
Excellent ideas 
 
CEO1 I think that is a challenge for most of the R&D driven 
firms biotech companies because a/ they are limited by 
their financial resources and b/and the same time, so the 
focus, and at the same time making sure that what they 
do that they are ‘leading’... that you maintain your 
competitive edge which by definition means that you 
need to continue to innovate and that’s ... finding the 
right balance 
Focus is difficult seen the quality of the 
people in R&D. This is a re-
confirmation of the statement made by 
CEOs that the focus is on maintaining 
the firm’s competitive edge, and not 
allowing R&D to explore non-core 
academic) routes (see Chapter 4) 
CEO5 Yeah, it’s really tough, a tough balance 
CEO15 Yeah me too... 
CEO1 Yeah I agree with that...I agree with that.. Within the 
whole context of – what is it... 
CEO15 I think it’s focus, I believe it... a problem of early stage 
when you have many choices but once you have the 
focus...is clear, we know what to do and..where we need 
to go. I think it’s motivation... because initially R&D 
teams will complain well it’s unclear from management 
what we are going to do which direction, that direction 
etc... they want to see that focus and they need 
structure and focus and once structure and focus is 
there, then the next step how do you keep them 
functioning at such a high level... Because once the focus 
is there the teams tarts to grow, and certainly people at 
the very high level, they hate it if there is too much 
routine... 
What I am a firm believer in and I saw it from the other 
side, (the experience I had in the US) the company I 
worked for had an extremely open policy and very open 
communication, we knew how much money there was 
on the account, you new exactly what the CEO was 
doing, why he was doing it...we had a very open 
communication, and that really led to commitment... I 
knew exactly what they were doing... and saw exactly OK 
that is how they approach it...and saw commitment 
because I was learning at a high speed and I was learning 
so much and I am translating that this to the company 
right now... I think it is the learning that is motivating. 
They know exactly I am at (name of conference), these 
people are investigating this and this and that and when 
I come back from.. I go to outside meetings , e.g. to a 
course on reimbursement , but upon my return I share 
all that information with them (R&D) not in the largest 
detail and not on every single day..otherwise nothing 
gets done but they really feel like there is nothing 
hidden, everything is out clear in the open, everything is 
on the table and they see as well that I also have to do 
my daily jobs in terms of finance, making sure the bills 
get paid...and all of that stuff and ...they are committed.. 
Although not explicitly raised during 
the CEO and the R&D executive 
interviews, CEO15 raises the issue of 
R&D motivation. CEO15 argues that 
R&D motivation may be ignited 
through a culture of transparency, that 
generates commitment from R&D. The 
arguments raised by CEO5 indicates 
that the concept of CEO commitment 
has its counterpart in R&D 
commitment. Although it is very 
premature to argue, but is an 
interesting concept in that the CEO role 
behavior such as CEO attitude etc. may 
have /may need their respective R&D 
counteracts in order for innovation to 
flourish, such that for example CEO 
commitment triggers R&D 
commitment and vice versa 
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CEO5 I do something similar. I write a CEO blog when I go to 
for example conferences, the things I see .. how others 
are doing...we share on a quarterly basis all our 
financials.. so we have an open employee round table – 
we try to keep transparency with the employees on the 
things that are happening... but there are two other 
things that appear and we try to do: one main thing that 
I try to do is around purpose: the question of why? Why 
are we a company, what are we trying to do...what is the 
bigger mission for us, what is the purpose? It really is in 
our case of making a difference in terms of treating 
patients.. how we want to bring (name of product) 
everywhere in the world, make it easy, reproducible to 
change how researchers are developing drugs and the 
focus on (therapeutic area): what makes a difference... 
we had  (name of person) came over and give a very 
personal speech of himself as a patient and what is 
happening in (therapeutic area) and explaining why what 
we are doing is making such a difference.. it really rallies 
the employees around a common purpose... and repeat 
that all the time... so that is one key element  
The second key element is the ‘fun factor’, so we actually 
have as one of our core principles that people should 
work hard and have fun.. measured actually...it is one of 
the performance metrics...are you having fun yes or 
no?.. we try and celebrate small victories so we have 
many parties, dj’s at the company...and so we really try 
to keep that chemistry inside the company...that is fun, if 
there is any negative talk we try to react immediately on 
it and put the spotlight on it...to keep this chemistry, this 
excitement 
CEO15 I think key, key is communication and you often tend to 
forget about it...if it gets extremely busy...you tend to 
cancel a staff meeting and you can do it once...you can 
do it twice 
 
CEO1 I think the larger a company is of course...the more 
difficult that becomes 
CEO15 The more difficult this becomes 
CEO1 The more challenging it is... but for me there are two 
things where I wanted to.. for example, the scientist who 
determined what is going to in the pipeline which are for 
me very key people just make sure that they stay 
connected with what they do is creating value and that is 
what I always try to do...and showing results of our 
business partners Ok so they claim ownership of that – 
that they are very much disconnected from where the 
value in the market has been created... 
Again, CEO1 reaffirms the need for 
focus for R&D, such that R&D is not 
distracted/disconnected from the core 
objectives which is to conduct R&D 
with a market objective 
CEO1 Another way of motivating is well business having, 
having... business deals. We had two major business 
deals whereby – I would not call them service deals – but 
whereby they had to deliver and being part of it...having 
been able to contribute to that was always very 
motivating because they worked I  teams with other 
companies and they discuss the issues and problems , it 
is seen as motivating 
CEO5 Valuing their work is really important – there are small 
things that you can do like for example in December I 
went into the pilot line and there I made a (name of 
product) together with the team...so they had to explain 
to me all the 39 steps... putting this product together... 
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and so this team spent a half a day making that product 
with me... you show that you care about it...what they 
are doing, you show that you are there to support them.. 
these small things can take you so far way.. 
CEO1 That is what I spend quite some time in spending time 
with all levels within the company... for example people 
working in the (name of unit),  really I valued them what 
they did...very much... And I always sensed that for them 
that was highly appreciated but very motivating... Again, 
it is about valuing their work, their contribution to the 
company...wherever you are (in the company) 
Here the concept of CEOs operates at 
all levels emerges again 
CEO15 I saw that in the States in a company of 60 people: every 
other week he CEO walked around and talked to almost 
everybody in the organization: just ask what are you 
doing, and not to scrutinize, not at all, purely out of 
interest, interest in you as a person and valuing what 
you are doing for the company, that is such a boost – 
every- body was talking about it.. that is one point and I 
think – that is the point that you make  (pointing to 
CEO3) the external business and service I noticed that 
people are a bit slightly more motivated if it is an 
external project then an internal project – because it’s 
their name on the report and they will go that extra 
length to ensure . they represent the company...they are 
absolutely proud of that... 
Talking at all levels 
CEO1 We did that to (referring to the all-levels visits of the 
CEO) every two months... 
CEO15 We do the same – we call it a corporate day and in the 
morning we have the management presentations 
(financially etc).. feedback from the board and so 
forth...and in the afternoon, small team building... 
CEO8 In our company, we are bit different we are xx people, In 
my case the biggest challenge is to keep up with the 
science, there is a lot of advancement in the field.. so 
many things come out and actually, they see the 
(scientific) paper and it has immediate impact on what 
we do... so trying to follow that ... 
Here the topic of ‘CEO has expert 
knowledge’ reappears  
CEO1 .. but how far do you go in that because you have to 
make choices everyday and when you see all these new 
... you know ... on the one hand these are threats or 
opportunities...  
CEO8 For me it is related to the vision – my company is x year 
in the running and the same vision still stands... the 
strategy can change a little – the vision is on which 
mountain do you want to stand and strategy is which 
road will you take.... and that is very ‘public’ and from 
that we cascade everything down (to the finances). We 
also have a very flat organization – a leadership team of 
8 people...there are just 2 layers...the team knows 
exactly how much cash we have and so on... 
The other people I must say I would tell them – they are 
rather more interested in the science, the status of the 
projects, what clients think... sometimes scientists argue 
that it is better for them not to know how much such a 
test costs that we are conducting... My experience is that 
they (R&D ) are not so much interested in for example 
the cash status...that is not what they are typically 
interested in... 
The concept of CEO-attention re-
emerges as part of the discussion how 
and which R&D project to support. The 
focus that underlies the long-term 
view. 
CEO15 You have to judge your team very carefully and see 
whether they have the mental power to really put this 
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into the right perspective, because some people may not 
be able to cope with it...depending on certain situations 
your company is in, I am not putting everything on the 
table... I 
CEO15 know exactly what I want to convey and am definitely 
holding stuff back as well, because you do not want your 
team to be worried.. 
CEO8 We have cash for another (x) years which for a biotech 
company is quite a lot... but even that makes some 
people very, very nervous... sometimes we inform our 
people ahead of a press release of what we plan to do 
 
CEO15 It is extremely motivating that you share the information 
with the people before it actually goes public  
CEO8 .... but that is quite a risk isn’t it? 
CEO5 Communicating means that sometimes you need to keep 
things internal to the company 
CEO1 Especially because it is a small world and everyone 
knows everyone... 
CEO15 That is the case in the US as well... it is a very small 
community... 
At this stage a discussion develops on the technical and commercial value of therapeutic areas and 
opportunities and the moderators interferes and stops the discussion to keep the focus on the topic and 
specifically on the topic of ‘knowledge’ (as the need for knowledge was a frequently recurring topic of discussion 
with the R&D executives) 
CEO8 You do not need to understand everything but at least to 
the level that you are capable to have discussion...with 
the scientists, with the CSO. Often things can change 
quite quickly and then you need to understand what the 
implications are and putting it into the perspective and 
what the companies would like to see or not see;: what 
are the technologies that are available. It is always 
surprising how things that are standard now were 
considered not possible 12 months ago. There are so 
many technologies coming online...and it goes so 
quick...that you need to see quickly the implications... 
 
CEO8 so all these things actually come into play in the business 
discussions and how do I figure out what information I 
can disclose or not... 
 
No further discussion of knowledge is taking place as was observed during the CEO interviews. It is not on top of 
their mind set. If you would be asked to identify a CEO for a life science R&D firms, what characteristics would 
you identify as crucial? Is it knowledge? Is it brainpower? 
CEO8 By definition, I do not think there is a key thing...if there 
is a key thing it is probably the multi-functionality  - 
there are lots of different things 
This section addresses the 
requirements of a CEO of a life science 
R&D firm. Again, the concept of 
learning new R&D knowledge linked to 
their absorptive capacity is stressed.  
In addition CEO5 stresses the ‘learning 
agility’ and not necessary the ‘learning 
ability’ of the CEO. In addition, 
communication, emotional 
intelligence, motivation-ability, 
knowledge of the market, or the 
capability to translate this knowledge 
in a simple way. 
CEO5 Well I think it is one of the things that we talked about... 
at least from my personal perspective I would say 
‘learning agility’; the agility to learn, un-learn and re-
learn... because un-learning is pretty important in a 
world that changes... this learning agility 
Communication... these are general themes, not really 
specific to life sciences...  
 
 
CEO5 General leadership abilities, emotional intelligence, 
ability to motivate the people; I do not know that if I 
were a board member that I would mandate that the 
CEO has to be a scientist, what I think is much more 
important is that the CEO can understand the market 
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and translate that into a simple way, communicate to 
shareholders; so there must be some base level of 
translation, but really understanding all in great detail is 
not necessary... 
CEO15 For me the situation was different as I was leading the 
team scientifically, before I became CEO, and I noticed 
that I had a much clearer vision, the less I got involved in 
science, the involvement of a CEO in science should be 
from a distance, because the more close you are 
involved the more blurred your vision becomes… you are 
sidetracked... I think it is really ... I think emotional 
intelligence is very important, bringing in the right 
people at the right point in time and you of course need 
to have market knowledge and know your business 
really well... and also understanding that a company is 
evolving ...and the team at the beginning should not be 
the team at the end and you have to make sure you are 
capable to identify a weak link running around and 
everybody sees it, the CEO sees and does not act upon 
it...it’s killing...because everybody gets de-motivated.. 
Also if a company changes you need to change the 
company’s environment.. always be one step ahead...Ok 
this is where we need to get to, not right now but we 
need to prepare ourselves… for example retrain your 
people 
Also excellent people skills are necessary... 
And also offer trust so that you should not be involved in 
every little factor.. 
According to CEO15, dis-involvement in 
the science is an important behavior in 
order to create a clear vision for the 
future, the creation of a certain 
distance from the science 
CEO1 
Yes you need to put these things (the science) in the 
grand scheme of things 
The commitment theme is an 
important role behavior of the CEO, 
illustrated by the hiring of the right 
people at the right time. A clear view 
on the future (CEO attention) and focus 
and trusts towards the R&D function. 
CEO8 That is what I meant there is no single key characteristic 
you need to be distinctive in, it is almost the opposite, 
you have to be in a lot of things at least good, but if 
there is one thing among these things in which you are 
not good in, I think there is an issue... 
According to CEO8, all the above 
characteristics seem to be important as 
a ‘whole’, while the absence of one 
characteristic may be detrimental, or 
should be compensated by another 
member in the top management team. CEO15 Well if you know your own weakness then make sure 
there is somebody who is there with the strength to 
balance you weakness...for example, if I am weak on the 
science part of things, get a good CSO... 
CEO8 But again, if you are not good on the science you have an 
issue, if you are not good at the people level you have an 
issue...if you are not good in making decisions you have 
an issue, if you are not goof in communicating you have 
an issue 
However, CEO8 is still not convinced if 
the knowledge of the scientific 
principles is not present in the CEO, 
then ‘you have an issue’. In other 
words, the concept of ‘knowledge’ 
remains a discussion topic among CEOs 
and R&D executives 
CEO1 Yes but these (manufacturing) guys are excellent in 
operational capabilities...here you need of course – we 
are all R&D driven... high risk, capital intensive.. 
CEO5 What are the most successful CEOs in the 
pharmaceutical industry? The current CEO of (name of 
company X in pharmaceutical industry) is the former 
CEO of (name of company in food industry). He has zero 
life science exposure.... 
CEO1 But maybe X, that is not a life science company 
anymore....would this work in a small biotech start-up 
where you put someone with no experience with the 
start-up, dealing with VCs, managing expectations,  
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Is there a characteristic that differentiates a life science CEO from let’s say a manufacturing CEO? 
CEO5 Could you imagine an internet CEO joining the biotech 
industry? He knows the VC’s, the start-up culture 
etc...??? 
 
 Silence  
CEO8 I don’t think it matters a lot  
CEO1 I think it all comes down to personality to what the 
person is.... 
 
CEO15 I think that is true...  
CEO1 Our company was once managed by a CEO from a major 
multinational coming in managing the small R&D 
company of 35 people, it was a disaster... no affinity with 
the science...it killed him...he even looked at them as if 
they (R&D ) were wasting money... 
 
CEO5 They need to have the learning agility....one advantage 
of coming from the life science industry is that they have 
relationships, the network,  
 
CEO1 I think the network is very important in this business...  
CEO8 I think that is everywhere he?  
CEO1 Yes, but the time you need to invest in building that 
network is . 
 
CEO8 I think the other thing is flexibility, the ability to ‘move 
around’ and probably a little bit more stress 
resistant...and being comfortable to dealing with lots of 
uncertainties 
 
CEO1 Each of us is exploring unknown territory...  
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Appendix L. Procedure for the interviews of the R&D 
executives  
 
The research that investigates the role of the CEO as seen by R&D executives is also 
exploratory. This is justified by the fact that it is a continuation of the previous research 
that investigated the role of the CEO as seen by CEOs. The main argument to define this 
research as exploratory is that there is still ‘little or no scientific knowledge about the 
group, process, activity or situation they want to examine but nevertheless have reason 
to believe it contains elements worth discovering’ (Stebbins, 2001). That little is known 
about the perception of R&D executives about their CEO’s role in innovation was shown 
by the review of the literature: no empirical study was identified in which R&D 
executives’ perceptions about their CEOs’ role in innovation was studied. The 
continuation of a structured interview based exploration with R&D executives can be 
argued as follows: 
 
- first, the first part of the research was an interview based exploration. It would 
be difficult to defend the use of another method when both research streams 
focus on CEO roles, either used by CEOs or perceived by R&D  
- second, if one of the objectives of the research is to explore differences between 
the roles that CEOs use to describe their role in innovation  and the roles of the 
CEO as perceived by R&D then it is required and necessary to use identical 
methods. 
It was therefore decided to continue this part of our research using a structured 
interview based exploration.  
Interview procedure  
 
Selection of R&D scientists  
Each CEO who joined the research project agreed for his /her key R&D managers be 
interviewed. The list of the 39 R&D executives selected by the CEOs are listed in 
Appendix M. The R&D executives were approached individually and informed about 
their selection by the CEO for a research interview. A date and place for the interview 
was set and an agreement was reached on the duration of each interview.  
 
From R&D research questions to R&D interview questions 
As it is decided to proceed with this research by means of structured interviews, 
interview questions should be developed that allow the research questions to be 
answered. The interview questions that will be asked to R&D executives should mirror 
the interview questions asked to the CEOs. For example, while the question asked to the 
CEO: ‘What do you think are the attributes of the role of a CEO in innovation in a life 
science R&D firm?’ requires the CEO to respond with his/her view about his/her role, 
the same question, when asked to the R&D function, explores how the R&D function 
perceives the role of the CEO. Other interview questions which were asked to the CEO 
are slightly modified such that the question is not asked to the CEO, but to R&D 
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executive about the CEO. The questions that will be asked to the R&D executives are 
included in the table. The questionnaire is added below. 
 
Contrasting the interview questions  
Q Question as used in CEO interviews Question to R&D: 
Q1 What do you think are the attributes of the 
role of a CEO in a life science R&D firm?  
What do you think are the attributes of the 
role of a CEO in a life science R&D firm? 
Q2 What are in your opinion the major leadership 
characteristics of a CEO in a life science R&D 
firm?  
What are in your opinion the major leadership 
characteristics of a CEO in a life science R&D 
firm? 
Q3 What is in your opinion the most important 
driving force for R&D innovation in the 
organization and why?  
What is in your opinion the most important 
driving force for R&D innovation in the 
organization and why? 
Q4 How do you create a climate of innovation 
and why?  
How does he/she create a climate of 
innovation and why? 
Q5 Is an innovational climate important even in 
R&D firms which should be, by definition, 
innovative because of the nature of the work?  
Is an innovational climate important even in 
R&D firms which should be, by definition, 
innovative because of the nature of the work? 
Q6 How much time and effort do you make 
available to obtain information from your 
R&D team in percentage? 
How much time and effort does he/she make 
available to obtain information from your 
R&D team in percentage? 
Q7 How are new ideas developed in R&D? How are new ideas developed in R&D? 
Q8 How do you identify new ideas in your firm 
and exploit those ideas? 
How does he/she identify new ideas in your 
firm and exploit those ideas? 
Q9 Are you actively looking yourself for new 
ideas in the organization? 
Is he/she actively looking yourself for new 
ideas in the organization? 
Q10 What are your driving factors to invest in, 
make available resources and support R&D? 
What are his/her driving factors to invest in, 
make available resources and support R&D? 
Q11 How do you as a CEO actually increase the 
output of R&D? 
How does he/she as a CEO actually increase 
the output of R&D? 
Q12 What are your incentives to stimulate 
innovation in R&D? 
What are his/her incentives to stimulate 
innovation in R&D? 
Q13 How do you live with and manage the risk 
associated with R&D? 
How do you think does he/she  live with and 
manage the risk associated with R&D? 
Q14 How do you bridge the gap between the 
scientific/ biomedical knowledge in R&D and 
your (general management’s) knowledge? 
How does he/she bridges the gap between 
the scientific/ biomedical knowledge in R&D 
and your (general management’s) 
knowledge? 
Q15 With whom and how frequently (times/w, m, 
y) do you actually discuss R&D, and why? 
With whom and how frequently (times/w, m, 
y) does he/she actually discuss R&D, and 
why? 
Q17 To what depth are you involved in the NPD 
discussions and why? 
To what depth is he/she involved in the NPD 
discussions and why? 
Q18 What is your role in advancing new product 
development? 
What is his/her role in advancing new product 
development? 
Q19 How do you describe your role as CEO in R&D 
vs the role of your CSO? 
How does he/she describe your role as CEO in 
R&D vs the role of your CSO? 
Q19 Who takes R&D decisions and why? ( Who takes R&D decisions and why?  
Q20 Who decides on the final product design and 
why?   
Who decides on the final product design and 
why?   
Q21 Who is the most important driver in new 
innovations in your firm? 
Who is the most important driver in new 
innovations in your firm? 
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Q22 Have you seen CEOs who were particularly 
effective in driving R&D, and why do you think 
they are? 
Have you seen CEOs who were particularly 
effective in driving R&D, and why do you think 
they are? 
Content analysis 
The interview procedure was identical to the procedure followed for the CEO (pilot) 
interviews (approach, confidentiality, recording, transcription).  Each theme that 
emerged during the interview with the R&D executives was analyzed using the same 
primary/secondary node structure used for the transcript analysis of the CEO interviews 
and assigned to  
 
- either an a priori literature based theme (CEO attitude: ‘ATI attitude’, CEO 
attention: ‘ATT attention’, CEO commitment: ‘COM commitment’, CEO 
involvement : ‘INV Involvement’ and CEO innovativeness: ‘INN Innovativeness’) 
or  
- to a theme that emerged from the CEO interviews (CEO-OTH1 to 53) 
If new  themes would emerge that could not be assigned to any of the a priori themes 
and the ‘CEO-OTH’ themes, they were codified as ‘RD-OTH1’, ‘RD-OTH2’, ‘RD-OTH3’ etc., 
in analogy with the other roles that emerged from the interviews of the 15 CEOs (and 
which were previously identified as CEO-OTH1, 2, 3 ... 53).  
Arguments for a pilot study 
There are several reasons why a pilot study is worthwhile: 
 
- first, the pilot study is needed to obtain a ‘feel’ for the interview of high level 
industrial scientists: how will they respond to academic research that explores 
their relationship with and attitude towards their CEO?  
- second, one of the inquiries that are put forward to R&D top management 
executives is whether they ‘have seen CEOs who were particularly effective in  
driving R&D, and why do you think they are?’. It is important to observe the 
feedback from the executives to see whether this inquiry is considered 
inappropriate realizing that by answering these questions they may 
inadvertently judge their own CEOs? 
- third, it is also important to observe and ‘feel’ the response of the R&D scientists 
when they are approached to discuss the role of their CEO. Do they respond 
openly and open up with their own ideas?   
- fourth, it is also useful from the interviewer’s point of view to look for an optimal 
interview style with R&D executives: would there be specific conditions that have 
to be met when interviewing top level R&D scientists? 
- fifth, if R&D top management ‘copies’ the role descriptions offered by the CEO, 
and therefore does not offer an alternative view on the role of the CEO in 
innovation, is it worthwhile to proceed with the study before recruitment starts 
of R&D executives? 
- sixth, alternatively, if the R&D top managers offer strikingly different views as 
compared with the CEO views, it may drive the R&D executive research into 
other avenues and potentially into an alternative methodological approach. 
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Execution of the pilot study 
The same firms introduced in the pilot studies for the CEO interviews were also selected 
for the pilot R&D interviews.  The first pilot R&D study was conducted in the same firm 
where the first pilot CEO (CEO1P) was interviewed. The second pilot R&D interview could 
not be conducted in the same firm where the second pilot CEO interview was done 
(CEO2 P), because the firm went through a difficult time and appointments were 
continuously postponed. Therefore, the second R&D pilot study was conducted in the 
firm that could make its R&D executives readily available for an interview.  This was the 
firm led by CEO2. The questions asked to the R&D executives of the firm led by CEO1P 
were questions 1, 2, 6, 10, 14, 18 and 22 because the CSO only accepted a 30 minute 
interview for each (see shaded area in the table above). All 22 questions were asked to 
the R&D executives of the firm led by CEO2 because the CSO allowed a full 1 hour 
interview with him/herself and each of his/her R&D managers.  All interviews were 
conducted on the same day. In the first pilot firm, four R&D executives were interviewed 
each during 30 minutes while in the second pilot firm, 2 executives were interviewed 
during 1 hour each. All interviews were recorded, transcribed and analyzed according to 
the operational principles laid down in Appendix E. The number of transcript pages was 
45. 
 
Pilot interviews of R&D executives reporting to CEO1P 
 
The R&D executives in the first pilot study consist of a chief scientific officer (CSO) and 
three senior R&D scientists who report to the CSO and frequently interact with the CEO 
(as confirmed by the CSO). The findings are divided in two parts: the first part presents 
the emergence of literature-based a priori themes) followed by a 2nd section that 
presents the emergence of new themes. 
 
Primary/secondary node structure based upon the outcome of the final CEO interviews (cfr 
table) and used for the analysis of the (pilot) R&D interview transcripts 
ATI Attitude 
ATI1 CEO fosters a culture of innovation 
ATI2 CEO fosters experimentation and accepts failures 
ATI3 CEO fosters internal communication 
ATI4 CEO fosters the exchange of diverse ideas 
ATI5 CEO fosters external collaboration to increase internal innovation 
ATI6 CEO fosters flexibility and adaptability 
ATI7 CEO fosters learning in the organization 
ATI8 CEO states that processes may stifle innovation 
ATI9 CEO has an inquisitive nature: asking, listening, probing 
ATT Attention 
ATT1 CEO sets the direction/goal and vision in which innovation to take place 
ATT2 CEO sets the focus and boundaries in which innovation to take place 
COM Commitment 
COM1 CEO hires selects and develops innovative leadership 
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COM2 CEO creates incentives and rewards for the R&D function 
COM3 CEO prioritizes resources 
COM4 CEO makes available human and financial resources 
COM5 CEO empowers R&D to execute on new ideas 
COM6 CEO creates hierarchical flat organizational structures for innovation 
COM7 CEO reduces development risk by hiring expert people and developing options 
COM8 CEO manages ideal cash flow for LFRD firms 
INV Involvement 
INV1 CEO challenges R&D for efficiency 
INV2 CEO challenges R&D technically 
INV3 CEO acts as sounding board 
INV4 CEO interacts with R&D to solve technical problems 
INV5 CEO is involved in NPD 
INV6 CEO holds frequent formalized meetings with R&D 
INV7 CEO is involved at the start of an R&D project and then delegates it 
INV8 CEO comes up with new innovative ideas 
INV9 CEO evaluates economic viability of R&D project 
INV10 CEO picks up to R&D innovational opportunities 
INN Innovator 
INN1 CEO drives new product development in person 
INN2 CEO takes control of every detail of NDP 
INN3 CEO wants to transform/disrupt the market 
CEO-OTH CEO Other roles 
CEO-OTH1 CEO admits limited knowledge in specific R&D area 
CEO-OTH2 CEO admits not driving innovation but rather the direction of innovation 
CEO-OTH3 CEO interacts with R&D only in those matters he/she has personal knowledge in 
CEO-OTH4 CEO should not focus on technology 
CEO-OTH5 CEO stresses the importance of strong knowledge in the field of innovation 
CEO-OTH6 CEO requires R&D data to be simplified for strategic decision and communication 
CEO-OTH7 CEO wants R&D to step out of academic thinking 
CEO-OTH8 CEO role model is knowledge based 
CEO-OTH9 CEO aims to obtain respect from R&D 
CEO-OTH10 CEO attempts to understand R&D expertise 
CEO-OTH 11 CEO carries R&D through difficult times 
CEO-OTH12 CEO considers it an advantage to be untrained in science 
CEO-OTH13 CEO considers himself at a disadvantage as a non-scientist 
CEO-OTH14 CEO informs R&D about the company's position 
CEO-OTH15 CEO role model is business driven 
CEO-OTH16 CEO wants to protect R&D from the mundane aspects of running a firm 
CEO-OTH17 CEO acts as a role model for innovation 
CEO-OTH18 CEO role is to link R&D to internal & external stakeholders 
CEO-OTH19 CEO reduces risk by fail fast fail cheap 
CEO-OTH20 CEO gets information from/discusses R&D with all levels 
CEO-OTH21 CEO role in R&D is not different from CEO role in non-R&D 
CEO-OTH22 CEO looks for the best possible management team 
CEO-OTH23 CEO requires persistence and resilience in LFSR 
CEO-OTH24 CEO argues that innovation comes from top down and bottom up 
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CEO-OTH25 CEO and CSO are innovative forces together 
CEO-OTH26 CEO innovates by challenging the organization (time, costs etc) 
CEO-OTH27 CEO argues that innovation also occurs outside R&D 
CEO-OTH 28 CEO argues that R&D should always be one step ahead 
CEO-OTH29 CEO educates the firm’s environment 
CEO-OTH30 CEO argues that value is as important as market 
CEO-OTH31 CEO and R&D should have relationship of trust and confidence 
CEO-OTH32 CEO should have firm belief in the product 
CEO-OTH33 CEO considers patients as innovation drivers 
CEO-OTH34 CEO needs to understands process/risks of R&D 
CEO-OTH35 CEO needs to understand culture of science 
CEO-OTH36 CEO needs to know how to lead scientists 
CEO-OTH37 CEO’s understanding of scientists is more important than being a scientist 
CEO-OTH38 CEO should have some basic understanding of science 
CEO-OTH39 CEOs of LFRD firms should not be dominant 
CEO-OTH40 CEO needs bottom-up ideas in LFSR firms 
CEO-OTH41 CEO top scientist/top business man/women is ideal 
CEO-OTH42 CEO argues that simple messages make for flawed decisions 
CEO-OTH43 CEO – not R&D - should simplify the message  
CEO-OTH44 CEO should make sure scientists can remain scientists (and not become managers) 
CEO-OTH45 CEO should be very flexible 
CEO-OTH46 CEOs should be/act transparent 
CEO-OTH47 CEO can prevent a R&D knowledge gap by growing from within R&D 
CEO-OTH48 CEO teaches R&D about business 
CEO-OTH49 CEO does not need to be a scientist 
CEO-OTH50 CEO has no time to talk to the scientists in R&D 
CEO-OTH51 CEO balances R&D vision with the Board’s vision 
CEO-OTH52 CEO challenges R&D and is challenged by R&D 
CEO-OTH53 CEO knows how to challenge R&D because of his experience 
 
Literature based a priori themes.  
The theme of CEO innovativeness (INN) did not emerge from the interviews indicating 
that the R&D’s perception of the CEO as innovator is aligned with the CEO’s view that 
they do not consider themselves as innovators (as was observed during the CEO 
interviews). Three themes appeared during the interviews: CEO involvement (INV), CEO 
commitment (COM) and CEO attention (ATT). The R&D executives emphasize the CEO’s 
commitment and attention, i.e. his/her hiring policy and the presence of a clear vision 
about the future: 
 
‘it was our task to give a realistic idea of what is feasible and 
not feasible, to give a realistic idea of the disclaimers to the R&D 
idea ...maybe that the interaction of the CEO, CSO and a 
number of other (R&D) people has to be installed to start 
thinking about strategically, how should the future of this 
company look like?’ 
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This is made clear through the statement ‘CEO involves R&D into vision’ (RD-OTH4-P; 
see other themes below). CEO commitment is perceived by R&D as the CEO’s vision to 
increase the potential for innovation by creating flat organizational structures and 
hierarchies and the hiring of the right people:  
 ‘I think what a CEO ... (should do is) only two things: define a 
line of vision and hire the right people. .. what he needs to do is 
to make sure that there is at least a level of communication 
which people in the different departments feel involved’ 
The commitment theme is also made clear by R&D executives who perceive the CEO as 
capable to ‘bring in the money’. Upon the question whether they have seen CEOs who 
were particularly effective in driving R&D , they responded by arguing that these CEOs 
had a clear vision and focus. A concept that is linked to the theme of CEO attention: 
 ‘the CEO of (name of other firm), focused on making one thing 
happen... getting drugs in development... So that is something 
we expect from him....a clear kind of defined buy-in, the 
definition of the boundaries in which we can work...not exact 
but roughly...’ 
RDE1P and RDE4P referred to the vision (CEO attention), organizational structures, 
hiring policies (CEO commitment) and CEO involvement. Only RDE3P referred to the 
CEO’s attitude in leading a life science based firm.  The reason for the absence of this 
theme with the other R&D executives may be caused by the fact that R&D executives 
assume their CEOs were selected by the boards to have the right attitude to lead a 
science-based R&D firm and consider this not to be worth mentioning.  
Other themes.  
There are 21 themes that appeared during the interview of the R&D executives that 
could not be assigned to any theme previously identified (they are listed in the table 
below - RD-OTH1-P to RD-OTH21P).  When asked about the necessary attributes of a 
CEO of a life science R&D firm, the CSO responded that he/she should have ‘trust and 
have confidence’ in his/her R&D executives (RD-OTH1): 
 
‘the CEO has to provide confidence and trust in the CSO’ and 
‘It’s a question of confidence’ 
On the one hand R&D requires the CEO to show trust and confidence in its expertise but 
on the other hand they expect they can trust the CEO in taking their contributions into 
account: 
‘...the hope is that (there is) trust in the CEO ... to come to (a) 
reasonable collaborative teamwork and agreements’ 
The concept of trust was presented by R&D executives as a bimodal concept in that trust 
exists either in the CEO by R&D and by the CEO in R&D. The trust of the CEO in R&D is 
linked to his/her willingness to accept failures while the trust of R&D in the CEO  
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R&D Other 
roles codes: 
Other themes: 
R
D
E1
 P
 
R
D
E2
 P
 
R
D
E3
 P
 
R
D
E4
 P
 
 
 
Comments 
RD-OTH1-P Trust by the CEO in R&D + nm nm nm According to the Chief Scientific Officer , the concept of ‘trust’ is 
key in the relationship between CEO and R&D. This argument was 
made several times by the CSO during the interview and with 
visible affirmation. 
Trust in the CEO by R&D + nm nm nm 
RD-OTH2-P CEO offers freedom to R&D + nm nm nm The concept of offering freedom was used by the CEO of this firm; 
it is here reaffirmed by the CSO. The offering of freedom to R&D 
obviously is a sign of trust and constitutes an attitude of the CEO 
towards innovation 
RD-OTH3-P CEO has no time to talk to R&D + nm + nm The time taken by the CEO to talk to R&D is indicative of his 
commitment (time and effort) 
RD-OTH4-P CEO involves R&D into vision  + nm nm nm Involvement from the viewpoint of R&D means that the CEO looks 
for R&D input to develop a strategy for the firm 
RD-OTH5-P CEO is approached with simplified data + nm nm + This is a re-affirmation of the observation made during the 
interviews of the CEO that data are reduced in complexity when 
interacting with the CEO 
RD-OTH6-P CEO is involved in R&D projects for valuation + nm nm nm The involvement of the CEO in project evaluation is part of the 
construct of absorptive capacity as was argued in the first part of 
the research 
RD-OTH7-P CEO has sufficient knowledge for R&D to feel comfortable + nm nm nm The concept of knowledge takes a strange ‘twist’ when seen from 
the viewpoint of R&D: the knowledge of the CEO should be such 
that R&D feels comfortable discussing R&D with the CEO not 
necessarily for the CEO to take decisions 
RD-OTH8-P CEO is teached by R&D on the value of R&D  + nm nm nm Part of the comfort creation of the R&D function is to teach the 
CEO about the science 
RD-OTH9 –P CEO links all stakeholders to build a new product + nm nm nm The CEO ‘who links all stakeholders’ is a new concept that appears 
in these interviews  
RD-OTH10-P CEO for a LFSRD firm should ideally be a seasoned scientist and a 
seasoned business man/women 
+ nm nm nm The concept of the ideal CEO from a viewpoint of R&D is a ‘rare 
animal’ who is not only capable to deal with the science but even 
more to extract the fraction from the science that can be used to 
create ‘wealth’. 
RD-OTH11-P CEO is not aware about the gap in knowledge between him/her and 
R&D 
+ nm nm nm This is part of the knowledge discussions held in the first part of 
the research during the CEO interviews when ‘CEOs argue that 
there is a gap right?’ 
RD-OTH12-P CEO receives messages that are considerably transformed for him/her 
to assess their value 
+ nm nm nm Same as above 
 
 
Appendix L 
308 
 
RD-OTH13-P CEO does not need to know all the details about the scientific research 
that we conduct 
nm + nm nm According to R&D a CEO should not be knowledgeable about all 
the scientific details. In other words, there can be a gap, as long as 
it can be bridged ‘comfortably’ 
RD-OTH14-P CEO may have difficulties linking the details of the science with the 
value behind them 
nm + nm + See comments under RDOTH6-P 
RD-OTH15-P CEO is very approachable nm nm + nm This comment was made in view of the personality characteristics, 
such that a CEO is not a distanced figure the scientists should be 
afraid of to approach 
RD-OTH16-P CEO may underestimate the complexity of scientific R&D nm nm nm + Some CEOs actually do not understand the complexity of the 
science 
RD-OTH17-P CEO is not a scientist per se (he should have other qualities) nm nm nm + The argument that the CEO acc. to the R&D function should not 
be a scientist is based on the fact that R&D would appreciate 
learning from the CEO about the place of their research and 
development work in the larger framework of the business 
RD-OTH18-P CEO need for involvement is company size dependent nm nm nm + The R&D executive argues that the need for detailed knowledge 
depends on firm size, with the largest need for knowledge in 
smaller firms 
RD-OTH19-P CEO involvement is ok but not in my daily research work nm nm nm + The argument that a CEO can be involved is accepted but not to 
the level that he/she starts to meddle with the R&D work 
RD-OTH20-P CEO talks to all levels of R&D nm nm nm + This is confirmed by the CEO in the CEO interview in this firm who 
argued that he/she interacts with all R&D levels in the firm 
RD-OTH21-P CEO is genuinely interested in R&D nm nm nm + The CEO is interested in the science no because he wants to 
understand the work of R&D  
nm: not mentioned;  
New themes emerging from interviews RDE1P to RDE4P 
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is linked to the concern of R&D whether the CEO will actually be willing to accept R&D 
failures. In other words, the R&D executives’ concept of trust can be described as ‘can 
R&D trust the CEO to trust R&D?’ The concept of trust by the CEO in R&D explains the 
appearance of another theme of the CEO offering freedom to R&D (RD-OTH2-P): 
 
‘he gives sufficient amount of freedom to the chiefs (of R&D)’ 
Theoretically, the theme of ‘CEO offering freedom to R&D’ could be categorized either 
in the a priori theme of ‘CEO attitude’ or in the new theme of ‘Trust by the CEO in R&D 
and trust in the CEO by R&D’. It was decided at this point of time to keep these concepts 
separated and to keep sufficient granularity in order to avoid the risk of ‘burying’ a 
potentially interesting concept as any re-assignment of subthemes can still take place at 
a later date during the research. 
Other themes that appeared during the interview were the themes ‘CEO has no time to 
talk to R&D’ (RD-OTH3-P) and ‘CEO involves R&D into the development of a vision’ (RD-
OTH4-P). Of particular interest are the themes that pertain to the concept of knowledge: 
‘CEO is approached with simplified data’ (RD-OTH5-P), ‘CEO should have sufficient 
knowledge for R&D to feel comfortable’ (RD-OTH7-P), ‘CEO is not aware about the gap 
in knowledge between him/her and R&D’ (RD-OTH11-P) ‘CEO receives messages that 
are considerably transformed for him/her to assess their value’ (RD-OTH12-P), ‘CEO is 
involved in R&D projects for valuation’ (RD-OTH6-P), ‘CEO does not need to know all the 
details about the scientific research that we conduct’ (RD-OTH13-P), ‘CEO may have 
difficulties linking the details of the science with the value behind them’ (RD-OTH14-P) 
and ‘CEO may underestimate the complexity of scientific R&D (RD-OTH16-P) 
As was observed during the interviews with the CEOs, the transfer of complex R&D 
knowledge is accompanied by a transformation such that the CEO can absorb the 
knowledge. The CSO argues that the CEO should not be aware of the gap in knowledge 
with R&D and that R&D should feel comfortable in interacting with the CEO when 
discussing R&D data. In other words, R&D has to feel comfortable discussing science 
with the CEO and train him/her CEO (‘CEO is teached by R&D on the value of R&D’ RD-
OTH8) in order for him/her to understand the science. This may lead to a relationship of 
trust between R&D and CEO, as was made clear by the CSO: 
‘I think as well it is the task of the CSO to explain as clearly 
as possible why the given (R&D) vision will be followed; so 
it is not like that the CSO has to expect that the CEO has a 
full understanding and a full scope and idea what it takes 
to become innovative...  it’s the task of the CSO I believe 
... and the hope is that ... the trust in the CEO is there ...’ 
Teaching the CEO about the science is part of the transfer of R&D knowledge. According 
to this CSO, trust shown by the CEO in R&D can be developed by teaching the CEO.  This 
learning process leads to a CEO with an increased understanding of R&D conducted in 
his/her firm and to a R&D function who feels comfortable with the increased knowledge 
of the CEO. R&D therefore ‘trusts’ he/she will involve R&D in strategic decision making, 
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an ambition that is clearly articulated by this CSO. A number of granular themes 
appeared during the interview which are at first sight unrelated to the other themes 
such as ‘CEO links all stakeholders to build a new product’ (RD-OTH9 –P), ‘CEO for a 
LFSRD firm should ideally be a seasoned scientist and a seasoned business man/women’ 
(RD-OTH10-P), ‘CEO is very approachable’ (RD-OTH15-P), ‘CEO is not a scientist per se 
(he should have other qualities)’ (RD-OTH17-P), ‘CEO need for involvement is company 
size dependent’ (RD-OTH18-P), ‘CEO involvement is ok but not in my daily research 
work’ (RD-OTH19-P), ‘CEO talks to all levels of R&D’ (RD-OTH20-P) and  ‘CEO is genuinely 
interested in R&D’ (RD-OTH21-P).  
Conclusion 
This first pilot study showed that the CSO and the senior scientists use role concepts that 
did not emerge when these questions were raised to the CEO. The concept of trust both 
in and by the CEO were clearly articulated by the CSO. However, whether this new theme 
will prove to be consistent in the final interviews will need to be explored. It was 
therefore decided that in the final interviews any reference to the theme of trust was to 
be avoided in order to observe whether this theme emerged ‘organically’ during the 
interview and should be considered a firmly held belief of the R&D executives or simply 
a spurious observation.  The theme of R&D data complexity reduction, which was clearly 
articulated by the CEOs during their interviews, surfaced again during this interview with 
R&D executives. The theme of learning took a dyadic form whereby CEO and a R&D 
executive learned from each other. From an operational point of view, it was observed 
that the questions were sufficiently clear to the R&D executives. It was therefore 
decided to proceed with these questions into the next pilot study. The second firm, 
although introduced into this pilot research by accident because the originally selected 
firm could not allow the interviews within the projected timeframe, proved to an 
interesting testing ground for our research as will be shown in the next section. 
 
Pilot interviews of R&D executives reporting to CEO2 
 
The second firm is the life science R&D firm headed by CEO2 who received scientific 
training but left the scientific and academic community to become a ‘serial’ CEO of 
biotech start ups. He/she argues that he/she does not want to ‘be told rubbish’ and 
allows his/her scientists only a limited amount of time to present and defend their R&D 
data to him/her. This firm saw its chief scientific officer leave and the core of the 
innovational activities resided with two experienced and top level R&D scientists who 
reported temporarily to the CEO.   
 
Literature based a priori themes 
The theme of CEO innovativeness (INN) did not emerge from the interviews. On the 
other hand, the theme of CEO-attitude is used by both scientists: the CEO is the 
individual who ‘should definitely enable innovation’. This is in contrast with the first pilot 
study in which attitude was not raised frequently if at all. This company clearly suffered 
from the absence of the CSO as the CEO was ‘hardly capable to have meaningful 
discussions with the scientists’ (see below under Other themes). The same applies to the 
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theme of attention, and both scientists find the long term vision of the CEO to be 
important: 
 
 ‘He or she should probably also manage the innovation in a 
sense that it needs to be controlled and directed against 
longer term opportunities or even shorter term 
opportunities’ 
 ‘I would expect some guidance for what the long term 
visions of the company and where the innovation framework 
really is’ 
The concept of CEO attention is also made clear by the RDE5P who argues that CEOs 
should create long-term stability in the firm to allow innovation to take place: 
 ‘... it requires a certain long term vision and you need ... 
stability in order to make innovation work, mostly it takes a 
little bit more time (cynical) than a few quarters ... business 
changes, context changes so depending on good reasons there 
might be a reason to stop ... but small short term fluctuations 
shouldn’t really impact the overall innovation...’ 
RDE6P recognizes the heavy burden on the shoulder of the CEO but argues that he/she 
should be visible to R&D and show clear signs of interest in R&D without becoming too 
much involved: 
‘I do not think that a CEO should be involved in the day to 
day discussions and scientific content’ 
At the same time his commitment should become clear in the hiring process, a concept 
that was also made clear by the CSO in the first pilot firm.  
Other themes 
The themes that emerged from the interview with the two scientists RDE5P and RDE6P 
are listed in table below (RD-OTH22-P to RD-OTH47-P). Among them, the theme that 
emerged again was the concept of ‘trust’. Trust seemed to be a sensitive topic because 
during the interview with RDE5P and RDE6P, the theme trust appeared 6 and 10 times 
respectively. Trust was specifically considered as trust by the CEO in R&D.   
 
 ‘We lack that kind of trust relationship’ and ‘the CEO should 
trust the right people to delegate those detailed discussion’ 
‘you need to trust your people’ (i.e; referring to the CEO) 
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R&D Other 
roles codes: 
Other themes: 
R
D
E1
 P
 
R
D
E2
 P
 
 
 
Comment 
RD-OTH22-P CEO not only enables but also manage innovation + nm This refers to the attitude of the CEO who is not only the 
manager but is also capable to lead the innovation (the 
company has no CSO) 
RD-OTH23-P CEO is involved in the operational aspects of innovation 
only 
+ nm This is a criticism by the R&D function about the distance 
of the CEO and the R&D function whereby the CEO only 
refers to R&D as an ‘operational’ department as any other 
department in the firm. In other words, the CEO is not 
capable to observe the particular characteristics of a R&D 
environment  
RD-OTH24-P CEO is not capable to judge the innovative character of an 
R&D proposal 
+ nm This is a fierce criticism of the R&D function  
RD-OTH25-P CEO does not trust his CSO and R&D + + According to the CSO, the concept of ‘trust’ is key in the 
relationship between CEO and R&D. This argument was 
made several times by the CSO during the interview. 
RD-OTH26-P CEO does not have the scientific credentials to evaluate 
new proposals on its merits 
+ + See RDOTH26-P 
RD-OTH27-P CEO empowers the CSO to make decisions + nm This is the criticism made by R&D that a CEO makes 
decisions that are in fact ‘terrain’ of the R&D function. It is 
also related to the concept of trust. 
RD-OTH28-P CEO is only suitable to think about budgets, timelines, 
deals 
+ nm See RDOTH23-P 
RD-OTH29-P CEO does not have detailed knowledge in the science + + This is part of the knowledge discussions held in the first 
part of the research during the CEO interviews when ‘CEOs 
argue that there is a gap right?’ see RDOTH11-P 
RD-OTH30-P CEO receives highly transformed R&D message that does 
not make any sense anymore to R&D 
+ nm idem 
RD-OTH31-P CEO will more easily say ‘no’ to a project the more 
innovative it is 
+ nm This is linked to the criticism of R&D that the R&D function 
is considered an operational piece of the organization and 
innovative ideas disturb the ‘balance’ within the 
organization and therefore  may consume resources that 
will ‘not pay off’. This is a visible sign of ‘dis’-trust. 
RD-OTH32-P CEO refuses R&D to take decisions + nm See RDOTH27-P 
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RD-OTH33-P CEO acts very intimidating and dominant towards the 
science community in the firm 
+ + This observation was also made by the R&D function in the 
first pilot R&D interview where the CEO is ‘very 
approachable’ and does not act as a dominant and 
intimidating individual 
RD-OTH34-P CEO takes a step back and tap into the brain power of the 
organization 
nm + This R&D statement refers to the CEO who uses all the 
brainpower in his/her firm to come up with new 
innovative ideas, work-procedures etc. 
RD-OTH35-P CEO is very approachable nm + Same as in RDOTH33-P 
RD-OTH36-P CEO communicates the firm strategy to R&D nm + The sensitive link between R&D and strategy. This is linked 
to the concept of trust as the need for involvement of R&D 
in the development of firm strategy is a sensitive issue in 
R&D 
RD-OTH37-P CEO involves R&D to develop a strategy and vision for the 
firm 
nm + Same as RDOTH36-P 
RD-OTH38-P CEO of a LSRD firm does not run the firm as a finance 
manager 
nm + Same as RDOTH23-P 
RD-OTH39-P CEO understand the risks and challenges of life science 
R&D 
nm + If the CEO does not understand the science he/she should 
at least understand the risk of new product development 
in a life science firm 
RD-OTH40-P CEO is very isolated from R&D nm + The time taken by the CEO to talk to R&D is indicative of 
his commitment (time and effort) – see also RDOTH3-P RD-OTH41-P CEO has not time to talk to R&D nm + 
RD-OTH42-P CEO prevents R&D to do science for the sake of science nm + This is the mirror statement of the statement made by 
several CEOs during the CEO interviews in that the focus of 
the R&D activities should be an science for business, not 
science for science  
RD-OTH43-P CEO is able to judge the value of his/her CSO nm + The CEO should be sufficiently experienced in life science 
R&D firms that they are capable to distinguishing a 
powerful CSO from a mediocre one 
RD-OTH44-P CEO does not receive oversimplified messages as they can 
mislead him 
nm + This statement was also made buy one CEO during the  
CEO interviews who argued that oversimplified message 
could lead to flawed decision making  
RD-OTH45-P CEO becomes nervous when science discussions take too 
long 
nm + This is also corroborated by the CEO in this firm who 
stated that ‘it starts to itch’ when science meetings take 
too long 
RD-OTH46-P CEO interacts more with us to unload his perspective to us nm + This R&D perspective points to the unidirectional 
relationship and the dominant attitude of the CEO vis-à-vis 
R&D 
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RD-OTH47-P CEO teaches us about the business side of a LSRD firm nm + The CEO should teach R&D about the business ‘we are in’ 
nm: not mentioned 
New themes emerging from interviews of RDE5P - RDE6P 
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‘I think he also needs to be able to trust his CSO for example 
to a certain point so that there is a back and forward 
communication through his team’ 
‘It’s also about trust’ 
This concept of trust was linked to the R&D executives’ argument that there is no need 
for a CEO to have detailed scientific knowledge as the science ‘is our responsibility’ and 
‘therefore there is a need for trust in our capabilities’. On the other hand RDE6P argues 
that trust needs to work in two directions, and R&D scientists also need to trust their 
CEO (an argument that was also made by the scientists in the first pilot interview of R&D 
executives): 
‘people really need to trust him’ 
Another theme that was strongly emphasized by RDE5P is the concept of knowledge 
transformation when communicating R&D knowledge to the CEO (‘CEO receives highly 
transformed R&D message that does not make any sense anymore to R&D’ (RD-OTH30-
P)). 
 ‘I think it qualifies as heavy transformation because the content 
is completely gone, the exact details on what you want to do and 
how you want to go about it is no longer present … we don’t even 
discuss too much the details of what the output will be, it’s simply 
a marketable asset. It has been completely transformed, it’s 
almost metaphysical in the sense that we no longer talk about 
the subject, we talk about the overall aspect, the weight and the 
colour, this is a black 100 grams object....’. 
In addition, according to RDE6P, there is a risk that if the R&D message to the CEO is 
made too simple, it may be misleading for the CEO and his/her team. This comment was 
also made by CEO8 who argued that CEOs should not make decisions on (over-simplified 
R&D knowledge. The CEO should teach his R&D organization about the ‘business side of 
things’ in order for the R&D function to become an integral part in the strategy building 
of the firm, an argument which was also raised by the R&D executives in the first pilot 
firm. A number of knowledge related themes appeared such as ‘CEO is not capable to 
judge the innovative character of an R&D proposal’ (RD-OTH24-P), ‘CEO does not have 
the scientific credentials to evaluate new proposals on its merits ‘(RD-OTH26-P) and 
‘CEO does not have detailed knowledge in the science’ (RD-OTH29-P). 
Again, other themes appeared that are considered granular and isolated from the 
majority of a priori themes. They are: ‘CEO not only enables but also manages 
innovation’ (RD-OTH22-P), ‘CEO is involved in the operational aspects of innovation only’ 
(RD-OTH23-P), ‘CEO empowers the CSO to make decisions’ (RD-OTH27-P), ‘CEO is only 
suitable to think about budgets, timelines, deals’ (RD-OTH28-P), ‘CEO will more easily 
say ‘no’ to a project the more innovative it is’ (RD-OTH31-P), ‘CEO refuses R&D to take 
decisions’ (RD-OTH32-P), ‘CEO acts very intimidating and dominant towards the science 
community in the firm’ (RD-OTH33-P), ‘CEO takes a step back and tap into the brain 
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power of the organization’ (RD-OTH34-P), ‘CEO is very approachable’ (RD-OTH35-P), 
‘CEO communicates the firm strategy to R&D’ (RD-OTH36-P), ‘CEO of a LSRD firm does 
not run the firm as a finance manager’ (RD-OTH38-P) ‘CEO involves R&D to develop a 
strategy and vision for the firm’ (RD-OTH37-P); ‘CEO understand the risks and challenges 
of life science R&D’ (RD-OTH39-P), ‘CEO is very isolated from R&D’(RD-OTH40-P), ‘CEO 
has not time to talk to R&D’ (RD-OTH41-P), ‘CEO prevents R&D to do science for the sake 
of science’ (RD-OTH42-P), ‘CEO is able to judge the value of his/her CSO’ (RD-OTH43-P), 
‘CEO does not receive oversimplified messages as they can mislead him’ (RD-OTH44-P), 
‘CEO becomes nervous when science discussions take too long ‘(RD-OTH45-P), ‘CEO 
interacts more with us to unload his perspective to us’ (RD-OTH46-P) and ‘CEO teaches 
us about the business side of a LSRD firm’ (RD-OTH47-P). 
Conclusion 
This second pilot study shows that senior R&D scientists use still other role concepts to 
describe the role of the CEO in innovation in R&D.  Because of the absence of a chief 
scientific officer in this firm it was possible to inquire about the role of the CEO with two 
senior R&D executives who were not accustomed to interact with the CEO and whose 
views can be considered ‘fresh and unspoiled’ from potential top management practices 
and politics. Although themes that emerged from the interviews are different from the 
themes that appeared from the interviews in the first pilot study, two themes re-
emerged: the theme of ‘trust’ and the important role that it plays in the relationship 
with the CEO and the theme of ‘learning’ and ‘knowledge transformation’ when 
interacting with the CEO about their R&D projects.   
Conclusion of the pilot interviews 
First, concepts such as trust both in and by the CEO were articulated. It seems that ‘trust’ 
is a sensitive topic for R&D executives when discussing R&D and its relationship with the 
CEO. In both cases the concept of trust appeared without any stimulus from the part of 
the interviewer. Trust was referred to as a bi-directional concept: both the trust by the 
CEO in R&D as the trust by R&D in the CEO seemed to be important for R&D.  In addition, 
the concept of trust was not referred to ‘superficially’, or as a ‘passing theme’ that 
emerged and disappeared among a myriad of other themes. On the contrary, it was 
articulated forcefully by the R&D scientists as if some sort of fundamental concept was 
addressed.  What also re-emerged strongly during the interviews was the theme of R&D 
data complexity reduction.  As one scientist argued – with visible irritation - :  ‘nothing 
is left over of my scientific proposal once it reaches the executive room- it’s almost 
metaphysical in the sense that we no longer talk about the subject’.  In addition, the 
theme of ‘learning’ and, related to that, the theme of ‘knowledge’, appeared frequently 
during the interviews and was bidirectional: the CEO teaches R&D about the market and 
business environment, while R&D teaches the CEO about the science. However, because 
the interview questions revealed a number of unexpected concepts in these pilot 
studies, it was decided to proceed with these questions into the final interviews. 
Because the theme of trust was clearly articulated it was tempting to modify our 
questionnaire to explore this theme further but it was decided not to do so and take the 
research forward using the questionnaire used for the pilot R&D studies above and – 
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assuming that the concept of trust plays an important role - it would emerge ‘by itself’ 
during the following 33 interviews. 
It also became clear during the interviews that R&D executives do not mind to be 
interviewed about their CEOs and the majority agreed to an interview without any 
restrictions. These R&D executives did not feel uncomfortable discussing top 
management leadership in R&D, they were however pleased to hear that: 
- their CEO, nor anybody else in or outside the firm, will be informed about their 
individual visions about top management leadership 
- the questions and the answers were destined for academic research purposes 
only and the interview was not part of a consultancy project introduced into the 
firm to improve their R&D effectiveness 
In order to protect anonymity, it was decided to prepare a statement that would 
guarantee full confidentiality of the final interviews in addition to the confidentiality 
agreement that was agreed with the firm (through the CEO).  
Final interview approach 
For the analysis of the final R&D interviews, the approach presented below was used. 
The primary/secondary nodes structure which was developed after the interview of the 
CEO interviews was used for the content analysis of the interview transcripts of the R&D 
executives. The procedure followed for the final interviews followed the same approach 
as for the previous interviews: interview and recording, transcription of the recorded 
interview, correction of the transcript and analysis of the transcript were conducted in 
the same way as for the pilot CEO, the final CEO and the pilot R&D interviews. The 
diagram below presents the approach. 
 
 
 
 
 
Collect quotes from 
interviews with 33 
R&D executives
Quotes on the role 
of the CEO made 
by R&D executives 
and by CEOs
Quotes on the role 
of the CEO made 
by R&D executives 
and not made by 
by CEOs
Can R&D quote be 
assigned to a theme 
that is also used by 
the CEOs to describe 
their roles?
Theme:
ATI 1-9
ATT 1-2
COM 1-8
INV 1-10
Inn 1-3
CEO-OTH 1-53
Theme:
RD-OTH 1- X
Assign each quote 
to a theme used 
by CEOs
Assign each quote 
to a theme used 
by R&D
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At the start of the R&D interview, each R&D executive was given a signed confidentiality 
statement. Each of the quotes is analyzed and either: 
 
- assigned to a theme previously used by CEOs during their interviews and which 
they used to describe their role in innovation (i.e. to an a priori literature based 
theme ATI1--9, ATT1-2, COM1-8, INV1-10 or INN1-3 or to a CEO-based theme 
obtained from the CEO interviews CEO-OTH 1 to CEO-OTH53) or 
- to a new theme that cannot be assigned to any of the themes above and is only 
used by R&D executives to describe the role of CEOs in innovation. If a quote 
reflects a theme that has not emerged during the interview with the CEOs, it is 
assigned a code ‘RD-OTHx’ indicating that it is a theme used by R&D executives 
(‘RD’), that it is different from the literature concepts (‘OTH’ from ‘other’) and 
that it is the ‘x’th  theme identified in the R&D executives’ interviews (‘x’) 
The code ‘RD-OTHx’ is then identified as a new theme to which similar comments, 
quotes and remarks are assigned.  
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Appendix M. Overview of R&D executives 
Firm  Function R&D 
Executive: 
code* 
CEO Interview 
date 
Interview 
mode 
Rec. 
** 
T Chief Scientific Officer RDE1 P CEO1P September 17, 2012 Face-to-face Yes 
Senior Manager Search and Evaluation RDE2 P September 17, 2012 Face-to-face Yes 
Head of Pharmacology, Oncology RDE3 P September 17, 2012 Face-to-face Yes 
Senior manager Discovery Operations RDE4 P September 17, 2012 Face-to-face Yes 
A1 Principal Scientist Target Scouting RDE5 P CEO2 October 8, 2012 Face-to-face Yes 
Senior Director Pharmacology RDE6 P October 8, 2012 Face-to-face Yes 
A2 Chief Scientific Officer RDE7 CEO2P November 8, 2012 Face-to-face Yes 
Manager Science and Technology RDE8 November 8, 2012 Face-to-face Yes 
C Senior Manager Technology  RDE9 CEO1 December 11, 2012 Face-to-face Yes 
Gent - GBR/PG  RDE10 December 11, 2012 Face-to-face Yes 
Research Expert  RDE11 December 11, 2012 Face-to-face Yes 
B Chief Scientific Officer RDE12 CEO3 October 31, 2012 Face-to-face Yes 
Director Assay, R&D RDE13 October 19, 2012 Face-to-face Yes 
Research Manager RDE14 October 19, 2012 Face-to-face Yes 
Director Life Sciences RDE15 October 19, 2012 Face-to-face Yes 
T Chief Scientific Officer RDE16 CEO4 December 6, 2012 Face-to-face Yes 
A 3 Chief Scientific Officer RDE17 CEO5 December 3, 2012 Face-to-face Yes 
Vice president Chemistry RDE18 December 3, 2012 Face-to-face Yes 
Vice president Biology RDE19 December 3, 2012 Face-to-face Yes 
Vice president NCD RDE20 December 3, 2012 Face-to-face Yes 
A4 Chief Scientific Officer RDE21 CEO6 November 20, 2012 Face-to-face Yes 
Research Fellow RDE22 November 20, 2012 Face-to-face Yes 
C Chief Scientific Officer RDE23 CEO7 October 30, 2012 Face-to-face Yes 
R Chief Scientific Officer RDE24 CEO8 October 15, 2012 Face-to-face Yes 
Senior Scientist RDE25 October 15, 2012 Face-to-face Yes 
Senior Scientist RDE26 October 15, 2012 Face-to-face Yes 
S Manager Science and Technology RDE27 CEO9 November 5, 2012 Face-to-face Yes 
Manager R&D RDE28 November 5, 2012 Face-to-face Yes 
O Chief Scientific Officer RDE29 CEO10 December 10, 2012 Face-to-face Yes 
J Global Head Drug Discovery J&J RDE30 CEO11 November 21, 2012 Face-to-face Yes 
G Chief Scientific Officer RDE31 CEO12 January 24, 2013 Telephone No 
President Grünenthal Innovation  RDE32 November 22, 2012 Telephone Yes 
Sr vice president Marketing RDE33 October 16, 2012 Face-to-face Yes 
Sr vice president NCD RDE34 October 16, 2012 Face-to-face Yes 
Sr vice president Formulation RDE35 October 16, 2012 Face-to-face No 
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O Chief Scientific Officer RDE36 CEO13 December 7, 2012 Telephone Yes 
A5 Director Non Clinical Operations RDE37 CEO14 December 20, 2012 Face-to-face Yes 
P Director R&D Operations RDE38 CEO15 December 17, 2012 Face-to-face Yes 
Director R&D Technology RDE39 December 17, 2012 Face-to-face Yes 
*: each interviewed R&D executive was assigned a code for identification and classification purposes; **: recording 
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Appendix N. Operational data of the R&D interviews  
 
Interviewee 
R&D executive 
Recording 
Nr. 
Duration 
(in min) 
Conversation 
type 
Transcript* 
(nr of pages) 
Nr of quotes 
extracted 
RDE7 LS110137 48 face-to-face 10 13 
RDE8 LS110136 43 face-to-face 10 15 
RDE9 LS110163 32 face-to-face 9 12 
RDE10 LS110161 27 face-to-face 7 5 
RDE11 LS110162 27 face-to-face 7 10 
RDE12 LS110132 56 face-to-face 12 30 
RDE13 LS110131 29 face-to-face 7 18 
RDE14 LS110129 29 face-to-face 8 14 
RDE15 LS110130 29 face-to-face 7 14 
RDE16 LS110158 36 face-to-face 10 23 
RDE17 LS110157 33 face-to-face 9 27 
RDE18 LS110154 43 face-to-face 10 15 
RDE19 LS110155 35 face-to-face 9 17 
RDE20 LS110156 24 face-to-face 7 19 
RDE21 LS110138 43 face-to-face 11 20 
RDE22 LS110139 17 face-to-face 6 7 
RDE23 LS110149 57 face-to-face 16 18 
RDE24 LS110124 48 face-to-face 12 27 
RDE25 LS110126 21 face-to-face 6 15 
RDE26 LS110125 23 face-to-face 5 17 
RDE27 LS110133 45 face-to-face 11 16 
RDE28 LS110134 31 face-to-face 9 13 
RDE29 LS110160 31 face-to-face 9 16 
RDE30 LS110140 34 face-to-face 8 15 
RDE31 na - face-to-face ** 7 
RDE32 LS110142 24 telephone 6 7 
RDE33 LS110127 32 face-to-face 8 13 
RDE34 LS110128 20 face-to-face 5 15 
RDE35 na - telephone *** 5 
RDE36 LS110159 20 telephone 5 14 
RDE37 LS110166 25 face-to-face 6 15 
RDE38 LS110165 22 face-to-face 7 16 
RDE39 LS110164 25 face-to-face 8 6 
  1100 min 
18.3 hrs 
 260 494 
*A4, Calibri, 11 font size, 1,15 line, space below section; **: interview not recorded as 
interviewee objected to recording; ***: interview not recorded due to instrument failure 
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Appendix O.  Categorization of the R&D quotes  
This appendix includes: 
- Identification of the interviewed R&D executive (i.e. R&D Executive: RDE7 to RDE39  
- a number assigned to each quote for each R&D executive (column 1). For example, during the interview with R&D executive 
RDE7 , 14 quotes were made each assigned a number 1 tot 14  
- The actual quote made by the R&D executive (column 2) 
- The argument (in the third column) why the quote in column 2, falls either in the category of 
o a theme previously used by CEOs (a priori theme or CEO-OTH theme; 4th column) 
o a new theme used by R&D executives and not by CEOs, i.e.  RD-OTH1, RD-OTH2… RD-OTHn (5th column) 
 
Overview and categorization of quotes observed during the interviews with the R&D executives 
Quotes made by R&D executives in chronological order as observed 
during the interview  
 
 
↓ 
Assignment of the quote to a theme that was either used by CEOs to describe their role in 
innovation or to a newly developed R&D based theme that was used by R&D executives to 
describe the role of their CEO in innovation 
↓ 
 
PSNn 
CEO 
theme 
New 
R&D 
theme 
Quotes made by R&D executive RDE7 and assignment of the quotes to a ‘PSN theme’ or a new R&D theme (‘RDOTH’) 
1 CEO should be generous and show signs of selflessness The argument that a CEO of a life science R&D firm should be altruistic, generous and have a noble purpose 
(see quote RDE7 3) cannot be assigned to any theme that emerged from a CEO interview. It is therefore 
assigned to a theme that is specific for R&D executives: RD-OTH1 CEO should focus on common good and 
act beyond personal ambition   
RD-OTH1 
2 CEO is rigid in control and drive No CEO argued that he/she should have a strong controlling nature and show rigidity in his/her 
management of a LFSRD firm. However, it is argued by R&D executives that he/she should avoid 
discharging such a style: RD-OTH 2 CEO manages LSRD firms with rigidity and strict control 
RDOTH2 
3 CEO should have a noble purpose and not be limited to 
shareholder value 
See above RDOTH1 
4 CEO should be willing to offer his/her time to R&D This refers to CEO commitment and the willingness to ‘devote time’ to innovational efforts 
but – in line with our a priori definitions – is better defined as ‘involvement’ and is assigned 
to ‘CEO holds frequent formalized meetings R&D” 
INV6  
5 CEO should give time to people in R&D because he believes in 
them 
CEO should trust R&D. A CEO who believes in ‘his people’ shows trust. The quote is 
therefore assigned to code CEO-OTH31 ‘CEO and R&D should have a relationship of trust 
and confidence’ 
CEO-OTH31 
6 CEO should act more qualitatively instead of quantitatively This R&D executive argued that it is necessary for a CEO of a LSRD firm to use as well qualitative as 
quantitative thinking. He/she means that the CEO should understand not only the (financial)  figures but 
RD-OTH3 
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also the ‘soft side’ of managing and leading scientists and scientific R&D: RD-OTH3 CEO manages 
qualitatively and quantitatively   
7 CEO should learn more about human relations in order to be 
able to work with R&D 
See above RD-OTH3 
8 CEO should have a lot of inside energy RD-OTH4  CEO should be forceful and full of drive RD-OTH4 
9 CEO should have a relationship with R&D scientists built on 
trust 
CEO should trust R&D. This quote refers to the concept of ‘trust’ and is therefore assigned 
to code CEO-OTH 31 ‘CEO trusts R&D’ 
CEO-OTH31  
10 CEO of a LFSRD firm should not act as dominantly This was also raised by a CEO during his/her interview. This refers to the CEO quote that 
CEOs in a life science R&D organization should not act as ‘dominant’ figures 
CEO-OTH39 
11 CEO should have deep insight in the mechanisms that rune 
the world 
No interviewed CEO argued that he/she should have a philosophical insight into ‘reality’. This CSO feels that 
CEOs should be more than only managers, they should have a strong literature background and knowledge 
of philosophy. RD-OTH5 CEO has a strong cultural and literature background 
RD-OTH5 
12 CEO should not become involved in the details irrespective of 
his background 
No CEO who was interviewed argued that he/she should (not) meddle with the scientific activities of the 
R&D scientists. However, R&D executives who appreciate CEO involvement do not appreciate CEOs who 
‘meddle’ with the science, either in the lab or in specialized in-depth scientific dialogue. RD-OTH6 CEO 
should not interfere with the science 
RD-OTH6 
13 CEO trusted me to do things CEO should trust R&D. This quote refers to the concept of ‘trust’ and is therefore assigned 
to code CEO-OTH 31 ‘CEO and R&D should have a relationship of trust and confidence ’ 
CEO-OTH31  
14 CEO should not meddle with the science see above RD-OTH6 
Quotes made by R&D executive RDE8 and assignment of the quotes to a ‘PSN theme’ or a new R&D theme (‘RDOTH’) 
1 CEO role is primarily strategic CEO sets the direction/goal and vision in which innovation to take place. The attention of a 
CEO to identify innovational opportunities in the market and to develop an appropriate 
strategy and the direction in which to proceed: a vision for the firm 
ATT1  
2 CEO role in innovation is to focus The attention of a CEO to find innovational opportunities in the market place, to focus on 
this opportunity and to set the boundaries in which to proceed 
ATT2 
3 CEO should balance R vs. D and balance academic vs. 
industrial R&D 
No CEO argued that it is necessary to ‘balance’ industrial vs. academic research; on the contrary, industrial 
research was the CEO’s primary objective. This R&D executive requires a balance between both research 
streams.  RD-OTH 7CEO should balance industrial vs. academic work 
RD-OTH7 
4 CEO should not only rely on academic advice This R&D executive argued that it is dangerous for a CEO to fully rely on the advice of an academic (the firm 
is an academic spin-off). This reliance may be useful but is only part of the full and balanced picture that a 
CEO requires about the potential of a scientific/ commercial opportunity. RD-OTH8 CEO requires a balanced 
view of the potential of R&D 
RD-OTH8 
5 CEO needs a scientific advisor independent from academia Same as above RD-OTH8 
6 CEO should be careful with scientists who fall in love with 
their technology 
The CEOs argued that they should not focus on the technology because it detracts from the 
focus of the R&D activities 
CEO-OTH4  
7 CEO should not be dislocated from the site where R&D is 
conducted 
The CEO should never be dislocated from the main research center as this prohibits the potential 
interaction between CEO and R&D. RD-OTH10 CEO should be located in proximity of the R&D site. 
RD-OTH10 
8 CEO needs to have the final word in biotech R&D The CEO, not the management team or the CSO should have the final word in R&D decisions.  
RD-OTH10 CEO makes final R&D decision 
RD-OTH11 
9 CEO should be a good listener Not only should the CEO be a good communicator, according to R&D he should also be a good listener.  
RD-OTH12 CEO is a good listener 
RD-OTH12 
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10 CEO should be able to talk the language of the different 
departments in the firm 
Not only should the CEO be a good communicator (according to the CEO), he should also be a good listener 
(according to R&D) but he should also be capable to use the different languages especially the language and 
jargon of scientists. RD-OTH13 CEO is capable to talk the language of scientists 
RD-OTH13 
11 CEO does not need to know the ins and outs of science The ‘ins and outs’ of science refer to the detailed level of knowledge required by R&D 
scientists to conduct research. The level of knowledge is not needed for a CEO. It implies 
that – although the ‘ins and outs’ are not required, CEOs should have some understanding 
of the science in which their firms are engaged 
CEO-OTH38  
12 CEO should be sufficiently well trained in science to be able to 
cope with the pressure from an academic CSO 
See above RD-OTH8 
13 CEO is capable to see the value of science and how to achieve 
its potential 
According to R&D, CEOs should be capable of evaluating a scientific project or innovational idea. This is 
linked to the observations of absorptive capacity that emerged from the CEO interviews and is now 
supported by R&D. If CEOs should be capable to evaluate new knowledge (before eventual firm assimilation 
and exploitation takes place) he/she should be able to understand it. Knowledge that is available in R&D 
should be ‘absorbable’ by a CEO. RD-OTH9 CEO should be capable to evaluate R&D knowledge 
RD-OTH9 
14 CEO should receive R&D knowledge that is reduced to a level 
that he/she can challenge it 
CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6  
15 CEO should be careful in running a company that is ‘run’ by a 
strong academically oriented CSO 
See above RD-OTH8 
Quotes made by R&D executive RDE9 and assignment of the quotes to a ‘PSN theme’ or a new R&D theme (‘RDOTH’) 
1 CEO should have devoted budget This refers to a CEO commitment – the willingness to make available human and financial 
resources to a project. CEO makes available human and financial resources 
COM4  
2 CEO should create culture of innovation CEO fosters a culture of innovation ATI1  
3 CEO recognizes the need for innovation A CEO who recognizes the need for innovation has the ‘correct attitude’ to allow innovation 
to proceed. Although this quote is of a general nature, it is decided to assign this quote to 
theme ATT1.  
ATI1  
4 CEO double-checks the information received from R&D This quote refers to the statement made by the R&D executive who argues that if the CEO 
would start double-checking the opinions and/or data, this would be considered a lack of 
trust. This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 
31 ‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31  
5 CEO is offered R&D knowledge without details and which is 
self-explanatory 
CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6  
6 CEO attempts to understand the science in R&D See above CEO-OTH10  
7 CEO should have prior knowledge so that R&D can convince 
him/her about budget needs 
See above CEO-OTH5  
8 CEO should receive the correct know-how from R&D This quote is made by a R&D executive who argues that if he/she is responsible for offering 
R&D know how to the CEO, that this know-how should be such that the CEO receives correct 
information thereby building the foundation for a relationship built on trust. This quote 
refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 ‘CEO and R&D 
should have a relationship of trust and confidence’ 
CEO-OTH31  
9 CEO should not only ‘manage people’ This quote is made by R&D executives who argue that R&D scientists should not be ‘managed’ but led.  
RD-OTH13 CEO should lead scientists, not manage them 
RD-OTH14 
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10 CEO should understand the science within R&D The CEO should have an understanding and have sufficient knowledge of the science that is being used in 
the LSRD firm. RD-OTH15 CEO should have sufficient knowledge of science to be effective 
RD-OTH15 
11 CEO talk to everybody in R&D CEO gets information  from/discusses R&D with all levels CEO-OTH20  
12 CEO should receive considerably simplified R&D know-how CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6  
Quotes made by R&D executive RDE10 and assignment of the quotes to a ‘PSN theme’ or a new R&D theme (‘RDOTH’) 
1 CEO pulls all science resources together to achieve a goal Although this quote refers to ‘resources’, it indicates that the CEO pulls ‘everybody and 
everything’ together to achieve a goal. In this sense, the quote refers to ‘setting a 
direction/goal’ (more than to pull ‘human and financial resources’ together) and even more 
to ‘focus’ and the setting of boundaries, which is only done when a project is well defined. 
Therefore, the quote is assigned to ATT2.  
ATT2  
2 CEO sets the right direction CEO sets the direction/goal and vision in which innovation to take place. CEO sets the 
direction/goal and vision in which innovation to take place 
ATT1 
3 CEO should make sure no R&D unit works in silo This refers to a CEO commitment – the creation of appropriate organizational structures for 
an innovation project to be successful   
COM6 
4 CEO should involve people from the floor in innovation CEOs should involve people from the R&D floor as they have a lot of know-how and sometimes have great 
innovative ideas RD-OTH16 CEO should involve all levels of R&D  
RD-OTH16 
5 CEO is not expected to offer new topics for innovation According to R&D it is not the CEO who proposes topics for innovation. In this case, innovational ideation is 
limited to the scientists. RD-OTH17 CEO is not expected to come up with new ideas 
RD-OTH17 
Quotes made by R&D executive RDE11 and assignment of the quotes to a ‘PSN theme’ or a new R&D theme (‘RDOTH’) 
1 CEO offers freedom to R&D Obtaining freedom to operate in an R&D environment requires the CEO to have trust in the 
R&D function and is part of a relationship of trust between CEO and R&D. This quote refers 
to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 ‘CEO and R&D should 
have a relationship of trust and confidence’ 
CEO-OTH31  
2 CEO offers his confidence and trusts me This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
3 CEO receives oversimplified R&D messages and based on 
timelines and budget 
CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6  
4 CEO may take the wrong decision when receiving the 
simplified message 
CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6 
5 CEO offers an environment for open discussion CEO fosters a culture of innovation ATI1 
6 CEO should have knowledge on the science of R&D CEO stresses the importance of strong knowledge in the field of innovation CEO-OTH5 
7 CEO who drives a LSRD firm based on financial is catastrophic R&D executives argue that a CEO who is driven by financial figures when it comes to R&D may be 
detrimental for R&D in the firm.  RD-OTH 18 CEO should drive R&D not only from a financial point of view 
RD-OTH 18 
8 CEO sets the right long term strategy CEO sets the direction/goal and vision in which innovation to take place. The attention of a 
CEO to identify innovational opportunities in the market and to develop an appropriate 
strategy and the direction in which to proceed: a vision for the firm 
ATT1  
9 CEO is a fast learner and has a scientific background Although CEOs argued that they foster communication and learning in the organization, their arguments 
focuses on the learning of the organization itself and not necessarily on the learning of the CEOs by the 
R&D function. According to R&D CEOs can be divided in fast learners and slow learners.  
RD-OTH15 
10 CEO is a slow learner and has no biotech R&D knowledge See above RD-OTH15 
Quotes made by R&D executive RDE12 and assignment of the quotes to a ‘PSN theme’ or a new R&D theme (‘RDOTH’) 
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1 CEO brings a lot of industrial experience in the company During the CEO interviews no CEO argued that part of his management of a life science R&D resides in their 
experience accumulated during the previous years. According to R&D executives the level of experience of 
a CEO is important to better understand the risk associated with R&D.RD-OTH19 CEO contributes to R&D by 
means of his/her experience   
RD-OTH19 
2 CEO should make the company survive CEO makes available human and financial resources COM4  
3 CEO should continue to do innovation CEO fosters a culture of innovation ATI1 
4 CEO needs direction and focus and look for opportunities CEO sets the direction/goal and vision in which innovation to take place. The attention of a 
CEO to identify innovational opportunities in the market and to develop an appropriate 
strategy and the direction in which to proceed: a vision for the firm 
ATT 
5 CEO should not be a life-scientist Although CEOs referred to their knowledge in science as part of the discussion on their involvement, 
according to R&D executives there is no strict requirement as to the prior knowledge of CEOs.  That a CEO is 
a life scientist is neither an advantage nor a disadvantage. According to R&D executives, CEO attitude is 
much more important than prior knowledge.  The fact that R&D can learn from their CEOs that is 
complementary to their own knowledge is considered worthwhile. Alternatively, R&D can teach the CEO 
what he/she does not know or understand. R&D executives however find it easier to have a CEO with a 
science background because it makes the explaining of the science to the CEO easier.  
RD-OTH19 CEO do not need scientific knowledge (but when it is available it may help). 
RD-OTH20 
6 CEO should create the right environment CEO fosters a culture of innovation ATI1  
7 CEO should help us focus The attention of a CEO to find innovational opportunities in the market place, to focus on 
this opportunity and to set the boundaries in which to proceed 
ATT2 
8 CEO focus that is where he is really strong – I think he is really 
focused 
The attention of a CEO to find innovational opportunities in the market place, to focus on 
this opportunity and to set the boundaries in which to proceed 
ATT2 
9 CEO should be involved at all levels CEO gets information  from/discusses R&D with all levels CEO-OTH20 
10 CEO keeps the focus The attention of a CEO to find innovational opportunities in the market place, to focus on 
this opportunity and to set the boundaries in which to proceed 
ATT2 
11 CEO builds structures and the organization This refers to a CEO commitment – the creation of appropriate organizational structures for 
an innovation project to be successful   
COM6 
12 CEO builds innovation teams in order not to detract from 
market orientation 
This refers to a CEO commitment – the creation of appropriate organizational structures for 
an innovation project to be successful   
COM6 
13 CEO builds a culture of innovation CEO fosters a culture of innovation ATI1 
14 CEO networks helps R&D to innovate CEO fosters external collaboration  to increase internal innovation ATI5 
15 CEO tries to stimulate people to innovate CEO fosters a culture of innovation ATI1 
16 CEO thinks along with us to create innovation CEO comes up with new innovative ideas INV8  
17 CEO trust and belief in the team is important This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
18 CEO learns from R&D and joins in scientific meetings During the CEO interviews the CEOs referred to the learning of the organization but not their own learning 
neither to the learning of R&D. Both R&D and CEO learn from each other. RD-OTH21 CEO learns from R&D 
and R&D learns from CEO 
RD-OTH21 
19 CEO receives R&D knowledge reduced to the medical need in 
the market to allow portfolio discussions 
CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6  
20 CEO teaches R&D about the market See above RD-OTH21 
21 CEO does not need a scientific background CEO considers it an advantage to be untrained in science CEO-OTH12  
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22 CEO learns about innovations made by R&D so that he can 
take decisions 
See above RD-OTH21 
23 CEO contributes to innovation using his expertise only CEO comes up with new innovative ideas INV8  
24 CEO challenges R&D with a market focus  CEO challenges R&D technically INV2* 
25 CEO may be dominating the meetings This refers to the CEO quote that CEOs in a life science R&D organization should not act as 
‘dominant’ figures 
CEO-OTH39 
26 CEO receives know how from R&D that is reduced in 
complexity 
CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6 
27 CEO helps to maintain the right innovation environment CEO fosters a culture of innovation ATI1 
28 CEO uses ‘corridor talks’ to become informed about 
innovation 
CEO gets information  from/discusses R&D with all levels CEO-OTH20 
29 CEO requires experience in the field to be effective in 
innovation and not necessarily relevant education or 
knowledge 
See above   RD-OTH19 
30 CEO grows from within the firm to become effective in 
leading research 
See above   RD-OTH19 
Quotes made by R&D executive RDE13 and assignment of the quotes to a ‘PSN theme’ or a new R&D theme (‘RDOTH’) 
1 CEO should make sure there is an environment for innovation CEO fosters a culture of innovation ATI1  
2 CEO should have a long term view CEO sets the direction/goal and vision in which innovation to take place. The attention of a 
CEO to identify innovational opportunities in the market and to develop an appropriate 
strategy and the direction in which to proceed: a vision for the firm 
ATT1 
3 CEO should have focus The attention of a CEO to find innovational opportunities in the market place, to focus on 
this opportunity and to set the boundaries in which to proceed 
ATT2 
4 CEO balances short – and long term innovation vs day-to-day 
management of R&D 
According to R&D executives long term innovation and short term innovation should be balanced in order 
not to jeopardize the long term survival of the firm. RD-OTH CEO balances short-term vs. long term 
innovation  
RD-OTH22 
5 CEO learns science from R&D See above RD-OTH21 
6 CEO should not be an expert in science CEOs should have some understanding of the science in which their firms are engaged CEO-OTH38  
7 CEO talks at all levels in R&D CEO gets information  from/discusses R&D with all levels CEO-OTH20 
8 CEO should walk around in R&D in order to avoid a limited, 
poor, reduced version of R&D 
CEO gets information  from/discusses R&D with all levels CEO-OTH20 
9 CEO is capable to use science to make money CEO top scientist/top business man/women is ideal CEO-OTH41 
10 CEO is an extremely smart person and absorbs knowledge 
fast 
See above RD-OTH9 
11 CEO is eager to learn from the scientists See above RD-OTH21 
12 CEO wants to learn from R&D because of lack in knowledge 
but interest in R&D 
CEO attempts to understand R&D expertise CEO-OTH10  
13 CEO only wants to discuss budget and timelines CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6  
14 CEO teaches R&D about the market and makes sense of my 
R&D 
See above RD-OTH21 
15 CEO learns from R&D and R&D learns from the CEO See above RD-OTH21 
16 CEO should have a long term visions CEO sets the direction/goal and vision in which innovation to take place. ATT1  
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17 CEO should have some science background but more 
importantly a strong business background 
See above  RD-OTH20 
18 CEO experience is more important than scientific expertise See above RD-OTH19 
Quotes made by R&D executive RDE14 and assignment of the quotes to a ‘PSN theme’ or a new R&D theme (‘RDOTH’) 
1 CEO should pick up opportunities CEO sets the direction/goal and vision in which innovation to take place. The attention of a 
CEO to identify innovational opportunities in the market and to develop an appropriate 
strategy and the direction in which to proceed: a vision for the firm 
ATT1  
2 CEO communicates these opportunities The attention of a CEO to find innovational opportunities in the market place, to focus on 
this opportunity and to set the boundaries in which to proceed 
ATT2 
3 CEO has sufficient budget CEO makes available human and financial resources COM4 
4 CEO should have a good business view on opportunities CEO sets the direction/goal and vision in which innovation to take place. The attention of a 
CEO to identify innovational opportunities in the market and to develop an appropriate 
strategy and the direction in which to proceed: a vision for the firm 
ATT1 
5 CEO should be supportive for innovation CEO fosters a culture of innovation ATI1 
6 CEO should leave research alone Obtaining freedom to operate in an R&D environment requires the CEO to have trust in the 
R&D function and is part of a relationship of trust between CEO and R&D. This quote refers 
to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 ‘CEO and R&D should 
have a relationship of trust and confidence’ 
CEO-OTH31 
7 CEO should focus The attention of a CEO to find innovational opportunities in the market place, to focus on 
this opportunity and to set the boundaries in which to proceed 
ATT2 
8 CEO should allow researcher to act freely Obtaining freedom to operate in an R&D environment requires the CEO to have trust in the 
R&D function and is part of a relationship of trust between CEO and R&D. This quote refers 
to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 ‘CEO and R&D should 
have a relationship of trust and confidence’ 
CEO-OTH31 
9 CEO is involved from the business opportunity side CEO evaluates economic viability of R&D project INV9 
10 CEO receives data that are reduced in complexity in order for 
the CEO to graps the message 
CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6 
11 CEO receives message which are reduced in complexity and 
helps R&D to think about the real issues  
CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6 
12 CEO trust me This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
13 CEO can be a non-scientist and that is not a disadvantage See above RD-OTH20 
14 CEO trust is always important This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31  
Quotes made by R&D executive RDE15 and assignment of the quotes to a ‘PSN theme’ or a new R&D theme (‘RDOTH’) 
1 CEO should recognize the value of the technology See above RD-OTH9 
2 CEO should be able to exploit our technologies CEO evaluates economic viability of R&D project RD-OTH9 
3 CEO should scan the environment for opportunities CEO sets the direction/goal and vision in which innovation to take place. The attention of a 
CEO to identify innovational opportunities in the market and to develop an appropriate 
strategy and the direction in which to proceed: a vision for the firm 
ATT1  
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4 CEO should be a master in communication CEOs do not reflect on their ability as communicator, but R&D executives stressed the fact that CEO should 
be particularly well good communicators especially in view of articulating their vision for the firm: RD-OTH 
23CEO is a good communicator 
RD-OTH23 
5 CEO should give the direction towards a common goal CEO sets the direction/goal and vision in which innovation to take place. The attention of a 
CEO to identify innovational opportunities in the market and to develop an appropriate 
strategy and the direction in which to proceed: a vision for the firm and  
ATT1  
6 CEO should have corridor meetings to avoid agendas By ‘corridor’ meetings was meant the action taken by CEOs to walk through the labs and talk 
about the scientific problems and projects whereby he/she obtains information 
from/discusses R&D with all levels 
CEO-OTH20 
7 CEO teaches R&D and R&D teaches CEO See above RD-OTH21 
8 CEO learns from R&D in corridor meetings See above RD-OTH21 
9 CEO receives RD messages for the CEO to understand CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6  
10 CEO receives simplified messages CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6 
11 CEO already has some background knowledge that helps the 
message to be constructed 
CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6 
12 CEO is teached by R&D for him to understand the message See above RD-OTH21 
13 CEO teaches us about the market See above RD-OTH21 
14 CEO should trust us This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31  
Quotes made by R&D executive RDE16 and assignment of the quotes to a ‘PSN theme’ or a new R&D theme (‘RDOTH’) 
1 CEO sets the direction CEO sets the direction/goal and vision in which innovation to take place. The attention of a 
CEO to identify innovational opportunities in the market and to develop an appropriate 
strategy and the direction in which to proceed: a vision for the firm 
ATT1  
2 CEO makes use the interactions are conducive to innovation CEO fosters a culture of innovation ATI1 
3 CEO is involved in the teams to steer the teams CEO is involved in NPD INV5 
4 CEO needs a basic understanding of the development of new 
products in life science 
RD-OTH 24 CEO understand the new product development process and its risks RD-OTH24 
5 CEO dares to take decisions R&D executives want their CEOs not only to be smart and have a lot of experience, they also want their 
CEOs to be courageous in taking bold ideas into an innovative environment RD-OTH25  should be willing to 
take risks in innovation  
RD-OTH25 
6 CEO should set another direction if needed CEO sets the direction/goal and vision in which innovation to take place. The attention of a 
CEO to identify innovational opportunities in the market and to develop an appropriate 
strategy and the direction in which to proceed: a vision for the firm 
ATT1  
7 CEO needs some basic knowledge about the science See above CEO-OTH5  
8 CEO should respect R&D and R&D should respect the CEO Respect in this case is also interpreted as trust; each party should trust each other and 
therefore respects each other experiences, arguments , expertise and conclusions 
CEO-OTH9  
9 CEO is a challenger CEO challenges R&D technically INV2 
10 CEO is a catalyst CEO fosters a culture of innovation ATI1 
11 CEO as a scientist has some advantage See above RD-OTH20 
12 CEO who is not a scientist can act as outside ‘quality control’ 
of R&D 
This argument was used by one CEO who stated that is much more useful to be a non-
scientists so that I can ask the right questions 
CEO-OTH12  
13 CEO should not interfere See above RD-OTH6 
 
 
Appendix O 
330 
 
14 CEO brings valuable ideas from his network CEO fosters external collaboration  to increase internal innovation ATI5  
15 CEO should not tell us what to do with new ideas and 
proposals 
See above RD-OTH6 
16 CEO learns from R&D See above  RD-OTH21 
17 CEO receives R&D know how that is reduced in complexity CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6  
18 CEO receives presentations from R&D that are market 
context driven 
CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6 
19 CEO as a scientist has an advantage but also carries a risk to 
become too much involved in the science 
See above 
 
RD-OTH6 
20 CEO should trust his R&D people This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31  
21 CEO should be trusted by R&D This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
22 CEO should know where the company goes CEO sets the direction/goal and vision in which innovation to take place. The attention of a 
CEO to identify innovational opportunities in the market and to develop an appropriate 
strategy and the direction in which to proceed: a vision for the firm 
ATT1 
23 CEO should trust his R&D people This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
Quotes made by R&D executive RDE17 and assignment of the quotes to a ‘PSN theme’ or a new R&D theme (‘RDOTH’) 
1 CEO should define the strategy and direction CEO sets the direction/goal and vision in which innovation to take place. The attention of a 
CEO to identify innovational opportunities in the market and to develop an appropriate 
strategy and the direction in which to proceed: a vision for the firm 
ATT1  
2 CEO should make sure all legal aspects of R&D are covered Surprisingly, R&D executives want their CEOs to make sure that all legal aspects of the development of new 
products are fulfilled.RD-OTH CEO makes sure that innovation is conducted in compliance with regulations 
RD-OTH25 
3 CEO with a scientific background can play a role in creating 
new opportunities 
See above RD-OTH15 
4 CEO without science knowledge needs a science manager to 
run the science 
See above RD-OTH20 
5 CEO uses his /her network to engage R&D CEO fosters external collaboration  to increase internal innovation ATI5  
6 CEO as a scientist is risky as they can get too involved in 
science 
See above RD-OTH6 
7 CEO as a scientists should let go off the science See above RD-OTH6 
8 CEO should be familiar with drug development processes and 
risks 
See above RD-OTH24 
9 CEO should network to discover opportunities CEO fosters external collaboration  to increase internal innovation ATI5  
10 CEO who is as knowledgeable as the CSO should take a step 
back 
See above RD-OTH6 
11 CEO who interferes with the scientist’s work will not be able 
to keep their scientists 
See above RD-OTH6 
12 CEO should leave the science to the scientists at one point 
during the company’s growth 
See above RD-OTH6 
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13 CEO as a good scientists are not good CEOs because they 
meddle too much 
See above RD-OTH6 
14 CEO innovates by challenging processes in R&D CEO challenges R&D for efficiency INV1  
15 CEO has a good understanding of the science   CEO-OTH5  
16 CEO with science based background will be better placed to 
assess the risks of a R&D project 
See above RD-OTH15 
17 CEO without a science background need to be controlled by a 
CSO in order for the CEO to make the correct scientific 
decisions 
See above RD-OTH15 
18 CEO should guarantee a stable environment for R&D to 
conduct its work 
R&D executives argue that a CEO should be able to make sure that the environment to 
innovate is stable, i.e. that they van focus on their objectives without frequent changes in 
focus 
ATT2  
19 CEO messages from R&D need to be simplified CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6 
20 CEO is open and honest  CEO fosters a culture of innovation ATI1 
21 CEO challenges R&D CEO challenges R&D for efficiency INV1 
22 CEO should trust his CSO and R&D This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
23 CEO looks for opportunities himself CEO sets the direction/goal and vision in which innovation to take place. The attention of a 
CEO to identify innovational opportunities in the market and to develop an appropriate 
strategy and the direction in which to proceed: a vision for the firm 
ATT1 
24 CEO without science knowledge or experience will have a 
difficult time to understand R&D and its underlying processes 
See above RD-OTH15 
25 CEO biggest problem of the experience of the development 
aspect of R&D 
See above RD-OTH19 
26 CEO is bright but it all comes down to experience in 
development 
See above RD-OTH19 
27 CEO without experience will overreact to R&D issues See above RD-OTH19 
Quotes made by R&D executive RDE18 and assignment of the quotes to a ‘PSN theme’ or a new R&D theme (‘RDOTH’) 
1 CEO should have a vision CEO sets the direction/goal and vision in which innovation to take place. The attention of a 
CEO to identify innovational opportunities in the market and to develop an appropriate 
strategy and the direction in which to proceed: a vision for the firm 
ATT1  
2 CEO should have scientific focus and drive The attention of a CEO to find innovational opportunities in the market place, to focus on 
this opportunity and to set the boundaries in which to proceed 
ATT2 
3 CEO should balance internal and external resources CEO fosters external collaboration to foster internal innovation ATI5 
4 CEO needs to build trust in the company This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
5 CEO should build structures for innovation CEO makes available human and financial resources COM4 
6 CEO should instill integrity in the company See above RD-OTH1 
7 CEO acts as a challenger of science CEO challenges R&D for efficiency INV1  
8 CEO learns from R&D See above RD-OTH21 
9 CEO understands the basics of R&D CEOs should have some understanding of the science in which their firms are engaged CEO-OTH38  
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10 CEO receives ‘balanced’ information from R&D This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
11 CEO has sufficient knowledge that prevents the message to 
be simplified 
CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6 
12 CEO should have a clear vision CEO sets the direction/goal and vision in which innovation to take place. The attention of a 
CEO to identify innovational opportunities in the market and to develop an appropriate 
strategy and the direction in which to proceed: a vision for the firm 
ATT1 
13 CEO receives oversimplified messages that can lead to the 
wrong decisions 
CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6 
14 CEO as a strong businessman and strong scientists is the ideal CEO top scientist/top business man/women is ideal CEO-OTH41 
15 CEO should have a vision CEO sets the direction/goal and vision in which innovation to take place. The attention of a 
CEO to identify innovational opportunities in the market and to develop an appropriate 
strategy and the direction in which to proceed: a vision for the firm 
ATT1 
16 CEO looks for new ideas him/herself CEO comes up with new innovative ideas INV8  
Quotes made by R&D executive RDE19 and assignment of the quotes to a ‘PSN theme’ or a new R&D theme (‘RDOTH’) 
1 CEO needs to make sure money flows into the company CEO makes available human and financial resources COM4  
2 CEO needs to trust his scientists This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
3 CEO needs to think strategically and build a strategy The attention of a CEO to identify innovational opportunities in the market and to develop 
an appropriate strategy and the direction in which to proceed: a vision for the firm 
ATT1 
4 CEO should trust their scientists This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
5 CEO with science background is too much inward looking 
while a business CEO is outward looking 
See above 
 
RD-OTH6 
6 CEO builds  a scientific network for us to profit from CEO fosters external collaboration  to increase internal innovation ATI5  
7 CEO builds scientific network that may help build trust with 
his/her R&D 
This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
8 CEO who double checks has a trust problem This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
9 CEO needs experience in R&D environments and their 
markets 
See above 
 
RD-OTH19 
10 CEO understand the process of new product development 
and the risks involved 
CEO needs to understand process/risks of R&D CEO-OTH34  
11 CEO with science knowledge is an advantage for R&D See above RD-OTH15 
12 CEO with no science background can do a great job See above RD-OTH20 
13 CEO learns from R&D See above RD-OTH21 
14 CEO builds a strategic vision CEO sets the direction/goal and vision in which innovation to take place. The attention of a 
CEO to identify innovational opportunities in the market and to develop an appropriate 
strategy and the direction in which to proceed: a vision for the firm 
ATT1  
15 CEO build network that are important fro R&D CEO fosters external collaboration  to increase internal innovation ATI5 
16 CEO should offer us his trust This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
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17 CEO prior knowledge leads to faster decision making See above RD-OTH15 
Quotes made by R&D executive RDE20 and assignment of the quotes to a ‘PSN theme’ or a new R&D theme (‘RDOTH’) 
1 CEO should represent R&D to the outside world RD-OTH 25 CEOs should be able to represent the science of their firms RD-OTH26 
2 CEO should be able to talk about R&D to the outside world at 
a professional level 
See above RD-OTH26 
3 CEO should set the vision for the future CEO sets the direction/goal and vision in which innovation to take place. The attention of a 
CEO to identify innovational opportunities in the market and to develop an appropriate 
strategy and the direction in which to proceed: a vision for the firm 
ATT1  
4 CEO needs to be pulled down to reality by means of scientific 
arguments 
R&D executives argue that in some cases CEOs ‘oversell’ their science. RD-OTH26 CEOs should be brought 
back to scientific reality 
RD-OTH27 
5 CEO needs to have an open mind and empower people CEO fosters a culture of innovation ATT1  
6 CEO needs to have a clear vision CEO sets the direction/goal and vision in which innovation to take place. The attention of a 
CEO to identify innovational opportunities in the market and to develop an appropriate 
strategy and the direction in which to proceed: a vision for the firm 
ATT1 
7 CEO should make sure there are resources available CEO makes available human and financial resources COM4 
8 CEO should not push back new innovative ideas R&D executives argue that some CEOs are afraid of innovative ideas RD-OTH27  CEOs should embrace new 
innovative ideas 
RD-OTH28 
9 CEO looks ahead? Then R&D will also look ahead! CEO acts as a role model for innovation CEO-OTH17  
10 CEO should share and articulate his vision with R&D  CEO fosters internal communication ATI3 
11 CEO does not make sufficient time available for R&D CEO has no time to talk to R&D CEO-OTH50 
12 CEO does not trust me if he mingles with R&D  If the CEO would start to mingle with the scientists this behavior would be considered a sign 
of distrust by this R&D executive. This quote refers to the concept of ‘trust’ and is therefore 
assigned to code CEO-OTH 31 ‘CEO and R&D should have a relationship of trust and 
confidence’ 
CEO-OTH31 
13 CEO receives simplified R&D messages not because he could 
not understand otherwise but because he would become 
confused 
CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6 
14 CEO is knowledgeable about the development process CEO needs to understand process/risks of R&D CEO-OTH34 
15 CEO should make sure there are resources and money CEO makes available human and financial resources COM4 
16 CEO as a strong businessman and strong scientists is the ideal CEO top scientist/top business man/women is ideal CEO-OTH41 
17 CEO acting as a CSO cannot be successful because he is too 
much involved in the science 
See above RD-OTH6 
18 CEO needs to trust his people This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31  
19 CEO challenges the process continuously CEO challenges R&D for efficiency INV1 
 Quotes made by R&D executive RDE21 and assignment of the quotes to a ‘PSN theme’ or a new R&D theme (‘RDOTH’) 
1 CEO offers the opportunity to explore the novel principles 
that makes sense to the business 
If the CEO allows the R&D function to explore opportunities of novel principles this is 
indicative of a sign of trust. This quote refers to the concept of ‘trust’ and is therefore 
assigned to code CEO-OTH 31 ‘CEO and R&D should have a relationship of trust and 
confidence’ 
CEO-OTH31  
2 CEO has strong scientific background See above RD-OTH15 
 
 
Appendix O 
334 
 
3 CEO needs to trust R&D This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31  
4 CEO without background in the R&D cannot decide See above  RD-OTH15 
5 CEO can only point into a certain direction because he 
understand the science 
See above  RD-OTH15 
6 CEO translates the science into a selling proposition If a CEO is capable to translate the science in a selling proposition , it means that he was able to evaluate 
the scientific proposition. It is part of his absorptive capacity.  
RD-OTH9 
7 CEO is really and honestly interested in science See above  RD-OTH21 
8 CEO should be visible to R&D CEO fosters internal communication ATI3  
9 CEO is transparent and communicative CEO fosters a culture of innovation ATI1 
10 CEO discusses science ad hoc CEO acts as a sounding board INV3 
11 CEO trusts me and therefore a knowledge gap exists If there is a knowledge gap and the CEO does not wants to become informed about the 
science, he/she can do so because he/she fully trusts me. This quote refers to the concept of 
‘trust’ and is therefore assigned to code CEO-OTH 31 ‘CEO and R&D should have a 
relationship of trust and confidence’ 
CEO-OTH31 
12 CEO builds networks that are useful for R&D CEO fosters external collaboration  to increase internal innovation ATI5 
13 CEO sets the direction CEO sets the direction/goal and vision in which innovation to take place. The attention of a 
CEO to identify innovational opportunities in the market and to develop an appropriate 
strategy and the direction in which to proceed: a vision for the firm 
ATT1 
14 CEO learns R&D about the business and the market through 
its networks 
CEO fosters external collaboration  to increase internal innovation ATI5 
15 CEO has a good background in science See above  RD-OTH15 
16 CEO is a good communicator See above RD-OTH26 
17 CEO requires a minimum of science knowledge See above RD-OTH15 
18 CEO should not be dominant This refers to the CEO quote that CEOs in a life science R&D organization should not act as 
‘dominant’ figures 
CEO-OTH39  
19 CEO receives simplified messages from R&D CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6 
20 CEO should conduct the complexity reduction of the science, 
not R&D 
CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6 
Quotes made by R&D executive RDE22 and assignment of the quotes to a ‘PSN theme’ or a new R&D theme (‘RDOTH’) 
1 CEO opens the door to innovation CEO fosters a culture of innovation ATI1  
2 CEO builds networks from which R&D learns CEO fosters external collaboration  to increase internal innovation ATI5 
3 CEO knows where to go with firm CEO sets the direction/goal and vision in which innovation to take place. The attention of a 
CEO to identify innovational opportunities in the market and to develop an appropriate 
strategy and the direction in which to proceed: a vision for the firm 
ATT1 
4 CEO has a good knowledge of science CEOs should have some understanding of the science in which their firms are engaged CEO-OTH38 
5 CEO received R&D data that are simplified in order to create 
the necessary perception with him/her 
CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6 
6 CEO should trust R&D CEO-OTH31 ‘CEO and R&D should have a relationship of trust and confidence’ CEO-OTH31 
7 CEO makes efforts to understand the background of science CEO attempts to understand R&D expertise CEO-OTH10 
Quotes made by R&D executive RDE23 and assignment of the quotes to a ‘PSN theme’ or a new R&D theme (‘RDOTH’) 
1 CEO should make innovation possible CEO fosters a culture of innovation ATI1  
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2 CEO should not become too much involved  RD-OTH6 
3 CEO should not be dominant This refers to the CEO quote that CEOs in a life science R&D organization should not act as 
‘dominant’ figures 
CEO-OTH39  
4 CEO should create an environment that is conduce to 
innovation 
CEO fosters a culture of innovation ATI1 
5 CEO should hire the right people CEO hires selects and develops innovative leadership COM1  
6 CEO should not be dominant This refers to the CEO quote that CEOs in a life science R&D organization should not act as 
‘dominant’ figures 
CEO-OTH39 
7 CEO has to create the environment to allow innovation CEO fosters a culture of innovation ATI1 
8 CEO should show the direction to innovate CEO sets the direction/goal and vision in which innovation to take place. ATT1 
9 CEO should create the right conditions for innovation: hire 
the right people 
CEO makes available human and financial resources COM4  
10 CEO should give the right direction to R&D people CEO sets the direction/goal and vision in which innovation to take place. The attention of a 
CEO to identify innovational opportunities in the market and to develop an appropriate 
strategy and the direction in which to proceed: a vision for the firm 
ATT1 
11 CEO should shows the direction in which R&D should move CEO sets the direction/goal and vision in which innovation to take place. The attention of a 
CEO to identify innovational opportunities in the market and to develop an appropriate 
strategy and the direction in which to proceed: a vision for the firm 
ATT1 
12 CEO should allow communication, listen to suggestions, 
comments, positive or negative 
CEO fosters a culture of innovation ATI1 
13 CEO needs to find the right means the right people, create the 
atmosphere, the possibilities 
CEO makes available human and financial resources COM4  
14 CEO needs to find the right means the right people, create the 
atmosphere, the possibilities 
CEO fosters a culture of innovation ATI1 
15 CEO builds networks R&D can profit from CEO fosters external collaboration  to increase internal innovation ATI5 
16 CEO challenges R&D CEO challenges R&D technically INV2 
17 CEO without science background is more difficult to convince See above RD-OTH15 
18 CEO message is being simplified CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6  
Quotes made by R&D executive RDE24 and assignment of the quotes to a ‘PSN theme’ or a new R&D theme (‘RDOTH’) 
1 CEO trust in R&D supports innovation This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31  
2 CEO challenges and criticizes R&D  CEO challenges R&D technically INV2 
3 CEO is trusted by R&D so that challenging can take place CEO-OTH 31 ‘CEO and R&D should have a relationship of trust and confidence’ CEO-OTH31 
4 CEO builds a network  CEO fosters external collaboration  to increase internal innovation ATI5 
5 CEO has perspectives that may contribute to R&D See above  RD-OTH19 
6 CEO creates an atmosphere of trust that we are working for 
the whole  
This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31  
7 CEO accepts arguments and will not misinterpret them and 
used against you 
The R&D executive argues that it is important that the communi-cation of sensitive data to 
the CEO will not ‘fire back’ when it is made public and in ‘the open’. This quote refers to the 
concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 ‘CEO and R&D should have 
a relationship of trust and confidence’ 
CEO-OTH31 
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8 CEO should trust our expertise : that is a basic  This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31  
9 CEO trusts our data as he is using them in his network This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
10 CEO should trusts R&D because the data are not in his field of 
expertise 
This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31  
11 CEO is involved in matters that are linked to his expertise CEO-OTH3 CEO-OTH3 
12 CEO contributes to innovation because he challenges CEO challenges R&D for efficiency INV1  
13 CEO has no knowledge gap but has knowledge that 
complements the R&D knowledge 
CEO and CSO are innovative forces together CEO-OTH25 
14 CEO background is not very important, attitude is more 
important 
CEO fosters a culture of innovation ATI1  
15 CEO will be teached by R&D if he/she shows a lack in 
knowledge 
See above RD-OTH21 
16 CEO does not need to have deep R&D knowledge to challenge 
the data 
CEOs should have some understanding of the science in which their firms are engaged CEO-OTH38  
17 CEO messages are simplified to make them ‘absorbable’ CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6 
18 CEO should have no prior detailed knowledge but should 
have analytical capabilities 
See above  RD-OTH20 
19 CEO argues that we are not in for academic work CEO wants R&D to step out of academic thinking CEO-OTH7  
20 CEO should trust us that we ourselves with increase the 
output of R&D 
This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
21 CEO trust is more important than a bonus This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
22 CEO should promote open communication CEO fosters internal communication ATI3 
23 CEO argues about the direction R&D needs to take CEO sets the direction/goal and vision in which innovation to take place. ATT1 
24 CEO has a strong vision CEO sets the direction/goal and vision in which innovation to take place. ATT1 
25 CEO should be very much motivating and supporting the R&D 
people to get the best of them 
CEO fosters a culture of innovation ATI1 
26 CEO should be very involved and interested in our work CEO is involved in NPD INV5 
27 CEO knowledge is not that important, its attitude See above  RD-OTH20 
Quotes made by R&D executive RDE25 and assignment of the quotes to a ‘PSN theme’ or a new R&D theme (‘RDOTH’) 
1 CEO builds networks for R&D  CEO fosters external collaboration  to increase internal innovation ATI5  
2 CEO allows R&D to learn through the network CEO fosters external collaboration  to increase internal innovation ATI5 
3 CEO sees the science in a broader context and learns R&D to 
see through that broader context (ie business) 
See above RD-OTH21 
4 CEO does not necessarily need to be a scientist See above RD-OTH20 
5 CEO offers the resources to R&D CEO makes available human and financial resources COM4  
6 CEO should be critical and should ‘juggle’ with our data CEO challenges R&D technically INV2 
7 CEO should offer the R&D trust and confidence for 
operational freedom 
This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
8 CEO is open to (operational) freedom and is open minded CEO fosters a culture of innovation ATI1 
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9 CEO looks at the R&D data from his own perspective CEO interacts with R&D only in those matters he/she has personal knowledge in CEO-OTH3 
10 CEO teaches R&D about the market See above RD-OTH21 
11 CEO allows R&D to learn from his/her network CEO fosters external collaboration  to increase internal innovation ATI5  
12 CEO trusts his R&D team leader This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
13 CEO can be trusted by R&D This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
14 CEO trust leads to more innovation  This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
15 CEO trust leads to more innovation because R&D can show its 
ideas without restriction 
This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
Quotes made by R&D executive RDE26 and assignment of the quotes to a ‘PSN theme’ or a new R&D theme (‘RDOTH’) 
1 CEO has to play a positive role in innovation and to create the 
atmosphere to innovate 
CEO fosters a culture of innovation ATI1  
2 CEO should trust his CSO and R&D and it’s the most 
important thing 
This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
3 CEO is being trusted by R&D This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
4 CEO teaches R&D about his expertise See above RD-OTH21 
5 CEO has weekly meetings with R&D CEO holds frequent formalized meetings with R&D INV6  
6 CEO should give us his trust This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
7 CEO should give the people the opportunity to learn CEO fosters learning in the organization ATI7 
8 CEO teaches R&D about his expertise outside of science See above RD-OTH21 
9 CEO needs to give the direction to R&D CEO sets the direction/goal and vision in which innovation to take place. The attention of a 
CEO to identify innovational opportunities in the market and to develop an appropriate 
strategy and the direction in which to proceed: a vision for the firm 
ATT1  
10 CEO attitude towards the R&D people on the floor is very 
important 
CEO fosters a culture of innovation ATI1 
11 CEO should be involved from time to time in discussions with 
the CSO and the other team players 
CEO holds frequent formalized meetings with R&D INV6 
12 CEO does not need prior knowledge on the topic CEO considers it an advantage to be untrained in science CEO-OTH12 
13 CEO should offer trust to R&D This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
14 CEO should offer freedom to R&D Obtaining freedom to operate in an R&D environment requires the CEO to have trust in the 
R&D function and is part of a relationship of trust between CEO and R&D. This quote refers 
to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 ‘CEO and R&D should 
have a relationship of trust and confidence’ 
CEO-OTH31 
15 CEO should be involved in R&D CEO holds frequent formalized meetings with R&D INV6 
16 CEO should have an open-door policy CEO fosters a culture of innovation ATI1 
17 CEO should not meddle with the scientists See above RD-OTH6 
Quotes made by R&D executive RDE27 and assignment of the quotes to a ‘PSN theme’ or a new R&D theme (‘RDOTH’) 
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1 CEO science knowledge steers the development in the right 
direction 
CEO fosters a culture of innovation ATI1  
2 CEO has the same level of knowledge as R&D See above RD-OTH15 
3 CEO acting as a scientist risks micromanaging people in R&D  See above RD-OTH6 
4 CEO without science background has more vision and the 
right experience 
See above RD-OTH20 
5 CEO has focus The attention of a CEO to find innovational opportunities in the market place, to focus on 
this opportunity and to set the boundaries in which to proceed 
ATT2  
6 CEO relationship with R&D is based upon trust This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
7 CEO talks with all levels of the organization CEO gets information  from/discusses R&D with all levels CEO-OTH20 
8 CEO needs to know whether he/she finds himself in ‘quick 
sand’ when talking to R&D 
This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
9 CEO should really challenge us CEO challenges rD1 technically INV2 
10 CEO receives R&D messages which are written in a non-
science language 
CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6 
11 CEO information from R&D should be accompanied by 
potential outcome of the R&D effort 
CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6 
12 CEO without a science background is informed about R&D 
projects in term of ‘outcome’ not in terms of ‘science’ 
CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6 
13 CEO needs to trust R&D This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
14 CEO should be open but not always CEO fosters a culture of innovation ATI1 
15 CEO should have a strong business background more than a 
strong science background 
See above RD-OTH19 
16 CEO with non –science background contributes to innovation 
and complements R&D knowledge 
See above RD-OTH19 
Quotes made by R&D executive RDE28 and assignment of the quotes to a ‘PSN theme’ or a new R&D theme (‘RDOTH’) 
1 CEO should act as an entrepreneur RD-OTH28 CEO should act as an entrepreneur  RD-OTH28 
2 CEO should have a clear vision CEO sets the direction/goal and vision in which innovation to take place. The attention of a 
CEO to identify innovational opportunities in the market and to develop an appropriate 
strategy and the direction in which to proceed: a vision for the firm 
ATT1  
3 CEO of a start up should have specific knowledge of R&D 
thereafter it is not necessary 
See above RD-OTH19 
4 CEO should be good networker (to look for new 
opportunities) 
CEO fosters external collaboration  to increase internal innovation ATI5  
5 CEO expertise should not necessarily  be in science but in 
market knowledge 
See above RD-OTH19 
6 CEO should understand the science and technology behind 
R&D 
CEO attempts to understand R&D expertise CEO-OTH10  
7 CEO message from R&D should be presentable to anyone CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6 
8 CEO with science backgrounds drive the innovation See above RD-OTH15 
 
 
Appendix O 
339 
 
9 CEO message are simplified to motivate the CEO to approve 
the proposal 
CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6  
10 CEO should have vast experience in leading R&D firms See above  RD-OTH19 
11 CEO has an amazing talent to understand the science right 
away and is driven by genuine interest 
See above RD-OTH15 
12 CEO need for prior knowledge is driven by how good the 
scientific group operates 
CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6  
13 CEO message from R&D is transformed to a level driven by 
the CEO prior knowledge 
CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6 
Quotes made by R&D executive RDE29 and assignment of the quotes to a ‘PSN theme’ or a new R&D theme (‘RDOTH’) 
1 CEO should be the individual with the most experience in the 
whole company 
See above RD-OTH19 
2 CEO should always ask the question where do e go from 
here? 
CEO sets the direction/goal and vision in which innovation to take place. The attention of a 
CEO to identify innovational opportunities in the market and to develop an appropriate 
strategy and the direction in which to proceed: a vision for the firm 
ATT1  
3 CEO creates a link between all levels in the organization CEO gets information  from/discusses R&D with all levels CEO-OTH20 
4 CEO communicates with all stakeholders in the organization CEO fosters internal communication ATI3 
5 CEO should challenge the status quo considerably CEO challenges R&D for efficiency INV1 
6 CEO acts at all levels to create the link between vision and 
strategy 
This refers to a CEO commitment – the creation of appropriate organizational structures for 
an innovation project to be successful   
COM6 
7 CEO shows his personal commitment and engagement to the 
organization 
CEO acts as a role model for innovation CEO-OTH17 
8 CEO can steer development because he understands the 
science and has a science background 
See above RD-OTH15 
9 CEO has a vision for the patient CEO sets the direction/goal and vision in which innovation to take place. The attention of a 
CEO to identify innovational opportunities in the market and to develop an appropriate 
strategy and the direction in which to proceed: a vision for the firm 
ATT1  
10 CEO and CSO are complementary in innovation CEO and CSO are innovative forces together CEO-OTH25 
11 CEO considers it to be a disadvantage not to be a scientist 
because it results in non-integrated unstable long term 
visions 
See above RD-OTH15 
12 CEO with science/entrepreneur capabilities has a longer term 
vision for the company 
See above RD-OTH28 
13 CEO challenges R&D CEO challenges R&D for efficiency INV1  
14 CEO uses his network to build and foster R&D CEO fosters external collaboration  to increase internal innovation ATI5 
15 CEO should show very strong commitment CEO acts as a role model for innovation CEO-OTH17 
16 CEO scientists may meddle with your research activities See above RD-OTH6 
Quotes made by R&D executive RDE30 and assignment of the quotes to a ‘PSN theme’ or a new R&D theme (‘RDOTH’) 
1 CEO creates the right environment to innovate CEO fosters a culture of innovation ATI1  
2 CEO has the right vision CEO sets the direction/goal and vision in which innovation to take place ATT2 
3 CEO has the commitment CEO makes available human and financial resources COM4 
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4 CEO articulates the vision in the company CEO sets the direction/goal and vision in which innovation to take place. The attention of a 
CEO to identify innovational opportunities in the market and to develop an appropriate 
strategy and the direction in which to proceed: a vision for the firm 
ATT1 
5 CEO triggers to act upon the vision CEO sets the focus and boundaries in which innovation to take place. ‘Trigger upon the 
vision’, means in this context that the CEO wants R&D to act in line with the direction and 
keep their activities within the boundaries 
ATT2 
6 CEO gives his active support  CEO makes available human and financial resources COM4 
7 CEO creates innovation across boundaries and interfaces CEO fosters internal communication ATI3 
8 CEO should establish an open and transparent atmosphere 
were ideas can be exchanged 
CEO fosters a culture of innovation ATI1 
9 CEO should generate trust and openness in order to create an 
environment of innovation 
This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
10 CEO without R&D knowledge is not prepared to invest time in 
discussions with R&D 
See above RD-OTH15 
11 CEO with a global role cannot make time available to discuss 
R&D 
RD-OTH 29 CEO should make time available for R&D RD-OTH29 
12 CEO learns R&D to bridge the knowledge gap See above RD-OTH21 
13 CEO lack of knowledge is compensated by his/her experience See above RD-OTH19 
14 CEO has a noble purpose This quote or a quote similar to this quote was not observed during the interviews with CEOs RD-OTH1 
15 CEO needs a clear vision CEO sets the direction/goal and vision in which innovation to take place. The attention of a 
CEO to identify innovational opportunities in the market and to develop an appropriate 
strategy and the direction in which to proceed: a vision for the firm 
ATT1  
Quotes made by R&D executive RDE31 and assignment of the quotes to a ‘PSN theme’ or a new R&D theme (‘RDOTH’) 
1 CEO should bring people together CEO fosters internal communication ATI3  
2 CEO should be supportive of innovation CEO fosters a culture of innovation ATI1 
3 CEO message should be considerably simplified CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6 
4 CEO should be able to learn his expertise to R&D See above RD-OTH19 
5 CEO should network considerably for R&D to profit from CEO fosters learning in the organization ATI7  
6 CEO should be more qualitatively then quantitatively oriented See above RD-OTH3 
7 CEO should offer trust to R&D This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31  
Quotes made by R&D executive RDE32 and assignment of the quotes to a ‘PSN theme’ or a new R&D theme (‘RDOTH’) 
1 CEO needs a thorough understanding of the market See above RD-OTH19 
2 CEO should have a good knowledge of the development 
process 
See above RD-OTH24 
3 CEO does not need scientific knowledge See above RD-OTH20 
4 CEO should have an open communication model CEO fosters internal communication ATI3  
5 CEO message from R&D is transformed, simplified R&D 
knowledge 
CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6 
6 CEO message should be simplified otherwise it is risky CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6 
7 CEO acts at a top level when they are as well top scientists 
and how to make money from the science 
CEO top scientist/business man/women is ideal CEO-OTH41 
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Quotes made by R&D executive RDE33 and assignment of the quotes to a ‘PSN theme’ or a new R&D theme (‘RDOTH’) 
1 CEO should drive the strategy CEO sets the direction/goal and vision in which innovation to take place. The attention of a 
CEO to identify innovational opportunities in the market and to develop an appropriate 
strategy and the direction in which to proceed: a vision for the firm 
ATT1  
2 CEO should balance trust and challenge This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
3 CEO should trust the R&D organization This quote refers to the concept of ‘trust’ and is therefore assigned to CEO-OTH 31 ‘CEO and 
R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
4 CEO should not micromanage R&D See above RD-OTH6 
5 CEO should challenge in order to trigger the conscience of 
R&D 
CEO challenges R&D for efficiency INV1  
6 CEO should ask questions sufficient to make people sweat CEO challenges R&D technically INV2 
7 CEO forces R&D to think differently See above RD-OTH21 
8 CEO message is simplified CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6  
9 CEO learns from R&D See above RD-OTH21 
10 CEO teaches the R&D organization about the business See above RD-OTH21 
11 CEO is coached by R&D to understand R&D knowledge See above RD-OTH21 
12 CEO knowledge from R&D is titrated to a common ground CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6  
13 CEO should foster transparency to instill trust in the 
organization 
This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
Quotes made by R&D executive RDE34 and assignment of the quotes to a ‘PSN theme’ or a new R&D theme (‘RDOTH’) 
1 CEO should have the right attitude for innovation CEO fosters a culture of innovation ATI1  
2 CEO should commit for resources for a long term perspective 
and commitment 
CEO makes available human and financial resources COM4 
3 CEO should show trust in R&D and supports innovation This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
4 CEO should make clear that there is trust among the top 
management team members 
This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
5 CEO should have trust in R&D and be assured that the money 
is well spent 
This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
6 CEO needs to create a stable environment for innovation to 
take place 
R&D executives argue that a CEO should be able to make sure that the environment to 
innovate is stable, i.e. that they van focus on their objectives without frequent changes in 
focus 
ATT2 
7 CEO shows trust in R&D even when things go wrong This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
8 CEO should create an atmosphere of trust such tat scientist 
can explore new ways 
This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
9 CEO is capable to understand the science CEOs should have some understanding of the science in which their firms are engaged CEO-OTH38 
10 CEO should not mistrust innovation This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
11 CEO should have trust in the data This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31  
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12 CEO can challenge if he/she shows trust This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
13 CEO learns R&D about the business and the markets See above RD-OTH21 
14 CEO receives simplified R&D know how CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6  
15 CEO wants to understand the data in order to be able to 
challenge it 
CEO attempts to understand R&D expertise CEO-OTH10 
Quotes made by R&D executive RDE35 and assignment of the quotes to a ‘PSN theme’ or a new R&D theme (‘RDOTH’) 
1 CEO should make sure there enough resources CEO makes available human and financial resources COM4  
2 CEO should show trust: it comes when all the rest is there This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
3 CEO should show sincere interest CEO acts as a sounding board INV3 
4 CEO should have a clear strategy CEO sets the direction/goal and vision in which innovation to take place. The attention of a 
CEO to identify innovational opportunities in the market and to develop an appropriate 
strategy and the direction in which to proceed: a vision for the firm 
ATT1 
5 CEO should not exchange trust with money This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31 
Quotes made by R&D executive RDE36 and assignment of the quotes to a ‘PSN theme’ or a new R&D theme (‘RDOTH’) 
1 CEO should be a scientist to some extent and have at least 
some knowledge 
CEOs should have some understanding of the science in which their firms are engaged CEO-OTH38  
2 CEO should build a network for R&D to become engaged in CEO fosters external collaboration  to increase internal innovation ATI5 
3 CEO should attract the right people CEO hires selects and develops innovative leadership COM1 
4 CEO should be a trustworthy person This quote refers to the concept of ‘trust’ and is therefore assigned to code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH3 
5 CEO should be a stable factor in the organization R&D executives argue that a CEO should be able to make sure that the environment to 
innovate is stable, i.e. that they van focus on their objectives without frequent changes in 
focus 
ATT2 
6 CEO should have a clear vision CEO sets the direction/goal and vision in which innovation to take place ATT2 
7 CEO and R&D are at both ends of a knowledge gap See above RD-OTH15 
8 CEO is teached by R&D about the science See above RD-OTH21 
9 CEO is given a simplified message to some extent CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6  
10 CEO should have at least some knowledge about science See above RD-OTH21 
11 CEO should stimulate people to innovate CEO fosters a culture of innovation ATI1  
12 CEO should trust R&D This quote refers to the concept of ‘trust’ and is therefore assigned the code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-
OTH31 
13 CEO should be trusted by R&D This quote refers to the concept of ‘trust’ and is therefore assigned the code CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-
OTH31 
14 CEO should bring in the money CEO makes available human and financial resources COM4 
Quotes made by R&D executive RDE37 and assignment of the quotes to a ‘PSN theme’ or a new R&D theme (‘RDOTH’) 
1 CEO knows the science really good and that is an advantage 
for a small company 
See above RD-OTH15 
2 CEO understands the science so I do not need to explain it See above RD-OTH15 
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3 CEO who does not understand the science needs somebody 
to explain it 
See above RD-OTH15 
4 CEO has a vast network from which R&D can profit and bring 
R&D into contact with other R&D people 
CEO fosters external collaboration  to increase internal innovation ATI5  
5 CEO is a good communicator to direct and link all internal 
stakeholders 
CEO fosters internal communication ATI3 
6 CEO is a good communicator and is very approachable CEO fosters internal communication ATI3 
7 CEO wants to understand what is going on in R&D CEO attempts to understand R&D expertise CEO-OTH10 
8 CEO comes up with his own ideas CEO comes up with new innovative ideas INV8 
9 CEO contributes to R&D in those areas in which he has 
expertise 
CEO interacts with R&D only in those matters he/she has personal knowledge in CEO-OTH3 
10 CEO should develop a climate of innovation CEO fosters a culture of innovation ATI1  
11 CEO should have extensive industry experience See above RD-OTH19 
12 CEO teaches me how to develop a product See above RD-OTH21 
13 CEO needs to understand what we are doing in R&D and how 
it progresses 
See above RD-OTH21 
14 CEO who knows about the science can more effectively 
secure money 
See above RD-OTH21 
15 CEO explicitly wants to understand the science CEO attempts to understand R&D expertise CEO-OTH10  
Quotes made by R&D executive RDE38 and assignment of the quotes to a ‘PSN theme’ or a new R&D theme (‘RDOTH’) 
1 CEO should not be the innovator of the company See above RD-OTH16 
2 CEO should makes sure that innovation can happen CEO fosters a culture of innovation ATI1  
3 CEO should put the right people in place CEO hires selects and develops innovative leadership COM1 
4 CEO should have clear vision for the company CEO sets the direction/goal and vision in which innovation to take place ATT1 
5 CEO should make sure the TMT has the right skills CEO looks for the best possible management team CEO-OTH22 
6 CEO should be capable to communicate with everyone in the 
organization 
CEO gets information  from/discusses R&D with all levels CEO-OTH20  
7 CEO should have different background from the science such 
that his/her knowledge is complementary 
See above RD-OTH19 
8 CEO should have some degree of knowledge CEOs should have some understanding of the science in which their firms are engaged CEO-OTH38  
9 CEO should have an experienced CEO more than a CEO who 
know life science R&D 
See above RD-OTH19 
10 CEO from outside the company may potentially see more 
opportunities than an internally grown CEO 
See above RD-OTH19 
11 CEO who is not trained as a scientist is capable to ask the 
right questions the scientists would never ask 
See above CEO-OTH12  
12 CEO messages need to be simplified in order to see the 
advantage of a technology 
CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6  
13 CEO message which are simplified are not necessarily 
unscientific 
CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6 
14 CEO who is grown from within the company  may focus too 
much on the operational aspects of the firm 
See above RD-OTH6 
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15 CEO should take a step back from R&D See above RD-OTH6 
16 CEO should not need in depth knowledge of the field of R&D See above RD-OTH20 
Quotes made by R&D executive RDE39 and assignment of the quotes to a ‘PSN theme’ or a new R&D theme (‘RDOTH’) 
1 CEO should motivate people to innovate CEO fosters a culture of innovation ATI3  
2 CEO should foster a policy on open communication CEO fosters internal communication ATI3 
3 CEO who has some knowledge  allows easier science 
discussions 
See above RD-OTH15 
4 CEO who offers a financial bonus does not necessarily 
motivate scientists 
R&D scientists, although pleased with a financial bonus, are not necessarily motivated by it. 
Their motivation stems from their contribution to a new product, their involvement and the 
trust that they receive from top management with respect to their expertise CEO-OTH 31 
‘CEO and R&D should have a relationship of trust and confidence’ 
CEO-OTH31  
5 CEO can be convinced easier about a new innovation if 
he/she is knowledgeable about the subject and to explain my 
’stuff’ 
CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6 
6 CEO requires non science data for him/her to be informed 
about R&D 
CEO requires R&D data to be simplified for strategic decision and communication CEO-OTH6 
*Involvement by CEO can be either technically (INV2) of for reasons of efficiency (INV1). Whether INV1 or INV2 was chosen depends on the case context 
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Appendix P.  R&D interview observations  
This section proceeds with an analysis of the interview observations on trust and 
complexity reduction. Because of the difference in degree of emergence of the concept 
of trust in the interviews of CEOs and R&D executives and the re-appearance of the 
concept of complexity reduction, it was decided to continue the interview analysis and 
observations for both. The first section presents the findings on trust and shows the 
concept of trust emerging in the interviews of the R&D executives. The second section 
in this appendix addresses the CEO’s absorptive capacity. 
 
TRUST 
 
RDE7 is the CSO of a small biotech firm and a world renown scientist. He/she has made 
his/her name in industry and in academia in a particular area of biomedical science. His 
experience in dealing with chief executive officers has not been without problems.  The 
fact that one of the drugs that were under development did not made it to the market, 
was - according to this CSO - caused by the fundamental problem of the difference in 
view between CSO and CEO. The CEO was a dominant-science educated -  figure who 
managed with ‘rigidity and control’ and made decisions on his/her own without paying 
attention to the concerns and scientific/medical arguments of the CSO and his/her team. 
The failure of the drug would not have happened – according to the CSO - if he/she 
would have listened to the CSO and his/her team. The CSO therefore argues that a CEO  
 
‘ should give time to the (R&D) people he/she is working with 
because you believe in these (R&D) people and you want to 
have a generous personal relationship with them, whereby you 
help (achieve) the objectives’ 
 
The CSO  therefore is convinced that a fruitful and effective relationship... 
 
‘would only work if the CEO had senior scientists who had a very 
good relationship with them and there was a bond of trust’ 
 
however this bond of trust was harmed because the former CEO... 
 
‘was a very charismatic powerful individual who thought he 
could make his own judgements on certain aspects of (drug) 
development, even basic biology and in that process ...  he 
convinced himself that his approach would be acceptable ...  
even when his own advisors and his professional people said no, 
he went outside and got other opinions and came back and 
argued (against us) ....  he believed because he had a science 
background that he understood us when he didn’t really and he 
wasn’t aware that he in a way was being self destructive’ 
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The former CEO, although he/she had a science background, was not considered 
effective in dealing with the R&D function, because he was searching support for his/her 
own vision with outside consultants who could offer him/her the necessary ammunition 
to tackle the arguments of his R&D staff. After the fiasco of the failed drug development 
project, the CEO-scientist was replaced by a finance CEO (CEO2P in our CEO pilot study) 
who did not understand the science, and focused on the financial aspects (in order for 
the company to survive).When asked about the relationship with the finance-CEO, the 
CSO argues  that:  
 
‘we trust each other absolutely’ 
 
This relationship is a relationship of trust between 2 individuals with 2 different 
educational and experiential backgrounds and who complement each other. However, 
this should be taken with some caution, as this CEO argued during the pilot interview 
that he hopes that 
 
‘’The CSO is not deliberately misleading me’ 
 
Indicating that such a trust relationship is subject to personal interpretations. From the 
viewpoint of this CSO, this is an ideal situation as he/she argues that it is inappropriate 
for a CEO to meddle with the science activities in his firm. According to this CSO, a CEO 
should make available the resources but the strategy for the approach in getting a new 
product on the market should rest entirely with the R&D function. This first interview 
offered a first impression of the potential difficult relationship between CEO and R&D. 
Even if the CEO has a science background and has a sincere interest in the science, 
his/her interference with the science is strongly objected by R&D executives. The CEO 
should trust the arguments raised by the R&D function: without trust says this CEO – 
irrespective of the prior educational background of the CEO - a R&D intensive firm 
cannot be managed properly. 
 
Besides commitment to the scientific exploration and the attitude of the CEO, RDE9 
however supports the CEO’s point of view that he/she should double check the 
information received from R&D:  
 
‘he’s a scientist ... but I think what is good with him is - and I 
think some people do not like it-  but he is always double 
checking the information ... I like it personally because it means 
he’s checking and I don’t see this double check as a negative 
aspect...’ 
 
The fact that the CEO double-checks the claims made by the CEO is not considered a sign 
of distrust by RDE9. It is not the first time that a ‘double check’ step made by the CEO is 
not considered a sign of distrust by RDE9 (a CSO) and a university Professor. This is likely 
due to the fact that the essence of the scientific exploration is the possibility of one’s 
work to be checked and rechecked and is therefore not considered as a sign of distrust, 
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but rather a normal part of the scientific endeavour. That this double-checking was 
severely disapproved by RDE7 is likely caused by the fact that RDE7 – an academic with 
a strong international prestige – had a difficult time being challenged by a business 
executive on his/her terrain. 
 
In the case of RDE9, the essence of CEO double-checking is to make sure that he/she has 
the correct information. RDE9 argues that it is imperative for R&D to gather the right 
information for the CEO to take the right conclusion: 
 
 ‘What I want to say that he’s understanding the science and 
where we want to go that’s really important for the vision and 
he needs to understand exactly what we do ..... its very 
important that our CEO has the right information,  not being 
distorted by somebody else in between and I think that’s 
probably one of his strengths to recognise that and make sure 
that he has the correct source of information, that’s very 
important...’ 
 
The fact that this R&D executive argues that he/she should make sure that his/her CEO 
receives the right information is a source of trust between both. Therefore, in this case, 
the CSO has no issues with his/her CEO double-checking the information, as this double-
checking already took place by RDE9 in an attempt by the CSO to build trust between 
him/her and the CEO. If the information were not correct this could potentially lead to 
a trust fracture between the two actors. It must be emphasized that this CSO was a 
recent hire by the CEO and the CSO obviously wants to make sure that this relationship 
is functioning properly from the start. In the case of RDE7, the CEO was hired by the 
board and pushed into the company to work with RDE7.   
 
When asked what the role of the CEO is in innovation, RDE11 argues that the CEO should 
offer freedom to explore new ideas under the leadership of the CEO:  
 
‘...the chance to have is coming with - sometimes crazy - ideas 
to the CEO and he/she tells me: ok just do it... of course there’s 
some questioning, of course he knows what it’s it about, it’s not 
like he’s taken by surprise but still: .... it’s something special and 
there’s really, there’s confidence and the freedom that I’ve been 
given where the CEO tells me just do it, let’s go that way, it’s a 
good idea, let’s do it!’ 
 
This trust - made explicit by the CEO offering freedom to invent and innovate - is also 
articulated by RDE12: 
 
‘I think certainly trust and belief in the team is very important’ 
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The concept of trust by the CEO in R&D is considered a condition sine qua none that - in 
the case of RDE14 - does not require too much discussion: 
 
‘I am trusted that is not the issue..’ and ‘trust is always 
important’ 
 
RDE15 , a senior vice president of a life science firm discusses how trust develops when 
firms change from small start-ups to larger firms: 
 
‘... I think our company is actually a very good case study ... 
when we were a small start up it was very good to have a very 
involved knowledgeable scientist as a CEO ... I think at that 
moment that was also quite necessary for the outward facing 
discussions but also for the inward facing discussions in a very 
young and less mature company... (on the other hand) we have 
now extended quite a bit ...  so I do fully understand the need 
for a different type of CEO that is more commercially oriented 
which has less R&D or life science experience but should trust 
us to kind of make the translation into what it can actually 
mean for the market and to make it a commercial success, so 
with this respect I don’t think its absolutely necessary that our 
current CEO has a lot of R&D experience or he should be a 
scientist but he should of course understand the market very 
well and understand what the R&D unit should together with 
R&D unit what would make the best sense for the company. 
 
The argument made by RDE15 is that in small firms, the CEO is generally knowledgeable 
in the science that is conducted in the firm and while the firm is growing the need 
appears to have a more commercially oriented CEO, who is less versed in the firm’s 
science and technology, but will then need to develop trust is in his scientific cadre. In 
other words, RDE15 argues that by having a less knowledgeable CEO, the higher the 
need for the trust level of the CEO in R&D. This links both the concept of knowledge to 
the concept of trust in that the less prior knowledge the CEO has, the less his/her 
absorptive capacity is, the more the knowledge will need to be reduced in complexity 
and the more trust the CEO will need to have in R&D that they are informing him/her 
correctly. In other words, there seems to be a relationship between absorptive capacity 
of the CEO and the trust he/she has in innovation.  
 
This concept of prior knowledge is also corroborated by RDE16 who argues that prior 
knowledge is helpful for the R&D executives, but entails some ‘risks’. On the one hand, 
prior knowledge of the CEO makes the challenging process and the decision making 
process more effective because a knowledgeable CEO is able to interact in a meaningful 
way with R&D. However: 
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‘... I think it is an advantage to have a scientific (CEO) but you 
need to be very careful that at the end of the day you have to 
make products and not only do the science ... so I think ...  it has 
an advantage because the bigger advantage about challenging 
and understanding, capturing the complexity so that you 
(RED16 refers to the CEO) know when you (the CEO) can take 
the right decision also from your (the CEO) own experience and 
not only because your people tell it-  I mean you have to trust 
your people no problem - but if you feel as a CEO self confident 
that this looks: ok we can go the next step...’ 
 
RDE16 argues that a scientific background of a CEO may prove to be useful but entails 
the risk of over-involvement - even meddling - with research and to deviate from the 
objective of the firm, a comment that was also raised by the CEOs during their 
interviews. RDE16 also refers to the fine balance between CEO challenge and CEO trust: 
 
‘... you need to strike that balance and as a CEO pushing is very 
important but also feeling ok I’ve reached a limit I feel that and 
I trust also my people when they say we cannot do this or I think 
we will then take a decision which is not ready then also listen 
to it and I think ...  if you strike that balance , I think you have a 
key for success and that’s an important one’ 
 
RDE16 also reverts the trust equation; not only should the CEO trust R&D , R&D 
executives should also be able to trust the CEO in his/her decisions with respect to where 
he/she wants to bring the firm: 
 
‘you (R&D) can only feel confident in the future and in the way 
your company is going if you can trust what he (the CEO) does 
.... you need to trust him/her ... ‘ 
 
RDE33 argues that trust and challenge should be in balance: 
 
 ‘I think it’s a mixture between challenging, challenging on a 
content side, certainly not in a deep scientific level but 
understanding what’s going on, on the other side a supporter so 
the balance I think between trust and challenge for me on the 
CEO level is absolutely essential because you can deconstruct any 
R&D organization if you ask the nasty questions, you just don’t 
always have answers and that’s where the trust part comes in’ 
 
RDE17 argues that trust is one of the key characteristics of a CEO who runs a life science 
R&D firm especially when the financial pressure become intense:  
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‘... I expect a very trusting relationship because there are 
inevitably times when he or she, the CEO is going to get pressure 
on finance ... so there needs to be a lot of trust and loyalty 
between those two (the CEO and the CSO) and that’s important 
because you just see it all the time that some VC’s have a 
different view on the science so the CEO might then say ok well 
… there’s got to be a lot of trust, there’s so many pressures 
coming externally on that relationship...’ 
 
RDE18 boldly puts trust at the same level of importance as vision for a life science R&D 
company: 
 
‘.... So ok vision is the first point, (but then again) just as 
leadership you need to build trust...’ 
 
RDE19 argues that a relationship of trust may be harmed when CEOs use too many 
consultants to double check his/her scientist’s arguments.  From the R&D executives 
point of view, a CEO who double-checks the claims made by his/her scientists is actually 
in the process of building trust in his R&D function while at the same time risking that 
the R&D function may perceive this as a sign of distrust: 
 
‘we see it (the CEO asking consultants to give their advice on the 
claims made by his scientists) as a matter of fact I would say 
building his trust; I don’t know what he thinks but the way I see 
it is that not being an expert in what we are doing he needs to 
get external input on whether things are being done properly, … 
our perception is maybe well he’s not really trusting us, we’re 
telling him something but he wants to hear it from someone else. 
That his purpose may very well just to understand better what 
we are doing but then on the other hand if he doesn’t understand 
he can always come and ask and get the information there, there 
are different ways...’ 
 
‘what I expect from him/her is trust in that we are putting 
together’ 
 
The concept of trust is also linked to the a priori concept of involvement and the 
deteriorated version of involvement: intervening in or meddling with the scientific 
activities of R&D. RDE20 argues that: 
‘the fact that ..(he/she).. will mingle with my scientists ... that 
would be for me a message that he doesn’t really trust what I do 
but then again its nice if he wants to be involved in the sense that 
he wants to be updated..’ 
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RDE20 again refers to the link between trust and knowledge and decision making as 
follows: 
 
‘... (the CEO) maybe a very clever person who knows its limits, but 
if you don’t understand the details then you have to trust the 
people who are giving you recommendations, if you’re clever and 
you have chosen your people properly and you trust them, even 
if you don’t understand it …’ 
 
The concept of trust is not always articulated explicitly but is also implied by the fact 
that CEOs offer the CSO the opportunity to explore novel principles that may make 
business sense. The fact that CEOs allow the R&D function to explore novel paths that 
have not been explored before is a clear sign of trust in his/her scientists. As stated by 
RDE21: 
 
‘I think it’s very important that my CEO gives me the opportunity 
to explore novel principles, novel applications of (name of 
chemical substances) but always keeping in mind what is 
relevant for the business, meaning that I’m not wasting an awful 
lot of money, resources...’ 
 
This CSO also balances trust versus prior knowledge, in that he/she argues that it is 
advisable to have a CEO who is knowledgeable about the scientific principles that govern 
the firm’s R&D and the R&D knowledge that is generated in the firm.  Such prior 
knowledge prevents the need for ‘trust’ between both actors because their interaction 
is based on the exchange of verifiable and challengeable data . In this case a relationship 
based on trust – although valuable in its own right, but which may be misused or 
disappear– is not required.  In other words, because trust is such a delicate concept, it 
is better to replace trust by data checking: 
 
‘I’ve seen other CEO’s in my previous life who didn’t know the 
science so well and I think that is a limitation, if such persons 
completely have to trust their CSO … I think that makes such a 
person (the CEO) fully dependent on others and also he/she 
cannot have a good judgement on things which are happening in 
the company …’ 
 
From this perspective the statement made by the CEO2P of the second pilot firm and 
who is not knowledgeable at all about the science taking place in his/her firm speaks 
volumes:  
 
 ‘I hope that my CSO is not deliberately misleading me’ 
 
In other words, although a relationship of trust seems to be worthwhile, it is not 
necessarily the optimal situation because scientists prefer a CEO who is knowledgeable 
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about the science but also about the business and the market. Therefore, as argued by 
the R&D scientists during these interviews, a combination of a top scientist with the 
personality and business acumen of a top business man/women is considered the ideal 
CEO of a life science R&D firm. It is acknowledged that this constitutes a rare breed of 
CEOs because it combines two characteristics that are considered contradictory: the 
outgoing character of a business executive with the inward looking attitude of a 
scientist.  On the one hand, if the knowledge base of both actors is similar, trust as the 
basis of the relationship can be replaced by a verifiable data exchange. On the other 
hand, if the knowledge base differs substantially, the complementarity of knowledge 
becomes increasingly important such that both actors learn from each other, but there 
will be a strong bond of trust if the relationship is successful. 
 
As argued by RDE21 when discussing the knowledge gap with the CEO: 
 
‘What is the gap? I’ve been in (name of scientific discipline) for 
so many years, so when we started four years ago we made 
(name of chemical substances) which were good against (name 
of disease area) and you really need a very high affinity, a high 
strength and the antibodies which we have are ok but they 
should be better if we really look at the competition.  It was 
important to improve on that, then I can say something I know 
that matters and the CEO doesn’t know, that is a gap in 
knowledge, is that essential? Not at all because he really trusts 
me...’ 
 
When asked about the role of the CEO in innovation, RDE24 refers to the balance 
between the challenge by the CEO - for which knowledge is required - and trust by the 
CEO:  
 
‘… I think his role should be a supportive role, a role in which he,  
first of all trusts his employees involved in research and 
development in what they are doing but at the same time be 
critical to what they do, I mean it comes from both sides a 
respectful lets say relationship so to speak, professional 
relationship in which there is trust but at the same time there’s 
also room to challenge each other, I think that this is important 
to really push, push is perhaps not the right word but to foster a 
healthy environment, I think that is a very important aspect. 
 
Knowledge generated in a life science R&D firm can be divided in two fractions: 
knowledge that the CEO is able to challenge because of prior knowledge available 
through education or experience and knowledge conferred to him by his/her R&D 
scientists that he is unable challenge because of lack of knowledge and for which he/she 
needs trust to handle it. RDE24 remarks that the trust from CEO in the R&D function, is 
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only one part of the equation: there is also the need of trust by R&D scientists in their 
CEO: 
 
‘Well how do you define it? … at least the way I see it is that 
within an organization like ours you have some sort of 
relationship with each other from a professional point of course 
and in any relationship there should be trust -  I mean by  trust: 
this person is really here for the benefit, he’s really not working 
much on agenda but really to make the company better...  that 
you do not set up your own interest … sometimes it happens that 
the CEO  says something to me and I’m really bothered by that, 
I’m actually angry but then I always try to understand because I 
trust the CEO,  because if I wouldn’t trust the CEO then probably 
I wouldn’t work here anymore ....’ 
 
RDE24, RDE25 and RDE26 consider the bidirectional aspect of trust (CEO trusts R&D and 
R&D trusts CEO) as a condition sine qua non: 
 
‘... for everybody within the company equally important that they 
can trust not only scientists but also of course each other and not 
only the CEO but each other but of course I mean if there was 
doubt in my scientific capabilities then of course then I trust that 
he would tell me that ‘he can only sell the data when he really 
hopes and believes  ... there’s an effort to understand the data 
but of course there’s always the trust that what I deliver to him 
is of course correct at least to the best of my knowledge’ 
 
RDE25 considers trust as one of the key aspects of his/her relationship with the CEO. 
According to RDE25, trust is bidirectional in that: 
 
‘It’s two-way, he/she trusts you because of your science and you 
trust him/her because of his/her knowledge of the market. In 
addition, I can trust him/her because I can just show the ideas 
you have, you know that he/she trusts me’ 
 
The bidirectional aspect of trust is also corroborated by RDE26: 
 
‘I think he/she has to give the trust to the CSO and his team and 
the scientists in his/her team go for it ... (but) ... I think that’s 
important that we also can trust the leadership by the CEO and 
that we don’t have to be afraid of the CEO to discuss ideas openly 
and that its very, that everything can be discussed very openly 
without any wrong feelings I think that’s very important’  
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‘...that the CEO has to give you the time and the trust to discuss 
scientific findings and topics on your way and I think that’s 
important’  
 
‘....I think he really has to give the trust towards the people on 
the floor, to give the people the opportunity to learn and to 
achieve their objectives and to think together in a team how to 
reach …’ 
 
RDE33 also discusses this bi-directional aspect of trust: 
 
‘I think this is getting to – what I said at the beginning was that 
the very difficult balance between challenge and trust so just 
enough challenge to trigger the conscience in the R&D 
organization that we constantly need to challenge ourselves,  but 
not challenge to the point where it disrupts R&D and innovation, 
innovative activities that’s what I mean really, so its really the 
trust of the CEO into the R&D organization but autonomous 
sounds like leave it alone it’s a black box, that’s not what I mean 
and yes it also works the other way around there needs to be 
trust from the R&D side into the CEO that there is a sustainability 
in the approach to innovation …’ 
 
RDE36 argues that a CEO must be: 
 
‘an absolutely trustworthy person and has a cool way of handling 
if there’s some hick-up in one of the programs and people get a 
bit nervous that they see that the CEO is sort of, has things under 
control and that there’s no reason for panic’ 
 
The CEO should also trust the R&D function to increase its output.  As RDE24 
argues: 
 
‘Well sometimes he thinks along in that way although he also 
then in a way trusts that we already …’ 
 
RDE26 continues on trust versus bonus and financial rewards: 
 
‘… at least what I know, but compared to financial or salary or 
bonuses I think at this moment for me that’s less important than 
trust and maybe after trust I think for me at least learning 
because at this moment ok I’m still young and I know I still have 
to learn a lot so first thing for me is ok trust, he trusts you in what 
you are doing so it gives me the opportunity to work in a team, 
in a company to learn’  
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and on trust and freedom: 
 
‘Yes he has to give you the freedom, he has to be involved in the 
discussions but he has to give you the freedom to operate and 
again to openly discuss and to do what you are thinking that’s 
what’s right so I think its also important for the CEO to do that …’ 
 
According to RDE27 the concept of trust is also linked to credibility as follows: when 
trust is developed between two actors, the exchange of information is based on the trust 
that one of the actors has with regard to the other actor. It should be stated here that 
the CEO of this company has no scientific degree at all and succeeded a CEO with a 
considerable scientific background. The concept of trust therefore plays to it’s full 
extent: 
 
‘my current CEO has an extremely developed analytical brain, 
immediately listens very carefully and so it becomes extremely 
critical... you have to make sure that people start to believe what 
you’re saying, build credibility, so the communication between 
me and him/her now is more based on credibility …’ 
 
The absence of in depth knowledge forces the CEO to check and double check, in order 
to make sure that the trust can be build between him/her and the R&D function: 
 
‘…he needs to know if he’s in quick sand or if solid ground so I 
would think that more gradually as he gets to know the people 
better then he’s going to depend more on people but now I think 
it’s the best thing he can do is double check and double check ‘ 
 
When asked what is important for him as a senior scientist vis-a-vis the CEO, RDE27 
comments: 
  
‘Well trust is of course number one, I don’t expect a CEO to be 
always completely open and the other way around I mean people 
have certain responsibilities and I think the word responsibility 
means that it’s your thing, you collect all the information you 
need to execute that responsibility when you do it and if it fails 
then you’ll figure it out later, so I don’t want him to inform me 
about everything, so openness is not the most important, trust, 
trust is more important because if you’re open it means that you 
know you do everything together and with trust you can go and 
do your own thing and be more efficient’ 
 
On the relationship between openness and trust RDE30 comments as follows: 
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‘Most important between trust and openness I would categorise 
them at an equal level, I think first to develop some trust but trust 
you can build very quickly if you know that you can talk openly to 
each other so it’s a little bit the chicken and the egg situation.’ 
 
The trust equation is not unidirectional but bifocal in that the R&D function believes in 
the CEO. RDE33’s comment that the ‘trust’ part comes in when the answers are not 
coming in’  indicates, that trust and knowledge are intrinsically linked and more so if the 
knowledge levels between two actors start to differ substantially.  In addition: 
 
‘What I meant primarily was the trust into the R&D organization 
is that they’re doing the right things because I don’t think as a 
CEO you can micro manage an R&D organization and you have 
that patience and trust go together...’ 
 
RDE34 explores the concept of trust from 3 different angles. First, the financial angle: 
 
‘....trust means that the money, the company the corporation 
puts into this is believed that’s worth to be spent.’ 
 
Then, from the long term commitment: 
 
R&D is nothing which you can very much titrate up and down, 
you can do it on a minor scale but you cannot ramp it up like hell, 
double the investment within one year and then drop it the next 
year because we have long term commitments with external 
partners and so on, so trust in this respect means we need a long 
term perspective that’s dependent on the growth from the 
company and that we maintain a stable investment, this is for 
me the trust, ...’ 
 
and from the impact at all levels: 
 
‘its becoming very much from bottom up:  scientists are reading 
papers, they are visiting conferences and the environment needs 
to be there to be open and trustful that they can bring their 
innovations to a kind of lets say auditorium’’...’ 
 
‘the more you can trust the more you can challenge’ 
 
 
KNOWLEDGE COMPLEXITY REDUCTION 
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Because of the similarity in degree of emergence of the concept of complexity reduction 
in the interviews of CEO and R&D executives, it was decided to continue the interview 
analysis and observations for complexity reduction. 
 
RDE8 is the senior director of the company where RDE7 is the chief scientific officer. 
He/she has a more balanced view of the role of the CEO vs the role of the CSO. In his/her 
opinion, it would be difficult to accept that a CEO would rely completely on the advice 
of an academically oriented CSO and should look for outside and independent advisers 
in order to obtain a balanced view of what is being conducted in his/her firm and it is 
the CEO who should have the final word even in R&D, an argument that would not be 
readily supported by the CSO. However, the CEO should be a good communicator and a 
good listener such that he can differentiates between the academic value of the 
scientific proposition and the commercial value.  Therefore, in view of the CEO’s 
expertise, he/she argues that: 
 
 ‘He does not need to know the ins and outs of the detailed 
science and that is one of the dangers is that when you talk to 
an academic (chief scientific officer) , he/she will fill you in with 
facts that are not crucial...’ 
 
and therefore the CEO 
 
‘should be able to cope with the academic pressures’ and  
‘should be able to see the value of science and how to achieve 
that value’ 
 
According to RDE8, a CEO can only focus on the essentials of the R&D message if he/she 
is not drawn into the details of science but receives a scientific message that is reduced 
in complexity: 
 
‘I don’t regard simplification as sort of a patronising thing, to 
simplify the science is not something you do to patronise people 
who don’t understand science, ...  to simplify science and its 
objectives is a key commercial art anyway because you know 
what’s key at the end of it is still down to the objectives, the 
value, the time it takes to get there’ 
 
and: 
 
‘… he/she (the CEO) does not want the details of the science. He 
/she wants the basics and when it gives the answers, this is 
sufficient for him/her to run the company and the innovation’ 
 
The concept of complexity reduction that is described above and which was identified 
during the CEO interviews, is raised here by a member of the R&D function and 
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considered a useful approach. It should be emphasized here that RDE8 was appointed 
by the CEO to assist him/her in addressing his/her questions that was the result of the 
absence of any scientific background of the CEO and to assist him in making the ‘de-
complexification’ step and to extract from the knowledge the core message that is 
required to allow a challenge to take place and to make decisions.  
 
According to RDE9, the data transmitted to the CEO requires a simplification step in an 
attempt for the CEO to understand the data: 
 
‘... sometimes we need to simplify a lot because we want to 
bring something into the playing field ... then we need to 
simplify a lot but he’s always asking what did we do, in fact so 
he wants to know what we are simplifying, so we cannot just 
tell him that it works in exactly the same way, an animal cell 
compared to a plant cell, we can tell him the mechanism is the 
same but the individual steps are different and then he wants 
to know how different are they, how difficult it would be to try 
to even something directly, how long would it take, what this 
team needs to discover before it can be – so he wants to know, 
we have to simplify a lot that’s sure but I think its linked to the 
time we have with him but in some cases he has the details and 
he can add another hour to a meeting that’s fine, if he needs it 
we do that, he wants the facts I think all the time’ 
 
A simplification step however is not always without risk according to RDE11: 
 
‘...  there could be a risk (that simplification leads to the wrong 
decision)  but I think the responsibility would lie with me to 
make sure that the CEO has understood the story ... and then 
the simplification is more to make the topic more accessible to 
the other people especially for example the finance people who 
are actually going to put the money on the table, they want to 
know what they’re going to get back for it...’. 
 
However the simplification also entails a les scientific rationale of the topic and a more 
financial operational driven simplification: 
 
‘Well I guess you know the answer right so its less and less 
scientific, its more and more simplified and more and more 
based on timelines and deliverables so it starts by … at least it 
starts really the concept and the background, the story behind 
and then after that it gets into practical steps, how many FTE’s, 
how long will it take, how much work cost and the higher up 
you get the less its scientific’ 
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The concept of reducing the complexity of the R&D knowledge is considered a 
responsibility of R&D executive RDE12 in order to make sure that the CEO is capable to 
absorb the new knowledge: 
 
‘it’s more a responsibility that you have to tell your story to the 
management team you have to make sure that they understand 
this, ....  you have to translate the project and this takes a lot of 
my time because it’s not my core activity ... what I have to make 
sure is that I first do the basic scientific checks on the project 
before presenting it ...  it’s a responsibility that I should not 
forget doing ‘ 
 
RDE14 argues that the complexity reduction step is not only an exercise conducted to 
inform the CEO and make sure he/she understands the message. In addition to ‘teach’ 
the CEO about the R&D know-how the complexity reduction step allows the R&D 
executive to focus on the message and the objectives of his/her research. This is linked 
to the concern of CEOs that research in their companies may become too much 
academically oriented or for the sake of technology: 
 
‘... you need to reduce it in its complexity in order for them to 
grasp it quickly, it helps a lot because it focuses also the thinking 
about your own issues ...  I don’t see this as an issue, I have to 
be able to explain this to my wife for example’ 
 
The argument that the science should be transformed to a level that the R&D executives’ 
wife is able to understand’ is analogous to the comments made by CEO5 that he should 
be able to explain ‘the data to his son’. In this context, the complexity reduction of R&D 
knowledge is both advantageous for the CEO in that it allows him/her to absorb the 
knowledge, thereby modifying the knowledge or requiring the knowledge to be 
modified to a level that is aligned with his/her absorptive capacity while at the same 
time allowing the R&D executive, while doing this exercise, to critically assess the value 
of the knowledge and its potential for the firm.  
 
When referring to the major role of the CEO in innovation, RDE15 argues that it is the 
CEOs capability to  
 
‘...recognise the value of the technology and research that we 
basically supply and hopefully continue and to translate that 
together with other people into a commercially viable success 
for the company so that means recognising... the short term 
and the long term value of the R&D that we do and how that 
translates into a product that is very attractive for our potential 
customers’ 
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In order for the CEO to be able to value knowledge – as part of his/her absorptive 
capability– it is important for R&D executives ‘gauge’ the absorptive capacity of the CEO:  
 
‘what we try to do is basically try to understand what level he 
has and bring the main messages at that level and fill them in 
with the science connections because of course he is a PhD and 
therefore he is very well versed in (scientific discipline) so that 
already helps the fact that we can go to a certain depth, we 
don’t have to really drill it down ‘ 
 
This exercise of R&D executives to assess the level of scientific knowledge of the CEO 
and then fine- tune the R&D knowledge to a level that the CEO is capable to evaluate it 
(and eventually to assimilate and exploit it) supports the previous argument that the 
complexity reduction step is titrated to the CEO’s absorptive capacity. The capability of 
a CEO to absorb new knowledge, a constituent of the overall absorptive capacity of the 
firm, is driven by his/her previous knowledge and – in case the level of such previous 
level of knowledge is limited – will require the modification of knowledge to such a level 
of complexity that the CEO is capable to absorb it. What is observed here is the creation 
of equilibrium between two actors with differing levels of knowledge. The objective of 
the complexity reduction is also, according to RDE16, to make clear the goals of the 
knowledge and why it was generated in the first place: 
 
‘...the most important one is if you do an experiment there is a 
certain goal in the experiment so I think the presentation of the 
results should be in the context of why did we do this 
experiment, for what was it intended to be used and so what 
are the results telling us in the big context so the presentation 
is a reductive presentation but it has a certain goal it is really 
what we wanted to do is that because we wanted to go there...’ 
 
RDE17 is a chief scientist led by a CEO with a strong scientific curriculum and extensive 
experience in life science R&D firms. His relationship with the CEO is such that there is 
no need for complexity reduction because: 
 
‘... in this case with the current CEO I can talk on the same level 
because he has a scientific background and he understands, 
because I think he performed the role that I do now himself for 
12 months before he recruited a CSO, so I can talk to him very 
knowledgeably on the same level, I don’t have to modify how I 
talk’ 
 
RDE18, a colleague R&D senior scientist of RDE17 and working under the same CEO 
leadership, also argues that a complexity reduction is not a good approach because it 
may lead to the wrong decisions.  
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‘No, I don’t think that it should be a good idea because before 
you are –either- able to manage a pharma company or not, you 
know ...  you need some basic knowledge of drug development 
and this knowledge is crucial and its part of knowledge which you 
should know, if you want to be, to stand in front of any audience 
which are only be all the CEO’s you need that… because it could 
lead to wrong decisions, it could if there is a strong 
misconception …’ 
 
RDE20 argues that a de-complexification step is not only required for the CEO to 
understand but to make sure that the R&D knowledge is presented such that  the CEO  
is not confused: 
 
‘I simplify the message for him to understand and not necessarily 
because he doesn’t understand, I think in particular in my area 
he’s quite confident but just because I see him once a month and 
if I bother him with the latest analytical problem he will get 
confused’ 
 
RDE21 also refers to the complexity reduction step as one of the steps required to do 
the ‘selling story’ and the use of the simplified message to attract new capital, new 
collaborators, new investors. This was also argued by RDE7 and by CEO1. In addition, 
RDE21 finds his/her CEO to be capable to the reduction exercise him/herself in order to 
do the story-telling: 
 
‘No I think that is the art of the job also the CEO masters very 
well..’ 
 
RDE23 adapts the R&D knowledge to the level of the CEO thereby reducing the 
complexity to a level that he/she gauges to be present in the CEO. As was stated above 
the CSO tries to find a common platform on which the science data can be placed such 
that both scientists and non-scientists can discuss the data:  
 
‘... I would try to adapt to the person and depending if it would 
be a financial guy you would use more financial data at the end 
of the day you would say look that we could make a business plan 
-  I always say to my people here also if you go to a meeting you 
have to know who’s there... ‘ 
 
When inquiring about the concept of knowledge complexity reduction, the RDE24 
responds: 
 
‘I do simplify the message but not that’s incorrect to leave out 
unnecessary details, I do that yes unless he asks more specific 
and then I explain in more detail. I speak in a different way with 
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him such that the knowledge becomes absorbable and speak 
with him other than I do with my team’  
 
In view of the knowledge transfer from R&D to CEO, RDE27 argues that the ‘language of 
R&D’ should be transformed such that the content matches the absorptive capabilities 
of the CEO: 
 
…‘the language (used in the communication of R&D knowledge 
between the R&D function and the CEO) has to match that of the 
understanding of the CEO’ 
 
RDE27 has experienced two very different CEOs, the first CEO was a top-level scientist 
while the CEO who succeeded him/her is a finance trained CEO. RDE27 comments: 
 
‘I think the difference between the two CEO’s I needed perhaps a 
lot fewer words to explain what I was doing to the first one, I 
could have explained it in five minutes’ 
 
The message that is communicated to the current CEO should be simplified in order for 
the CEO to become motivated according to RDE28 (a colleague of RDE27): 
 
…‘when the scientific team drive the innovation I think they need 
to be able to simplify and to be able to explain and let’s say 
motivate the CEO to go after it...’ 
 
On the transformation that R&D knowledge undergoes during the communication to 
the CEO, RDE31 comments that: 
 
‘… I (the CSO) have not so much detailed knowledge... the more 
and more you go through the upper regions in a firm you need to 
get more and more abstract...The complexity of R&D knowledge 
is reduced tremendously. It is also risky to convey detailed 
knowledge to the CEO... it could be disastrous for the company...’ 
 
Transforming R&D data for communication also learns the R&D function to think about 
the business context of their activities. According to RDE33: 
 
‘the data from R&D are being transformed, or modified such that 
it becomes open to challenge, the challenge is to simplify data, 
actually learn R&D, it is the coaching R&D to become a business 
organization, its for me a vital part of what’s happening. 
 
The exchange of knowledge between CEO and R&D is a learning activity that goes both 
ways by which knowledge is ‘titrated’ to find a common ground: 
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‘....we titrated ourselves or each other really to a middle ground 
where we can talk about value and risk but still having a tie to 
the actual project that also the R&D colleagues could support...’ 
 
and  
 
‘the simplification process is also a very valuable process for both 
parties to learn from each other’ 
 
On the topic of complexity reduction, RDE33 comments that if the data would not be 
de-complexified,  it would paralyze the R&D function: 
 
‘by putting too much emphasis to the technical detail you may 
oversee the big picture. A clear answer from my side : if you do 
not simplify, it’s a nightmare and then you can imagine how to 
prepare for such kind of a meeting, this is the next and you will 
completely eliminate lets say the driving force in the team 
because they are focusing what may happen if he’s asking for 
this, are we prepared, do we have backup for this and that, then 
we are not focusing on the progress but on the status quo of the 
project’ 
 
In a way, it also educates the R&D function: 
 
‘So in fact the whole exercise of between transforming the 
research data into a simplified form is not to bridge the gap 
with the absent knowledge in science of the CEO but to make it 
available for challenge... 
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